610 Medizin und Gesundheit
Refine
Year of publication
Document Type
- Journal article (3837)
- Doctoral Thesis (3675)
- Conference Proceeding (33)
- Book article / Book chapter (18)
- Preprint (14)
- Review (9)
- Report (8)
- Book (7)
- Other (7)
- Master Thesis (2)
Language
- English (4158)
- German (3452)
- Multiple languages (1)
Keywords
- Toxikologie (119)
- Medizin (102)
- inflammation (87)
- apoptosis (64)
- depression (61)
- Herzinsuffizienz (56)
- cancer (55)
- therapy (52)
- COVID-19 (51)
- MRI (49)
- children (45)
- multiple myeloma (45)
- Neurobiologie (44)
- gene expression (44)
- HIV (43)
- Diabetes mellitus (42)
- Depression (41)
- Herzinfarkt (41)
- Lebensqualität (41)
- myocardial infarction (40)
- PET (39)
- breast cancer (39)
- cytokines (39)
- Apoptosis (38)
- heart failure (38)
- ADHD (36)
- Maus (36)
- expression (36)
- multiple sclerosis (36)
- oxidative stress (36)
- prostate cancer (36)
- Virologie (35)
- ischemic stroke (35)
- Schizophrenie (34)
- T cells (33)
- infection (33)
- stroke (33)
- Immunologie (32)
- Tissue Engineering (32)
- quality of life (32)
- Chirurgie (31)
- NMR-Tomographie (31)
- SARS-CoV-2 (31)
- biomarker (31)
- Strahlentherapie (30)
- machine learning (29)
- Entzündung (28)
- Neisseria meningitidis (28)
- Therapie (28)
- Zellkultur (28)
- immunotherapy (28)
- macrophages (28)
- magnetic resonance imaging (28)
- mice (28)
- Brustkrebs (27)
- Schlaganfall (27)
- melanoma (27)
- prognosis (27)
- Apoptose (26)
- DNA damage (26)
- Endothel (26)
- Positronen-Emissions-Tomografie (26)
- Signaltransduktion (26)
- positron emission tomography (26)
- CXCR4 (25)
- MRT (25)
- Multiple Sklerose (25)
- anxiety (25)
- B cells (24)
- Dendritische Zelle (24)
- Immuntherapie (24)
- Ratte (24)
- heart (24)
- mortality (24)
- mouse (24)
- obesity (24)
- pain (24)
- radiotherapy (24)
- tissue engineering (24)
- Rezidiv (23)
- Serotonin (23)
- dendritic cells (23)
- medicine (23)
- platelets (23)
- rat (23)
- Arteriosklerose (22)
- Fabry disease (22)
- Kinder (22)
- Krebs <Medizin> (22)
- Melanom (22)
- Myokardinfarkt (22)
- Plasmozytom (22)
- T-Lymphozyt (22)
- chronic kidney disease (22)
- diagnosis (22)
- in vitro (22)
- neuroinflammation (22)
- schizophrenia (22)
- survival (22)
- Aspergillus fumigatus (21)
- Schmerz (21)
- adrenocortical carcinoma (21)
- brain (21)
- gene (21)
- immunohistochemistry (21)
- neuropathic pain (21)
- surgery (21)
- Adipositas (20)
- Biomarker (20)
- Escherichia coli (20)
- Zytokine (20)
- atherosclerosis (20)
- genetics (20)
- metabolism (20)
- recurrence (20)
- regulatory T cells (20)
- signal transduction (20)
- 3D printing (19)
- DNA methylation (19)
- Fettsucht (19)
- Herz (19)
- Oxidativer Stress (19)
- Parkinson’s disease (19)
- Proliferation (19)
- Tumor (19)
- bone (19)
- microRNA (19)
- Blut-Hirn-Schranke (18)
- Candida albicans (18)
- Kernspintomografie (18)
- Stickstoffmonoxid (18)
- Thrombozyt (18)
- aging (18)
- echocardiography (18)
- endothelial cells (18)
- hippocampus (18)
- stem cells (18)
- ADHS (17)
- Angst (17)
- Calcium (17)
- EEG (17)
- Glaukom (17)
- Knochenzement (17)
- Palliativmedizin (17)
- Parkinson's disease (17)
- Sprachentwicklung (17)
- Tiermodell (17)
- activation (17)
- blood (17)
- blood-brain barrier (17)
- deep brain stimulation (17)
- diabetes (17)
- human (17)
- identification (17)
- lymphoma (17)
- mouse model (17)
- osteoporosis (17)
- physical activity (17)
- proliferation (17)
- serotonin (17)
- theranostics (17)
- BDNF (16)
- Dickdarmkrebs (16)
- Expression (16)
- Germany (16)
- Immunsystem (16)
- Inflammation (16)
- Makrophage (16)
- Multiples Myelom (16)
- Polymorphismus (16)
- blood pressure (16)
- chemotherapy (16)
- colorectal cancer (16)
- follow-up (16)
- mitochondria (16)
- outcome (16)
- pregnancy (16)
- risk factors (16)
- sepsis (16)
- 3D-Druck (15)
- Antikörper (15)
- Autoantikörper (15)
- Chemotherapie (15)
- EAE (15)
- Genexpression (15)
- Osteoporose (15)
- Parkinson-Krankheit (15)
- Staphylococcus aureus (15)
- diabetes mellitus (15)
- disease (15)
- epidemiology (15)
- extracellular matrix (15)
- flow cytometry (15)
- immune response (15)
- ischemia (15)
- mental health (15)
- mouse models (15)
- toxicity (15)
- transplantation (15)
- treatment (15)
- Atherosklerose (14)
- Aufmerksamkeits-Defizit-Syndrom (14)
- Cancer (14)
- Fabry-Krankheit (14)
- Heart failure (14)
- Kollagen (14)
- Maligne Hyperthermie (14)
- PET/CT (14)
- Plattenepithelcarcinom (14)
- Prostatakarzinom (14)
- Prostatakrebs (14)
- Remodeling (14)
- SPECT (14)
- Würzburg (14)
- autophagy (14)
- calcium (14)
- classification (14)
- deep learning (14)
- differentiation (14)
- escherichia coli (14)
- mesenchymal stem cells (14)
- miRNA (14)
- monocytes (14)
- neuroprotection (14)
- prevalence (14)
- resistance (14)
- transcriptome (14)
- ARDS (13)
- Angiogenese (13)
- Cytokine (13)
- DNA (13)
- Elektrophysiologie (13)
- Glioblastom (13)
- HNSCC (13)
- Herzmuskel (13)
- Immunsuppression (13)
- Kolonkarzinom (13)
- Mausmodell (13)
- Medicine (13)
- Merkel cell carcinoma (13)
- NFATc1 (13)
- Polymerase-Kettenreaktion (13)
- Pädiatrie (13)
- Rehabilitation (13)
- Stammzelle (13)
- TNF (13)
- Ultraschall (13)
- angiogenesis (13)
- cardiomyopathy (13)
- exercise (13)
- fNIRS (13)
- genotoxicity (13)
- glaucoma (13)
- guidelines (13)
- hemodialysis (13)
- metastasis (13)
- migration (13)
- phosphorylation (13)
- preterm infants (13)
- protein (13)
- tumor (13)
- Autoimmunität (12)
- BMP (12)
- Bestrahlung (12)
- Chronische Herzinsuffizienz (12)
- Diabetes (12)
- Diagnostik (12)
- Dialyse (12)
- Entwicklung (12)
- Gehirn (12)
- Hippocampus (12)
- Hämodialyse (12)
- Immunmodulation (12)
- Ischämie (12)
- Kind (12)
- Komposit (12)
- MRSA (12)
- Niere (12)
- PSMA (12)
- Polyneuropathie (12)
- Prognose (12)
- Real time quantitative PCR (12)
- Rotatorenmanschette (12)
- Screening (12)
- Sepsis (12)
- T-Zellen (12)
- antibodies (12)
- autoantibodies (12)
- biomarkers (12)
- blood–brain barrier (12)
- cAMP (12)
- cell staining (12)
- cells (12)
- colorectal carcinoma (12)
- fibrosis (12)
- glioblastoma (12)
- kidney (12)
- micronuclei (12)
- neurodegeneration (12)
- nitric oxide (12)
- receptor (12)
- rehabilitation (12)
- transcription factors (12)
- virulence (12)
- Überleben (12)
- DNA repair (11)
- Elektroencephalogramm (11)
- Genetik (11)
- Herzhypertrophie (11)
- Immunbiologie (11)
- Infektion (11)
- Insulin (11)
- Komplikationen (11)
- Koronare Herzkrankheit (11)
- Lippen-Kiefer-Gaumenspalte (11)
- Makrophagen (11)
- NK cells (11)
- Onkologie (11)
- Osteoinduktion (11)
- PRRT (11)
- Rheumatoide Arthritis (11)
- Risikofaktor (11)
- Schultergelenk (11)
- Schwangerschaft (11)
- Stammzelltransplantation (11)
- TRAIL (11)
- Transkriptionsfaktor (11)
- Transplantation (11)
- additive manufacturing (11)
- adolescents (11)
- artificial intelligence (11)
- asthma (11)
- autoimmunity (11)
- cartilage (11)
- cell death (11)
- cochlear implant (11)
- complications (11)
- dementia (11)
- development (11)
- endothelium (11)
- evolution (11)
- head and neck cancer (11)
- hypertension (11)
- hypoxia (11)
- immunosuppression (11)
- lymphocytes (11)
- mRNA (11)
- malignant hyperthermia (11)
- miRNS (11)
- neutrophils (11)
- p53 (11)
- pancreatic cancer (11)
- prediction (11)
- prefrontal cortex (11)
- prevention (11)
- relapse (11)
- rheumatoid arthritis (11)
- stress (11)
- therapeutic drug monitoring (11)
- tinnitus (11)
- total knee arthroplasty (11)
- trabeculectomy (11)
- vitamin D (11)
- Anorexia nervosa (10)
- Aspergillus (10)
- BERA (10)
- Biologie (10)
- Chemokine (10)
- Chronische Niereninsuffizienz (10)
- Colonkrebs (10)
- Comet Assay (10)
- HIV-Infektion (10)
- HSM-Satztest (10)
- Herzfrequenzvariabilität (10)
- Hypertonie (10)
- Immunhistochemie (10)
- Knochenersatz (10)
- LASP1 (10)
- MSC (10)
- MYC (10)
- NIRS (10)
- Nebenniere (10)
- Osteoarthritis (10)
- Polytrauma (10)
- Radiotherapy (10)
- Reperfusion (10)
- Risikofaktoren (10)
- Simulation (10)
- T-cells (10)
- Transplantat-Wirt-Reaktion (10)
- Tumor-Nekrose-Faktor <alpha> (10)
- Wundheilung (10)
- active zone (10)
- age (10)
- atrial fibrillation (10)
- bipolar disorder (10)
- case report (10)
- chemokines (10)
- cytokine (10)
- dosimetry (10)
- eNOS (10)
- epigenetics (10)
- fracture (10)
- glycine receptor (10)
- imaging (10)
- in-vitro (10)
- inhibition (10)
- lung cancer (10)
- management (10)
- microglia (10)
- molecular imaging (10)
- neuroendocrine tumor (10)
- neurology (10)
- oncology (10)
- osteoarthritis (10)
- periodontitis (10)
- polymorphism (10)
- rats (10)
- systematic review (10)
- tumor microenvironment (10)
- ultrasound (10)
- vertigo (10)
- AIDS (9)
- Activation (9)
- Adenosine receptors (9)
- Adenosinrezeptor (9)
- Aortenstenose (9)
- Arbeitsgedächtnis (9)
- B-Zell-Lymphom (9)
- Biomechanik (9)
- Butyrat (9)
- Calciumphosphat (9)
- Children (9)
- Cochlear-Implantat (9)
- Computertomographie (9)
- DNS-Reparatur (9)
- Echokardiographie (9)
- Fibrose (9)
- Fragebogen (9)
- Immuncytochemie (9)
- Immunreaktion (9)
- Implantat (9)
- Inhibition (9)
- MS (9)
- Magnetresonanztomographie (9)
- Masernvirus (9)
- Mikrokerne (9)
- Myc (9)
- NFAT (9)
- NIR-Spektroskopie (9)
- Nierentransplantation (9)
- Parodontitis (9)
- Prävention (9)
- Rituximab (9)
- SNP (9)
- Schilddrüse (9)
- Schizophrenia (9)
- Schlafapnoe (9)
- Schwindel (9)
- Schädel-Hirn-Trauma (9)
- Sprachverstehen (9)
- Sterblichkeit (9)
- VASP (9)
- VEGF (9)
- Zellzyklus (9)
- allergy (9)
- animal model (9)
- antibody (9)
- association (9)
- bacteria (9)
- cardiac hypertrophy (9)
- cerebrospinal fluid (9)
- chronic heart failure (9)
- coronary artery disease (9)
- cytotoxicity (9)
- diet (9)
- dopamine (9)
- epithelial cells (9)
- glioblastoma multiforme (9)
- humans (9)
- immunology (9)
- immunomodulation (9)
- in vivo (9)
- incidence (9)
- insulin (9)
- knockout (9)
- liver (9)
- mechanisms (9)
- melt electrowriting (9)
- messenger RNA (9)
- mutation (9)
- mutations (9)
- neuropathy (9)
- ovarian cancer (9)
- prognostic factors (9)
- proteins (9)
- reactive oxygen species (9)
- rectal cancer (9)
- remodeling (9)
- risk (9)
- safety (9)
- thrombosis (9)
- tight junctions (9)
- traumatic brain injury (9)
- working memory (9)
- Allergie (8)
- Alter (8)
- Alzheimer’s disease (8)
- Angiotensin II (8)
- Arthroskopie (8)
- Atherosclerosis (8)
- BMP-2 (8)
- Blutdruck (8)
- CRISPR/Cas-Methode (8)
- Candida (8)
- DLBCL (8)
- DNS-Schädigung (8)
- Differenzierung (8)
- Durchflusscytometrie (8)
- Epidemiologie (8)
- Ernährung (8)
- Frühgeborene (8)
- Herzchirurgie (8)
- Herzmuskelkrankheit (8)
- Hirntumor (8)
- Immunotherapy (8)
- In vitro (8)
- Kieferorthopädie (8)
- Kinderheilkunde (8)
- Kolorektales Karzinom (8)
- Langerhans-Inseln (8)
- Lymphozyt (8)
- Medulloblastom (8)
- Molekulargenetik (8)
- Morbus Fabry (8)
- Mutagenität (8)
- Mutation (8)
- NAFLD (8)
- Neuropathie (8)
- Non-Hodgkin-Lymphom (8)
- PCR (8)
- PD-L1 (8)
- Pankreaskarzinom (8)
- Parathormon (8)
- Parkinson (8)
- Perfusion (8)
- Pharmakologie (8)
- Plattenepithelkarzinom (8)
- Quantifizierung (8)
- ROS (8)
- Rezeptor (8)
- Sarkoidose (8)
- Spinale Muskelatrophie (8)
- Sprachaudiometrie (8)
- Stickstoffmonoxid-Synthase (8)
- Stress (8)
- Survival (8)
- Säugling (8)
- Tanzania (8)
- Therapeutisches Drug Monitoring (8)
- Trabekulektomie (8)
- Transplantat (8)
- Transthorakale Echokardiographie (8)
- Vitamin D (8)
- Zelldifferenzierung (8)
- Zellmigration (8)
- actin (8)
- antibiotics (8)
- binding (8)
- biofabrication (8)
- chronic pain (8)
- coagulation (8)
- cognitive impairment (8)
- collagen (8)
- cytoskeleton (8)
- cytotoxic T cells (8)
- dendritic cell (8)
- dystonia (8)
- enzyme replacement therapy (8)
- glioma (8)
- heart rate (8)
- induced pluripotent stem cells (8)
- injury (8)
- innate immunity (8)
- kinematic alignment (8)
- measles virus (8)
- model (8)
- myocardium (8)
- nanoparticles (8)
- nervous system (8)
- neurons (8)
- nutrition (8)
- platelet (8)
- primary care (8)
- psychiatric disorders (8)
- radioligand therapy (8)
- randomized controlled trial (8)
- reliability (8)
- shoulder (8)
- stem cell transplantation (8)
- translation (8)
- tumors (8)
- type 2 diabetes (8)
- ubiquitin (8)
- Östrogene (8)
- 3D (7)
- Actin (7)
- Asthma (7)
- Audiometrie (7)
- Aufmerksamkeit (7)
- Brain-derived neurotrophic factor (7)
- CRISPR/Cas9 (7)
- Charcot-Marie-Tooth (7)
- DHEA (7)
- Demenz (7)
- Drosophila (7)
- Dysgnathie (7)
- Epigenetik (7)
- Ereigniskorreliertes Potenzial (7)
- FISH (7)
- Fanconi-Anämie (7)
- Genotoxicity (7)
- Genregulation (7)
- Geriatrie (7)
- Guanylatcyclase (7)
- Haut (7)
- Hernie (7)
- Hüftgelenk (7)
- Immunology (7)
- Impfung (7)
- Interferon (7)
- Kardiologie (7)
- Kephalometrie (7)
- Kernspintomographie (7)
- Kniegelenk (7)
- Knochenersatzmaterial (7)
- Knockout <Molekulargenetik> (7)
- Komplikation (7)
- Komposit <Zahnmedizin> (7)
- Kontrastmittel (7)
- LPS (7)
- Lunge (7)
- Lungenfibrose (7)
- Lymphom (7)
- Magnesiumphosphate (7)
- Mesenchymale Stammzellen (7)
- Methylphenidat (7)
- Migration (7)
- Mikrokerntest (7)
- Model (7)
- Monozyt (7)
- Mortalität (7)
- Motoneuron (7)
- Mukoviszidose (7)
- Myokarditis (7)
- NO (7)
- Nachsorge (7)
- Natürliche Killerzelle (7)
- Nebennierenrindenkarzinom (7)
- Neisseria gonorrhoeae (7)
- Neurodegeneration (7)
- Neurootologie (7)
- Neuropathischer Schmerz (7)
- Niereninsuffizienz (7)
- Nuklearmedizin (7)
- Operation (7)
- Osteosynthese (7)
- P300 (7)
- PD-1 (7)
- Pain (7)
- Persönlichkeit (7)
- Prevalence (7)
- Propofol (7)
- Psychiatrie (7)
- Psychoonkologie (7)
- Quality of life (7)
- RNA (7)
- RNA-seq (7)
- Rekonstruktion (7)
- Rheumatoid arthritis (7)
- Schmerzforschung (7)
- Schmerztherapie (7)
- Schulter (7)
- Spiroergometrie (7)
- Stent (7)
- Störlärm (7)
- Tansania (7)
- Thymus (7)
- Tumor-Nekrose-Faktor (7)
- Ultraschalldiagnostik (7)
- Vasodilatator-stimuliertes Phosphoprotein (7)
- acute kidney injury (7)
- adhesion (7)
- adolescence (7)
- ageing (7)
- allogeneic stem cell transplantation (7)
- antimicrobial resistance (7)
- biocompatibility (7)
- bladder cancer (7)
- bone cement (7)
- bone regeneration (7)
- butyrate (7)
- cGMP (7)
- cancer therapy (7)
- cell culture (7)
- central nervous system (7)
- cerebellum (7)
- chemokine receptor (7)
- clinical trial (7)
- comparison (7)
- complex (7)
- coronary heart disease (7)
- cortisol (7)
- efficacy (7)
- fatigue (7)
- fear conditioning (7)
- fibromyalgia syndrome (7)
- gender (7)
- gene regulation (7)
- glucocorticoid receptor (7)
- hearing (7)
- hyaluronic acid (7)
- hypophosphatasia (7)
- immune evasion (7)
- in vivo imaging (7)
- in-vivo (7)
- interferon (7)
- leukemia (7)
- lymph nodes (7)
- mass spectrometry (7)
- mechanotransduction (7)
- meningitis (7)
- metaanalysis (7)
- methionine (7)
- mri (7)
- myocarditis (7)
- organoids (7)
- oxidativer Stress (7)
- panic disorder (7)
- pathogens (7)
- pediatrics (7)
- peripheral nervous system (7)
- personalized medicine (7)
- precision medicine (7)
- psoriasis (7)
- quality assurance (7)
- questionnaire (7)
- radioiodine therapy (7)
- reperfusion (7)
- secondary prevention (7)
- speech audiometry (7)
- sphingolipids (7)
- spinal muscular atrophy (7)
- subthalamic nucleus (7)
- tDCS (7)
- translational research (7)
- vestibular schwannoma (7)
- zebrafish (7)
- 53BP1 (6)
- ACC (6)
- Akt (6)
- Aldosteron (6)
- Altern (6)
- Alzheimer disease (6)
- Antibiotikum (6)
- Anxiety (6)
- Anästhesie (6)
- Aortenklappenersatz (6)
- Arthrose (6)
- Aspergillose (6)
- Asymmetrie (6)
- B-Zelle (6)
- Bauchspeicheldrüse (6)
- Biofilm (6)
- Biokompatibilität (6)
- Blutstammzelle (6)
- Bordetella pertussis (6)
- CML (6)
- CT (6)
- Carcinogen (6)
- Catecholmethyltransferase <Catechol-0-Methyltransferase> (6)
- DNA binding (6)
- Dehydroepiandrosteron (6)
- Depressivität (6)
- Diagnose (6)
- ELISA (6)
- ERN (6)
- ERP (6)
- Echinococcus (6)
- Eierstockkrebs (6)
- Elektrokardiogramm (6)
- Endodontie (6)
- Epithel (6)
- Erbrechen (6)
- Extrazelluläre Matrix (6)
- Fibromyalgie (6)
- Fluoreszenz (6)
- Fraktur (6)
- GPCR (6)
- Gelenkknorpel (6)
- Genotoxizität (6)
- Glucocorticosteroide (6)
- HAART (6)
- HGF (6)
- Harnwegsinfektion (6)
- Hautbiopsie (6)
- Hepatitis C (6)
- Histologie (6)
- Hypertrophie (6)
- Hypophosphatasie (6)
- Hörgerät (6)
- Hüftgelenkprothese (6)
- Immunantwort (6)
- Immunfluoreszenz (6)
- KHK (6)
- Kardiomyopathie (6)
- Kiefergelenk (6)
- Knieprothese (6)
- Knochen (6)
- Knochen-Morphogenese-Proteine (6)
- Knochenregeneration (6)
- Knockout (6)
- Knorpel (6)
- Körperliche Aktivität (6)
- LOH (6)
- Langzeitergebnisse (6)
- Leonhard classification (6)
- Leonhard-Klassifikation (6)
- MAP-Kinase (6)
- Macrophage (6)
- Malaria (6)
- Mammakarzinom (6)
- Masern (6)
- Meningokokken (6)
- Mice (6)
- Monoklonaler Antikörper (6)
- Mundschleimhaut (6)
- Myocardial infarction (6)
- NLRP3 (6)
- Nebennierenrindenkrebs (6)
- Neugeborene (6)
- Neurogenese (6)
- Neuromonitoring (6)
- Nierenfunktion (6)
- Notfallmedizin (6)
- Outcome (6)
- PONV (6)
- Periphere arterielle Verschlusskrankheit (6)
- Präfrontaler Cortex (6)
- Pulmonale Hypertonie (6)
- Qualitätssicherung (6)
- RNS-Interferenz (6)
- RT-PCR (6)
- Revision (6)
- SSTR (6)
- Schilddrüsenkrebs (6)
- Sprachentwicklungsstörung (6)
- Sprachtest (6)
- Stammzellen (6)
- Stroke (6)
- Struvit (6)
- T cell (6)
- TDM (6)
- TNF-alpha (6)
- TWEAK (6)
- Tinnitus (6)
- Toxizität (6)
- Toxoplasma gondii (6)
- Training (6)
- Transcription (6)
- Trauma (6)
- Troponin (6)
- Tumorantigen (6)
- Vagus (6)
- Zahnmedizin (6)
- Zelladhäsion (6)
- acute ischemic stroke (6)
- acute myeloid leukemia (6)
- adherence (6)
- adult neurogenesis (6)
- adults (6)
- anemia (6)
- antibiotic resistance (6)
- arthroscopy (6)
- astrocytes (6)
- astrocytoma (6)
- bariatric surgery (6)
- bioprinting (6)
- biopsy (6)
- blood brain barrier (6)
- blood flow (6)
- bone marrow (6)
- bone mineral density (6)
- caffeine (6)
- cancer treatment (6)
- carcinoma (6)
- cardiovascular disease (6)
- cardiovascular diseases (6)
- catecholamines (6)
- cell adhesion (6)
- cell migration (6)
- cell wall (6)
- cement (6)
- childhood (6)
- cleft lip and palate (6)
- comet assay (6)
- coping (6)
- cystic fibrosis (6)
- dendritische Zellen (6)
- dental education (6)
- diagnostics (6)
- dialysis (6)
- domain (6)
- endovascular (6)
- experimental autoimmune encephalomyelitis (6)
- fungal infection (6)
- gene therapy (6)
- gephyrin (6)
- glucose (6)
- growth (6)
- health-related quality of life (6)
- hip (6)
- immunofluorescence (6)
- implant (6)
- infarction (6)
- inhibitor (6)
- integrins (6)
- intraocular pressure (6)
- invasion (6)
- juvenile idiopathic arthritis (6)
- knee (6)
- kolorektales Karzinom (6)
- latency (6)
- lung (6)
- lung fibrosis (6)
- mHealth (6)
- major depression (6)
- measles (6)
- mechanical thrombectomy (6)
- medical education (6)
- medulloblastoma (6)
- megakaryocytes (6)
- melt electrospinning writing (6)
- mesenchymale Stammzellen (6)
- meta-analysis (6)
- microbiology (6)
- microdialysis (6)
- microenvironment (6)
- molecular biology (6)
- monoclonal antibodies (6)
- monoklonale Antikörper (6)
- movement disorders (6)
- myelin (6)
- neurogenesis (6)
- neurotrophins (6)
- next generation sequencing (6)
- noise (6)
- nuclear medicine (6)
- osteoinduction (6)
- pancreas (6)
- pathogenesis (6)
- pathway (6)
- pemphigus (6)
- perfusion (6)
- personality (6)
- pharmacokinetics (6)
- plasticity (6)
- platelet activation (6)
- polyneuropathy (6)
- preconditioning (6)
- progression (6)
- prospective (6)
- proteomics (6)
- radiosensitivity (6)
- reconstruction (6)
- regulation (6)
- retinal pigment epithelium (6)
- review (6)
- screening (6)
- senescence (6)
- sensitivity (6)
- serotonin transporter (6)
- shear stress (6)
- simulation (6)
- skin biopsy (6)
- small fiber neuropathy (6)
- spectral karyotyping (6)
- survey (6)
- susceptibility (6)
- synaptic plasticity (6)
- target (6)
- targeted therapy (6)
- thymus (6)
- thyroid cancer (6)
- transcription (6)
- transcriptomics (6)
- translocation (6)
- vaccination (6)
- validation (6)
- volatile anesthetics (6)
- wound healing (6)
- Überlebenszeit (6)
- 18F-FDG (5)
- 3D-Pulverdruck (5)
- 5-HTTLPR (5)
- ACE-Hemmer (5)
- Adenokarzinom (5)
- Adenosin (5)
- Adhärenz (5)
- Adulte Stammzelle (5)
- Aktin (5)
- Akustikustumor (5)
- Akute myeloische Leukämie (5)
- Alzheimer's disease (5)
- Alzheimer-Krankheit (5)
- Angststörung (5)
- Antibiotika (5)
- Anämie (5)
- Aortenaneurysma (5)
- Aortenklappenstenose (5)
- Assoziationsstudie (5)
- Augmentation (5)
- Autoimmunity (5)
- B-Lymphozyt (5)
- Bakterielle Infektion (5)
- Bakterien (5)
- Bauchspeicheldrüsenkrebs (5)
- Behandlung (5)
- Biographie (5)
- Biomaterial (5)
- Biopsie (5)
- Bruxismus (5)
- C-reactive protein (5)
- CD28 (5)
- CEACAM1 (5)
- CMV (5)
- COMT (5)
- COPD (5)
- CVID (5)
- Cadherine (5)
- Calciumphosphate (5)
- Candida auris (5)
- Chronisch thromboembolische pulmonale Hypertonie (5)
- Cisplatin (5)
- Cochlea (5)
- Computertomografie (5)
- Cyclo-AMP (5)
- Cytokines (5)
- DNS-Doppelstrangbruch (5)
- Dendritische Zellen (5)
- Desfluran (5)
- Durchblutung (5)
- Durchflusszytometrie (5)
- Dystonie (5)
- Dünndarm (5)
- EGFR (5)
- EKP (5)
- ERK1/2 (5)
- Endoprothetik (5)
- Endothelzelle (5)
- Erwachsener (5)
- Evaluation (5)
- FGFR (5)
- Fanconi Anämie (5)
- Fibroblast (5)
- Fluoreszenz-in-situ-Hybridisierung (5)
- Furcht (5)
- GABA (5)
- Gefäßprothese (5)
- Genmutation (5)
- Gentoxizität (5)
- Gewebedoppler (5)
- Glioblastoma (5)
- Gliom (5)
- Glutamattransporter (5)
- HBMEC (5)
- HLA-G (5)
- HUVEC (5)
- Hals-Nasen-Ohren-Tumor (5)
- Heart (5)
- Helicobacter pylori (5)
- Hepatitis B (5)
- Hepatozyten-Wachstumsfaktor (5)
- Herzkatheter (5)
- Hyaliner Knorpel (5)
- Hydrogel (5)
- Hydroxylapatit (5)
- Hypertension (5)
- Hypothalamus (5)
- Hörscreening (5)
- ICD-10 (5)
- Immun-Checkpoint (5)
- Immunglobuline (5)
- Immunobiologie (5)
- Impulsivität (5)
- Inhibitor (5)
- Integrin (5)
- Intensivstation (5)
- Invasion (5)
- Juvenile chronische Arthritis (5)
- Kaliumkanal (5)
- Kandidatengen (5)
- Karl Leonhard (5)
- Kidney (5)
- Klassifikation (5)
- Kniegelenkprothese (5)
- Knochendichte (5)
- Komorbiditäten (5)
- Komplement (5)
- Kreuzband (5)
- Körperliche Leistungsfähigkeit (5)
- LASP-1 (5)
- LL-37 (5)
- Laktat (5)
- Lautheit (5)
- Leberzirrhose (5)
- Legionella pneumophila (5)
- Lungenfunktion (5)
- Lymphome (5)
- Magenbypass (5)
- Magnetic resonance imaging (5)
- Manisch-depressive Krankheit (5)
- Mechanisms (5)
- Medulloblastoma (5)
- Meningitis (5)
- Mesenchymzelle (5)
- Methylierung (5)
- Microarray (5)
- Mitochondrium (5)
- Monitoring (5)
- Monozyten (5)
- Morphologie (5)
- Multiple myeloma (5)
- Multiple sclerosis (5)
- Myokard (5)
- Myokardprotektion (5)
- NFκB (5)
- NGA (5)
- NRF2 (5)
- NSCLC (5)
- Nanopartikel (5)
- Narkose (5)
- Nasenschleimhaut (5)
- Nebennierentumor (5)
- Netzhaut (5)
- Neugeborenes (5)
- Neuralgie (5)
- Neuroinflammation (5)
- Neuronale Plastizität (5)
- Nierenversagen (5)
- Notfall (5)
- Occludin (5)
- Oncology (5)
- Parkinson disease (5)
- Patientenzufriedenheit (5)
- Pemphigus (5)
- Plattenosteosynthese (5)
- Polysomnographie (5)
- Prostaglandine (5)
- Protein (5)
- Prothetik (5)
- Präkonditionierung (5)
- Psychotherapie (5)
- Quantitative anatomy (5)
- RADS (5)
- Randschluss (5)
- Ranvier-Schnürring (5)
- Rat (5)
- Regenerative Medizin (5)
- Regulatorischer T-Lymphozyt (5)
- Regulatory T cells (5)
- Rektumkarzinom (5)
- Resistenz (5)
- Reverse Transkriptase-Polymerase-Kettenreaktion (5)
- Ribavirin (5)
- Salmonella (5)
- Schistosomiasis (5)
- Sensitivität (5)
- Skin (5)
- Sonographie (5)
- Spumaviren (5)
- Strahlensensibilität (5)
- T lymphocytes (5)
- T-Lymphozyten (5)
- TAVI (5)
- TMJ (5)
- Therapieerfolg (5)
- Tight junction (5)
- Titan (5)
- Toll-like-Rezeptoren (5)
- Transfektion (5)
- Ultraschallkardiographie (5)
- Unterkiefer (5)
- Vascular endothelial Growth Factor (5)
- Ventilation (5)
- Verbundfestigkeit (5)
- Vergleich (5)
- Vestibularisschwannom (5)
- Wachstum (5)
- Wundinfektion (5)
- Würzburger Hörfeld (5)
- Zelltod (5)
- Zentralnervensystem (5)
- acoustic neuroma (5)
- acute heart failure (5)
- adenocarcinoma (5)
- adipose tissue (5)
- adrenal (5)
- adrenal insufficiency (5)
- akute Herzinsuffizienz (5)
- aldosterone (5)
- amygdala (5)
- animal models (5)
- anorexia nervosa (5)
- antibacterial activity (5)
- anticoagulation (5)
- antidepressant (5)
- antidepressants (5)
- anxiety disorders (5)
- aorta (5)
- aspergillosis (5)
- aspergillus fumigatus (5)
- basal ganglia (5)
- behavior (5)
- bioink (5)
- biomechanics (5)
- brain development (5)
- brain tumor (5)
- bronchopulmonary dysplasia (5)
- caloric restriction (5)
- candidate gene (5)
- cardiac (5)
- cardiac surgery (5)
- cartilage regeneration (5)
- ceramides (5)
- child (5)
- chondrocytes (5)
- ciliary neurotrophic factor (5)
- cognitive decline (5)
- comorbidity (5)
- complement (5)
- computed tomography (5)
- congestive heart failure (5)
- creatine kinase (5)
- critical illness (5)
- dSTORM (5)
- demyelination (5)
- dexamethasone (5)
- ecological momentary assessment (5)
- ejection fraction (5)
- electrospinning (5)
- end-stage renal disease (5)
- endothelial dysfunction (5)
- energy metabolism (5)
- epithelial-mesenchymal transition (5)
- estrogens (5)
- event-related potentials (5)
- extracellular vesicles (5)
- fMRI (5)
- factor XII (5)
- follicular lymphoma (5)
- forensic neuropathology (5)
- galactomannan (5)
- gastric cancer (5)
- gastrointestinal tract (5)
- genome (5)
- genome-wide association (5)
- giant cell arteritis (5)
- glutamate (5)
- glycoprotein VI (5)
- guideline adherence (5)
- hypertrophy (5)
- immune cells (5)
- impact (5)
- inflammasome (5)
- inflammatory bowel disease (5)
- irradiation (5)
- keratinocytes (5)
- kidneys (5)
- knockout mice (5)
- lactate (5)
- late enhancement (5)
- lesions (5)
- long-term outcome (5)
- loss of heterozygosity (5)
- loudness (5)
- macrophage (5)
- magnesium phosphate cement (5)
- membrane proteins (5)
- memory (5)
- metabolomics (5)
- methylation (5)
- methylphenidate (5)
- middle cerebral artery occlusion (5)
- migraine (5)
- migrants (5)
- minimal invasiv (5)
- minimally invasive (5)
- molecular docking (5)
- monoclonal antibody (5)
- monocyte (5)
- near-infrared spectroscopy (5)
- neuromuscular junction (5)
- neuronal differentiation (5)
- neuroscience (5)
- newborn hearing screening (5)
- nitric oxide synthase (5)
- optogenetics (5)
- outcomes (5)
- paraganglioma (5)
- parasitic diseases (5)
- pathways (5)
- pediatric (5)
- phenotype (5)
- pheochromocytoma (5)
- polycaprolactone (5)
- preclinical research (5)
- prostate-specific membrane antigen (5)
- protein expression (5)
- psychological distress (5)
- public health (5)
- pulmonary hypertension (5)
- quantification (5)
- radiation (5)
- receptors (5)
- recovery (5)
- refractory (5)
- regeneration (5)
- regulatorische T-Zellen (5)
- renal cell carcinoma (5)
- repair (5)
- responses (5)
- retrospective (5)
- risk factor (5)
- risk stratification (5)
- rotator cuff (5)
- rotator cuff tear (5)
- saliva (5)
- scaffold (5)
- serum (5)
- sevoflurane (5)
- sex differences (5)
- skeletal muscle (5)
- skin punch biopsy (5)
- small interfering RNAs (5)
- smoking (5)
- somatic mutations (5)
- somatostatin receptor (5)
- stem-cell transplantation (5)
- strain (5)
- subarachnoid hemorrhage (5)
- sympathetic nervous system (5)
- symptoms (5)
- thrombo-inflammation (5)
- tissue (5)
- tomography (5)
- total hip arthroplasty (5)
- tumor necrosis factor (5)
- uveal melanoma (5)
- virtual reality (5)
- xx (5)
- Überlebensrate (5)
- 19. Jahrhundert (4)
- ACTH (4)
- ASSR (4)
- ATP (4)
- Adenylate cyclase (4)
- Adhäsion (4)
- Akustikusneurinom (4)
- Akute Leukämie (4)
- Alkoholabhängigkeit (4)
- Alkoholismus (4)
- Alzheimers disease (4)
- Amplifikation (4)
- Anaphylaxis (4)
- Angstsensitivität (4)
- Anura (4)
- Arzneimittelüberwachung (4)
- Audiologie (4)
- Auge (4)
- Augenheilkunde (4)
- Autophagie (4)
- B cell (4)
- B-cell lymphoma (4)
- B7-H1 (4)
- BERAphon® (4)
- BRAF (4)
- BRCA1 (4)
- Barth syndrome (4)
- Basaliom (4)
- Beschichtung (4)
- Beta-Rezeptor (4)
- Bevacizumab (4)
- Bildgebendes Verfahren (4)
- Biofabrication (4)
- Bipolar disorder (4)
- Blimp-1 (4)
- Blut (4)
- Blutgerinnung (4)
- Bone regeneration (4)
- Bruschit (4)
- Bypass (4)
- CCI (4)
- CD40 (4)
- CNS (4)
- CNTF (4)
- CPT (4)
- CRP (4)
- CRPS (4)
- CT angiography (4)
- Cancer genetics (4)
- Carcinogenesis (4)
- Carotisstenose (4)
- Cephalometry (4)
- Cholesterin (4)
- Chromosomenaberration (4)
- Chronischer Schmerz (4)
- Colitis ulcerosa (4)
- Covid-19 (4)
- Cushing’s syndrome (4)
- Cyclo-GMP (4)
- Cytomegalie-Virus (4)
- DHEAS (4)
- Darm (4)
- Dasatinib (4)
- Dendritic cells (4)
- Desmosom (4)
- Deutschland (4)
- Dimension 3 (4)
- Dopamin (4)
- EBV (4)
- ECG (4)
- ECM (4)
- EKG (4)
- ELISPOT (4)
- ERK (4)
- Elektrocochleographie (4)
- Elektroencephalographie (4)
- Elektroporation (4)
- Emotionsregulation (4)
- Endoprothese (4)
- Endotheldysfunktion (4)
- Endothelium (4)
- Entwicklungsländer (4)
- Enzyme replacement therapy (4)
- Epidermaler Wachstumsfaktor-Rezeptor (4)
- Fazialisparese (4)
- First Responder (4)
- Fluoreszenz-Resonanz-Energie-Transfer (4)
- Fluoreszenzmikroskopie (4)
- Fn14 (4)
- Furchtkonditionierung (4)
- G proteins (4)
- G-Protein gekoppelte Rezeptoren (4)
- G-protein (4)
- GDNF (4)
- GFAP (4)
- Geburtshilfe (4)
- Genanalyse (4)
- Gene-expression (4)
- Genetics (4)
- Gentherapie (4)
- Geschlecht (4)
- Geschlechtsunterschied (4)
- Glucose (4)
- Graft-versus-host-disease (4)
- Growth (4)
- Guillain-Barré-Syndrom (4)
- GvHD (4)
- HSM-sentence-test (4)
- Haemophilus influenzae (4)
- Halothan (4)
- Harnblasenkarzinom (4)
- Herzfrequenz (4)
- Herzschrittmacher (4)
- Hirnödem (4)
- Histopathologie (4)
- Hormone (4)
- Hornhaut (4)
- Hyaluronsäure (4)
- Hypertrophische Herzmuskelkrankheit (4)
- Hämodynamik (4)
- Hörtest (4)
- Hörverlust (4)
- ICSI (4)
- IL-10 (4)
- IL-6 (4)
- Immunoassay (4)
- Inanspruchnahme (4)
- Integrine (4)
- Interleukin 8 (4)
- Ionenkanal (4)
- JNK (4)
- Jugend (4)
- Jugendliche (4)
- Juvenile idiopathische Arthritis (4)
- Kerntransport (4)
- Kinder- und Jugendpsychiatrie (4)
- Kindesalter (4)
- Kleinkern (4)
- Klinisches Experiment (4)
- Knochenzemente (4)
- Kohlenhydrate (4)
- Kombinationstherapie (4)
- Komorbidität (4)
- Komplement <Immunologie> (4)
- Kontrollierte klinische Studie (4)
- Krebs (4)
- Kreuzreaktion (4)
- LC/MS (4)
- Lactate (4)
- Lagerungsplagiozephalus (4)
- Langerhans cells (4)
- Langfristige Prognose (4)
- Laparoskopie (4)
- Laufzeit (4)
- Leber (4)
- Leptin (4)
- Lokalisation (4)
- Loss of heterozygosity (4)
- Lungenembolie (4)
- Lungenkrebs (4)
- Lymphozyten (4)
- MHC (4)
- MMP (4)
- MR-Spektroskopie (4)
- MSCs (4)
- Macrophages (4)
- Magenkrebs (4)
- Makuladegeneration (4)
- Mammographie (4)
- Mangelernährung (4)
- Maschinelles Lernen (4)
- Medizingeschichte (4)
- Meerschweinchen (4)
- Micronuclei (4)
- Migräne (4)
- Mikrodialyse (4)
- Mikroglia (4)
- Mikrokern (4)
- Mikrosatelliteninstabilität (4)
- Minimal-invasive Chirurgie (4)
- Mitomycin C (4)
- Mittelohr (4)
- Monoklonaler bispezifischer Antikörper (4)
- Morbidität (4)
- Morbus Crohn (4)
- Mortality (4)
- Multiple Myeloma (4)
- Muskel (4)
- NASH (4)
- NET (4)
- NF-AT (4)
- NF-κB (4)
- NSSI (4)
- Nachuntersuchung (4)
- Narbenhernie (4)
- Nebennierenkarzinom (4)
- Nebennierenrinde (4)
- Nebennierenrindeninsuffizienz (4)
- Nebenschilddrüse (4)
- Neugeborenenhörscreening (4)
- Neurofascin (4)
- Neuropathy (4)
- Nigeria (4)
- OCD (4)
- OCT (4)
- Obesity (4)
- Omarthrose (4)
- Onkogen (4)
- Osteoinduction (4)
- Osteotomie (4)
- Oxidative Stress (4)
- PBMC (4)
- PSA (4)
- PSMA-RADS (4)
- PTCA (4)
- PTEN (4)
- Panikstörung (4)
- Pankreas (4)
- Paracetamol (4)
- Pathologie (4)
- Periphere Stammzellentransplantation (4)
- Phagozytose (4)
- Pharmakokinetik (4)
- Phäochromozytom (4)
- Prednisolon (4)
- Promotor (4)
- Propriozeption (4)
- Prostata (4)
- Proteasom (4)
- Protein p53 (4)
- Prothese (4)
- Prädiktoren (4)
- Präparation (4)
- Prävalenz (4)
- Punktion (4)
- Punktmutation (4)
- Puppenhandillusion (4)
- Qualitätsmanagement (4)
- RNA sequencing (4)
- RNA-binding proteins (4)
- RNS (4)
- Rac1 (4)
- Rachitis (4)
- Radioiodtherapie (4)
- Radioonkologie (4)
- Raf-Kinasen (4)
- Randqualität (4)
- Rapid Prototyping (4)
- Regulation (4)
- Reproduktionsmedizin (4)
- Resektion (4)
- Resilienz (4)
- Retina (4)
- Rheumatismus (4)
- Risiko (4)
- Rotatorenmanschettenruptur (4)
- Roux-en-Y gastric bypass surgery (4)
- SMA (4)
- SMN (4)
- SOAT1 (4)
- Salzhydratschmelze (4)
- Scaffold (4)
- Schnarchen (4)
- Schrei (4)
- Schulterendoprothetik (4)
- Sekundärprävention (4)
- Selenoproteine (4)
- Sensitivity (4)
- Sequenzanalyse (4)
- Sevofluran (4)
- Silber (4)
- Skalierung (4)
- Skelettmuskel (4)
- Speichel (4)
- Spracherwerb (4)
- Sprachverständnistest (4)
- Stabilität (4)
- Startle (4)
- Stathmin (4)
- Stem cells (4)
- Sterilität (4)
- Stickstoffoxidsynthase (4)
- Stimulation (4)
- Stressinkontinenz (4)
- Stroma (4)
- Synuclein <alpha-> (4)
- Südafrika (4)
- T cell receptor (4)
- T-Lymphozyten-Rezeptor (4)
- T-Zelle (4)
- T-lymphocytes (4)
- TGF-beta (4)
- TNF receptor superfamily (4)
- TNFR2 (4)
- TP53 (4)
- Therapeutic Drug Monitoring (4)
- Therapy (4)
- Thrombose (4)
- Thrombozyten (4)
- Toleranz (4)
- Totalendoprothese (4)
- Transforming Growth Factor beta (4)
- Transgenic mice (4)
- Transplantatabstoßung (4)
- Treatment (4)
- Tumorzelle (4)
- Ubiquitin (4)
- United States (4)
- Ureaplasma parvum (4)
- Urämie (4)
- VEP (4)
- Vaccination (4)
- Validierung (4)
- Vaskularisation (4)
- Versorgungsqualität (4)
- Virulenz (4)
- Virus (4)
- Virusinfektion (4)
- Vitamin-D-Mangel (4)
- Wirbelsäulenverletzung (4)
- Wuerzburg (4)
- Zement (4)
- acute respiratory distress syndrome (4)
- adjuvant treatment (4)
- age-related macular degeneration (4)
- amplification (4)
- analgesia (4)
- anatomy (4)
- aneurysm (4)
- angiography (4)
- animal behavior (4)
- antibacterial (4)
- antimicrobial stewardship (4)
- antiretroviral therapy (4)
- appendicitis (4)
- arrhythmia (4)
- atopic dermatitis (4)
- attention (4)
- attention-deficit/hyperactivity disorder (ADHD) (4)
- auditory pathway (4)
- autoantigen (4)
- autonomic nervous system (4)
- biofilms (4)
- biokinetics (4)
- bioreactor (4)
- body weight (4)
- calcium phosphate (4)
- cancer immunotherapy (4)
- capsaicin (4)
- carcinomas (4)
- cardiac metabolism (4)
- cardioprotection (4)
- cardiovascular (4)
- cardiovascular genetics (4)
- cardiovascular risk factors (4)
- cell biology (4)
- cell cycle (4)
- cell differentiation (4)
- cell proliferation (4)
- cerebral ischemia (4)
- cervical dystonia (4)
- chemokine (4)
- chondrogenic differentiation (4)
- clinical study (4)
- co-culture (4)
- collagens (4)
- colon (4)
- colon cancer (4)
- correction (4)
- costs (4)
- critical care (4)
- decellularization (4)
- definition (4)
- degeneration (4)
- dentate gyrus (4)
- dermatology (4)
- desflurane (4)
- desmosome (4)
- desmosomes (4)
- developmental biology (4)
- diagnostic markers (4)
- drug (4)
- drug repurposing (4)
- dysgnathia (4)
- editorial (4)
- education (4)
- electrocardiography (4)
- electroencephalography (4)
- electrophysiology (4)
- emotion regulation (4)
- encephalitis (4)
- endoscopy (4)
- endothelial progenitor cells (4)
- enzyme-linked immunoassays (4)
- epithelium (4)
- estrogen (4)
- evaluation (4)
- failure (4)
- fear (4)
- ferroptosis (4)
- fish (4)
- fluorescence microscopy (4)
- forensic neurotraumatology (4)
- gait initiation (4)
- genetic loci (4)
- genomic damage (4)
- gingivitis (4)
- glaucoma surgery (4)
- glucocorticoids (4)
- gynecology (4)
- halothane (4)
- hematopoietic stem cells (4)
- hernia (4)
- heterochromatin (4)
- histology (4)
- homeostasis (4)
- hydroxyapatite (4)
- hypercortisolism (4)
- hyperekplexia (4)
- hypofractionation (4)
- imaging techniques (4)
- immune checkpoint blockade (4)
- immune system (4)
- implementation (4)
- in vitro model (4)
- infections (4)
- inflammatory pain (4)
- influenza (4)
- inpatient rehabilitation (4)
- insulin resistance (4)
- integrin (4)
- intensive care (4)
- interaction (4)
- intestinal barrier (4)
- intestine (4)
- invasive aspergillosis (4)
- invasive pulmonary aspergillosis (4)
- iron (4)
- kidney function (4)
- knee arthroplasty (4)
- learning (4)
- left ventricular hypertrophy (4)
- lenalidomide (4)
- lines (4)
- linkage (4)
- lipids (4)
- lithium (4)
- luciferase (4)
- mRNA expression (4)
- malaria (4)
- mapping (4)
- mast cells (4)
- matrix metalloproteinases (4)
- medical rehabilitation (4)
- medullary thyroid carcinoma (4)
- memory B cells (4)
- meningioma (4)
- meningococcal disease (4)
- metabolic syndrome (4)
- metabolic test (4)
- miR-21 (4)
- microarray (4)
- microbiome (4)
- microsatellite instability (4)
- middle ear (4)
- molecular medicine (4)
- morbidity (4)
- motor learning (4)
- muscle (4)
- mutagenicity (4)
- mycotoxin (4)
- myocardial perfusion (4)
- natural killer cells (4)
- neural networks (4)
- neuroblastoma (4)
- neurodevelopment (4)
- neuroimmunology (4)
- neuronal plasticity (4)
- neurotrophic factor (4)
- norepinephrine transporter (4)
- oligodendrocytes (4)
- oncolytic virus (4)
- opioids (4)
- optimization (4)
- osteoblast (4)
- osteogenic differentiation (4)
- osteosynthesis (4)
- outbreak (4)
- pH (4)
- paediatrics (4)
- palliative care (4)
- parathyroid (4)
- parathyroid hormone (4)
- pathogenicity (4)
- patient blood management (4)
- perception (4)
- performance (4)
- perioperative management (4)
- periprosthetic infection (4)
- periprothetische Infektion (4)
- phosphate (4)
- phytic acid (4)
- plasma cells (4)
- plasmodium falciparum (4)
- platelet aggregation (4)
- polyomavirus (4)
- post-traumatic stress disorder (4)
- postoperative Komplikationen (4)
- prognostic factor (4)
- prognostic value (4)
- propofol (4)
- protein kinase (4)
- protein synthesis (4)
- psychiatry (4)
- psycho-oncology (4)
- psychology (4)
- radial (4)
- radiochemotherapy (4)
- radionuclide therapy (4)
- receptor tyrosine kinase (4)
- recombination (4)
- recommendations (4)
- regenerative medicine (4)
- regression analysis (4)
- renal failure (4)
- renal function (4)
- reoperation (4)
- replacement (4)
- replication (4)
- resilience (4)
- results (4)
- retrospektiv (4)
- reveals (4)
- revision (4)
- sRNA (4)
- sarcopenia (4)
- scale (4)
- scaling (4)
- score (4)
- secretion (4)
- segmentation (4)
- selenium (4)
- sequence (4)
- sex chromosomes (4)
- shRNA (4)
- signaling pathway (4)
- silver (4)
- sleep bruxism (4)
- sleeping sickness (4)
- small RNA (4)
- small intestine (4)
- software (4)
- specificity (4)
- spinal cord (4)
- spleen (4)
- startle disease (4)
- statins (4)
- stimulation (4)
- strain rate (4)
- super-resolution microscopy (4)
- surgical and invasive medical procedures (4)
- synaptic vesicles (4)
- synthesis (4)
- telemedicine (4)
- testosterone (4)
- thrombin (4)
- thromboembolism (4)
- thrombolysis (4)
- thymoma (4)
- thyroid (4)
- tight junction (4)
- total knee replacement (4)
- toxicology (4)
- transcranial direct current stimulation (4)
- transcription factor (4)
- transfection (4)
- transient ischemic attack (4)
- tremor (4)
- trial (4)
- troponin (4)
- tumor heterogeneity (4)
- vaccine (4)
- viability (4)
- viral infection (4)
- virus (4)
- vitamin C (4)
- weight loss (4)
- x (4)
- zinc oxide (4)
- zinc oxide nanoparticles (4)
- γ-H2AX (4)
- - (3)
- --- (3)
- 1 (3)
- 18F-DCFPyL (3)
- 18F-FDG PET/CT (3)
- 18F-LMI1195 (3)
- 3D Printing (3)
- 3D tissue model (3)
- 3D-Stereophotogrammetrie (3)
- 5-Fluorouracil (3)
- 5-HTT (3)
- 5-Methylcytosine (3)
- 5-fluorouracil (3)
- ABR (3)
- ACE (3)
- ALS (3)
- AMD (3)
- ANP (3)
- ARIA (3)
- ASC (3)
- Acetylsalicylsäure (3)
- Adenom-Karzinom-Sequenz (3)
- Adult (3)
- Africa (3)
- Aging (3)
- Akromioklavikulargelenk (3)
- Aktivierung (3)
- Akutes Nierenversagen (3)
- Albino rats (3)
- Alkalische Phosphatase (3)
- Allogeneic stem cell transplantation (3)
- Alopecia areata (3)
- Alternative Medizin (3)
- Altersbestimmung (3)
- Alzheimerkrankheit (3)
- Amplitude (3)
- Analgesie (3)
- Anandamid (3)
- Anastomose (3)
- Aneurysma (3)
- Angeborene Immunität (3)
- Angiogenesis (3)
- Angiographie (3)
- Angiotensin (3)
- Antagonist (3)
- Antiangiogenese (3)
- Antigen (3)
- Antigen CD28 (3)
- Antigen CD40 (3)
- Antigenpräsentation (3)
- Aorta (3)
- Apherese (3)
- Appendizitis (3)
- Arthrodese (3)
- Arthroplasty (3)
- Aseptische Lockerung (3)
- Atemwegsinfektion (3)
- Atorvastatin (3)
- Attraktivität (3)
- Aufmerksamkeitsdefizit-Syndrom (3)
- Augendruck (3)
- Autoantibodies (3)
- Autoantigen (3)
- Autophagy (3)
- Avidität (3)
- B-Zellen (3)
- B-cells (3)
- BIS (3)
- BMD (3)
- BP180 (3)
- Basilarmembran (3)
- Bauchfellentzündung (3)
- Befestigungskomposit (3)
- Beschleunigungssensor (3)
- Beta-1-Rezeptor (3)
- Bildgebung (3)
- Bilharziose (3)
- Biochemie (3)
- Bisphosphonate (3)
- Blasenkrebs (3)
- Blutverlust (3)
- Bone marrow transplantation (3)
- Bone morphogenetic protein-2 (3)
- Borreliose (3)
- Bortezomib (3)
- Brackets (3)
- Brain (3)
- Bridging (3)
- Bruchpilot (3)
- Bupivacain (3)
- Butyrate (3)
- CAD/CAM (3)
- CAR T cell (3)
- CCL2 (3)
- CCR7 (3)
- CD4+ T cells (3)
- CD40L (3)
- CD8 T cell (3)
- CD95 (3)
- CDH13 (3)
- CEA (3)
- CGH (3)
- CIDP (3)
- CMR (3)
- CMT (3)
- COVID-19 pandemic (3)
- CSF (3)
- CVD (3)
- CYR61 (3)
- Calcineurin (3)
- Calciumhydroxid (3)
- Capsaicin (3)
- Carcino-embryonales Antigen (3)
- Carcinogenicity (3)
- Carcinogens (3)
- Cardiomyopathy (3)
- Cas9 (3)
- Catecholamine (3)
- Cerebellar cortex (3)
- Cerebrospinal fluid (3)
- Chimärismus (3)
- China (3)
- Chirp (3)
- Chronisch-myeloische Leukämie (3)
- Ciliary neurotrophic factor (3)
- Classification (3)
- Clopidogrel (3)
- Cochlea-Implantat (3)
- Coexpression (3)
- Cranio-Corpo-Graphie (3)
- Craniosynostosis (3)
- Crohn-Krankheit (3)
- Cushing-Syndrom (3)
- Cytologie (3)
- Cytotoxizität (3)
- DCM (3)
- DMD (3)
- DNA double strand breaks (3)
- DNA double-strand breaks (3)
- DNA transcription (3)
- DRG (3)
- DWI (3)
- DYT1 (3)
- DaTscan (3)
- Datenbank (3)
- Deletion (3)
- Dentalkeramik (3)
- Dermatologie (3)
- Development (3)
- Diabetes Mellitus (3)
- Diabetische Polyneuropathie (3)
- Diagnosis (3)
- Dilatation (3)
- Docetaxel (3)
- Doppler-Echokardiographie (3)
- Dünndarmtransplantation (3)
- ECMO (3)
- EMG (3)
- Echinococcus multilocularis (3)
- Einsilbiges Wort (3)
- Elektromyographie (3)
- Ellenbogen (3)
- Embryo (3)
- Emotion (3)
- Empfängnisverhütung (3)
- Endotheliale Dysfunktion (3)
- Endozytose (3)
- Enzyme induction (3)
- Ependymom (3)
- Epidermis (3)
- Erbkrankheit (3)
- Ereigniskorrelierte Potentiale (3)
- Ergospirometrie (3)
- Erste Hilfe (3)
- Ertaubung (3)
- Erwachsene (3)
- Erythropoietin (3)
- Essstörungen (3)
- Estrogene (3)
- Etomidat (3)
- FAEP (3)
- FDG (3)
- FKBP5 (3)
- FSHD (3)
- FTY720 (3)
- Fanconi Anaemia (3)
- Fanconi anemia (3)
- Fas-Ligand (3)
- Fatigue (3)
- Fernröntgenseitenbild (3)
- Fettgewebe (3)
- Fettleber (3)
- Fibroblastenwachstumsfaktor (3)
- Fibroblasts (3)
- Fluorescence (3)
- Follikuläres Lymphom (3)
- Fragmentbefestigung (3)
- Frailty (3)
- Freiburger Sprachverständnistest (3)
- Frühgeborenes (3)
- Fuchsbandwurm (3)
- Funktion (3)
- Fusarium (3)
- GLUT3 (3)
- GVHD (3)
- Gastrointestinaltrakt (3)
- Gebrechlichkeit (3)
- Gen (3)
- Gene (3)
- Genome (3)
- Gephyrin (3)
- Geschichte (3)
- Gesichtsschmerz (3)
- Gestationsdiabetes (3)
- Gewebekultur (3)
- Gingivitis (3)
- Glioblastoma multiforme (3)
- Glucocorticosteroidrezeptor (3)
- Glucosestoffwechsel (3)
- Glucosetransportproteine (3)
- Glutamat (3)
- Glutathione (3)
- Glycinrezeptor (3)
- Grading (3)
- Graft-versus-host disease (3)
- HFOV (3)
- HFmrEF (3)
- HFpEF (3)
- HIV-1 (3)
- HPLC (3)
- HSM (3)
- Hand (3)
- Handchirurgie (3)
- Haplotypanalyse (3)
- Harmonic Imaging (3)
- Harninkontinenz (3)
- Hautkrebs (3)
- Herz-Lungen-Maschine (3)
- Herzfunktion (3)
- Herzmuskelzelle (3)
- Herzoperation (3)
- Herzstoffwechsel (3)
- Herztransplantation (3)
- Hirnmetastasen (3)
- Hirnstimulation (3)
- Hirschsprung disease (3)
- Hitzeschock-Proteine (3)
- Hochdosischemotherapie (3)
- Hodgkin lymphoma (3)
- Humangenetik (3)
- Hyperalgesie (3)
- Hyperglykämie (3)
- Hyponatriämie (3)
- Hypophosphatasia (3)
- Hypoxie (3)
- Hörprüfung (3)
- Hörstörung (3)
- Hüftendoprothetik (3)
- Hüfttotalendoprothese (3)
- ICD (3)
- ICU (3)
- IGRT (3)
- IMRT (3)
- IVF (3)
- Identifizierung (3)
- IgE (3)
- IgM (3)
- Imaging (3)
- Immundefekt (3)
- Immunglobulin (3)
- Immunoblot (3)
- Immunosuppression (3)
- Implantation (3)
- In-vitro (3)
- In-vivo (3)
- Induzierte pluripotente Stammzelle (3)
- Influenza (3)
- Intensivmedizin (3)
- Intensivtransport (3)
- Interferon <gamma-> (3)
- Interleukin 1-beta (3)
- Interleukin 6 (3)
- Interleukin-1 (3)
- Interleukin-4 (3)
- Interleukin-6 (3)
- Interventionsradiologie (3)
- Intraokularer Druck (3)
- Inzidentalom (3)
- Inzidenz (3)
- Ischämische Präkonditionierung (3)
- Kaiserschnitt (3)
- Kalzium (3)
- Karzinom (3)
- Katarakt (3)
- Katatonie (3)
- Katecholamine (3)
- Keratinozyt (3)
- Keratinozyten (3)
- Ketogene Kost (3)
- Ketonkörper (3)
- Kiefer- und Gesichtschirurgie (3)
- Kindergarten (3)
- Klonalität (3)
- Klonierung (3)
- Knee (3)
- Kniegelenkarthrose (3)
- Knochenmark (3)
- Knochenstoffwechsel (3)
- Knochentumor (3)
- Knorpelregeneration (3)
- Kognition (3)
- Kolon (3)
- Konfokale Mikroskopie (3)
- Kontinenz (3)
- Kopforthesentherapie (3)
- Kraniometrie (3)
- Kraniopharyngeom (3)
- Kraniopharyngiom (3)
- Kraniosynostose (3)
- Krankheitsverarbeitung (3)
- Kreatinkinase (3)
- Körperwahrnehmung (3)
- Künstliche Intelligenz (3)
- L929 (3)
- LIF (3)
- LNCaP (3)
- LTD (3)
- Lactatdehydrogenase (3)
- Laminin (3)
- Langzeitdepression (3)
- Langzeitprognose (3)
- Larynx (3)
- Larynxkarzinom (3)
- Late Enhancement (3)
- Latrophilin (3)
- Leberzellkrebs (3)
- Leishmania (3)
- Lopinavir (3)
- Low-density-Lipoproteine (3)
- Lymphknoten (3)
- Lymphogranulomatose (3)
- MALT-Lymphom (3)
- MALT1 (3)
- MAPK (3)
- MDSC (3)
- MGMT (3)
- MIBG (3)
- MLC1 (3)
- MPFL (3)
- MPI (3)
- MSCT (3)
- MTUS1 (3)
- Magnetische Resonanz (3)
- Malaria tropica (3)
- Malignant hyperthermia (3)
- Malignes Lymphom (3)
- Mamma (3)
- Mechanorezeptor (3)
- Mechanotransduktion (3)
- Medizinische Ausbildung (3)
- Medizinische Rehabilitation (3)
- Melanoma (3)
- Meningococci (3)
- Meniskus (3)
- Mensch (3)
- Mesenchymale Stromazellen (3)
- Metabolisches Syndrom (3)
- Metabolismus (3)
- Metabolomics (3)
- Metastase (3)
- Methohexital (3)
- Methotrexate (3)
- Methylation (3)
- Microdialyse (3)
- Mikroverkapselung (3)
- Molekularbiologie (3)
- Mouse (3)
- Multiple Sclerosis (3)
- Mund-Kiefer-Gesichts-Chirurgie (3)
- Mundhöhle (3)
- Mundhöhlentumor (3)
- Muskeldystrophie (3)
- Muskelkraft (3)
- Mutationen (3)
- Myasthenia gravis (3)
- Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) (3)
- Myelom (3)
- Mykobakterien (3)
- NF-kappa-B (3)
- NF-kappaB (3)
- NFkB (3)
- NGF (3)
- NGS (3)
- NK-Zellen (3)
- NMDA-Rezeptor (3)
- NMR (3)
- NSG (3)
- NT-proBNP (3)
- NVP-BEZ235 (3)
- Nahtmaterial (3)
- Natalizumab (3)
- Nationalsozialismus (3)
- Natrium-Calcium-Austauscher (3)
- Nausea (3)
- Nebenwirkung (3)
- Nebenwirkungen (3)
- Nekrose (3)
- Nervenfaser (3)
- Nervenzelle (3)
- Nestin (3)
- Neurochirurgie (3)
- Neurologie (3)
- Neuromyelitis optica spectrum disorders (NMOSD) (3)
- Neurons (3)
- Neurotizismus (3)
- Neurotrophic factors (3)
- Neutrophiler Granulozyt (3)
- Nicht-kleinzelliges Bronchialkarzinom (3)
- Nierenzellkarzinom (3)
- Nociceptor (3)
- Nrf2 (3)
- Nuklearfaktor Kappa B (3)
- Operationstechnik (3)
- Opioide (3)
- Optic neuritis (3)
- Oropharynx (3)
- Orthopädie (3)
- Osseointegration (3)
- Osteoarthrose (3)
- Osteoblast (3)
- Osteoblasten (3)
- Osteoklast (3)
- Osteopontin (3)
- OxLDL (3)
- PCI (3)
- PKA (3)
- PMCA (3)
- PMMA (3)
- PNP (3)
- PROM (3)
- PTH (3)
- Palliative Care (3)
- Palliativversorgung (3)
- Pandemie (3)
- Passivrauchen (3)
- Patella (3)
- Patient (3)
- Patienten (3)
- Patientenverfügung (3)
- Pe (3)
- Peripheres Nervensystem (3)
- Peristaltik (3)
- Peritonitis (3)
- Persönlichkeitsmerkmale (3)
- Persönlichkeitsstörung (3)
- Pest (3)
- Pharmakotherapie (3)
- Phospholipide (3)
- Phosphorylierung (3)
- Phänotyp (3)
- Plaque (3)
- Plexus brachialis (3)
- Polyadenylierung (3)
- Polymerisation (3)
- Positron emission tomography (3)
- Pregnancy (3)
- Prognosefaktor (3)
- Prognosefaktoren (3)
- Prophylaxe (3)
- Prosodie (3)
- Prostate Cancer (3)
- Prostatektomie (3)
- Protein p8 (3)
- Protein-Tyrosin-Kinasen (3)
- Proteine (3)
- Proteinkinase C (3)
- Proteinurie (3)
- Pseudarthrose (3)
- Psychische Gesundheit (3)
- Psychopathologie (3)
- Purkinje cells (3)
- Quality of Life (3)
- Qualität (3)
- Qualitätskontrolle (3)
- RCT (3)
- RKIP (3)
- RNA interference (3)
- RNA polymerase II (3)
- RNA-sequencing (3)
- RNAi (3)
- RS-Virus (3)
- RT-qPCR (3)
- RYGB (3)
- Rac (3)
- Radiochemotherapie (3)
- Radiologie (3)
- Radiosurgery (3)
- Raf (3)
- Raman-Spektroskopie (3)
- Rauchen (3)
- Recurrence (3)
- Recurrensparese (3)
- Regeneration (3)
- Regression (3)
- Regulatorische T-Zellen (3)
- Remineralisation (3)
- Renal cell carcinoma (3)
- Renin-Angiotensin-System (3)
- Restaurative Zahnmedizin (3)
- Retroviren (3)
- Rezidivrate (3)
- RhoA (3)
- Ribosom (3)
- Risk (3)
- SBRT (3)
- SF-36 (3)
- SGLT1 (3)
- SIRS (3)
- SIV (3)
- SLOOP (3)
- SOX9 (3)
- SPECT/CT (3)
- Sagittalnahtsynostose (3)
- Salmonella typhi (3)
- Salmonella typhimurium (3)
- Schaf (3)
- Scherstress (3)
- Schichttechnik (3)
- Schlafkrankheit (3)
- Schleimhaut (3)
- Schockraumalgorithmus (3)
- Schwein (3)
- Score (3)
- Selbstmord (3)
- Selen (3)
- Selenoprotein P (3)
- Senile Makuladegeneration (3)
- Serum (3)
- Sicherheit (3)
- Silicone (3)
- Silikon (3)
- Siloran (3)
- Simulationstraining (3)
- Skiverletzung (3)
- South Africa (3)
- Speckle tracking (3)
- Speicheldrüse (3)
- Spektroskopie (3)
- Sphingolipide (3)
- Spinal Muscular Atrophy (3)
- Spinalganglion (3)
- Sprache (3)
- Sprachverständlichkeit (3)
- Staging (3)
- Statine (3)
- Stereophotogrammetrie (3)
- Stereophotogrammetry (3)
- Stoffwechsel (3)
- Strainrate (3)
- Streptomyces (3)
- Störgeräusch (3)
- Subarachnoidalblutung (3)
- Substantia nigra (3)
- Succinylcholine (3)
- Surgery (3)
- T cell activation (3)
- T-cell (3)
- T-cell lymphoma (3)
- THA (3)
- TKI (3)
- TNAP (3)
- TNF superfamily (3)
- TNF-α (3)
- TNFR1 (3)
- TRAF2 (3)
- TRH (3)
- Targeted therapy (3)
- Testosteron (3)
- Th17 (3)
- Therapieergebnisse (3)
- Thrombozytenaktivierung (3)
- Thymom (3)
- Tissue engineering (3)
- Tolerance (3)
- Tourette syndrome (3)
- Transkription (3)
- Transkription <Genetik> (3)
- Transkriptionsfaktoren (3)
- Transporter (3)
- Treg (3)
- Tricalciumphosphat (3)
- TrkB (3)
- Trypanosoma brucei (3)
- Trypanosomiase (3)
- Trypanosomiasis (3)
- Tumorerkrankungen (3)
- Tumorstoffwechsel (3)
- Tumorsuppressorgen (3)
- Tumortherapie (3)
- USP8 (3)
- Ultraschallkontrastmittel (3)
- Umfrage (3)
- Ureaplasma urealyticum (3)
- Urin (3)
- Urothelkarzinom (3)
- Urämietoxine (3)
- VE-Cadherin (3)
- VMAT (3)
- VSOP (3)
- Validation (3)
- Vaskularisierung (3)
- Verlauf (3)
- Vertigo (3)
- Vif (3)
- Vigilanz (3)
- Visus (3)
- Viszeralchirurgie (3)
- Volumentomographie (3)
- Vorsprachliche Entwicklung (3)
- WNT (3)
- Wachstumsfaktoren (3)
- Wertigkeit (3)
- Wiederbelebung (3)
- Wilms' tumor (3)
- Wnt-Proteine (3)
- Wurzelkanalbehandlung (3)
- Würzburg / Institut für Humangenetik (3)
- X-ray crystallography (3)
- Xenotransplantation (3)
- Yoga (3)
- Zahnersatz (3)
- Zahnprothetik (3)
- Zebrabärbling (3)
- Zellkontakt (3)
- Zufriedenheit (3)
- Zwangsstörung (3)
- Zytoskelett (3)
- Zytotoxizität (3)
- accuracy (3)
- acetylsalicylic acid (3)
- actins (3)
- acupuncture (3)
- acute renal failure (3)
- adalimumab (3)
- adaptive immune system (3)
- adenoma (3)
- adhesion molecules (3)
- adiponectin (3)
- adipose-derived stromal cells (3)
- adrenal crisis (3)
- adrenal gland (3)
- adrenocortical cancer (3)
- adsorption (3)
- adulthood (3)
- adverse events (3)
- aggregation (3)
- aggression (3)
- airway management (3)
- alkaline phosphatase (3)
- allogene Stammzelltransplantation (3)
- allogeneic hematopoietic stem cell transplantation (3)
- alpha-synuclein (3)
- amino acid (3)
- amyloidosis (3)
- amyotrophic lateral sclerosis (3)
- anaemia (3)
- analysis of variance (3)
- angiotensin II (3)
- ankle (3)
- antagonist (3)
- antibakteriell (3)
- anticoagulants (3)
- antigen (3)
- antimicrobial peptides (3)
- antimicrobials (3)
- antimikrobielle Peptide (3)
- aortic aneurysm (3)
- aortic stenosis (3)
- arrhythmogenic cardiomyopathy (3)
- artemisinin (3)
- arteriosclerosis (3)
- arthritis (3)
- arthrography (3)
- arthroplasty (3)
- aspirin (3)
- assay (3)
- association study (3)
- attention deficit/hyperactivity disorder (3)
- attentional bias (3)
- auditory cortex (3)
- auditory evoked potentials (3)
- autoantibody (3)
- autoimmune (3)
- autoimmune disease (3)
- autologous stem cell transplantation (3)
- automation (3)
- awareness (3)
- axonal damage (3)
- bacterial meningitis (3)
- balance (3)
- beta-D-glucan (3)
- bevacizumab (3)
- binding analysis (3)
- binding protein (3)
- biofilm (3)
- bioinformatics (3)
- biological models (3)
- biology (3)
- biomedical engineering (3)
- biomedical materials (3)
- biosensors (3)
- biosynthesis (3)
- birth cohort (3)
- bleeding (3)
- blood-brain-barrier (3)
- body mass index (3)
- bonding agent (3)
- bone adhesive (3)
- bone defect (3)
- bone density (3)
- bone disease (3)
- bone metabolism (3)
- bone substitute (3)
- bone-marrow (3)
- brain derived neurotrophic factor (3)
- brain edema (3)
- breast-tumors (3)
- bridging (3)
- bruxism (3)
- bullous pemphigoid (3)
- burden (3)
- c-Fos (3)
- cFLIP (3)
- calcium phosphate cement (3)
- cancer stem cells (3)
- capecitabine (3)
- cardiac rehabilitation (3)
- cardiolipin (3)
- cardiology (3)
- cardiomyocytes (3)
- cardiovascular magnetic resonance (3)
- cell fusion (3)
- cell membranes (3)
- ceramics (3)
- ceramide (3)
- cerebellar tDCS (3)
- channel (3)
- chlamydia trachomatis (3)
- cholesterol (3)
- chondrogenesis (3)
- chronic stress (3)
- claudin-1 (3)
- clinical outcome (3)
- clinical practice (3)
- clonality (3)
- cloning (3)
- closed head injury (3)
- coating (3)
- cochlear implantation (3)
- cohort studies (3)
- cohort study (3)
- colonoscopy (3)
- comparative genomic hybridization (3)
- comparative genomics (3)
- complement system (3)
- composite (3)
- contrast media (3)
- copy number variation (3)
- cornea (3)
- corneal confocal microscopy (3)
- criteria (3)
- crowdsensing (3)
- crystal structure (3)
- cycloid psychosis (3)
- damage (3)
- deafness (3)
- death receptors (3)
- decision making (3)
- deficient mice (3)
- degradation (3)
- density functional theory (3)
- dental implants (3)
- depressive disorder (3)
- desmin (3)
- diabetic nephropathy (3)
- differential diagnosis (3)
- diffuse large B-cell lymphoma (3)
- disability (3)
- dizziness (3)
- down regulation (3)
- drug adverse reaction (3)
- drug allergy (3)
- drug discovery (3)
- drug hypersensitivity (3)
- drug metabolism (3)
- drug resistance (3)
- drug therapy (3)
- drugs (3)
- dyslexia (3)
- eating disorders (3)
- efficiency (3)
- elderly (3)
- electrical impedance tomography (3)
- electrohydrodynamic (3)
- electromyography (3)
- electron microscopy (3)
- embryo (3)
- emotional regulation (3)
- emphysema (3)
- endoradiotherapy (3)
- endotheliale Vorläuferzellen (3)
- endurance (3)
- endurance training (3)
- environmental health (3)
- ependymoma (3)
- epidermis (3)
- esophagus (3)
- essential tremor (3)
- estrogen receptor (3)
- ethanol (3)
- etomidate (3)
- evidence-based medicine (3)
- evozierte Potentiale (3)
- exome sequencing (3)
- exosomes (3)
- experimental stroke (3)
- extracorporeal membrane oxygenation (3)
- eyes (3)
- fanconi anemia (3)
- fear generalization (3)
- fibroblast activation protein (3)
- fibromyalgia (3)
- fibronectin (3)
- fixation (3)
- fluorescence (3)
- foamy virus (3)
- follow up (3)
- fpVCT (3)
- fragment reattachment (3)
- frailty (3)
- frontotemporal dementia (3)
- gait (3)
- gait analysis (3)
- gastric bypass (3)
- gefitinib (3)
- gender differences (3)
- gene targeting (3)
- genes (3)
- genome annotation (3)
- genomics (3)
- genotype (3)
- germinal center (3)
- glial fibrillary acidic protein (3)
- glomerular filtration rate (3)
- glucose transporter (3)
- glutamate transporters (3)
- glutamine (3)
- glycolysis (3)
- growth cone (3)
- growth hormone deficiency (3)
- guided bone regeneration (3)
- guinea pig (3)
- haemodialysis (3)
- head and neck (3)
- hearing aid (3)
- hearing loss (3)
- hearing screening (3)
- heart rate variability (3)
- heart transplantation (3)
- hematology (3)
- hemodiafiltration (3)
- hepatitis C virus (3)
- herpesvirus (3)
- hiPSC-CM (3)
- hip fracture (3)
- histone H2AX (3)
- history of medicine (3)
- hormones (3)
- human behaviour (3)
- humanized mice (3)
- hydrodynamics (3)
- hydrogel (3)
- hydrogels (3)
- hyperalgesia (3)
- hypercholesterolemia (3)
- hyperexpression techniques (3)
- idiopathic pulmonary fibrosis (3)
- immediate early genes (3)
- immune reconstitution (3)
- immunity (3)
- immunization (3)
- immunoassay (3)
- immunoglobulin (3)
- immunohistochemistry techniques (3)
- immunosenescence (3)
- impulsivity (3)
- in situ hybridization (3)
- incisional hernia (3)
- indication for surgery (3)
- infant (3)
- integration (3)
- interleukin-6 (3)
- intervention (3)
- interview (3)
- invasive fungal infection (3)
- iron deficiency (3)
- ischemia/reperfusion injury (3)
- islet transplantation (3)
- islets of Langerhans (3)
- ketogenic diet (3)
- knee joint (3)
- laparoscopic ventral hernia repair (3)
- larynx (3)
- left ventricular ejection fraction (3)
- leishmania major (3)
- length of stenosis (3)
- leptin (3)
- leukocytes (3)
- library screening (3)
- lipid metabolism (3)
- lipid rafts (3)
- liraglutide (3)
- local field potentials (3)
- low back pain (3)
- low-grade glioma (3)
- lung injury (3)
- lymph node dissection (3)
- mCRP (3)
- malignancy (3)
- malignant tumors (3)
- malnutrition (3)
- mandible (3)
- medaka (3)
- medical (3)
- medical research (3)
- medical students (3)
- melt electrowriting (MEW) (3)
- membrane (3)
- men (3)
- meningococci (3)
- mental disorders (3)
- mesencephalic locomotor region (3)
- mesenchymal stem cell (3)
- mesenchymal stromal cells (3)
- metabolischer Test (3)
- methionine restriction (3)
- miR (3)
- microRNAs (3)
- microbiota (3)
- micronucleus test (3)
- microvascular endothelial cells (3)
- mineralization (3)
- minimal-invasiv (3)
- minimally invasive surgery (3)
- mitotane (3)
- mobile health (3)
- molecular modelling (3)
- molecular neuroscience (3)
- morphology (3)
- mothers (3)
- motility (3)
- motoneurons (3)
- motor control (3)
- mtDNA (3)
- multicenter (3)
- multilocularis (3)
- murine (3)
- myelination (3)
- myeloma (3)
- myofibroblast (3)
- nNOS (3)
- necroptosis (3)
- necrosis-factor-alpha (3)
- neisseria meningitidis (3)
- neonate (3)
- nephrotoxicity (3)
- neural stem cells (3)
- neurofilament light chain (3)
- neuroimaging (3)
- neurological disorders (3)
- neuromelanin (3)
- neuromonitoring (3)
- neuropathischer Schmerz (3)
- neuropathology (3)
- neuropsychiatric disorders (3)
- neuropsychology (3)
- neurotrophic factors (3)
- neutrophil (3)
- newborn (3)
- nociception (3)
- noradrenaline (3)
- nystagmus (3)
- occlusion (3)
- oncogenes (3)
- opioid receptors (3)
- optical coherence tomography (3)
- organoid (3)
- orofacial clefts (3)
- oropharynx (3)
- orthodontics (3)
- osteogenesis (3)
- ovarian carcinoma (3)
- oxygenation (3)
- p38 MAPK (3)
- palliativ (3)
- pandemic (3)
- parasitology (3)
- parents (3)
- pars plana vitrectomy (3)
- pathology (3)
- pathophysiology (3)
- patient education (3)
- pattern (3)
- pemphigus vulgaris (3)
- peptide (3)
- peptide receptor radionuclide therapy (3)
- periodic catatonia (3)
- periodische Katatonie (3)
- peristalsis (3)
- peritonitis (3)
- permeability (3)
- persistence (3)
- phagocytosis (3)
- pharmacogenetics (3)
- pharmacovigilance (3)
- phosphoantigen (3)
- photothrombotic stroke (3)
- physiology (3)
- plasma (3)
- plasma membrane (3)
- polarization (3)
- polygenic risk score (3)
- polymerase chain reaction (3)
- polymers (3)
- positron-emission-tomography (3)
- preterm (3)
- pro-inflammatory cytokines (3)
- progeria (3)
- prognostic marker (3)
- prostate-specific membrane antigen (PSMA) (3)
- protein kinases (3)
- psychische Belastung (3)
- psychophysics (3)
- pulmonary embolism (3)
- quality (3)
- radiography (3)
- radiology (3)
- radiomics (3)
- rapid prototyping (3)
- real time PCR (3)
- real-time PCR (3)
- recruitment (3)
- regulatorische T Zellen (3)
- regulatory T-cells (3)
- remineralization (3)
- remodelling (3)
- renal (3)
- reporting and data system (3)
- response inhibition (3)
- resuscitation (3)
- retina (3)
- retrospective analysis (3)
- reverse transcriptase (3)
- rheology (3)
- rhinitis (3)
- rickets (3)
- rubber hand illusion (3)
- salivary gland (3)
- salthydratic melt (3)
- sarcoidosis (3)
- scleroderma (3)
- selenoproteins (3)
- sensory neurons (3)
- serum concentration (3)
- sex (3)
- shock (3)
- shoulder arthroplasty (3)
- sialic acid (3)
- side effects (3)
- signaling (3)
- single-sided deafness (3)
- skin (3)
- smooth muscle (3)
- spacer (3)
- speckle tracking (3)
- spectroscopy (3)
- speech recognition (3)
- speech recognition test (3)
- sphingomyelinase (3)
- sphingosine-1-phosphate (3)
- spine (3)
- spiroergometry (3)
- splicing (3)
- squamous cell carcinoma (3)
- staphylococcus aureus (3)
- stemness (3)
- stenosis (3)
- stent (3)
- stereotactic body radiation therapy (3)
- stereotactic irradiation (3)
- strains (3)
- striatum (3)
- stromal cells (3)
- struvite (3)
- substantia nigra (3)
- substituent (3)
- subtypes (3)
- subunit (3)
- subventricular zone (3)
- sudden cardiac death (3)
- sulfur (3)
- surfactants (3)
- surgical oncology (3)
- survival rate (3)
- swine (3)
- synapse (3)
- synaptic inhibition (3)
- synaptic transmission (3)
- systemic sclerosis (3)
- systems biology (3)
- tMCAO (3)
- teaching (3)
- technology (3)
- teeth (3)
- telomeres (3)
- temozolomide (3)
- thermodynamics (3)
- thermoregulation (3)
- three-dimensional imaging (3)
- thymic carcinoma (3)
- tolerance (3)
- tool (3)
- tooth extraction (3)
- trabectome (3)
- trabecular meshwork (3)
- tranexamic acid (3)
- transactivation (3)
- transcranial magnetic stimulation (3)
- transgen (3)
- transgenic mice (3)
- transmission (3)
- transmission electron microscopy (3)
- transport (3)
- transporter (3)
- transposable elements (3)
- transtemporal (3)
- tumor cells (3)
- uremic toxins (3)
- urinary tract infections (3)
- urine (3)
- use (3)
- vaccinia virus (3)
- vancomycin (3)
- vandetanib (3)
- vascular (3)
- vascularization (3)
- vasculitis (3)
- vasculogenesis (3)
- ventilation (3)
- viral load (3)
- viruses (3)
- visual acuity (3)
- von Willebrand factor (3)
- vorsprachliche Entwicklung (3)
- wall shear stress (3)
- whole exome sequencing (3)
- wrist (3)
- xenotransplantation (3)
- xxx (3)
- zinc (3)
- Ätiologie (3)
- Östrogenrezeptor (3)
- Übelkeit (3)
- Übergewicht (3)
- "-omics" (2)
- 11C-HED (2)
- 123I-mIBG (2)
- 123I-metaiodobenzylguanidine (2)
- 18F-FDS (2)
- 19th century (2)
- 2 (2)
- 3-DPG (2)
- 31P-MRS (2)
- 3D - rapid prototyping (2)
- 3D analysis (2)
- 3D cell culture (2)
- 3D models (2)
- 3D powder printing (2)
- 3D scaffolds (2)
- 3D-Kultur (2)
- 3D-Ultraschall (2)
- 3D-Zellkultur (2)
- 3D-conformal radiotherapy (2)
- 3D-printed tooth (2)
- 4-Aminobiphenyl (2)
- 4-HNE (2)
- 4-aminobiphenyl (2)
- 5-Azacytidine (2)
- 5-Azadeoxycytidin (2)
- 5-FU (2)
- 5-HT transporter (2)
- 5-HT1A (2)
- 5-HT1A receptor (2)
- 5-HT2C (2)
- 5-azadeoxycytidine micronucleus (2)
- 68Ga-DOTATATE (2)
- 8p22 (2)
- A1 (2)
- A1 adenosine receptors (2)
- AAA-Knochen (2)
- ABC-Transporter (2)
- ABCG2 (2)
- ACL (2)
- ADAM9 (2)
- ADST (2)
- ALCL (2)
- AMADEUS (2)
- AML (2)
- ANCA (2)
- AP1 (2)
- APC (2)
- AQP4 (2)
- ASCA (2)
- ASCs (2)
- ATF4 (2)
- ATM (2)
- Ab interno trabeculectomy (2)
- Abrieb (2)
- Absolutquantifizierung (2)
- Abstoßung (2)
- Abszess (2)
- Acetylcholinrezeptor (2)
- Acetylcystein (2)
- Acne inversa (2)
- Activity (2)
- Acute myeloid leukemia (2)
- Adenoviren (2)
- Adhäsionsmoleküle (2)
- Adhäsivbrücke (2)
- Adhäsivfraktur (2)
- Adipokine (2)
- Adiponektin (2)
- Adrenocortical Carcinoma (2)
- Adrenostatika (2)
- Adulte Neurogenese (2)
- Adults (2)
- Advanced glycosylation end products (2)
- Adventitia (2)
- Affenimmundefizienzvirus (2)
- Aflatoxin (2)
- Agalsidase beta (2)
- Age (2)
- Agent (2)
- Aggression (2)
- Akademisierung (2)
- Aktionspotenzial (2)
- Aktivität (2)
- Akupunktur (2)
- Akustisch evoziertes Potenzial (2)
- Akute Extremitätenischämie (2)
- Albumin (2)
- Aldosterone (2)
- Aldosteronsynthaseinhibitor (2)
- Algorithmus (2)
- Allelische Verlustanalyse (2)
- Allgemeine Entzündungsreaktion (2)
- Allgemeinmedizin (2)
- Alloantigen (2)
- Allogene Stammzelltransplantation (2)
- Allograft rejection (2)
- Allotransplantation (2)
- Alternans (2)
- Altersdepression (2)
- Alveolarmakrophagen (2)
- Alzheimer (2)
- Ames test (2)
- Aminosäuren (2)
- Amputation (2)
- Amyloidose (2)
- Analfistel (2)
- Anastomosenheilung (2)
- Anastomoseninsuffizienz (2)
- Anatomie (2)
- Androgene (2)
- Aneuploidie (2)
- Angola (2)
- Angsterkrankungen (2)
- Anpassung (2)
- Anthocyane (2)
- Anthropometrie (2)
- Antibiotikafreisetzung (2)
- Antibiotikaresistenz (2)
- Antibiotikaresistenzen (2)
- Antibody (2)
- Antidepressiva (2)
- Antiepileptika (2)
- Antigen CD14 (2)
- Antikörper-Fusionsproteine (2)
- Antimikrobielle Peptide (2)
- Antimykotikaresistenz (2)
- Antioxidantien (2)
- Antipsychotics (2)
- Antipsychotika (2)
- Antisense RNA (2)
- Antisepsis (2)
- Antworthemmung (2)
- Antwortverhalten (2)
- Anästhesiologie (2)
- Anästhetika-induzierte Präkonditionierung (2)
- Aortenklappe (2)
- Aortic valve stenosis (2)
- Apobec (2)
- Apolipoprotein (2)
- Appetitlosigkeit (2)
- Approach-Avoidance-Task (2)
- Array (2)
- Arrhythmie (2)
- Arteria carotis interna (2)
- Arteriosclerosis (2)
- Arzneimittelforschung (2)
- Aspirin (2)
- Association (2)
- Association study (2)
- Ataciguat (2)
- Atemstörung (2)
- Atemwege (2)
- Atrophie (2)
- Auditory brainstem responses AER (2)
- Auditory steady-state responses ASSR (2)
- Aufklärungsgespräch (2)
- Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (2)
- Aufmerksamkeitskontrolle (2)
- Aufmerksamkeitslenkung (2)
- Aufmerksamkeitsprozesse (2)
- Aufmerksamkeitsverzerrung (2)
- Augenfolgebewegung (2)
- Augenhintergrund (2)
- Augenkrankheit (2)
- Augenlid (2)
- Autism spectrum disorders (2)
- Autismus-Spektrum-Störung (2)
- Autoaggressionskrankheit (2)
- Autogene Transplantation (2)
- Autologous hematopoietic stem cell transplantation (2)
- Autoradiography (2)
- Awareness (2)
- Axon degeneration (2)
- Axonal degeneration (2)
- B cell receptors (2)
- B chromosomes (2)
- B lymphocytes (2)
- B-Lymphozyten (2)
- B-lymphocytes (2)
- B-scan-Ultraschallkardiographie (2)
- BALF (2)
- BCG (2)
- BCL6 (2)
- BDNF stimulation (2)
- BERAphon (2)
- BMI (2)
- BMP variants (2)
- BNP (2)
- BOLD signal (2)
- BPD (2)
- BRAF mutation (2)
- BRCA2 (2)
- BTN3 (2)
- Bacillus subtilis (2)
- Balanced lethal System (2)
- Balanced lethal Systeme (2)
- Bariatrische Chirurgie (2)
- Barrett's esophagus (2)
- Barrettösophagus (2)
- Basalganglien (2)
- Basalmembran (2)
- Basketball (2)
- Bcl-2 (2)
- Beatmung (2)
- Bedürfnis (2)
- Befindlichkeit (2)
- Benzene (2)
- Benzochinone (2)
- Beta-Hydroxybutyrat (2)
- Betablocker (2)
- Bewegungsapparat (2)
- Bias (2)
- Bildqualität (2)
- Bindegewebe (2)
- BioVaSc (2)
- Biodruck (2)
- Biokinetics (2)
- Biokompatibel (2)
- Biology (2)
- Biomarkers (2)
- Bioprinting (2)
- Bioreaktor (2)
- Bisphosphonates (2)
- Blastozyste (2)
- Blinddarmentzündung (2)
- Blood pressure (2)
- Blut-Nerven-Barriere (2)
- Blutgefäß (2)
- Bluthochdruck (2)
- Blutstillung (2)
- Bocca (2)
- Body-Mass-Index (2)
- Bodyplethysmographie (2)
- Bone marrow (2)
- Bone-Lock-System (2)
- Bone-marrow-transplantation (2)
- Borrelien (2)
- Bradykinin (2)
- Brainstem-Evoked-Response-Audiometry BERA (2)
- Breast cancer (2)
- Breastcancer (2)
- Bruchfestigkeit (2)
- Bruchfläche (2)
- Bruchverhalten (2)
- Bulimia nervosa (2)
- Bypassoperation (2)
- C-X-C motif chemokine receptor 4 (2)
- C-reaktives Protein (2)
- C/EBP (2)
- C1-inhibitor (2)
- C3 (2)
- C5a (2)
- C5aR1 (2)
- CABG (2)
- CADe (2)
- CAR T cells (2)
- CBCT (2)
- CCL4 (2)
- CCN1 (2)
- CCR2 (2)
- CD1d (2)
- CD20 (2)
- CD274 (2)
- CD30 (2)
- CD38 (2)
- CD4(+) (2)
- CD4(+) T-cells (2)
- CD46 (2)
- CD8 (2)
- CDL (2)
- CI (2)
- CIP2A (2)
- CKD (2)
- CNS disorders (2)
- CNV (2)
- COVID‐19 (2)
- CRC (2)
- CSVD (2)
- CTEPH (2)
- CTLA-4 (2)
- CXCL10 (2)
- CXCL12 (2)
- CXCL13 (2)
- CXCR2 (2)
- CXCR7 (2)
- CYP11B2 (2)
- CYP2W1 (2)
- Cadherin (2)
- Caenorhabditis elegans (2)
- Calcitonin (2)
- Calciumphosphatzemente (2)
- Calearo (2)
- Campylobacter jejuni (2)
- Cancer treatment (2)
- Cannabinoide (2)
- Capecitabin (2)
- Cardiac Surgery (2)
- Cardiac hypertrophy (2)
- Cardiovascular diseases (2)
- Cardiovascular risk factors (2)
- Cartilage regeneration (2)
- Caspase (2)
- Caspase-1 (2)
- Caspasen (2)
- Caspr (2)
- Cefotaxim (2)
- Cell culture (2)
- Cell therapy (2)
- Cellculture (2)
- Cells (2)
- Cement (2)
- Central nervous system (2)
- Cephalometric (2)
- Cerebellum (2)
- Chagas disease (2)
- Charakterisierung (2)
- Charcot-Marie-Syndrom (2)
- Charcot-Marie-Tooth disease (2)
- Checkpoint-Inhibitor (2)
- Chemokin CXCL10 (2)
- Chemokinrezeptor (2)
- Chemokinrezpetor (2)
- Chemoresistenz (2)
- Chemotherapieresistenz (2)
- Chemotherapy (2)
- Childhood medulloblastoma (2)
- Chimerism (2)
- Chirp-Reiz (2)
- Chondrogenic Differentiation (2)
- Chorioamnionitis (2)
- Chromosom 8 (2)
- Chromosomenanalyse (2)
- Chromosomenverlust (2)
- Chronic heart failure (2)
- Chronic kidney disease (2)
- Chronische Nierenerkrankung (2)
- Chronophin (2)
- Chronotrope Inkompetenz (2)
- Ciclosporin (2)
- Claudin-1 (2)
- Claudine <Biologie> (2)
- Cleft (2)
- Clinical Neuroradiology (2)
- Clinical trial (2)
- Clostridium-difficile-Infektion (2)
- Cluster C Persönlichkeitsstörungen (2)
- Cochlea Implantat (2)
- Coffein (2)
- Collagen (2)
- Colombia (2)
- Comet-Assay (2)
- Comorbidity (2)
- Compliance <Patient> (2)
- Composite international diagnostic interview (2)
- Computed tomography (2)
- Connexin (2)
- Constant Score (2)
- Constant score (2)
- Constant-Score (2)
- Continuous Performance Test (2)
- Copeptin (2)
- Coping (2)
- Coronaviren (2)
- Coronavirus (2)
- Corpus striatum (2)
- Cortactin (2)
- Cortison (2)
- Craniomandibuläre Dysfunktion (2)
- Craniopharyngioma (2)
- Crohn's disease (2)
- Crohn´s disease (2)
- Crohn’s disease (2)
- Crouzon (2)
- Crush (2)
- Cryo-EM (2)
- Cue-Reaktivität (2)
- Cushing’s disease (2)
- Cyclonucleotide (2)
- Cyclophosphamid (2)
- Cys-loop receptor (2)
- Cytoskeleton (2)
- DAPI staining (2)
- DAT (2)
- DCIS (2)
- DM-domain gene (2)
- DM2 (2)
- DNA Binding (2)
- DNA double-strand break (2)
- DNA sequencing (2)
- DNA-Binding (2)
- DNA-PK (2)
- DNA-Reparaturgene (2)
- DNA-Schaden (2)
- DNA-Typisierung (2)
- DNA-binding proteins (2)
- DNA-typing (2)
- DNS (2)
- DOTATOC (2)
- DSG2 (2)
- DW-MRI (2)
- Dacron (2)
- Debonding (2)
- Deep learning (2)
- Definition (2)
- Deformität (2)
- Degradation (2)
- Delta-Valve (2)
- Demyelinisierung (2)
- Dentale Implantate (2)
- Dentalwerkstoff (2)
- Dentin (2)
- Dentinadhäsivsysteme (2)
- Dentinhaftvermittler (2)
- Desmoglein (2)
- Desmogleine (2)
- Detektion (2)
- Dexamethason (2)
- Diabetes mellitus Typ 2 (2)
- Diagnostic medicine (2)
- Dialysepatienten (2)
- Dialysis (2)
- Dickenmessung (2)
- Diethylstilbestrol (2)
- Differentialdiagnose (2)
- Differentielle Genexpression (2)
- Differenziertes Schilddrüsenkarzinom (2)
- Diffusion Tensor Imaging (2)
- Diffusions-MRT (2)
- Diffusionsgewichtete Magnetresonanztomographie (2)
- Dimorphismus (2)
- Diseases (2)
- Distale Radiusfraktur (2)
- Distress (2)
- Dobutamin-Stressechokardiographie (2)
- Domäne <Biochemie> (2)
- Dopamintransporter (2)
- Doppelkronen (2)
- Dorsal Root Ganglion (2)
- Dorsal root ganglion (2)
- Dose response (2)
- Dose-response relationship (2)
- Dosimetrie (2)
- Dosimetry (2)
- Dosisreduktion (2)
- Down syndrome (2)
- Dreidimensionale Rekonstruktion (2)
- Drosophila melanogaster (2)
- Druckmessung (2)
- Dsg2 (2)
- Dual-Source-Computertomographie (2)
- Duchenne (2)
- Duchenne muscular dystrophy (2)
- Duchenne-Syndrom (2)
- Durchflußzytometrie (2)
- Dynamik (2)
- Dystonia (2)
- Dämpfung (2)
- Dämpfungseigenschaften (2)
- Dünndarmtransplantat (2)
- E-cadherin (2)
- E-learning (2)
- E. coli (2)
- EAA (2)
- EBRA (2)
- ECMO-Therapie (2)
- EDA (2)
- EF (2)
- EF-1A (2)
- EGF (2)
- EGF-Rezeptor (2)
- EGF-receptor (2)
- EHEC (2)
- ELBWI (2)
- EMT (2)
- EPC (2)
- EUROASPIRE (2)
- EXKK (2)
- EZH2 (2)
- Echtzeit (2)
- Efavirenz (2)
- Einfluss (2)
- Einflussfaktoren (2)
- Einsilbersprachverständnistest (2)
- Elastizitätsmodul (2)
- Elderly (2)
- Electropermeabilization (2)
- Electrophysiology (2)
- Electrospinning (2)
- Elektrofusion (2)
- Elektroimpedanztomographie (2)
- Elektronenmikroskopie (2)
- Elektrospinnen (2)
- Elektrospinning (2)
- Elektrostimulation (2)
- Elmex (2)
- Emotional processing (2)
- Empowerment (2)
- End-of-Life Care (2)
- Endobrachyösophagus (2)
- Endocannabinoide (2)
- Endokrinologie (2)
- Endoskopie (2)
- Endosonographie (2)
- Endothelbarriere (2)
- Endothelial dysfunction (2)
- Endothelin (2)
- Endothelzellen (2)
- Energiestoffwechsel (2)
- Enoxaparin (2)
- Enterobacteriaceae (2)
- Entnahmemorbidität (2)
- Entscheidungsfindung (2)
- Entscheidungsunterstützungssystem (2)
- Entzündungsparameter (2)
- Enzephalitis (2)
- Enzyme-linked immunosorbent assay (2)
- Enzymersatztherapie (2)
- Epidemiology (2)
- Epithelial-mesenchymale Transition (2)
- Epithelzelle (2)
- Eplerenone (2)
- Epstein-Barr-Virus (2)
- Ergebnisse (2)
- Erlotinib (2)
- Erratum (2)
- Erregbarkeit (2)
- Erwachsenenalter (2)
- Erythrozyten (2)
- Escherichia coli K1 (2)
- Escitalopram (2)
- Estrogen (2)
- Ethanol (2)
- Europe (2)
- Euthanasie (2)
- Everolimus (2)
- Evolution (2)
- Ewing-Sarkom (2)
- Exercise capacity (2)
- Exercise testing (2)
- Expansion (2)
- Experimental autoimmune encephalomyelitis (2)
- Experimentelle autoimmune Enzephalomyelitis (2)
- Extinktion (2)
- Extraversion (2)
- Eyelid (2)
- Ezetimib (2)
- FACS (2)
- FAP (2)
- FDG PET/CT (2)
- FFPE (2)
- FGF-pathway (2)
- FGFR1 (2)
- FIB-4 (2)
- FMRI (2)
- FRET (2)
- Fabry (2)
- Fabry genotype (2)
- Fabry phenotype (2)
- Fahrradergometer (2)
- Faktorenanalyse (2)
- Familienuntersuchung (2)
- Family-Investigation (2)
- Fanconi Anemia (2)
- FasL (2)
- Fc-receptor (2)
- FcγR (2)
- Fear (2)
- Fehlstellung (2)
- Fettleibigkeit (2)
- Fettzelle (2)
- Fibroblasten (2)
- Fibromyalgia (2)
- Fibromyalgia syndrome (2)
- Fibronektin (2)
- Fluktuation (2)
- Fluorescence Microscopy (2)
- Fluoreszenzaktivierter Zellsortierer (2)
- Fluoxetin (2)
- Foamy virus (2)
- Fortpflanzung (2)
- FoxO3 (2)
- FoxP3 (2)
- Foxp3 (2)
- Frequency (2)
- Frequenzanalyse (2)
- Friedreich-Ataxie (2)
- Frühdiagnostik (2)
- Frühe Neuzeit (2)
- Frühe akustisch evozierte Potentiale FAEP (2)
- Frühgeburt (2)
- Frühphase (2)
- Fundoplikatio (2)
- Fundusautofluoreszenz (2)
- Funktionelle Kernspintomografie (2)
- Funktionelle NMR-Tomographie (2)
- Furchtgeneralisierung (2)
- G protein-coupled receptors (2)
- G-Protein (2)
- GABAA receptors (2)
- GATA-3 (2)
- GDF-5 (2)
- GERD (2)
- GLAST (2)
- GLP-1 (2)
- GLT1 (2)
- GLUT1 (2)
- GLUT2 (2)
- GLaD-Studie (2)
- GLaD-study (2)
- GM-CSF (2)
- GPVI (2)
- GSK3 (2)
- GWAS (2)
- Galectine (2)
- Galvanische Abscheidung (2)
- Ganganalyse (2)
- Gastric-banding (2)
- Gastroschisis (2)
- Gastroösophageale Refluxkrankheit (2)
- Gastroösophagealer Reflux (2)
- Gaumen (2)
- Gaumenplatte (2)
- Gaumenspalte (2)
- Gedächtnis (2)
- Gefäßchirurgie (2)
- Gelelektrophorese (2)
- Gelenkpositionierung (2)
- Gemeinschaftsunterkunft (2)
- Gender (2)
- Gene therapy (2)
- Genetic instability (2)
- Genetics research (2)
- Genklonierung (2)
- Genom (2)
- Genomschaden (2)
- Genotyp (2)
- Gentechnologie (2)
- Gentransfer (2)
- Geriatrics (2)
- German Hepatitis C-Registry (2)
- Geschichte der Zahnheilkunde (2)
- Geschlechtschromosomen (2)
- Gesicht (2)
- Gesundheitssystem (2)
- Gesundheitswesen (2)
- Gewalt (2)
- Gewebe (2)
- Gewichtsabnahme (2)
- Glasfaserstift (2)
- Glatiramer acetate (2)
- Glatte Muskulatur (2)
- Gleason score (2)
- Gliedergürtelmuskeldystrophie (2)
- Glucose metabolism (2)
- Glucosetransporter (2)
- Glutamin (2)
- Glycin (2)
- Grad-seq (2)
- Graft-versus-leukemia (2)
- Group B Streptococcus (2)
- Grundfrequenz (2)
- Guidelines (2)
- Guillain-Barre-Syndrome (2)
- Guillain-Barré syndrome (2)
- Gynäkologie (2)
- HBV (2)
- HCM (2)
- HD (2)
- HDGF (2)
- HES (2)
- HFQ (2)
- HFrEF (2)
- HHV-6 (2)
- HIV-infection (2)
- HIVDR (2)
- HLA-E (2)
- HPA axis (2)
- HPP (2)
- HRV (2)
- HSC (2)
- HSM-sentence test (2)
- HSM-test (2)
- HUWE1 (2)
- HaCaT (2)
- Haftvermittler (2)
- Halacha (2)
- Halcyon (2)
- Hallux (2)
- Halothane (2)
- Hals-Nasen-Ohren-Heilkunde (2)
- Hamburg (2)
- Haplotyp (2)
- Harnableitung (2)
- Harnwegsinfekt (2)
- Harnwegsinfektionen (2)
- Harris Hip Score (2)
- Hashimoto-Thyreoiditis (2)
- Hausarzt (2)
- Hauttumor (2)
- HeLa cells (2)
- Head orthosis therapy (2)
- Heart Failure (2)
- Hebamme (2)
- Helkimo (2)
- Hemmstoff (2)
- Heparin (2)
- Hereditäres Angioödem (2)
- Hernia (2)
- Hernienchirurgie (2)
- Herpes (2)
- Herpesvirus (2)
- Herzdekompensation (2)
- Herzkrankheit (2)
- Heterotope Ossifikation (2)
- Heterotransplantation (2)
- Heubacillus (2)
- Hfq (2)
- Hip (2)
- Hippo signaling (2)
- Hirndruck (2)
- Hirninfarkt (2)
- Hirnmetastase (2)
- Hirnstammimplantat (2)
- Histon-Deacetylase (2)
- History of Psychiatry (2)
- Hitzeschock (2)
- Hochfrequenz-Oszillations-Ventilation (2)
- Hodenhochstand (2)
- Hodgkin (2)
- Hormon (2)
- Hospitalismus <Hygiene> (2)
- Hospitalization (2)
- Hospiz (2)
- Hsp90 (2)
- Huh6 (2)
- Human papillomavirus (2)
- Humorale Immunität (2)
- Hyaluronic acid (2)
- Hydrocephalus (2)
- Hydroxybutyrat <3-> (2)
- Hydroxyethylstärke (2)
- Hyperandrogenämie (2)
- Hypercholesterinämie (2)
- Hyperekplexie (2)
- Hyperkapnie (2)
- Hypertherme Chemotherapie (2)
- Hypertrophy (2)
- Hypoparathyreoidismus (2)
- Hypopharynx (2)
- Hypopharynxkarzinom (2)
- Hypoxia (2)
- Hämatopoese (2)
- Hämochromatose (2)
- Hämodiafiltration (2)
- Hämoglobinaddukte (2)
- Hämophilie A (2)
- Härte (2)
- Höckerdeformation (2)
- Höranstrengung (2)
- Hörbahn (2)
- Hören (2)
- Hörsturz (2)
- Hüftdysplasie (2)
- Hüfte (2)
- IABP (2)
- IENFD (2)
- IGF-1 (2)
- IGF-I (2)
- IL-12 (2)
- IL-4 (2)
- IL-8 (2)
- ILEX (2)
- IMAT (2)
- IPOS (2)
- ISGF3 (2)
- ISRE (2)
- ISS (2)
- Identification (2)
- Idiopathische pulmonale Fibrose (2)
- IgG (2)
- IgG4 (2)
- Ileus (2)
- Image Quality (2)
- Image-guidance (2)
- Imatinib (2)
- Immunaktivierung (2)
- Immuncheckpointinhibitor (2)
- Immunglobulin M (2)
- Immunhistologie (2)
- Immunität <Medizin> (2)
- Immunological synapse (2)
- Immunrekonstitution (2)
- Impedanz (2)
- Impfstoff (2)
- Implantate (2)
- Implizites Gedächtnis (2)
- In-situ-Venenbypass (2)
- Incidentaloma (2)
- Indian Hedgehog (2)
- Induced apoptosis (2)
- Infarkt (2)
- Infarktheilung (2)
- Infections (2)
- Infectious disease (2)
- Infektiologie (2)
- Infektionen (2)
- Infektionsbiologie (2)
- Inferior colliculus (2)
- Inflammasom (2)
- Inflammatory pain (2)
- Inhibitorische Synapse (2)
- Inhibitory synapse (2)
- Injectability (2)
- Injury Severity Score (2)
- Inkontinenz (2)
- Innervation (2)
- Instabilität (2)
- Insulinresistenz (2)
- Intensitätsmodulierte Radiotherapie (2)
- Intensivkapazitäten (2)
- Interaktion (2)
- Interaktionen (2)
- Interaktionsanalyse (2)
- Interleukin (2)
- Interleukin 13 (2)
- Interleukin 2 (2)
- Interleukin 3 (2)
- Interleukin 4 (2)
- Interleukin-3 (2)
- Intimahyperplasie (2)
- Intravenös (2)
- Intubation (2)
- Invasive Aspergillose (2)
- Inzidenz <Medizin> (2)
- Iod (2)
- Ioflupane (2)
- Ionisierende Strahlung (2)
- Ischemia (2)
- Ischämischer Schlaganfall (2)
- JIA (2)
- JQ1 (2)
- KEAP1 (2)
- KLRG1 (2)
- KLT (2)
- Kallikrein-Kinin-System (2)
- Kalorimetrie (2)
- Kandidatengene (2)
- Kaninchen (2)
- Kanzerogenese (2)
- Kaposi sarcoma (2)
- Kapselshift (2)
- Kardiomyozyten (2)
- Kardiovaskuläre Krankheit (2)
- Kardiovaskuläre Risikofaktoren (2)
- Karzinomzellen (2)
- Kaukraft (2)
- Kehlkopf (2)
- Keimspektrum (2)
- Keimzellmosaik (2)
- Keimzentrum (2)
- Keramik (2)
- Keratokonus (2)
- Kernproteine (2)
- Ketogenic diet (2)
- Keuchhusten (2)
- Ki-67 (2)
- Ki67 (2)
- Kidney function (2)
- Kidney transplantation (2)
- Kiefergelenkkrankheit (2)
- Kieferorthopädische Drähte (2)
- Kieferosteonekrose (2)
- Kieferspalte (2)
- Kinderfuß (2)
- Kinderpsychiatrie (2)
- Kinderschuh (2)
- Kinderschutz (2)
- Kindertagesstätte (2)
- Kindesmisshandlung (2)
- Klassifikation der endogenen Psychosen (2)
- Kleinhirn (2)
- Klinik (2)
- Klinische Psychotherapie (2)
- Klinische Studie (2)
- Knie (2)
- Knochenbildung (2)
- Knochendefekt (2)
- Knochenersatzmaterialien (2)
- Knochenersatzwerkstoff (2)
- Knochenkleber (2)
- Knochenmarktransplantation (2)
- Knochenmarkzelle (2)
- Knochennekrose (2)
- Knockdown (2)
- Knorpelintegration (2)
- Knorpelzelle (2)
- Koffein (2)
- Kohäsivfraktur (2)
- Kollagenase (2)
- Komfortlaut (2)
- Komplementärmedizin (2)
- Kompressionstherapie (2)
- Konditionierung (2)
- Konflikterkennung (2)
- Kongestive Herzmuskelkrankheit (2)
- Konservierende Zahnmedizin (2)
- Kontamination (2)
- Kontext (2)
- Kopf (2)
- Kopf-Hals-Karzinom (2)
- Kopf-Hals-Tumore (2)
- Koronarangiographie (2)
- Koronarintervention (2)
- Koronarperfusion (2)
- Korrosion (2)
- Kosmetik (2)
- Kosten (2)
- Kraftmessung (2)
- Kraniostenose (2)
- Krankheit (2)
- Krankheitsverlauf (2)
- Krebskranker (2)
- Kreuzreaktivität (2)
- Kritische Extremitätenischämie (2)
- Kulturmedium (2)
- Kunstkopf (2)
- Körperselbstgefühl (2)
- Körpertherapie (2)
- LAD (2)
- LC-MS (2)
- LDL (2)
- LORETA (2)
- Laborleistungstests (2)
- Laborparameter (2)
- Lagerungsplagiocephalus (2)
- Langerhansinseln (2)
- Langzeit (2)
- Laryngoskop (2)
- Lasiocarpin (2)
- Latenz (2)
- Laufverletzungen (2)
- Lauge-Hansen (2)
- Lebenssinn (2)
- Lebermetastase (2)
- Leberresektion (2)
- Leishmania major (2)
- Leistenhernie (2)
- Leistungsdiagnostik (2)
- Leitlinie (2)
- Leitlinien (2)
- Lenalidomid (2)
- Lendenwirbelsäule (2)
- Lepra (2)
- Letalität (2)
- Leukoplakie (2)
- Leukozyt (2)
- Leukämie (2)
- Lichen ruber planus (2)
- Lichtheimia (2)
- Lichthärtung (2)
- Ligamentum cruciatum anterius (2)
- Ligand (2)
- Linksventrikuläre Hypertrophie (2)
- Lipodystrophie (2)
- Lipofuscin (2)
- Lipopolysaccharide (2)
- Lippenspalte (2)
- Listeria monocytogenes (2)
- Locus coeruleus (2)
- Lokalanästhesie (2)
- Longitudinally extensive transverse myelitis (LETM) (2)
- Lung (2)
- Lung cancer (2)
- Lungenfibroblasten (2)
- Lungenfunktionsdiagnostik (2)
- Lungenmetastase (2)
- Lungwitz (2)
- Lyme-Krankheit (2)
- Lymphadenektomie (2)
- Lymphoma (2)
- Lysosomale Speicherkrankheit (2)
- Lysozym (2)
- MACC1 (2)
- MALDI-MS (2)
- MALT (2)
- MALT-lymphoma (2)
- MASK (2)
- MATQ-seq (2)
- MBP (2)
- MCC950 (2)
- MCP-1 (2)
- MDD (2)
- ME/CFS (2)
- MEK (2)
- MHC I (2)
- MHC Klasse II (2)
- MHC molecules (2)
- MIF (2)
- MIS (2)
- MIZ1 (2)
- MK801 (2)
- MMP9 (2)
- MPS1 (2)
- MR (2)
- MRONJ (2)
- MSI (2)
- MUS (2)
- MYCN (2)
- Magenchirurgie (2)
- Magenkarzinom (2)
- Magnesiumphosphat (2)
- Magnetic Resonance Imaging (2)
- Magnetische Kernresonanz (2)
- Malawi (2)
- Malignant Hyperthermia (2)
- Malignant melanoma (2)
- Mangelgeborenes (2)
- Mantelzell-Lymphom (2)
- Mantle cell lymphoma (2)
- Massenspektrometrie (2)
- Mastdarmkrebs (2)
- Matrixmetalloproteinasen (2)
- Mc4r (2)
- Mechanosensation (2)
- Medikamente (2)
- Medizingeschichte <Fach> (2)
- Medizinische Klinik (2)
- Medizinkritik (2)
- Medizinphysik (2)
- Medizinstudent (2)
- Medizinstudium (2)
- Medullärer Schilddrüsenkrebs (2)
- Medulläres Schilddrüsenkarzinom (2)
- Melanin (2)
- Melt electrowriting (2)
- Memantin (2)
- Memory B cells (2)
- Mena (2)
- Meningeom (2)
- Meningioma (2)
- Meningoencephalitis (2)
- Menière-Krankheit (2)
- Menopause (2)
- Merkel cell polyomavirus (2)
- Merlin (2)
- Mesenchymal Stem Cell (2)
- Mesenchymal Stem Cells (2)
- Mesenchymal stem cells (2)
- Mesenchymal stem/stromal cells (2)
- Mesenteric circulation (2)
- Messenger-RNS (2)
- Met (2)
- Metaanalyse (2)
- Metabolism (2)
- Metabolom (2)
- Metalloproteinasen (2)
- Metastatic breast cancer (2)
- Methionin-Restriktion (2)
- Metoprolol (2)
- MicroRNA (2)
- Microcirculation (2)
- Microglia (2)
- Microscopy (2)
- Migrationsanalyse (2)
- Mikroarray (2)
- Mikrochirurgie (2)
- Mikronukleus (2)
- Mikrosatellit (2)
- Mikrosatelliten (2)
- Mikrosatellitenanalyse (2)
- Mikrotubulus (2)
- Mikrozirkulation (2)
- Milz (2)
- Mineralisation (2)
- Mineralokortikoidrezeptor (2)
- Minipig (2)
- Minisequenzierung (2)
- Mitochondria (2)
- Mitose (2)
- Mitotane (2)
- Mitoxantron (2)
- Mitralinsuffizienz (2)
- Molecular biology (2)
- Molekulare Bildgebung (2)
- Monoaminoxidase (2)
- Monocytes (2)
- Monozyten-Makrophagen-System (2)
- Morbus Alzheimer (2)
- Morbus Basedow (2)
- Morbus Menière (2)
- Morphology (2)
- Mosaik (2)
- Motorischer Cortex (2)
- Mouse model (2)
- Multimorbidität (2)
- Multiplex-PCR (2)
- Multivariate analysis (2)
- Mund- (2)
- Mund-Kiefer-Gesichtsbereich (2)
- Mundgesundheit (2)
- Mundhygiene (2)
- Mundhöhlenkarzinom (2)
- Mundhöhlenkrebs (2)
- Muscarinrezeptor (2)
- Muscle (2)
- Musikwahrnehmung (2)
- Muskelatrophie (2)
- Mutationsanalyse (2)
- Muttermilch (2)
- Mycobacterium tuberculosis (2)
- Mycophenolatmofetil (2)
- Myeloma (2)
- Myokardischämie (2)
- Myokardperfusion (2)
- Myosin (2)
- Männer (2)
- Mäuse (2)
- N-formyl peptides (2)
- NEUROWIND (2)
- NF-KAPPA-B (2)
- NFkappaB (2)
- NHL (2)
- NK-cells (2)
- NMDA-Antagonist (2)
- NMDAR (2)
- NMOSD (2)
- NMR-Bildgebung (2)
- NMR-Spektroskopie (2)
- NMR-tomography (2)
- NO-Synthase (2)
- NOAC (2)
- NONO (2)
- NOS (2)
- NOTCH (2)
- NPSR1 (2)
- NPY (2)
- NS-Zeit (2)
- NSAID (2)
- Nachbehandlung (2)
- Nachkriegszeit (2)
- Nah-Infrarot-Spektroskopie (2)
- Nahinfrarotspektroskopie (2)
- Naht (2)
- Nanoparticles (2)
- Narkoseeinleitung (2)
- Narkosezwischenfall (2)
- Nase (2)
- Natriumkanal (2)
- Navigation (2)
- Nebenniereninsuffizienz (2)
- Nebennierenkrise (2)
- Nebennierenrindencarcinom (2)
- Nebenschilddrüsen (2)
- Necrosis (2)
- Neisseria (2)
- Neisseria lactamica (2)
- Nephrektomie (2)
- Nephrologie (2)
- Nervenbiopsie (2)
- Nervenblockade (2)
- Nervenregeneration (2)
- Nervenstimulation (2)
- Nervus facialis (2)
- Nervus recurrens (2)
- Netz (2)
- Neugeborenen-Hörscreening (2)
- Neuroborreliose (2)
- Neuroendocrine Tumor (2)
- Neurofibromatose (2)
- Neuroimmunologie (2)
- Neuromelanin (2)
- Neuronal ceroid lipofuscinosis (2)
- Neuropathic Pain (2)
- Neuropathic pain (2)
- Neurophysiologie (2)
- Neuroprotektion (2)
- Neuropsychologie (2)
- Neuroregeneration (2)
- Neuroscience (2)
- Neurotrophe Faktoren (2)
- Neurotrophine (2)
- Neurowissenschaften (2)
- Neutropenie (2)
- Neutrophil (2)
- Neutrophile (2)
- Neutrophils (2)
- Nevirapin (2)
- Newberyit (2)
- Newborn Hearing Screening (2)
- Nfatc1 (2)
- Nichtionisierende Strahlung (2)
- Nicotin (2)
- Nicotinamid-N-Methyltransferase (2)
- Nicotine (2)
- Nissen (2)
- Nitric oxide (2)
- Non-coding RNAs (2)
- Normalwert (2)
- Notarzt (2)
- Nozizeption (2)
- Nozizeptor (2)
- Nucleus accumbens (2)
- Nude-mice (2)
- Nystagmus (2)
- OAA/S (2)
- OAT1 (2)
- OSAS (2)
- Oberes Sprunggelenk (2)
- Oberkiefer (2)
- Obstrucive sleep apnoea (2)
- Obstruktives Schlafapnoe Syndrom (2)
- Ochratoxin A (2)
- Off-Pump (2)
- Ohrgeräusch (2)
- Okklusionsstörung (2)
- Oldenburger Satztest (2)
- Olea (2)
- Omphalocele (2)
- Onchozerkose (2)
- Optimierung (2)
- Optogenetik (2)
- Oral squamous cell carcinoma (2)
- Organerhalt (2)
- Organtransplantation (2)
- Ostdeutschland (2)
- Osteochondrosis dissecans (2)
- Osteogene Differenzierung (2)
- Osteogenese (2)
- Osteoporosis (2)
- Outcome survey (2)
- Ovarialkarzinom (2)
- Overdrainage (2)
- Oxidative stress (2)
- Oxygen (2)
- P-glycoprotein (2)
- P50 (2)
- PARK2 (2)
- PDGF (2)
- PDZ-Domain (2)
- PDZ-Domäne (2)
- PEEK (2)
- PEG (2)
- PERG (2)
- PHQ-9 (2)
- PIK3R1 (2)
- PIP2 (2)
- PKB (2)
- PLC (2)
- PML (2)
- PP2A (2)
- PPAR (2)
- PPGL (2)
- PRDI-BF1 (2)
- PROMM (2)
- PSMA I&T (2)
- PSMA-PET (2)
- PTCL (2)
- PTSD (2)
- Paclitaxel (2)
- Paediatric (2)
- Palliativbedarf (2)
- Parameter (2)
- Parasit (2)
- Parasite (2)
- Parkinson Disease (2)
- Parkinsonism (2)
- Parkinsons disease (2)
- Pathogenese (2)
- Pathogenitätsinsel (2)
- Pathogens (2)
- Pathophysiologie (2)
- Pathway (2)
- Patient education (2)
- Patientenbefragung (2)
- Patientenschulung (2)
- Pedometer (2)
- Pemphigoid (2)
- Peptidsynthese (2)
- Perifusion (2)
- Periodontitis (2)
- Perioperativer Verlauf (2)
- Permeabilität (2)
- Peroxisomen-Proliferator-aktivierter Rezeptor (2)
- Pflegeheim (2)
- Pflegeheimbewohner (2)
- Phakoemulsifikation (2)
- Pharmazie (2)
- Phase-II (2)
- Phobie (2)
- Phosphat (2)
- Phosphatasen (2)
- Phosphodiesterasehemmer (2)
- Phosphoglykolatphosphatase (2)
- Phosphorylation (2)
- Photodynamische Therapie (2)
- Phylogenie (2)
- Physical activity (2)
- Physiologie (2)
- Physiotherapie (2)
- Pikler (2)
- Placebo (2)
- Plasma (2)
- Plasmakallikrein (2)
- Plasmid (2)
- Plasmodium falciparum (2)
- Plastische Chirurgie (2)
- Plastizität (2)
- Platin (2)
- Plötzlicher Herztod (2)
- Polyglycidol (2)
- Polymerisationsschrumpfung (2)
- Polymerisationsverfahren (2)
- Polymorphism (2)
- Polymorphismen (2)
- Polyomaviren (2)
- Polyomavirus (2)
- Polyposis nasi (2)
- Port (2)
- Positron Emission Tomography (2)
- Positronen-Emissions-Tomographie (2)
- Postkonditionierung (2)
- Potassium Channel (2)
- Presbyakusis (2)
- Prevention (2)
- Primary care (2)
- Progerie (2)
- Prognosis (2)
- Progredienzangst (2)
- Promoter (2)
- Proprioception (2)
- Prostaglandins (2)
- Proteaseinhibitor (2)
- Protein Kinase C (2)
- Protein-Protein-Interaktion (2)
- Proteininteraktion (2)
- Proteinkinase A (2)
- Proteinkinase B (2)
- Proteomanalyse (2)
- Prothesenlockerung (2)
- Protozoen (2)
- Proximaler Tubulus (2)
- Prädiktor (2)
- Pseudomonas aeruginosa (2)
- Psychiatric disorders (2)
- Psychiatriegeschichte (2)
- Psychisch Kranker (2)
- Psychische Belastung (2)
- Psychische Störung (2)
- Psychobiologie (2)
- Psychologie (2)
- Psychoneuroimmunologie (2)
- Psychooncology (2)
- Psychophysik (2)
- Psychotherapy (2)
- Putamen (2)
- Pyrimidin-Synthese (2)
- Pyrosequenzierung (2)
- Pyrrolizidinalkaloide (2)
- QST (2)
- QT-Zeit (2)
- Qualitative Inhaltsanalyse (2)
- RAD51C (2)
- RCC (2)
- RDI (2)
- REM (2)
- RGS2 (2)
- RHO (2)
- RIM101 (2)
- RN18 (2)
- RNA extraction (2)
- RNA splicing (2)
- RNA structure (2)
- RNA-Seq (2)
- ROCK (2)
- RSK (2)
- Rachen (2)
- Radialislappen (2)
- Radiatio (2)
- Radiation (2)
- Radiochirurgie (2)
- Radioligand binding (2)
- Radionuclide Therapy (2)
- Radionuklid (2)
- Radiosensibilisierung (2)
- Radiosensitivity (2)
- Radiosensitivität (2)
- Radiosynoviorthese (2)
- Radiotherapie (2)
- Raf kinases (2)
- Ramipril (2)
- Randdichtheit (2)
- Randomized controlled-trial (2)
- Rats (2)
- Raucher (2)
- Rauschen (2)
- Reanimation (2)
- Rebreathing (2)
- Receptor (2)
- Rechtsmedizin (2)
- Rectal cancer (2)
- Refluxkrankheit (2)
- Regionalanästhesie (2)
- Regressionsanalyse (2)
- Regulatorische T-Lymphozyt (2)
- Rekrutierung (2)
- Rektumresektion (2)
- Relapse (2)
- Reliabilität (2)
- Remifentanil (2)
- Remission (2)
- Reoperation (2)
- Replikation (2)
- Reproductive toxicity (2)
- Reproduzierbarkeit (2)
- Resistance (2)
- Resonanz (2)
- Restenose (2)
- Resuscitation (2)
- Retrospektive Auswertung (2)
- Retrovirus (2)
- Rettungskette (2)
- Reverse Transkriptase (2)
- Rezeptorblocker (2)
- Rheumatism (2)
- Rheumatoid Arthritis (2)
- Rhizopus (2)
- Rho (2)
- Rho-Proteine (2)
- Richtungsenthemmung (2)
- Richtungshören (2)
- Rimonabant (2)
- Risikoanalyse (2)
- Risk estimation (2)
- Risk factors (2)
- Rodents (2)
- Ropivacain (2)
- Rotavirus (2)
- Ruxolitinib (2)
- S. aureus (2)
- SARS‐CoV‐2 (2)
- SC-1 (2)
- SEM (2)
- SERT (2)
- SGA (2)
- SGLT (2)
- SGLT2 inhibitor (2)
- SGLT2 inhibitors (2)
- SHRSP (2)
- SLAP-Läsion (2)
- SLAP-lesion (2)
- SLC12A6 (2)
- SLX4 (2)
- SMAD signaling (2)
- SMFA-D (2)
- SNR (2)
- SPRED2 (2)
- SRT (2)
- SSRI (2)
- SSTR-RADS (2)
- STAT3 (2)
- STEMI (2)
- STIM2 (2)
- STR (2)
- STR profile (2)
- STS (2)
- SULT2A1 (2)
- SUV (2)
- Saccotomie (2)
- Salmonella typhi Ty21a (2)
- Salmonella-containing vacuole (SCV) (2)
- Salmonella/microsome assay (2)
- Salmonellosis (2)
- Sarkom (2)
- Sarkopenie (2)
- Satisfaction (2)
- Satztest (2)
- Sauerstoff (2)
- Sauerstoffkonzentration (2)
- Sauerstoffverbrauch (2)
- Schafmodell (2)
- Schallleitungsschwerhörigkeit (2)
- Scherfestigkeit (2)
- Schilddrüsenfunktionsstörung (2)
- Schilddrüsenkarzinom (2)
- Schilddrüsenoperation (2)
- Schilddrüsenvolumen (2)
- Schlaf (2)
- Schmerzchronifizierung (2)
- Schmerzfragebogen (2)
- Schockraumbehandlung (2)
- Schockraummanagement (2)
- Schreckreaktion (2)
- Schrittzähler (2)
- Schuppenflechte (2)
- Schwann cells (2)
- Schädel (2)
- Sectio caesarea (2)
- Sedierung (2)
- Sekundärglaukom (2)
- Sekundärkrankheit (2)
- Selbstwirksamkeit (2)
- Selenmangel (2)
- Sella turcica (2)
- Senescence (2)
- Senile Demenz (2)
- Sensibilität (2)
- Sensory Gating (2)
- Sequenzierung (2)
- Serotonerges System (2)
- Serotonin transporter (2)
- Serotonin-Reuptake-Hemmer (2)
- Serotonin-Transporter (2)
- Serotoninstoffwechsel (2)
- Serotonintransporter (2)
- Serumkonzentration (2)
- Sexualität (2)
- Shigella flexneri (2)
- Sickerkissen (2)
- Signal transduction (2)
- Signalkette (2)
- Sildenafil (2)
- Silicones (2)
- Simulator (2)
- Simvastatin (2)
- Sindbisvirus (2)
- Skala (2)
- Skapulatransplantat (2)
- Skelett (2)
- Sklerodermie (2)
- Skorbut (2)
- Small bowel transplantation (2)
- Small fiber neuropathy (2)
- SnMP (2)
- Somatosensorisch evoziertes Potenzial (2)
- Sonic hedgehog (2)
- SonoVue (2)
- Soziale Unterstützung (2)
- Spalten (2)
- Speckle Tracking (2)
- Speichenbruch (2)
- Speiseröhre (2)
- Spektrofluorimetrie (2)
- Spezifität (2)
- Sphingomyelinphosphodiesterase (2)
- Spielfilm (2)
- Spiral-CT (2)
- Spiral-Computertomographie (2)
- Spirometrie (2)
- Spironolacton (2)
- Spondylodese (2)
- Sport (2)
- Sporttraumatologie (2)
- Sportverletzung (2)
- Sportverletzungen (2)
- Sprache-Rauschen-Verhältnis (2)
- Spracherwerbstörung (2)
- Spred-Proteine (2)
- Sprunggelenk (2)
- Sprunggelenksfrakturen (2)
- Squalius alburnoides (2)
- Src-Proteine (2)
- Stabilisierung von Plasmiden (2)
- Stammbaum (2)
- Standardisierung (2)
- Standardwerte (2)
- Stanzbiopsie (2)
- Stapedektomie (2)
- Staphylococcus (2)
- Stat3 (2)
- Sterbebegleitung (2)
- Sterbehilfe (2)
- Stereolithographie (2)
- Stereology (2)
- Stereotactic body radiotherapy (2)
- Stereotaxie (2)
- Steroide (2)
- Stickstoffdioxid (2)
- Stickstoffoxide (2)
- Strain (2)
- Streptozocin (2)
- Streptozotocin (2)
- Stressfasern (2)
- Stressreaktion (2)
- Stroke unit (2)
- Subarachnoid hemorrhage (2)
- Sublay (2)
- Sucht (2)
- Suizid (2)
- Sulfadiazin (2)
- Sunitinib (2)
- Surveillance (2)
- Swine (2)
- Symptome (2)
- Synergie (2)
- Synergismus (2)
- Systematic review (2)
- Systematische Übersichtsarbeit (2)
- Systemic sclerosis (2)
- T Zellen (2)
- T cell development (2)
- T cell receptor excision circles (2)
- T-Cells (2)
- T-Helferzellen (2)
- T-Zell-Aktivierung (2)
- T-Zell-Lymphome (2)
- T-Zellmigration (2)
- T-cadherin (2)
- TB (2)
- TCR (2)
- TCS (2)
- TDMT (2)
- TFCC (2)
- TGF beta (2)
- TGF-β (2)
- TGFβ signaling (2)
- TGFβ1 (2)
- TIMP-1 (2)
- TIP39 (2)
- TLR2 (2)
- TLR4 (2)
- TMD (2)
- TMS (2)
- TNBC (2)
- TNF alpha (2)
- TNFα (2)
- TRIB3 (2)
- TRP-Kanäle (2)
- TRPA1 (2)
- TRPC4 (2)
- TRRAP (2)
- TTFields (2)
- TVT (2)
- Tages-Nacht-Vergleich (2)
- Tagesklinik (2)
- Tamoxifen (2)
- Teilkrone (2)
- Temozolomide (2)
- Terahertzbereich (2)
- Terahertzstrahlung (2)
- Tetracalciumphosphat (2)
- Th1 (2)
- Th17 cells (2)
- Th2 (2)
- Thalamus (2)
- Therapeutisches Drug monitoring (2)
- Therapieplan (2)
- Therapieresistenz (2)
- Therapieziel (2)
- Thiazolidindione (2)
- Thioredoxin (2)
- Thioredoxinreduktase (2)
- Third molar (2)
- Thorax (2)
- Thrombolyse (2)
- Thrombozytenfunktion (2)
- Thrombus (2)
- Thymuskarzinome (2)
- Thyroid cancer (2)
- Tibia (2)
- Tibiakopf (2)
- Tibiakopfbruch (2)
- Tibiakopfimpressionsfraktur (2)
- Tibiaplateau (2)
- Tierversuch (2)
- Tissue (2)
- Titanium (2)
- Tocilizumab (2)
- Toleranzinduktion (2)
- Toll like receptors (2)
- Toll-like Rezeptoren (2)
- Toll-like receptors (2)
- Tonsille (2)
- Tooth Mousse (2)
- Topoisomerase I (2)
- Total hip arthroplasty (2)
- Trans-Spleißen (2)
- Transcriptome (2)
- Transforming Growth Factor beta 1 (2)
- Transkatheter-Aortenklappenimplantation (2)
- Transkranielle Magnetstimulation (2)
- Transkranielle Sonographie (2)
- Transkranielle magnetische Stimulation (2)
- Transkranieller Ultraschall (2)
- Translation <Genetik> (2)
- Translational research (2)
- Transplantatentnahme (2)
- Transplantationsimmunologie (2)
- Transport (2)
- Transposon (2)
- Traumatologie (2)
- Tregs (2)
- Tregs (regulatory T cells) (2)
- Trisomie 21 (2)
- Troponin I (2)
- Trypanosoma (2)
- Tryptophan hydroxylase 2 (2)
- Tubulin (2)
- Tumor Microenvironment (2)
- Tumor Treating Fields (2)
- Tumor Treating Fields (TTFields) (2)
- Tumor-necrosis-factor (2)
- Tumoren (2)
- Tumorentstehung (2)
- Tumorpatienten (2)
- Tumorsuppressor-Gen (2)
- Tumortherapiefelder (2)
- Tumorvaccine (2)
- Tumorwachstum (2)
- Tumorzellen (2)
- Tumosuppresorgen (2)
- Tympanoplastik (2)
- Typ 2 (2)
- Typ 2-Diabetes (2)
- Tyrosinkinase (2)
- Tyrosinkinaseinhibitor (2)
- Tyrosinkinaseinhibitoren (2)
- Türkensattel (2)
- USP28 (2)
- Ulcerative colitis (2)
- Ulcus cruris (2)
- Ultrasound (2)
- Unfall (2)
- Unishunt (2)
- University Psychiatric Hospital Würzburg (2)
- Universitätsnervenklinik Würzburg (2)
- Unterkieferrekonstruktion (2)
- Uridin (2)
- Urinary tract infection (2)
- Urologie (2)
- Urteilsabgabe (2)
- Urteilsmethode (2)
- VAS (2)
- VCAM-1 (2)
- VFT (2)
- VLBW (2)
- VLBWI (2)
- VUR (2)
- Validität (2)
- Valproinsäure (2)
- Variants (2)
- Varizellen-Virus (2)
- Vasopressin (2)
- Vegetatives Nervensystem (2)
- Venlafaxin (2)
- Verbrennung (2)
- Verbundverhalten (2)
- Versorgungswünsche (2)
- Verteilung (2)
- Vestibularisstörung (2)
- Vestibulärer Schwindel (2)
- Viabilität (2)
- Vibrant Soundbridge (2)
- Vibrationstraining (2)
- Videolaryngoskopie (2)
- Viral (2)
- Virchow Node (2)
- Virology (2)
- Virulenzfaktoren (2)
- Vitamin C (2)
- Vitrektomie (2)
- Vokalisierung (2)
- Volatile Anästhetika (2)
- Volumenregulation (2)
- Volumensubstitution (2)
- Volumentherapie (2)
- Vomiting (2)
- Vorlesung (2)
- Vorläuferzelle (2)
- Vorsprachliche Diagnostik (2)
- WHF (2)
- WHO (2)
- WSS (2)
- Wachstumsfaktor (2)
- Wachstumsverhalten (2)
- Wasserstoffperoxid (2)
- Weimarer Zeit (2)
- Weisheitszahnentfernung (2)
- Westdeutschland (2)
- Western blot (2)
- Western diet (2)
- Wilms tumour (2)
- Wnt (2)
- Working memory (2)
- Wurzelfüllung (2)
- Würzburg / Institut für Geschichte der Medizin (2)
- Würzburg / Klinik und Poliklinik für Nuklearmedizin (2)
- X-ray computed (2)
- Xenopus oocytes (2)
- Xerostomie (2)
- Xiphophorus (2)
- Xmrk (2)
- YB-1 (2)
- ZO-1 (2)
- Zahn (2)
- Zahnchirurgie (2)
- Zahnentwicklung (2)
- Zahnerhaltung (2)
- Zahnextraktion (2)
- Zahnimplantat (2)
- Zahnpasta (2)
- Zahnschmelz (2)
- Zeitgang-BERA (2)
- Zelle (2)
- Zellkern (2)
- Zellkulturmodell (2)
- Zelllinie (2)
- Zellskelett (2)
- Zellteilung (2)
- Zellzyklusanalyse (2)
- Zellzykluskontrolle (2)
- Zellzyklusregulation (2)
- Zementpaste (2)
- Zervixkarzinom (2)
- Zidovudin (2)
- Zinkoxid (2)
- Zirkoniumdioxid (2)
- Zweitlinientherapie (2)
- Zwerchfellbruch (2)
- Zytokeratin (2)
- [177Lu]-DOTATATE/-DOTATOC (2)
- [68Ga] (2)
- [68Ga]PentixaFor (2)
- \(^{18}\)F-FDG (2)
- \(^{68}\)Ga-Pentixafor (2)
- abdominal trauma (2)
- abnormalities (2)
- accelerometer-sensor (2)
- accumulation (2)
- acetaminophen (2)
- acetylcholine (2)
- acid ceramidase inhibitor ceranib-2 (2)
- acid sphingomyelinase (2)
- acoustic analysis of snoring sound (2)
- actin cytoskeleton (2)
- action monitoring (2)
- activity (2)
- activity-dependent slowing (2)
- acute graft-versus-host disease (2)
- acute leukemia (2)
- acute lung injury (2)
- acute lymphoblastic leukemia (2)
- acute lymphocytic leukaemia (2)
- acute myeloid leukaemia (2)
- acute myocardial infarction (2)
- adaptation (2)
- adaptive immunity (2)
- adenomas (2)
- adenosine (2)
- adenosine diphosphate (2)
- adenosine receptor (2)
- adenovirus (2)
- adenylate cyclase toxin (2)
- adhesion molecule (2)
- adhesive (2)
- adhesive fracture (2)
- adipocytes (2)
- adipogenic differentiation (2)
- adipose (2)
- adjuvant (2)
- adolescent (2)
- adrenal cancer (2)
- adrenal incidentaloma (2)
- adrenal tumors (2)
- adrenocortical adenoma (2)
- adrenocortical tumors (2)
- adult-onset (2)
- adulte Neurogenese (2)
- adverse drug reaction (2)
- adverse drug reactions (2)
- adverse effects (2)
- adversity (2)
- affective disorders (2)
- affektive Störungen (2)
- age-related (2)
- age-related hearing loss (2)
- agonistic antibodies (2)
- agreement (2)
- akutes Koronarsyndrom (2)
- akutes Nierenversagen (2)
- albumin (2)
- albuminuria (2)
- alcohol (2)
- algorithm (2)
- alignment (2)
- alliance (2)
- allocation (2)
- alloreactive T cells (2)
- allostatic load (2)
- alpaca (2)
- alpha-Oxidation (2)
- alpha-oxidation (2)
- altersabhängig (2)
- alveolar bone loss (2)
- alveolar echinococcosis (2)
- ambulant (2)
- amino acid restriction (2)
- amino acid transporter (2)
- amitriptyline (2)
- ampicillin (2)
- amplicon sequencing (2)
- amyotrophic-lateral-sclerosis (2)
- anaesthesiology (2)
- anaesthetics (2)
- anandamide (2)
- anaplastic large cell lymphoma (2)
- androgen deprivation therapy (2)
- anesthetics (2)
- aneurysms (2)
- angeborenes Immunsystem (2)
- angioplasty (2)
- ankle fractures (2)
- antagonists (2)
- anthocyanins (2)
- anti-tumor agents (2)
- antibiotic (2)
- antibody fusion proteins (2)
- antifungal susceptibility (2)
- antifungals (2)
- antigen presentation (2)
- antigen testing (2)
- antigenic variation (2)
- antigens (2)
- antioxidant (2)
- antioxidants (2)
- antisense RNA (2)
- antisense RNAs (2)
- antiviral treatment (2)
- anxiety-like behavior (2)
- app (2)
- archaea (2)
- arteriovenous loop (2)
- articular chondrocytes (2)
- aseptic loosening (2)
- aspiration (2)
- assistierte Reproduktion (2)
- assistive devices (2)
- assoziative Paarstimulation (2)
- asymmetry (2)
- atonia (2)
- attention deficit hyperactivity disorder (2)
- attentional control (2)
- audiometry (2)
- auditory brainstem implant (2)
- augmentation (2)
- autism (2)
- autism spectrum disorder (2)
- autograft (2)
- autologe Stammzelltransplantation (2)
- autologous (2)
- autologous transplantation (2)
- autonomes Nervensystem (2)
- autosomal recessive (2)
- av-ECLA (2)
- avidity (2)
- axial length (2)
- axonal degeneration (2)
- axonal transport (2)
- axons (2)
- azidothymidine (2)
- b-cells (2)
- bacillus subtilis (2)
- back pain (2)
- background noise (2)
- bacterial (2)
- bacterial infection (2)
- bacterial pathogens (2)
- bacteriophage (2)
- baghdadite (2)
- basal cell carcinoma (2)
- base of support (2)
- benzoquinones (2)
- beta cells (2)
- beta-Zellproliferation (2)
- beta-adrenerge Signalwege (2)
- beta-catenin (2)
- beta-cell (2)
- beta-oxidation (2)
- beta1-adrenergic receptor (2)
- biased signaling (2)
- binaural alternierende Sprachdarbietung nach Bocca und Calearo (2)
- binaural hearing (2)
- binaurally alternated speech presentation according to Bocca and Calearo (2)
- biodosimetry (2)
- biography (2)
- biological sciences (2)
- biological techniques (2)
- biomechanical (2)
- biomedicine, general (2)
- bipolar affective disorder (2)
- bisphosphonates (2)
- bisulfite pyrosequencing (2)
- blastocyst (2)
- blastocysts (2)
- blood coagulation (2)
- blood gas analysis (2)
- blood loss (2)
- blood nerve barrier (2)
- blood plasma (2)
- blood platelets (2)
- blood vessel (2)
- blood-brain barrier (BBB) model (2)
- blood-nerve barrier (2)
- blood–labyrinth barrier (2)
- bond strength (2)
- bone fractures (2)
- bone graft substitutes (2)
- bone imaging (2)
- bone loss (2)
- bone marrow edema (2)
- bone marrow immune-microenvironment (2)
- bone metastases (2)
- bone metastasis (2)
- bone morphogenetic proteins (2)
- bone remodeling (2)
- bone replacement material (2)
- bortezomib (2)
- brain cancer (2)
- brain computer interface (2)
- brain disorders (2)
- brain endothelial cells (2)
- brain pathology (2)
- brain stem (2)
- breast carcinoma (2)
- breastfeeding (2)
- breath condensate (2)
- bronchoalveoläre Lavage (2)
- brushite (2)
- butyrophilin (2)
- c-MYC (2)
- c-Myc (2)
- c-myc (2)
- c-reactive protein (2)
- cEND (2)
- cadherins (2)
- calcification (2)
- calcium channel (2)
- calciumhydroxide (2)
- calipered (2)
- calorimetry (2)
- calpain (2)
- calprotectin (2)
- cancer cells (2)
- cancer diagnosis (2)
- cancer genomics (2)
- cancer metabolism (2)
- cancer microenvironment (2)
- cancer patients (2)
- cancer risk (2)
- cancers and neoplasms (2)
- candida (2)
- candida albicans (2)
- cannabinoids (2)
- capillary electrophoresis (2)
- carbohydrates (2)
- carbon dioxide (2)
- carcinogen (2)
- carcinogenesis (2)
- carcinoma cells (2)
- cardiac MRI (2)
- cardiac device (2)
- cardiac imaging (2)
- cardiac innervation imaging (2)
- cardiac magnetic resonance (2)
- cardiac magnetic resonance imaging (2)
- cardiac nerve (2)
- cardiac output (2)
- cardiac spectroscopy (2)
- cardiac transplantation (2)
- cardiogenetics (2)
- cardiogenic shock (2)
- cardiomyocyte (2)
- cardiovascular events (2)
- cardiovascular implantable electronic device (2)
- care (2)
- caregiver burden (2)
- caries (2)
- carotid atherosclerosis (2)
- carotid stenosis (2)
- carotid ultrasound (2)
- cartilage repair (2)
- caspase-3 (2)
- caspase-8 (2)
- catalase (2)
- cell (2)
- cell binding (2)
- cell cultures (2)
- cell cycle analysis (2)
- cell cycle and cell division (2)
- cell labeling (2)
- cell metabolism (2)
- cell of origin (2)
- cell signalling (2)
- central corneal thickness (2)
- central-nervous-system (2)
- cephalometry (2)
- cerebEND (2)
- cerebral autoregulation (2)
- cerebral blood flow (2)
- cerebrovascular disorders (2)
- chaperone (2)
- checkpoint inhibitors (2)
- chick (2)
- childhood asthma (2)
- childhood obesity (2)
- chimeric antigen receptor (2)
- chirurgische Freilegung (2)
- chlamydia (2)
- chlamydia infection (2)
- chorioamnionitis (2)
- chromatin (2)
- chromosomal aberration (2)
- chromosomale Verlustanalyse (2)
- chromosome loss (2)
- chronic cerebrovascular disease (2)
- chronic hepatitis C (2)
- chronic myelogenous leukemia (2)
- chronic myeloid leukemia (2)
- chronic non-bacterial osteomyelitis (2)
- chronic rejection (2)
- chronic wounds (2)
- chronophin (2)
- chronotropic incompetence (2)
- chronotype (2)
- cigarette smoking (2)
- cirrhosis (2)
- cisplatin (2)
- citrus (2)
- classification of endogenous psychosis (2)
- click chemistry (2)
- climate change (2)
- clothing (2)
- coated vesicles (2)
- coatings (2)
- cochlea (2)
- cochlear nucleus (2)
- cognition (2)
- cognitive function (2)
- cohesive fracture (2)
- collective invasion (2)
- collybistin (2)
- colonization (2)
- colony-forming assay (2)
- combined therapy (2)
- comet-assay (2)
- comorbidities (2)
- comparability (2)
- complementary alternative medicine (2)
- complex regional pain syndrome (2)
- complexes (2)
- compliance (2)
- complication (2)
- compression therapy (2)
- conditioning (2)
- cone beam CT (2)
- conservative treatment (2)
- consolidation (2)
- contact activation system (2)
- contact-kinin system (2)
- context (2)
- continuous performance test (2)
- contractility (2)
- contrast (2)
- contrast agent (2)
- convection volume (2)
- conversion (2)
- copeptin (2)
- cord blood (2)
- coronary angiography (2)
- coronary artery bypass grafting (2)
- coronavirus (2)
- coronavirus disease 2019 (2)
- cortical activation (2)
- cortical neurons (2)
- corticosteroids (2)
- costimulation (2)
- cranio-corpo-graphy (2)
- craniopharyngioma (2)
- critically ill (2)
- cross-sectional studies (2)
- crown fracture (2)
- crying (2)
- cue-reactivity (2)
- cushion (2)
- cushioning (2)
- cusp deflection (2)
- cyclic nucleotides (2)
- cyclodextrin (2)
- cycloid psychoses (2)
- cyclophosphamide (2)
- cyclosporine (2)
- cytogenetics (2)
- cytokine expression (2)
- cytokine release (2)
- cytosol (2)
- dRNA-Seq (2)
- dabrafenib (2)
- daratumumab (2)
- dasatinib (2)
- data acquisition (2)
- database (2)
- death (2)
- decay (2)
- deformation (2)
- degree of stenosis (2)
- dehydroepiandrosterone (2)
- dendritische Zelle (2)
- density (2)
- dental trauma (2)
- dependent protein-kinase (2)
- depressive symptoms (2)
- depth of sedation (2)
- derivatives (2)
- dermatitis (2)
- detoxification (2)
- development of speech (2)
- diabetic cardiomyopathy (2)
- diabetic neuropathy (2)
- diabetic retinopathy (2)
- diagnose (2)
- diagnostic medicine (2)
- dialysis adequacy (2)
- dialysis patients (2)
- diastolic dysfunction (2)
- diazepam (2)
- differential expression (2)
- differentiated thyroid carcinoma (2)
- differentiation potential (2)
- difficult airway (2)
- diffusion tensor imaging (2)
- dilated cardiomyopathy (2)
- dilation (2)
- dimensions (2)
- dimethyl fumarate (2)
- diode (2)
- direct-acting antivirals (2)
- discriminant analysis (2)
- disease control (2)
- disease genetics (2)
- disease model (2)
- disease progression (2)
- disease severity (2)
- diseases of the nervous system (2)
- disorder (2)
- disorders (2)
- distale Radiusfraktur (2)
- distress (2)
- distribution (2)
- dogs (2)
- donor-site morbidity (2)
- dorsal root ganglion (2)
- dose reduction (2)
- dose response (2)
- double-blind (2)
- drug delivery (2)
- drug monitoring (2)
- dual-energy CT (2)
- dual-stage crosslinking (2)
- duchenne muscular dystrophy (2)
- dynamic (2)
- dysfunction (2)
- dysphagia (2)
- eHealth (2)
- ePTFE (2)
- early detection (2)
- edema (2)
- education for sustainable healthcare (2)
- effectiveness (2)
- elbow (2)
- electrical and electronic engineering (2)
- electroactive (2)
- electrochemical deposition (2)
- electroencephalogram (2)
- electrohydrodynamics (2)
- electron tomography (2)
- element (2)
- elongation (2)
- embodiment (2)
- embryonic stem cell (2)
- embryonic stem cells (2)
- embryos (2)
- emotion (2)
- emotion processing (2)
- emotions (2)
- empagliflozin (2)
- empowerment (2)
- emulsions (2)
- endochondral ossification (2)
- endodontics (2)
- endoglin (2)
- endothelial nitric oxide synthase (2)
- endotheliale Dysfunktion (2)
- endothelin-1 (2)
- endovascular therapy (2)
- endovascular treatment (2)
- endovaskulär (2)
- energy intake (2)
- enoxaparin (2)
- enteric nervous system (2)
- enterica serovar typhimurium (2)
- environmental exposure (2)
- enzyme activation (2)
- enzyme inhibitors (2)
- epitope (2)
- error-related negativity (2)
- erythropoietin (2)
- etiology (2)
- euthanasia (2)
- evoked potentials (2)
- evolutionary genetics (2)
- exact matching (2)
- executive functions (2)
- exercise intensity (2)
- expansion (2)
- experience (2)
- experimental models of disease (2)
- exposure (2)
- extinction (2)
- extracellular domain (2)
- extramedullary disease (2)
- extranodal (2)
- extrazelluläre Matrix (2)
- fMRI time series (2)
- fabry disease (2)
- facial nerve (2)
- factor H (2)
- factor XI (2)
- factor-I (2)
- familial DCM (2)
- family (2)
- fatty acid (2)
- fatty acid metabolism (2)
- fatty acids (2)
- fatty liver (2)
- fatty liver disease (2)
- fear extinction (2)
- fear of progression (2)
- feasibility (2)
- fecal incontinence (2)
- feedback (2)
- fetal programming (2)
- fever (2)
- fiber (2)
- fibers (2)
- fibrin (2)
- fibrinogen (2)
- fibroblast (2)
- first pass (2)
- flexibility (2)
- flowcytometry (2)
- fluctuation (2)
- fluorescence imaging (2)
- fluorescent probes (2)
- fluoroquinolones (2)
- fluoroscopy (2)
- foamy viruses (2)
- food allergy (2)
- foot (2)
- force (2)
- forensic anthropology (2)
- fracture area (2)
- fracture strength (2)
- free jejunal graft (2)
- frequency (2)
- functional analysis (2)
- functional characterization (2)
- functional near-infrared spectroscopy (2)
- functional neuroimaging (2)
- fundoplication (2)
- fungal infections (2)
- fungi (2)
- funktionelle Kernspintomographie (2)
- fused deposition modeling (FDM) (2)
- fusion and fission (2)
- gametocyte (2)
- gametogenesis (2)
- gamma-H2AX (2)
- gastric carcinoma (2)
- gastroenterology (2)
- gastrointestinal infections (2)
- gastrointestinal motility (2)
- gastrointestinale Motilität (2)
- gastrointestinale Tumore (2)
- gender gap (2)
- gene conversion (2)
- gene expression profiling (2)
- gene-expression (2)
- general anaesthesia (2)
- general practice (2)
- generalized anxiety disorder (2)
- generalized cerebral edema (2)
- genetic aberrations (2)
- genetic engineering (2)
- genetic polymorphisms (2)
- genetic risk (2)
- genetic susceptibility (2)
- genetic testing (2)
- genetische Aberrationen (2)
- genome sequence (2)
- genome sequencing (2)
- genome wide (2)
- genome-wide association study (2)
- genomic libraries (2)
- genomic organization (2)
- genotype-phenotype correlation (2)
- genotyping (2)
- germination (2)
- germline mutation (2)
- gestational diabetes (2)
- gestational diabetes mellitus (2)
- glial fate modulation (2)
- glioblastoma multiforme (GBM) (2)
- globotriaosylceramide (2)
- glutathione (2)
- glycemic control (2)
- glycine (2)
- glycine receptor autoantibodies (2)
- glycoprotein Ib (2)
- glycoprotein receptor Ib (2)
- gp130 (2)
- grade 3B (2)
- graft (2)
- graft versus host disease (2)
- granules (2)
- granulocytes (2)
- growth factors (2)
- growth pattern (2)
- guanylyl cyclase (2)
- haemophilus influenzae (2)
- haemostasis (2)
- haplotype (2)
- harmonic imaging (2)
- head (2)
- head and neck squamous cell carcinoma (2)
- health care (2)
- health economics (2)
- health status (2)
- healthy volunteers (2)
- hearing impairment (2)
- hearing preservation (2)
- heart failure with mid-range ejection fraction (2)
- heartfailure (2)
- heat (2)
- heat shock protein (2)
- heat shock response (2)
- helicobacter (2)
- helminths (2)
- hematologic malignancies (2)
- hematopoietic stem cell transplantation (2)
- heme oxygenase-1 (2)
- hemodynamics (2)
- hemoglobin (2)
- hemoglobin adducts (2)
- hepatic stellate cell (2)
- hepatitis B virus (2)
- hepatocellular carcinoma (2)
- hereditary angioedema (2)
- hereditary breast and ovarian cancer (2)
- hereditary hemochromatosis (2)
- herpes simplex virus (2)
- heterosis (2)
- hiPSC (2)
- hiatal hernia (2)
- high risk (2)
- high-dose chemotherapy (2)
- high-intensity interval training (2)
- high-pressure freezing/freeze substitution (2)
- high-risk prostate cancer (2)
- hip arthroplasty (2)
- hip dysplasia (2)
- hippocampal neurogenesis (2)
- histologic (2)
- histologisch (2)
- histometric (2)
- histometrisch (2)
- histone (2)
- histopathology (2)
- history of dentistry (2)
- homologous recombination (2)
- hospital (2)
- hospitalization (2)
- hospitalizations (2)
- host-pathogen interactions (2)
- human adipose-derived stromal cells (2)
- human brain (2)
- human exposure (2)
- human genetics (2)
- human macrophages (2)
- human respiratory epithelial cells (2)
- humoral immunity (2)
- hydrocortisone (2)
- hyperactivity (2)
- hypersensitivity (2)
- hypogammaglobulinemia (2)
- hypopharynx (2)
- hypothermia (2)
- hypothyroidism (2)
- iNOS (2)
- iPSC (2)
- iPSC-cardiomyocytes (2)
- iStent (2)
- ileocecal resection (2)
- illness (2)
- image processing (2)
- image-guided radiation therapy (2)
- immune activation (2)
- immune cell infiltration (2)
- immune modulation (2)
- immune therapy (2)
- immunocytochemistry (2)
- immunodeficiency (2)
- immunoglobulin superfamily (2)
- immunoglobuline (2)
- immunoprecipitation (2)
- immunostaining (2)
- impedance (2)
- impedance spectroscopy (2)
- implantation (2)
- implants (2)
- in silico analysis (2)
- in vitro models (2)
- in vivo study (2)
- in-vitro fertilization (2)
- in-vitro-Modell (2)
- inactivation (2)
- incontinence (2)
- inducible nitric oxide synthase (2)
- induction (2)
- induction of tolerance (2)
- inebilizumab (2)
- infant cry (2)
- infection control (2)
- infectious diseases (2)
- infektion (2)
- inferior vena cava (2)
- infiltration (2)
- inflammatory cytokines (2)
- inflammatory neuropathy (2)
- inflammatory response (2)
- influenza A virus (2)
- informal caregiving (2)
- information (2)
- informed consent (2)
- inguinal hernia (2)
- inhibitory neurotransmission (2)
- inhibitory receptors (2)
- innate immune response (2)
- innervation (2)
- instrument (2)
- insulin receptor (2)
- insulin signaling (2)
- integrated stress response (2)
- intensity distribution (2)
- intensive care unit (2)
- interacts (2)
- interleukin 13 (2)
- interleukin 4 (2)
- interleukin 6 (2)
- interleukin-8 (2)
- interleukins (2)
- internal medicine (2)
- interventional radiology (2)
- intestinal epithelial barrier (2)
- intracranial bleeding (2)
- intracranial tumors (2)
- intrakranielle Tumoren (2)
- intraoperative imaging (2)
- intraoperative monitoring (2)
- invasive fungal infections (2)
- invasiveness (2)
- involvement (2)
- iodine (2)
- ion channel (2)
- ion channels (2)
- ipilimumab (2)
- iron oxide nanoparticles (2)
- ischemia reperfusion injury (2)
- ischemia-reperfusion injury (2)
- ischemic (2)
- ischemic penumbra (2)
- isocenter (2)
- isoforms (2)
- isolated rabbit lung (2)
- isoliert (2)
- isolierte Kaninchenlunge (2)
- isothermal titration calorimetry (2)
- isotopes (2)
- just noticeable difference (JND) (2)
- juvenile idiopathische Arthritis (2)
- jüdisches Recht (2)
- kardiale Hypertrophie (2)
- kardiovaskuläre Risikofaktoren (2)
- kidney cancer (2)
- kidney transplantation (2)
- kieferorthopädische Behandlung (2)
- kinase (2)
- kinase inhibitors (2)
- kinesin (2)
- klinische Studie (2)
- knee replacement (2)
- knock-out (2)
- kognitive Beeinträchtigung (2)
- kolorektale Karzinogenese (2)
- laboratory proficiency testing (2)
- lactation (2)
- lactose (2)
- language acquisition (2)
- language development (2)
- large T antigen (2)
- large vessel occlusion (2)
- laser surgery (2)
- late-onset (2)
- lateral cephalogram (2)
- laterale Verdichtung (2)
- laterality (2)
- left-ventricular function (2)
- leg ulcer (2)
- leishmania (2)
- length of stay (2)
- leprosy (2)
- lessons learned (2)
- life events (2)
- life history (2)
- lifestyle (2)
- ligand binding (2)
- light curing (2)
- lineage (2)
- linkage analysis (2)
- lipid bilayer (2)
- lipodystrophy (2)
- liquid chromatography/mass spectrometry (2)
- liver metastases (2)
- liver metastasis (2)
- locomotion (2)
- locomotor adaptation (2)
- locus coeruleus (2)
- loneliness (2)
- long-term depression (2)
- long-term potentiation (2)
- long-term results (2)
- long-term survivors (2)
- longitudinal studies (2)
- longitudinal study (2)
- low profile (2)
- lower body (2)
- lower extremity (2)
- lung fibroblasts (2)
- lung-cancer (2)
- lungenprotektive Beatmung (2)
- lymph node (2)
- lymphocyte differentiation (2)
- lymphomas (2)
- lyso-Gb3 (2)
- lysosome (2)
- mTOR (2)
- macrophage polarization (2)
- macular degeneration (2)
- magnesium (2)
- magnesium phosphate (2)
- major histocompatibility complex (2)
- malignant glaucoma (2)
- malocclusion (2)
- mammalian cells (2)
- mammalian genomics (2)
- mammography (2)
- mantle cell lymphoma (2)
- marcophages (2)
- marginal adaptation (2)
- marine sponges (2)
- marrow (2)
- mastocytosis (2)
- maternal exposure (2)
- mathematical modeling (2)
- matrix protein porin (2)
- measels virus (2)
- mechanical activation (2)
- mechanism (2)
- mediastinitis (2)
- medical nutrition therapy (2)
- medical physics (2)
- medication (2)
- medullary thyroid cancer (2)
- megavoltage computed-tomography (2)
- meiosis (2)
- melanoma cells (2)
- melanomas (2)
- melatonin (2)
- mellitus (2)
- melody (2)
- membrane potential (2)
- membrane receptor signaling (2)
- membrane skeleton (2)
- men who have sex with men (2)
- menopause (2)
- mesenchymal stromal cell (2)
- messenger-RNA (2)
- metabolic disease (2)
- metabolomic profiling (2)
- metagenomics (2)
- metallic trace elements (2)
- metalloproteinase (2)
- metastasis-directed therapy (2)
- metastatic (2)
- methylprednisolone (2)
- miR-182-5p (2)
- miR-30 (2)
- miRNA processing (2)
- miRNAs (2)
- microRNA-221 (2)
- microbial rhodopsins (2)
- microbial spectrum (2)
- microcirculation (2)
- micronucleus assay (2)
- micronutrients (2)
- microparticles (2)
- microscopy (2)
- microtubules (2)
- microvascular complications (2)
- microvascular obstruction (2)
- microvasculature (2)
- midazolam (2)
- midwife (2)
- migration analysis (2)
- mikrovaskuläre Obstruktion (2)
- mild cognitive impairment (2)
- mindfulness (2)
- mind–body intervention (2)
- mineralocorticoid receptor (2)
- minimal invasive (2)
- minimalinvasiv (2)
- minisequencing (2)
- minocycline (2)
- mismatch (2)
- mitochondrial DNA (2)
- mitochondrial toxicity (2)
- mitosis (2)
- mixed hearing loss (2)
- mixed methods (2)
- mobile apps (2)
- mobility (2)
- modified CRP (2)
- modulation (2)
- molecular alterations (2)
- molecular characterization (2)
- molecular cloning (2)
- molecular diagnostics (2)
- molecular dynamics (2)
- molecular epidemiology (2)
- molecular mechanisms (2)
- molecular modeling (2)
- molecular subtypes (2)
- monoamine oxidase (2)
- monosyllabic words (2)
- monosyllabic words recognition test (2)
- mood (2)
- mosaicism (2)
- motivation (2)
- motoneuron (2)
- motor cortex (2)
- movement disorder (2)
- mucoepidermoid carcinoma (2)
- mucous membrane pemphigoid (2)
- multidrug resistance (2)
- multiple system atrophy (2)
- multiples Myelom (2)
- multisensory integration (2)
- multivariate data analysis (2)
- murine model (2)
- muscle disease (2)
- muscle force (2)
- musculoskeletal system (2)
- music (2)
- musical syntax (2)
- mutagenesis (2)
- mycobacteria (2)
- mycophenolic acid (2)
- myeloperoxidase (2)
- myocardial blood flow (2)
- myocardial sympathetic innervation imaging (2)
- myocardial work (2)
- myocardial-infarction (2)
- myocyte (2)
- myofibrillar myopathy (2)
- myokardiale Perfusion (2)
- myokines (2)
- myopathy (2)
- myosin (2)
- myosin heavy chain (2)
- nCRP (2)
- naloxone (2)
- nanomedicine (2)
- nasal epithelia (2)
- nasal mucosa (2)
- nasal polyps (2)
- natriuretic peptide (2)
- natural history (2)
- natural killer cell (2)
- natürliche Antikörper (2)
- navigation (2)
- neck circumference (2)
- necrotic cell death (2)
- neoadjuvant (2)
- neonatal (2)
- neonates (2)
- neovascularization, physiologic (2)
- nephroblastoma (2)
- nephron sparing surgery (2)
- nerve biopsy (2)
- nerve fibers (2)
- nerve fibres (2)
- nervous-system (2)
- neural (2)
- neural stem cell (2)
- neurite outgrowth (2)
- neuroborreliosis (2)
- neurodevelopmental disorders (2)
- neuroendocrine tumor (NET) (2)
- neurofascin (2)
- neurofilaments (2)
- neuronal (2)
- neuronal dendrites (2)
- neuronal network (2)
- neuronal nitric oxide synthase (2)
- neurophysiology (2)
- neuroplasticity (2)
- neuroregeneration (2)
- neurosphere (2)
- neurosurgery (2)
- neurotoxicity (2)
- neurotransmitter release (2)
- neutral sphingomyelinase-2 (2)
- neutropenia (2)
- neutrophil granulocytes (2)
- next generation sequencing (NGS) (2)
- niche (2)
- nilotinib (2)
- nivolumab (2)
- no reflow (2)
- nocturnal (2)
- non-invasive ventilation (2)
- non-ionizing radiation (2)
- non-responder (2)
- non-union (2)
- norepinephrine (2)
- nucleotide excision repair (2)
- nude-mice (2)
- object detection (2)
- obsessive-compulsive disorder (2)
- obstetrics (2)
- obstructive pulmonary disease (2)
- occupancy (2)
- occupational medicine/industrial medicine (2)
- octreotide (2)
- off-pump (2)
- older adults (2)
- olecranon (2)
- olfaction (2)
- olfactory epithelium (2)
- olfaktorisches Epithel (2)
- oligodendrocyte (2)
- oligorecurrence (2)
- olive (2)
- oncolysis (2)
- oncolytic virotherapy (2)
- onset (2)
- open abdomen (2)
- open bite (2)
- opioid peptides (2)
- optic nerve (2)
- optic neuritis (2)
- oral anticancer drugs (2)
- oral cavity (2)
- oral health (2)
- oral hygiene (2)
- orale Antikoagulation (2)
- orale Chemotherapie (2)
- organ-on-a-chip (2)
- organic cation transporter (2)
- orthesis (2)
- orthodontic (2)
- orthodontic treatment (2)
- orthognathic surgery (2)
- os akromiale (2)
- oscillation (2)
- osseointegration (2)
- osteoblasts (2)
- osteoclasts (2)
- osteogenic potential (2)
- osteopontin (2)
- osteotomy (2)
- otitis media (2)
- outcomes research (2)
- outer membrane protein (2)
- outpatient (2)
- outpatients (2)
- overall survival (2)
- overexpression (2)
- oxLDL (2)
- oxidation (2)
- oxygen consumption (2)
- oxygen uptake (2)
- p38 (2)
- pCO2 (2)
- pain therapy (2)
- pain-related evoked potentials (2)
- paired associative stimulation (2)
- palate (2)
- palliative (2)
- pancreatic carcinoma (2)
- panel sequencing (2)
- paraspeckles (2)
- parenteral nutrition (2)
- parkinson's disease (2)
- parotid gland (2)
- participation (2)
- passive smoking (2)
- passive transfer (2)
- patellar tendon (2)
- pathogenic bacteria (2)
- patient (2)
- patient reported outcome measures (2)
- patient safety (2)
- patient satisfaction (2)
- patient survival (2)
- patients (2)
- patterns of care (2)
- peer review (2)
- pelvic examination (2)
- pelvic palpation (2)
- pembrolizumab (2)
- pemphigus foliaceus (2)
- penicillin allergy (2)
- penicillin hypersensitivity (2)
- people (2)
- peptide tyrosine tyrosine (PYY) (2)
- peptides (2)
- perfusion culture (2)
- perfusion imaging (2)
- pericytes (2)
- perineal (2)
- perineurium (2)
- perioperative care (2)
- peripartum (2)
- peripheral blood lymphocytes (2)
- peripheral nerve injury (2)
- peripheral neuropathy (2)
- peritoneal carcinomatosis (2)
- peroxisome (2)
- peroxisomes (2)
- personalised medicine (2)
- personality disorder (2)
- personality traits (2)
- personalized treatment (2)
- phacoemulsification (2)
- phaeochromocytoma (2)
- pharmaceutical applications (2)
- pharmacology (2)
- pharmacology/toxicology (2)
- pharmacotherapy (2)
- phase variation (2)
- phenotypic heterogeneity (2)
- phenprocoumon (2)
- phosphodiesterase inhibitor (2)
- photon-counting (2)
- photothrombosis (2)
- phylogenetic analysis (2)
- phylogeny (2)
- phytohormones (2)
- piperacillin/tazobactam (2)
- placebo-controlled trial (2)
- plaque (2)
- plasma proteins (2)
- plasminogen (2)
- plate (2)
- platelet physiology (2)
- platelet receptors (2)
- pleomorphic adenoma (2)
- pneumonia (2)
- point of care testing (2)
- point-of-care (2)
- polyadenylation (2)
- polycationic peptides (2)
- polycystic ovary syndrome (2)
- polymavirus (2)
- polymer processing (2)
- polymerization (2)
- polymyalgia rheumatica (2)
- polyphenols (2)
- pomalidomide (2)
- poor prognosis (2)
- population (2)
- population-based (2)
- pore formation (2)
- positional plagiocephaly (2)
- positioning device (2)
- positron emission tomography/computed tomography (2)
- postmenopausal women (2)
- postnatal development (2)
- postoperative Blutung (2)
- postoperative Nausea (2)
- postoperative Schmerzen (2)
- postoperative bleeding (2)
- postoperative complications (2)
- postoperative nausea and vomiting (2)
- postoperative pain (2)
- postoperative Übelkeit (2)
- posttranslational modifications (2)
- postural control (2)
- posture (2)
- potassium chloride co-transporter 3 (2)
- pre-messenger RNA (2)
- precancerous lesions (2)
- predictive marker (2)
- predictive markers (2)
- predictive value (2)
- predictors (2)
- prefrontal activity (2)
- prenatal exposure (2)
- prenatal stress (2)
- presbycusis (2)
- preschool children (2)
- presynaptic inhibition (2)
- preterm birth (2)
- preterm infant (2)
- primary cells (2)
- primary healthcare (2)
- primary prevention (2)
- principal component analysis (2)
- printed tooth (2)
- progenitor cells (2)
- progenitors (2)
- prognostische Faktoren (2)
- promoter polymorphism (2)
- propensity score matching (2)
- prophylaxis (2)
- prospektiv (2)
- prostaglandins (2)
- prostate-cancer (2)
- prostatectomy (2)
- prosthesis (2)
- protease inhibitors (2)
- protein adsorption (2)
- protein aggregation (2)
- protein kinase C (2)
- protein p8 (2)
- protein-coupled receptors (2)
- proteinuria (2)
- psychoeducation (2)
- psychopathology (2)
- psychotherapy (2)
- puberty (2)
- pulmonalarterieller Druck (2)
- pulmonale Hypertonie (2)
- pulmonary arterial pressure (2)
- punishment (2)
- purinergic receptors (2)
- pyrosequencing (2)
- qPCR (2)
- quality control (2)
- quality indicators (2)
- quantitative SPECT/CT (2)
- quantitative sensory testing (2)
- radial forearm flap (2)
- radiation pneumonitis (2)
- radiation therapy (2)
- radical prostatectomy (2)
- radii (2)
- radioiodine (2)
- radiopharmaceuticals (2)
- radiotherapy (RT) (2)
- radiotracer (2)
- radius (2)
- randomised controlled trial (2)
- randomized controlled-trial (2)
- randomized trial (2)
- rat heart (2)
- rat model (2)
- rate of recurrence (2)
- re-irradiation (2)
- reaction time (2)
- reactivity (2)
- real world evidence (2)
- real-time (2)
- receptor cluster (2)
- receptor expression (2)
- receptor tyrosine kinases (2)
- recognition (2)
- recombinant proteins (2)
- reconstructed human epidermis (2)
- rectal resection (2)
- rectum (2)
- recurrent nerve palsy (2)
- red blood cells (2)
- red fluorescent protein (2)
- reference values (2)
- reflux disease (2)
- regenerative capacity (2)
- register (2)
- regulatory T cell (2)
- regulatory t-cells (2)
- reinforcement learning (2)
- rejection (2)
- relaxation (2)
- remyelination (2)
- renal artery (2)
- renal disease (2)
- renal system (2)
- renal transplantation (2)
- reperfusion injury (2)
- replica (2)
- reporter gene (2)
- reproducibility (2)
- reproducibility of results (2)
- reproductive medicine (2)
- research (2)
- resection (2)
- resin composite (2)
- resolution (2)
- respiratory chain (2)
- respiratory distress index (2)
- respiratory syncytial virus (2)
- responding pattern (2)
- response regulator (2)
- restriction (2)
- restrictive cardiomyopathy (2)
- resveratrol (2)
- retinitis pigmentosa (2)
- retinoic acid (2)
- retropubic (2)
- retrospektive Analyse (2)
- retrovirus (2)
- reverse transcriptase inhibitors (2)
- reversible posterior leukoencephalopathy syndrome (2)
- reward (2)
- rheumatoide Arthritis (2)
- ribavirin (2)
- rimonabant (2)
- risk assessment (2)
- risk score (2)
- robotic surgery (2)
- root-canal treatment (2)
- rotation (2)
- rtPA (2)
- running injuries (2)
- rupture (2)
- sGC (2)
- saccotomy (2)
- sacral nerve stimulation (2)
- salivary gland tumors (2)
- salvage (2)
- salvage radiotherapy (2)
- sample (2)
- sarcoma (2)
- satisfaction with life (2)
- scapula (2)
- schizophrenie (2)
- sciatic nerve (2)
- scientific guidelines (2)
- scoping review (2)
- scurvy (2)
- second hit (2)
- secretion systems (2)
- selection (2)
- selen (2)
- selenoprotein P (2)
- self-help (2)
- self-management (2)
- senile lymphoproliferation (2)
- septic (2)
- septic shock (2)
- sequence analysis (2)
- sequence motif analysis (2)
- serology (2)
- seroprevalence (2)
- serotonin transporter gene (2)
- severe sepsis (2)
- sex determination (2)
- sexual development (2)
- shear bond strength (2)
- shedding (2)
- sheep (2)
- shiga toxin (2)
- shoulder pain (2)
- siRNA (2)
- sialyltransferase (2)
- signal to noise ratio (2)
- signal transduction pathway (2)
- signaling pathways (2)
- signalling (2)
- signalling pathways (2)
- signs and symptoms (2)
- silicone (2)
- simultaneous integrated boost (2)
- single-cell RNA-seq (2)
- sinusitis (2)
- sirolimus (2)
- sizing (2)
- skin cancer (2)
- skinned fiber (2)
- skull (2)
- sleep (2)
- sleeve gastrectomy (2)
- small RNAs (2)
- small bowel transplantation (2)
- small fiber pathology (2)
- small nucleolar RNAs (2)
- smoking cessation (2)
- smooth muscle cells (2)
- social support (2)
- sodium (2)
- sodium channels (2)
- sofosbuvir (2)
- soft tissue profile (2)
- solid tumors (2)
- solubility (2)
- somatostatin receptor (SSTR) (2)
- specific language impairment (2)
- speech (2)
- speech perception (2)
- speech reception (2)
- speech test (2)
- speech-noise-level (2)
- sperm DNA methylation (2)
- spherical pressfit cup (2)
- spheroids (2)
- sphingosine kinase inhibitor SKI-II (2)
- sphärische Pressfit-Pfanne (2)
- spider phobia (2)
- spinal cord injury (2)
- spinal-cord-injury (2)
- spiral ganglion neuron (2)
- spironolactone (2)
- split-belt treadmill (2)
- standard (2)
- stem (2)
- stem cell (2)
- stem cell therapy (2)
- stereotactic body radiotherapy (2)
- stereotaktische Bestrahlung (2)
- stomach (2)
- strategies (2)
- stratification (2)
- streptozotocin (2)
- stress fibers (2)
- stress resilience (2)
- stress resistance (2)
- stress signaling (2)
- stroke care (2)
- stroke unit (2)
- stroma (2)
- structure-activity (2)
- structure-activity relationships (2)
- structured illumination microscopy (2)
- student training (2)
- study (2)
- subcutaneous animal model (2)
- substantia nigra pars compacta (2)
- suicide (2)
- sulfates (2)
- supportive care (2)
- suppressor cells (2)
- surface coating (2)
- surface modification (2)
- surgical exposure (2)
- surgical site infection (2)
- surgical therapy (2)
- surveillance (2)
- survival analysis (2)
- survival rates (2)
- survivors (2)
- sustained fear (2)
- sustained inflammation (2)
- sweat osmolality (2)
- sweat secretion rate (2)
- swimming (2)
- symptom control (2)
- synapse formation (2)
- synapses (2)
- synaptische Plastizität (2)
- syndrome (2)
- synergism (2)
- system (2)
- systems (2)
- targeting (2)
- telemetry (2)
- temporal bone (2)
- temporal-lobe epilepsy (2)
- temporomandibular disorders (2)
- tensile strength (2)
- terahertz radiation (2)
- terminale Niereninsuffizienz (2)
- testing (2)
- tetracalciumphosphate (2)
- textile (2)
- therapiefreies Intervall (2)
- thorax (2)
- three-dimensional (2)
- three-dimensional printing (2)
- thromboinflammation (2)
- thrombopoiesis (2)
- thyroid gland (2)
- thyroid volume (2)
- time perception (2)
- time series (2)
- timing (2)
- tissue saturation index (2)
- titanium (2)
- tnf (2)
- tocilizumab (2)
- tolerability (2)
- tooth (2)
- topography (2)
- total joint arthroplasty (2)
- toxin (2)
- toxins (2)
- tracer (2)
- trachea (2)
- tracheotomy (2)
- trafficking (2)
- training (2)
- trans-Golgi network (2)
- trans-splicing (2)
- transcriptional regulation (2)
- transformative education (2)
- transgene Ratten (2)
- transgenic (2)
- transgenic mouse (2)
- transient middle cerebral artery occlusion (2)
- transkranielle Gleichstromstimulation (2)
- transkranielle Gleichstromstimulation (tDCS) (2)
- translation initiation (2)
- transposition (2)
- trauma (2)
- trauma care (2)
- treatment guidelines (2)
- treatment options (2)
- treatment outcome (2)
- treatment resistance (2)
- treatment response (2)
- trichoblastoma (2)
- triple-negative breast cancer (2)
- tryptophan (2)
- tuberculosis (2)
- tubulin (2)
- tumor growth (2)
- tumor immunity (2)
- tumor immunology (2)
- tumor necrosis factor (TNF) (2)
- tumor suppressor gene (2)
- tumormicroenvironment (2)
- tumour (2)
- tumour immunology (2)
- type I interferon (2)
- type VII secretion system (2)
- tyrosine kinase (2)
- tyrosine kinase inhibitor (2)
- tyrosine kinase inhibitors (2)
- ulcerative colitis (2)
- ultrasound contrast agent (2)
- unexpressed needs (2)
- unilateral (2)
- universal prevention (2)
- untranslated exons (2)
- untranslatierte Exons (2)
- up-regulation (2)
- upper extremity (2)
- uremic toxin (2)
- urinary tract infection (2)
- urticaria (2)
- utilization (2)
- variability (2)
- variant surface glycoprotein (2)
- variants (2)
- vascular access (2)
- vasoconstriction (2)
- vemurafenib (2)
- venous system (2)
- vesicles (2)
- vestibular dysfunction (2)
- vestibulär evozierte Potentiale (2)
- video analysis (2)
- video laryngoscopy (2)
- viral replication (2)
- virology (2)
- virotherapy (2)
- virus reactivation (2)
- viscosity (2)
- visual evoked potentials (2)
- visualization (2)
- vitamin B6 (2)
- vitamin D deficiency (2)
- vitamins (2)
- vitrectomy (2)
- volatile Anästhetika (2)
- volume regulation (2)
- voluntary movement (2)
- voxel-based morphometry (2)
- walking (2)
- warfarin (2)
- wear (2)
- white blood cells (2)
- whole-exome sequencing (2)
- women (2)
- work capacity evaluation (2)
- xerostomia (2)
- yoga (2)
- young children (2)
- zirconia (2)
- zonal (2)
- zykloide Psychose (2)
- Änderung (2)
- Ösophagus (2)
- Überlebensanalyse (2)
- γδ T cell (2)
- γδ T cells (2)
- "Familiär-sporadisch"- Konzept (1)
- (+)-limonene (1)
- (Mouse L-cell) (1)
- (Rat brain membrane) (1)
- (Rat liver) (1)
- (Salmonella) (1)
- (cardiac) surgery (1)
- (classical and atypical) Werner syndrome (1)
- .................................................................... (1)
- /immunofluorescence (1)
- 0 (1)
- 0 antigen (1)
- 1,2-benzisothiazolinone (1)
- 1,25-dihydroxyvitamin D\(_{3}\) (1)
- 1-Methylnicotinamid (1)
- 11-beta-Hydroxylase (1)
- 11C-Hydroxyephedrine (1)
- 11C-Methionine PET/CT (1)
- 11C-hydroxyephedrine (1)
- 120 kDa Protein (1)
- 120 kDa protein (1)
- 123I-Ioflupane (1)
- 131I (1)
- 133Ba (1)
- 13C-Methacetin-Atemtest (1)
- 14.7K (1)
- 1490 (1)
- 15-Deoxyspergualin (1)
- 16S (1)
- 16S rRNA (1)
- 16S rRNA Sequenzanalyse (1)
- 16S rRNA analyses (1)
- 16S-rDNA (1)
- 16S-rRNA (1)
- 16q22 (1)
- 177Lu (1)
- 177Lu SPECT/CT imaging (1)
- 177Lu-DOTATATE (1)
- 177Lu-DOTATOC (1)
- 177Lu-OPS201 (1)
- 17ßEstradiol (1)
- 18-F-fluorothymidine uptake (1)
- 18. Jahrhundert (1)
- 18F-DCFPL (1)
- 18F-flurpiridaz (1)
- 18FDG-PET/CT (1)
- 18FFBnTP (1)
- 18q21.1 (1)
- 18th century (1)
- 19. Century (1)
- 1950er (1)
- 1H-Magnetic resonance spectroscopy (1H-MRS) (1)
- 1p36 deletion syndrome (1)
- 1st-line treatment (1)
- 2 PM (1)
- 2 Tesla (1)
- 2',7'-dichlorofluorescin (1)
- 2- deoxy-2-(18F)fluoro-D-glucose (1)
- 2-APB (1)
- 2-Acetylaminofluorene (1)
- 2-Aminoethylphosphonic acid (1)
- 2-DG (1)
- 2-Dichloroethane (1)
- 2-Dioxetane (1)
- 2-Generation reproduction (1)
- 2-Stunden-Monitoring (1)
- 2-acetylaminofluorene (1)
- 2-deoxy-2-(18F)fluoro-D-glucose (1)
- 2-deoxy-2-18F-fluoro-D-sorbitol (1)
- 2-deoxy-D-glucose (1)
- 2-dimensional speckle tracking (1)
- 2-dimensional strain (1)
- 2-h-monitoring (1)
- 2-photon microscopy (1)
- 2-pore potassium channel (1)
- 2-step IMRT (1)
- 2015 (1)
- 212-2 (1)
- 21q22.2-q22.3 (1)
- 223Ra (1)
- 224Ra (1)
- 22q11.2 deletion syndrome (1)
- 23Na- NMR (1)
- 23Na-NMR (1)
- 24-Hydroxylase Promotoranalyse (1)
- 25-hydroxycholesterol 7 alpha-hydroxylase (1)
- 27.9c (1)
- 28 (1)
- 2D (1)
- 2D-SPLASH (1)
- 2D-perfusion angiography (1)
- 2p16.3 (1)
- 3 D bioprinting (1)
- 3 D rotational fluoroscopy (1)
- 3 Tesla (1)
- 3 dimensional cell culture model (1)
- 3 fucosyltransferase-VI (1)
- 3,0 Tesla (1)
- 3-D liver model (1)
- 3-ß-D-Glucan Synthase (1)
- 3-ß-D-Glucan Synthetase (1)
- 3.0 Tesla (1)
- 31-P-MR-Spectroskopie (1)
- 31-P-Magnetresonanztomographie (1)
- 316L stainless-steel (1)
- 31P (1)
- 31P-MR-Spectroscopy (1)
- 31P-MR-Spektroskopie (1)
- 31P-MR-spectroscopy (1)
- 3D Bioprinting (1)
- 3D Druck (1)
- 3D Mapping System (1)
- 3D Modell (1)
- 3D Pulverdruck (1)
- 3D Slicer (1)
- 3D breast cancer model (1)
- 3D cell cultures (1)
- 3D conformal silicone bolus (1)
- 3D culture (1)
- 3D cultures (1)
- 3D echocardiography (1)
- 3D electrophysiology (1)
- 3D ex vivo models (1)
- 3D fluoroscopy (1)
- 3D image analysis (1)
- 3D in vitro model (1)
- 3D in vitro models (1)
- 3D lung tumor tissue models (1)
- 3D mapping system (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D modeling (1)
- 3D neuronal networks (1)
- 3D organoids (1)
- 3D powder print (1)
- 3D printer (1)
- 3D reconstruction (1)
- 3D scan (1)
- 3D spheroid culture (1)
- 3D tissue models (1)
- 3D tumor model (1)
- 3D tumour model (1)
- 3D ultrasound (1)
- 3D-Bildanalyse (1)
- 3D-Biodruck (1)
- 3D-CSI (1)
- 3D-Druckzähne (1)
- 3D-Elektrode (1)
- 3D-Gewebemodell (1)
- 3D-Modell (1)
- 3D-Rekonstruktion (1)
- 3D-Scanner (1)
- 3D-gedruckter Zahn (1)
- 3D-konformale Radiotherapie (1)
- 3D-konformaler Bolus (1)
- 3D-ultrasound (1)
- 3R (1)
- 3d (1)
- 3d powder printing (1)
- 3d printing (1)
- 3d-echocardiography (1)
- 3ß-HSD II (1)
- 3 T (1)
- 4 (1)
- 4'-hydroxylation (1)
- 4-(p-nitrobenzyl)pyridine (1)
- 4-1BB Agonist (1)
- 4-1BB agonist (1)
- 4-dial (1)
- 4.977 bp-Deletion (1)
- 4D (1)
- 4D Studie (1)
- 4D flow (1)
- 4D flow MRI (1)
- 4D flow cardiovascular magnetic resonance (1)
- 4D study (1)
- 4D-MRI (1)
- 4D-Studie (1)
- 5' UTR (1)
- 5-Alpha-Reduktase (1)
- 5-Dihydroxycinnamat (1)
- 5-HIAA (1)
- 5-HT (1)
- 5-HT receptors (1)
- 5-HT1A-Polymorphismus (1)
- 5-HT1A-polymorphism (1)
- 5-HT2A (1)
- 5-HT3A (1)
- 5-HTT Knock Out (1)
- 5-HTT knockout mice (1)
- 5-HTT polymorphism (1)
- 5-HTT-Polymorphismus (1)
- 5-alpha-reductase (1)
- 5-bromodeoxyuridine (1)
- 5-dihydroxycinnamate (1)
- 5A-Modell (1)
- 5C6 (1)
- 5HT1A (1)
- 5HTT (1)
- 5HTTLPR (1)
- 5q22.2 (1)
- 6-percent hydroxyethyl starch (1)
- 60-nucleotide duplication (1)
- 65-kda isoform (1)
- 68Ga-DOTANOC (1)
- 68Ga-DOTATATE/-TOC (1)
- 68Ga-DOTATOC (1)
- 68Ga-OPS202 (1)
- 68Ga-PSMA ligand PET/CT (1)
- 68Ga-Pentixafor PET/CT (1)
- 6S RNA (1)
- 7 T (1)
- 7,8-dihydroxyflavone (7,8-DHF) (1)
- 7-Dehydrocholesterol (1)
- 7T (1)
- 8-Hydroxy-deoxyguanosine (1)
- 97 kDa Protein (1)
- 97 kDa protein (1)
- 977 bp-deletion (1)
- 99mTc-DTPA (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- A chromosomes (1)
- A(2B) receptors (1)
- A-Silicons (1)
- A-Silikone (1)
- A-delta fibers (1)
- A. fumigatus (1)
- A1 Adenosine receptors (1)
- A20 (1)
- A375 (1)
- A53T mutation (1)
- A53T-Mutation (1)
- A549 (1)
- A549 cell line (1)
- A<sub>2</sub> Adenosine receptor (1)
- AAA (1)
- AAA-bone (1)
- AAF (1)
- AAT (1)
- AB0- Testsubstanzen (1)
- AB0-test substances (1)
- ABI (1)
- ABL gene (1)
- ABR with time course step stimulus algorithm (1)
- ACAT (1)
- ACC/AHA classification (1)
- ACE inhibitor (1)
- ACE-Inhibitor (1)
- ACE-Inhibitors (1)
- ACE-inhibitor (1)
- ACH-2 (1)
- ACKR4 (1)
- ACL construct (1)
- ACL-Reconstruction (1)
- ACL-Rekonstruktion (1)
- ACM (1)
- ACMaster (1)
- ACO-Schema (1)
- ACO-scheme (1)
- ACPC (1)
- ACS (1)
- ACTH-Rezeptor (1)
- ACTH-rezeptor (1)
- ACVB (1)
- AD mouse modele (1)
- AD pathogenesis (1)
- AD-AID (1)
- ADAM10 (1)
- ADC (1)
- ADCC (1)
- ADGRL3 (1)
- ADHD patients (1)
- ADHDS (1)
- ADMA (1)
- ADMA/ADMA (1)
- ADP (1)
- ADP receptors (1)
- ADP-Rezeptoren (1)
- ADP-Ribosyltransferasen (1)
- ADP-ribosylation toxins (1)
- ADT (1)
- AED (1)
- AEP (1)
- AFLP (1)
- AFM (1)
- AGT (1)
- AHD-575 (1)
- AHF (1)
- AHF-Register Würzburg (1)
- AHI (1)
- AHRR (1)
- AI (1)
- AICD (1)
- AICDA (1)
- AID-ΔE4a (1)
- AIM2 (1)
- AIRE (1)
- AIRWAYS ICPs (1)
- AKT (1)
- AKT-Signalweg (1)
- AKT-signaling (1)
- AKT1 (1)
- ALI culture (1)
- ALK-1 (1)
- ALL-BFM-2000-Protokoll (1)
- ALP (1)
- ALPL (1)
- ALS mimic (1)
- ALS treatment (1)
- ALT (1)
- ALiOS (1)
- AMACR (1)
- AMARES (1)
- AMP-activated protein kinase (AMPK) (1)
- AMPA (1)
- AMPK (1)
- ANA (1)
- ANGPTL_4 (1)
- ANIMAX (1)
- AO (1)
- AOM/DSS (1)
- AORI-Klassifikation (1)
- AP-1 (1)
- APACHE <Klassifikation> (1)
- APECED (1)
- APERIO (1)
- APERIO Hybrid (1)
- APEX2 (1)
- APOBEC3G (1)
- APRI (1)
- AQP (1)
- ARCI (1)
- ARCI EM type III (1)
- ARDS (acute respiratory distress syndrome) (1)
- ARF tumor-suppressor induced lymphomagenes (1)
- ARI (1)
- ARM (1)
- ARMS-PCR (1)
- ARONJ (1)
- ART (1)
- ART outcome (1)
- ARVC (1)
- ASC-1 (1)
- ASE formula (1)
- ASIC 3 (1)
- ASIC1 (1)
- AT-1-Receptorantagonist (1)
- AT-1-Rezeptorantagonist (1)
- AT1-Rezeptor (1)
- AT1-Rezeptor-Antagonist (1)
- AT1-receptor (1)
- ATF3 (1)
- ATF5 (1)
- ATF6 (1)
- ATG (1)
- ATG8 (1)
- ATIP (1)
- ATM gene (1)
- ATMP (1)
- ATP generation (1)
- ATP-adenosine triphosphate (1)
- ATP-binding cassette transporter (1)
- ATPase activity (1)
- ATRA (1)
- ATRT (1)
- ATRX (1)
- ATTRv amyloidosis (1)
- AUY-922 (1)
- AV-Knoten (1)
- AV-Node (1)
- AVEMAR (1)
- AW-CSI (1)
- AZD4547 (1)
- AZD6140 (1)
- AZD6244 (1)
- AZT (1)
- A\(_{2A}\) adenosine receptor antagonist (1)
- Abatacept (1)
- Abbindeverhalten (1)
- Abciximab (1)
- Abdomen (1)
- Abdominaltrauma (1)
- Abelson helper integration-1 (AHI1) (1)
- Abeokuta (1)
- Aberrationen (1)
- Abformmaterial (1)
- Abformmaterialien (1)
- Abformung (1)
- Abfüllverfahren (1)
- Abhängigkeit (1)
- Abirateron (1)
- Ablation <Medizin> (1)
- Abnehmbarer Zahnersatz (1)
- Abrasion (1)
- Abscherfestigkeit (1)
- Abscherkraft (1)
- Abscherverhalten (1)
- Absolutkonzentrationen (1)
- Absorbed Doses (1)
- Abstinenz (1)
- Abszesse (1)
- Abszision (1)
- Abszission (1)
- Abtreibung (1)
- Abuse (1)
- Abzugfestigkeit (1)
- Acarbose (1)
- Accelerometer (1)
- Accelerometry (1)
- Acetaminophen (1)
- Acetessigester (1)
- Acetoacetat (1)
- Achilles (1)
- Achilles tendinopathy (1)
- Achilles tendo (1)
- Achillessehne (1)
- Achondroplasie (1)
- Achsenlänge (1)
- Achsenlänge des Auges (1)
- Acid-base-state (1)
- Acoustic neuroma (1)
- Acoustic radiation force imaging (ARFI) (1)
- AcrAB-TolC efflux pump (1)
- Acromesomelic dysplasias (1)
- Actin Dynamics (1)
- Actin-Filament (1)
- Actin-bindende Proteine (1)
- Actinomyceten (1)
- Actinomycetes (1)
- Activation induced cell death/AICD (1)
- Active disease (1)
- Acute Kidney Injury (1)
- Acute Limb Ischemia (1)
- Acute Respiratory Distress Syndrome (1)
- Acute ischaemic renal failure (1)
- Acute lymphoblastic leukemia (1)
- Acute lymphocytic leukaemia (1)
- Acute myeloid leukemia (AML) (1)
- Acute osteomyelitis (1)
- Acute tryptophan depletion (1)
- Acylcarnitin (1)
- Adam (1)
- Adamantiades-Behçet disease (1)
- Adaptation (1)
- Adaptive cell transfer (1)
- Adaptives Immunsystem (1)
- Adaptorproteine (1)
- Addison's disease (1)
- Addisons disease (1)
- Addition (1)
- Adeno (1)
- Adenocarcinom (1)
- Adenocarcinomas (1)
- Adenoide (1)
- Adenom (1)
- Adenom-carcinom-sequence (1)
- Adenosine receptor (1)
- Adenosine receptor antagonists (1)
- Adenoviraler Gentransfer (1)
- Adenovirus (1)
- Adenylate cyclase toxin (1)
- Aderhaut (1)
- Aderhautmelanom (1)
- Aderhautsarkom (1)
- Aderlaß (1)
- Adherence (1)
- Adhesion GPCR (1)
- Adhesion and Invasion (1)
- Adhesion-GPCR (1)
- Adhesive Hydrogels (1)
- Adhärens-/ Occludensjunktionen (1)
- Adhärenskontakte (1)
- Adhäsion <Pathologie> (1)
- Adhäsive Restauration (1)
- Adhäsivsystem (1)
- Adhäsivtechnik (1)
- Adipogenesis (1)
- Adiponectin (1)
- Adipose (1)
- Adipose-Derived Stromal/Stem Cells (1)
- Adipositas im Kindesalter (1)
- Adipositaschirurgie (1)
- Adjuvans (1)
- Adjuvante Behandlung (1)
- Adjuvante Therapie (1)
- Administered Activities (1)
- Adolescence (1)
- Adolescents (1)
- Adoleszenz (1)
- Adoptiver T Zell Transfer (1)
- Adrenalin (1)
- Adrenerge Stimu (1)
- Adrenerger Rezeptor (1)
- Adrenergic Receptor (1)
- Adrenergisches System (1)
- Adrenocortial carcinomas (1)
- Adrenocortical Cancer (1)
- Adrenocortical cancer (1)
- Adrenokortikales Karzinom (1)
- Adrenozeptor (1)
- Adult head (1)
- Adult patients (1)
- Adulthood (1)
- Advance Care Planning (1)
- Advanced Adrenocortical Carcinoma (1)
- Advanced Glycation Endproducts (1)
- Adverse Events (1)
- Adärenz (1)
- Aequalis (1)
- Aequilibriometrie (1)
- Aequorin (1)
- Aequos G1 (1)
- Aerobe Leistungsfähigkeit (1)
- Afatinib (1)
- Affective psychoses (1)
- Afferent nerve stimulation (1)
- Afferenzen (1)
- Affinity probe (1)
- Aflatoxin B1 (1)
- African-americans (1)
- Afrika (1)
- Afternystagmus (1)
- Agaphelin (1)
- Ageing (1)
- Agglomeration (1)
- Aggregation (1)
- Aggrekan (1)
- Aggressive behaviour (1)
- Agoraphobie (1)
- Agrin (1)
- Ahmed (1)
- Aiolos (1)
- Airlift-Kultur (1)
- Airtraq (1)
- Akademische Medizin (1)
- Akkommodation (1)
- Akkomodationsreiz (1)
- Akne (1)
- Akt/PKB (1)
- Aktiv-kontrollierten Bewegungsschiene (1)
- Aktivator / Bionator (1)
- Aktive Implantate (1)
- Aktive Sterbehilfe (1)
- Aktive Zone (1)
- Aktivierung <Physiologie> (1)
- Aktivitätsbeginn (1)
- Aktivitätsmarker (1)
- Akustischer Reiz (1)
- Akustischer Startle Reflex (1)
- Akute lymphatische Leukämie (1)
- Akute Ösophagusnekrose (1)
- Akutes Lungenversagen (1)
- Akutes ischämisches Nierenversagen (1)
- Akutphase (1)
- Akzeptanz (1)
- Alarmierungsalgorithmus (1)
- Albino rat (1)
- Albinoratten (1)
- Alcoholic and Non-Alcoholic Steatohepatitis (1)
- Alcoholism (1)
- Aldosteron Antagonisten (1)
- Aldosteronantagonist (1)
- Aldosterone Antagonists (1)
- Aldosteronome (1)
- Alemtuzumab (1)
- Alginat (1)
- Alginate (1)
- Alginate-Gelatine (1)
- Alien limb syndrome (1)
- Alignment <Biochemie> (1)
- Alkalidotierte Calciumphosphatcemente (1)
- Alkaline phosphatase (1)
- Alkalizemente (1)
- Alkaloid (1)
- Alkohol (1)
- Alkohol-Craving tDCS (1)
- Alkoholabhängikeit (1)
- Alkoholische Fettlebererkrankung (1)
- Alkoholische Polyneuropathie (1)
- Alkoholkonsum (1)
- Alkoholmissbrauch (1)
- Alkylation (1)
- All-In-One Adhesives (1)
- Allelfrequenzen (1)
- Allergic rhinitis (1)
- Allergiediagnostik (1)
- Allergiker (1)
- Allergy (1)
- Allgemeinanästhesie (1)
- AlloDerm (1)
- Alloantigen Expression (1)
- Alloantigenerkennung (1)
- Allodynie (1)
- Allogene hämatopoetische Stammzelltransplantation (1)
- Allogeneic transplantation (1)
- Allogenic hematopoietic stem cell transplantation (1)
- Allopeptidb (1)
- Allophrynidae (1)
- Alloreaktivität (1)
- Allotransplantatabstossung (1)
- Alpelisib (1)
- Alpha Fetoprotein (1)
- Alpha therapy (1)
- Alpha-2-Rezeptor (1)
- Alpha-Galactosidase (1)
- Alpha-ID-SE (1)
- Alpha-Lipoic acid (1)
- Alpha-Synuclein (1)
- Alpha-dependent apoptosis (1)
- Alpha-galactosidase (1)
- Alpha-synuclein oligomers (1)
- Altenpflege (1)
- Alter des Auges (1)
- Alternaria (1)
- Alternative (1)
- Alternative Krebstherapie (1)
- Alternative polyadenylation (1)
- Alternative test methods (1)
- Alternativmedizin (1)
- Altersabhängiger Lerneffekt (1)
- Altersabhängigkeit (1)
- Altersmedizin (1)
- Alterspsychiatrie (1)
- Aluminiumhydroxid (1)
- Aluminiumhydroxide (1)
- Alveolar (1)
- Alzheimer's diseas (1)
- Alzheimers-disease (1)
- Alzheimer´s disease (1)
- Alzheimer’s dementia (1)
- Amantadin (1)
- Amantadine (1)
- Ambulante Behandlung (1)
- Amelogenese (1)
- American Association of Oral and Maxillofacial Surgeons (1)
- American Thyroid Association (1)
- Amino acid composition (1)
- Amino acids (1)
- Aminobisphosphonate (1)
- Aminobuttersäure <gamma-> (1)
- Aminoglykoside (1)
- Aminopenicilline (1)
- Aminopeptidase (1)
- Aminosäure (1)
- Amisulprid (1)
- Amisulprid Kombinationsprophylaxe (1)
- Amisulprid PONV (1)
- Amitriptylin (1)
- Amphotericin B (1)
- Ampicillin (1)
- Amygdala (1)
- Amyloid-beta oligomers; (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- Amyotrophic-lateral-sclerosis (1)
- Anabolieagent (1)
- Analabszess (1)
- Analatresie (1)
- Analgesia (1)
- Analgetika (1)
- Analog (1)
- Anandamide (1)
- Anaphylactic shock (1)
- Anaphylaxie (1)
- Anaplasma phagocytophilum (1)
- Anaplasma phagozytophilum (1)
- Anaplastisches Schilddrüsenkarzinom (1)
- Anarchic limb syndrome (1)
- Anas crecca (1)
- Anastomosendurchblutung (1)
- Anastomosenrezidiv (1)
- Anastomosis healing (1)
- Anatomic reattachment (1)
- Anatomy (1)
- Androgenbioynthese (1)
- Androgendeprivation (1)
- Androgendeprivationstherapie (1)
- Anergy (1)
- Aneurysmaoperation (1)
- Aneurysmen (1)
- Ang II (1)
- Angewandte Toxikologie (1)
- Angina pectoris (1)
- Angiogenin (1)
- Angioplastie (1)
- Angiopoetin (1)
- Angiopoietin-1 (1)
- Angiopoietin-like 4 (1)
- Angiostatin (1)
- Angiotensin I (1)
- Angiotensin-II-Blocker (1)
- Angle Class II (1)
- Angle Kl. II (1)
- Angle-Kl. II/1 (1)
- Angle-Klasse II (1)
- Angotrip (1)
- Angst als Eigenschaft (1)
- Angst/Panik (1)
- Angstintensität (1)
- Angstsensitivitätsindex-3 (1)
- Angststörungen (1)
- Angstsyndrom (1)
- Angstverhalten (1)
- Anidulafungin (1)
- Aniline derivatives (1)
- Animal behavior (1)
- Animal model (1)
- Animal modell (1)
- Animal models (1)
- Animax (1)
- Anisotrope Diffusion (1)
- Ankerfibrillen (1)
- Ankopplungsbedingungen (1)
- Ankylose (1)
- Anopheles gambiae (1)
- Anorexia (1)
- Anorexia nervosa in childhood (1)
- Anorexia nervosa treatment satisfaction (1)
- Anosognosie (1)
- Anpassungskosten (1)
- Anreizsystem (1)
- Anschlussheilbehandlung (1)
- Anterior Cruciate Ligament (1)
- Anterior chamber perfusion model (1)
- Anterior cingulate (1)
- Anteriorer Cingulärer Kortex (1)
- Anteriorer cingulärer Cortex (1)
- Anteriores Cingulum (1)
- Anthocyanidine (1)
- Anthraquinone glycosides (1)
- Anti-GBM-Antikörper (1)
- Anti-Suizid-Vertrag (1)
- Anti-TNF-alpha agents (1)
- Anti-tank rocket (1)
- Anti-tank weapon (1)
- Antibiose (1)
- Antibiotic Stewardship (1)
- Antibiotic stewardship (1)
- Antibiotics (1)
- Antibiotikaprophylaxe (1)
- Antibiotikatherapie (1)
- Antibodies (1)
- Antibody index (1)
- Anticoagulants (1)
- Antidepressants (1)
- Antidepressivum (1)
- Antigen 4 (1)
- Antigen CD137 (1)
- Antigen CD25 (1)
- Antigen CD30 (1)
- Antigen CD4 (1)
- Antigen CD44 (1)
- Antigen CD45 (1)
- Antigen CD8 (1)
- Antigen CD95 (1)
- Antigen presentation (1)
- Antigenerkennung (1)
- Antigenexpression (1)
- Antigennachweis (1)
- Antigenpresentation (1)
- Antigenspezifische T-Zelle (1)
- Antigentherapie (1)
- Antiinflammatory agents (1)
- Antikoagulation (1)
- Antikoerper (1)
- Antikonvulsiva (1)
- Antikörper gegen N-Protein (1)
- Antimalariamittel (1)
- Antimicrobial (1)
- Antimicrobial activities (1)
- Antimicrobial proteins (1)
- Antimikrobiell (1)
- Antimikrobielle Aktivitäten (1)
- Antimikrobielle Resistenz (1)
- Antimikrobieller Wirkstoff (1)
- Antimutagen (1)
- Antimykotika-Empfindlichkeit (1)
- Antimykotikum (1)
- Antinozizeption (1)
- Antioxidans (1)
- Antioxidants (1)
- Antiparanodal Autoantibodies (1)
- Antirefluxchirugie (1)
- Antirefluxoperation (1)
- Antiretroviral Therapy (1)
- Antiretrovirale Therapie (1)
- Antisense (1)
- Antisocial behavior (1)
- Antitumorforschung (1)
- Antivirale Substanzen (1)
- Antizipation (1)
- Antrhopometry (1)
- Antwortinhibition (1)
- Anweisungs- und Sprachverstaendnis-Test (1)
- Anwenderfreundlichkeit (1)
- Anwenderschulung (1)
- Anwendung (1)
- Anxiety Sensetivity Index (1)
- Anxiety sensitivity (1)
- Anxiety-like behavior (1)
- Anästhetika-induzierte Postkonditionierung (1)
- Anästhetikum (1)
- Aortenbifurkationssyndrom (1)
- Aortenkonstriktion (1)
- Aortenringassay (1)
- Aortenwrapping (1)
- Aortic Valve Replacement (1)
- Aortic arch (1)
- Aortic valve replacement (1)
- Aortokoronarer Bypass (1)
- Apert (1)
- Aphthae (1)
- Apicomplexan (1)
- Apis mellifera (1)
- Aplastic anemia (1)
- Apnoe (1)
- ApoA-I D-4F (1)
- ApoE-Genotyp (1)
- ApoE-Knock-Out-Maus (1)
- ApoE-knock-out mice (1)
- ApoE/eNOS dko-Mäuse (1)
- Apolipoprotein-E Knockout (1)
- Apollonia-Kult (1)
- Apollonia-cult (1)
- Apoptoseinduktion (1)
- Apoptoseresistenz (1)
- Apoptosesensibilisierung (1)
- App-Entwicklung (1)
- Appearence (1)
- Appert (1)
- Apple Domäne (1)
- Apple Watch 7 (1)
- Apple domain (1)
- Applikatorposition (1)
- ApproTech (1)
- Approved immunomodulators (1)
- Aquaporin (1)
- Aquaporin 4 (1)
- Aquaporin-4 antibodies (AQP4-Ig, NMO-IgG)G (1)
- Aquaporin-4 antibodies (AQP4-IgG) (1)
- Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) (1)
- Aquaporin4 (1)
- Arachidonsäure (1)
- Arbeit (1)
- Arbeitsbelastung (1)
- Arbeitsg (1)
- Arbeitsmedizin (1)
- Arbeitssucht (1)
- Arbeitssüchtiger (1)
- ArcCHECK (1)
- Archaea (1)
- Archdiocese Bulawayo (1)
- Archimedisches Prinzip (1)
- Arginine (1)
- Argonaute (1)
- Armplexusverletzung (1)
- Arnold-Chiari-Syndrom (1)
- Arsen (1)
- Artemisinin (1)
- Arteria cerebri media (1)
- Arterial Diameters (1)
- Arterielle Gefäßsteifigkeit (1)
- Arterielle Verschlusskrankheit (1)
- Arterien (1)
- Arteriovenöser Bypass (1)
- Artery Models (1)
- Arthose (1)
- Arthrography (1)
- Arthropathy (1)
- Arthroplastik (1)
- Arthroscopy (1)
- Arthroseentstehung (1)
- Arthrosis deformans (1)
- Arthrotomie (1)
- Articular afferent (1)
- Articular-Cartilage (1)
- Artificial Nuclear Pores (1)
- Aryl Hydrocarbon Hydroxylase (1)
- Aryl hydrocarbon rnonooxygenase (1)
- Arzneimittelinteraktion (1)
- Arzneimittelmarkt (1)
- Arzneimittelnebenwirkung (1)
- Arzneimittel�berwachung (1)
- Arzneymittel (1)
- Arzt (1)
- Arzt ohne Gewissen – Privat-Klinik Prof. Lund (1959) (1)
- Arzt-Patienten-Verhältnis (1)
- Arztbegleiteter Patiententransport (1)
- Arztfilme (1)
- AsP (1)
- Asc-1 transporter (1)
- Ascaridiasis zoonoses (1)
- Ascaris lumbricoides (1)
- Aseptic loosening (1)
- Asfotase alfa (1)
- Asomatognosie (1)
- Aspartate Aminotransferases (1)
- Aspergillus fumigatus-spezifische CD154+/CD4+ Zellen (1)
- Aspergillus sp. (1)
- Aspiration (1)
- Aspirationspneumonie (1)
- Assay (1)
- Assessment (1)
- Assistierte Beatmung (1)
- Association analyses (1)
- Assoziation (1)
- Assoziationsanalyse (1)
- Assoziationsstudien (1)
- Astigmatism (1)
- Astigmatismus (1)
- Astigmatismusanalyse (1)
- Astigmatismuskorrektur (1)
- Astrocytes ; Schwann cells ; Interferon-gamma ; Fibroblast growth factor ; Cyclic AMP (1)
- Astrocytic tumor (1)
- Astrozyt (1)
- Astrozyten (1)
- Astrozytom (1)
- Asylbewerber (1)
- Asylum seeker (1)
- Ataxia (1)
- Ataxia telangiectasia (1)
- Atemantwortkurven (1)
- Atemluftanalyse (1)
- Atemnotsyndrom (1)
- Atempumpe Sarkoidose (1)
- Atemvariabilität (1)
- Atemwegserkrankung (1)
- Atemwegsinfektionen (1)
- Atemwegskrankheit (1)
- Atemwegsmanagement (1)
- Atemwegsschleimhaut (1)
- Atemwegswiderstand (1)
- Atherogenese (1)
- Atherosclerosis, intracranial arteries (1)
- Atherosclerotic plaque (1)
- Athlete's heart (1)
- Atlas (1)
- Atmung (1)
- Atomic force microscopy (1)
- Atomic-Force-Microscope (1)
- Atorvastatins (1)
- Atovaquone (1)
- Atresie (1)
- Atria (1)
- Atrial fibrillation (1)
- Atrial natriuretic peptide (1)
- Atriales natriuretisches Hormon (1)
- Atrioventrikuläre Verzögerung (1)
- Attention Deficit Hyperactivity Disorder (ADHD) (1)
- Attention Switching (1)
- Attention-deficit hyperactivity disorder (1)
- Attentional bias (1)
- Attentional performance (1)
- Attitude (1)
- Attraktion <Psychologie> (1)
- Atypische Antipsychotika (1)
- Atypische Pneumonie (1)
- Au/Ge(111) (1)
- Audiology (1)
- Audiometer (1)
- Audiometry (1)
- Audiovisuelle Medien (1)
- Auditorische steady-state Potentiale ASSP (1)
- Auditorischer Kortex (1)
- Auditory Evoked Potentials (1)
- Auditory brainstem implant (1)
- Auditory brainstem responses (1)
- Auditory pathway (1)
- Aufbissschiene (1)
- Aufklärung (1)
- Auflösung (1)
- Aufmerksamkeitsdefitit-/ Hyperaktivitätsstörung (1)
- Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (1)
- Aufmerksamkeitstest (1)
- Auftretenshäufigkeit (1)
- Aufwachverhalten (1)
- Augenbewegungen (1)
- Augenheilkunde im Nationalsozialismus (1)
- Augeninnendruck (1)
- Augeninnendruckreduktion (1)
- Augenlidtumor (1)
- Augenoberfläche (1)
- Augentropfen (1)
- Aureobasidium (1)
- Aurikuläre Vagusnervstimulation (1)
- AurisID (1)
- Ausbildungsforschung (1)
- Ausbruch (1)
- Ausdehnung (1)
- Ausländerstudium (1)
- Ausreifungscocktail (1)
- Ausstattung (1)
- Auswahl (1)
- Auswertung (1)
- Autism (1)
- Autismus (1)
- Auto-antibodies (1)
- AutoPulse (1)
- Autofluoreszenz (1)
- Autoimmune diseases (1)
- Autoimmune-Diseases (1)
- Autoimmunerkrankung (1)
- Autoimmungastritis (1)
- Autoimmunregulator (1)
- Autoimmuntherapie (1)
- Autoimmunthyreopathie (1)
- Autoinflammation (1)
- Autoinhibition (1)
- Autologe (1)
- Autologe Chondrozytentransplantation (1)
- Autologer In-Situ-Venenbypass (1)
- Autologous (1)
- Autologous Chondrocyte Transplantation (1)
- Automated analysis (1)
- Automatische Annäherungstendenzen (1)
- Automatische Identifikation (1)
- Automatische Klassifikation (1)
- Autonome Balance (1)
- Autonome Modulation (1)
- Autonomes Nervensystem (1)
- Autonomiv modulation (1)
- Autophagie <Physiologie> (1)
- Autoproteolysis (1)
- Autoradiographie (1)
- Autorotation (1)
- Autorotation des Unterkiefers (1)
- Autostimulation (1)
- Außenmembranprotein Opc (1)
- Außerklinischer Herz-Kreislauf-Stillstand (1)
- Avemar (1)
- Aversive tension (1)
- Avicenna (1)
- Aviophobia (1)
- Axenfeld-Rieger-Syndrom (1)
- Axenfeld-Rieger-Syndrome (1)
- Axilla (1)
- Axiographie (1)
- Axis (1)
- Axon Branching (1)
- Axon growth (1)
- Axon guidance (1)
- Axonal transport (1)
- Axonschaden (1)
- Axotomie (1)
- Azathioprine (1)
- Azidose (1)
- Aδ- and C-fibers (1)
- B (1)
- B Cell Receptor (1)
- B Lymphocytes (1)
- B Lymphozyten (1)
- B cell culture (1)
- B cell deficiency (1)
- B cell malignancies (1)
- B cell maturation (1)
- B cell receptor (1)
- B cell receptor (BCR) (1)
- B neisseria meningitidis (1)
- B- Zellen (1)
- B-Lympho (1)
- B-Lymphocyten (1)
- B-Lymphozyt-Tumor (1)
- B-Lymphozyten-Rezeptor (1)
- B-NHL (1)
- B-Zel (1)
- B-Zell Differenzierung (1)
- B-Zell Lymphome (1)
- B-Zell-ELISPOT-Test (1)
- B-Zell-Rezeptor (1)
- B-Zellen Differenzierung (1)
- B-cell (1)
- B-cell ELISPOT assay (1)
- B-cell Lymphome (1)
- B-cell differentiation (1)
- B-lymphocyte (1)
- B-zellen (1)
- B7-H1 Antigen (1)
- B7DC (1)
- B7H1 (1)
- BAC-Konstrukt (1)
- BAC-construct (1)
- BAFF-Receptor (1)
- BAFF-Rezeptor (1)
- BAL (1)
- BALB/c Maus (1)
- BAR (1)
- BARB-4 (1)
- BARF-mutated melanoma (1)
- BB/OKL rats (1)
- BBC3 (1)
- BCI (1)
- BCL-X-L P53 (1)
- BCL1 rearrangement (1)
- BCL1-Rearrangement (1)
- BCMA (1)
- BCOR (1)
- BCORL1 (1)
- BCR-ABL (1)
- BCR‐ABL (1)
- BDG (1)
- BDNF Astrozyten depressive Episode (1)
- BDNF Val66Met (1)
- BEAM (1)
- BET Inhibitor (1)
- BETA(2)-adrenergic receptor (1)
- BFU (1)
- BG-1 Zellen (1)
- BG-1 cells (1)
- BGA (1)
- BH3-only proteins (1)
- BIRC7 (1)
- BK channel (1)
- BK-Virus (1)
- BLAST (1)
- BLIMP1 (1)
- BM (1)
- BMP antagonist (1)
- BMP signaling (1)
- BMP- Varianten (1)
- BMP-2 delivery (1)
- BMP-2 mutants (1)
- BMP-2-Mutanten (1)
- BMP-6 (1)
- BMP-Mutanten (1)
- BMP-Varianten (1)
- BMP-mutants (1)
- BMPR1B (1)
- BMS-5 (1)
- BMSC (1)
- BN 52021 (1)
- BNDF (1)
- BNIP3 (1)
- BOLD (1)
- BOLD effect (1)
- BOLD-Effekt (1)
- BON-1 (1)
- BONJ (1)
- BP 180 NC16A (1)
- BP180 NC16A (1)
- BRAF inhibition (1)
- BRAF(V600E) mutation (1)
- BRCA (1)
- BRD (1)
- BRD4 (1)
- BRENDA (1)
- BRET (1)
- BRIP1 gene (1)
- BRONJ (1)
- BRP (1)
- BSGC (1)
- BSS directive (1)
- BSTA (1)
- BTN (1)
- BTN2 (1)
- BTN2A1 (1)
- BTN3A1 (1)
- BT_1884 (1)
- BV-2 (1)
- Babylotse-Plus (1)
- Babyschrei (1)
- BacT/ALERT (1)
- Bacillus-Calmette-Guerin (1)
- Background Epithelioid haemangioma (1)
- Bacteria (1)
- Bacteria-Host Cell Interaction (1)
- Bacterial Fitness (1)
- Bacterial conjugation (1)
- Bacterial infection (1)
- Bacterial meningitis (1)
- Bacterial pathogens (1)
- Baerveldt (1)
- Baghdadit (1)
- Baghdadite (1)
- Baha (1)
- Bahnung (1)
- Bakterielle Konjugation (1)
- Bakterien / Taxonomie (1)
- Bakteriophagen (1)
- Balanced Lethal System (1)
- Balints-Syndrome (1)
- Ballerspiel (1)
- Ballistics (1)
- Balneologie (1)
- Bandage (1)
- Bandspannung (1)
- Bandwürmer (1)
- Bankart Läsion (1)
- Barbiturat (1)
- Barbiturates (1)
- Bariatric surgery (1)
- Bariatric/metabolic surgery (1)
- Bariatrische Operation (1)
- Barium-133 (1)
- Barkhof criteria (1)
- Barrett (1)
- Barrett-Karzinom (1)
- Barrett-Ösophagus (1)
- Barriereeigenschaften (1)
- Barth Syndrome (1)
- Barthel Index (1)
- Barthel-Index modified Rankin-Scale (1)
- Barthel-Index modifizierte Rankin-Skala (1)
- Basal Cell Carcinoma (1)
- Basal ganglia (1)
- Basale Stimulation (1)
- Basaliome (1)
- Basalzellkarzinom (1)
- Base composition (1)
- Basement membrane (1)
- Basendefizit (1)
- Basiocciput (1)
- Basiokziput (1)
- Basischarakteristika (1)
- Basisfertigkeiten Laparoskopie (1)
- Basophil activation test (1)
- Batf3 (1)
- Bauchaorta (1)
- Bauchdeckenverschluss (1)
- Bauchlage (1)
- Bauchspalte (1)
- Bauchspeicheldruesenkrebs (1)
- Bauchspeicheldrüsentumor (1)
- Bauchwand (1)
- Bauchwandhernie (1)
- Bauer (1)
- Bauspeicheldrüse (1)
- Bavaria (1)
- Bayern (1)
- Bcl-2 Familie (1)
- Bcl-2 family (1)
- Bcl-2-Gen (1)
- Bcl-2-Proteinfamilie (1)
- Bcl-2-gene (1)
- Bcl-X (1)
- Bcr-Abl (1)
- Beals (1)
- Beam-Walking-Test (1)
- Beckenbodendysfunktion (1)
- Beckenbodenmuskulatur (1)
- Beckenbodensenkung (1)
- Beckenfraktur (1)
- Beckengefäße (1)
- Beckenkammtransfer (1)
- Beckenkammtransplantate (1)
- Beckenring (1)
- Becker (1)
- Becker naevus (1)
- Becker naevus syndrome (1)
- Becker-Kiener-Syndrom (1)
- Bedarf (1)
- Bedeutung (1)
- Bedürfnisse (1)
- Beer-lambert law (1)
- Befestigungszement (1)
- Befund (1)
- Begrenzung (1)
- Begrenzung am Lebensende (1)
- Behandlung von Zahnschmelzverfärbungen (1)
- Behandlungsansätze in der orthognathen Chirurgie (1)
- Behandlungsdauer (1)
- Behandlungserwartung (1)
- Behandlungsgenauigkeit (1)
- Behandlungsmethoden (1)
- Behandlungsverfahren (1)
- Behandlungswunsch (1)
- Behandlungszufriedenheit kindlicher Patienten mit Anorexia nervosa nach stationärem Klinikaufenthalt (1)
- Behçet’s disease (1)
- Beige adipocytes (1)
- Beinachse (1)
- Beinahe - Ertrinkungsunfälle (1)
- Beingefäße (1)
- Belastung (1)
- Belastung Eltern (1)
- Belastungsdyspnoe (1)
- Belastungselektrokardiogramm (1)
- Belegung (1)
- Beleibtheit (1)
- Benefit Finding (1)
- Benennungsgeschwindigkeit (1)
- Benfotiamin (1)
- Bennettwinkel (1)
- Benzefuran dioxetane (1)
- Benzefuran epoxide (1)
- Benzimidazoles (1)
- Benzo(a)pyrene (1)
- Benzo(a)pyrene-DNA binding (1)
- Benzoporphyrinderivat (1)
- Benzopyren (1)
- Beobachtung (1)
- Beobachtungsbogen (1)
- Beraphon (1)
- Berechnung (1)
- Berenil (1)
- Berichterstattung (1)
- Beris, Johannes (1)
- Berliner Blau (1)
- Bernard- Fries Technik (1)
- Bernard- Fries technique (1)
- Beru (1)
- Beruf (1)
- Berufsklassifikation (1)
- Berufskrankheit (1)
- Berufssport (1)
- Beschichtung von Titandioxid-Nanopartikeln (1)
- Beschichtungsanlage (1)
- Besiedelung (1)
- Bestimmung (1)
- Bestimmung der hochgradigen Mitralklappeninsuffizienz (1)
- Bestrahlung von Hirnmetastasen (1)
- Bestrahlungsplan (1)
- Bestrahlungstechniken (1)
- Beta(1)-adrenergic receptor (1)
- Beta(2)-adrenergic receptor (1)
- Beta- adrenergic receptors (1)
- Beta-Receptor (1)
- Beta-Receptor subtypes (1)
- Beta-Rezeptor Subtypen (1)
- Beta-Strahlenexposition (1)
- Beta-Zelle (1)
- Beta-Zellen (1)
- Beta-adrenerge Rezeptoren (1)
- Beta-blocker (1)
- Beta-catenin (1)
- Beta-cell (1)
- Betaadrenerge Rezeptoren (1)
- Betahydroxybutyrat (1)
- Betazelle (1)
- Betazellen (1)
- Betreuungsverfügung (1)
- Betriebsmedizin (1)
- Bettnetz (1)
- Bettpartner (1)
- Beugesehnennaht (1)
- Beurteilung (1)
- Bewegung (1)
- Bewegungsprogramm (1)
- Bewegungsstörung (1)
- Bewertung des Medizinstudiums in Deutschland (1)
- Bewertungsplattform (1)
- Bewertungsschemata (1)
- Bewältigung (1)
- Bewältigungsfähigkeiten (1)
- Biased gene conversion (1)
- Biaxiale Biegefestigkeit (1)
- Bidirektional (1)
- Biegefestigkeit (1)
- Bienengiftallergie (1)
- Big Five (1)
- Big picture (1)
- Bikuspide Aortenklappe (1)
- Bild (1)
- Bildanalyse (1)
- Bildartefakte (1)
- Bildfusion (1)
- Bildrekonstruktion (1)
- Bilirubin (1)
- Bim (1)
- Binaural (1)
- Bindegewebstransplantat (1)
- Binocular (1)
- Binokular (1)
- BioOSS (1)
- Biobank (1)
- Biochemical-Diagnosis (1)
- Biochemische Kontrolle (1)
- Biocompatibility (1)
- Biodegradable polymer scaffolds (1)
- Biodegradation (1)
- Biofabrikation (1)
- Biofeedback (1)
- Biofeedback-Therapie (1)
- Biofilmentfernung (1)
- Biogenese (1)
- Biografie (1)
- Biographical questionnaire (1)
- Biographischer Fragebogen (1)
- Bioharz (1)
- Biohazard (1)
- Bioimpedance (1)
- Bioimpedanz (1)
- Bioimpedanzanalyse (1)
- Bioinformatik (1)
- Bioink (1)
- Biokeramik (1)
- Biologika (1)
- Biologische Ernährung (1)
- Biologische Uhr (1)
- Biologischer Abbau (1)
- Bioluminescence (1)
- Bioluminescence imaging (1)
- Biomarke (1)
- Biomarker der Fibrose (1)
- Biomechanica (1)
- Biomechanical Properties (1)
- Biomechanical properties (1)
- Biomechanics (1)
- Biomechanisch (1)
- Biomechanische Analyse (1)
- Biomechanische Eigenschaften (1)
- Biomedical Application of MR (1)
- Biomedicine (1)
- Biomedizin (1)
- Biomedizinische Anwendung von MR (1)
- Biometrie (1)
- Biomonitoring (1)
- Bionator (1)
- Biopsy (1)
- Bioreactor (1)
- Bioreaktorplattform (1)
- Bioresorption (1)
- Biotechnologie (1)
- Biotinte (1)
- Biotype (1)
- Biowissenschaften (1)
- Biozement (1)
- Bipolar (1)
- Bipolar DGKH-GAT Endophänotypen (1)
- Bipolar Disorder (1)
- Bipolar-affektive Störung (1)
- Bipolare Störung (1)
- Bipolare affektive Störung (1)
- Biseko (1)
- Bispektral Index (1)
- Bisphosphonat (1)
- Bizepssehne (1)
- Bizepssehnenpathologie (1)
- Bland–Altman (1)
- Blasen bildende Autoimmundermatosen (1)
- Blasenbildung (1)
- Bleeding (1)
- Blei (1)
- Blepharoplastik (1)
- Blimp1 (1)
- Blind Pericardiocentesis (1)
- Blinde Perikardiozentese (1)
- Blindheit (1)
- Blockade (1)
- Blockierende Faktoren (1)
- Blood (1)
- Blood contamination (1)
- Blood nerve barrier (1)
- Blood stream infection (1)
- Blood-Brain Barrier (1)
- Blood-Brain-Barrier (1)
- Blood-brain barrier (1)
- Blood–brain barrier (1)
- Blumentrost (1)
- Blut-Luft-Schranke (1)
- Blut-Nerve-Schranke (1)
- Blut-Nerven-Schranke (1)
- Blutflussgeschwindigkeit (1)
- Blutflussrate (1)
- Blutgasanalyse (1)
- Blutgasstatus (1)
- Blutgefäßdichte (1)
- Blutgerinnungsfaktor XII (1)
- Blutgruppe (1)
- Blutgruppen (1)
- Blutgruppenbestimmung (1)
- Blutkontakt (1)
- Blutkontamination (1)
- Blutlymphozyten (1)
- Blutplättchen (1)
- Blutspiegel (1)
- Bluttransfusion (1)
- Blutung (1)
- Blutuntersuchung (1)
- Blutvolumen (1)
- Blutzelle (1)
- Blutzuckerverlauf (1)
- Body Image Disturbance (1)
- Body weight (1)
- Bogengang <Anatomie> (1)
- Bogengangsdehiszenz (1)
- Bolton-Standards (1)
- Bolustriggerung (1)
- Bombenkalorimetrie (1)
- Bombesin ; Bombesin receptor ; Chromosomal localization (1)
- Bombus terrestris (1)
- Bombyx mori (1)
- Bonding Agent (1)
- Bonding systems (1)
- Bone (1)
- Bone Cement (1)
- Bone Mineral Density (1)
- Bone chips (1)
- Bone disease (1)
- Bone graft (1)
- Bone marrow cells (1)
- Bone marrow stromal cell (1)
- Bone marrow transplantantation (1)
- Bone morphogenetic protein (1)
- Bone morphogenetic protein 2 (1)
- Bone tissue engineering (1)
- Bone tumor (1)
- Bone-replacement (1)
- Boolesches Netz (1)
- Bootstrap-Statistik (1)
- Bor (1)
- Bordeiella pertussis (1)
- Borderzone (1)
- Borna Disease Virus (1)
- Borrelia (1)
- Borrelia burgdorferi (1)
- Borrelienserologie (1)
- Borreliosis (1)
- Borylenkomplexe (1)
- Borylkomplexe (1)
- Botulinumtoxin- A- Behandlung (1)
- Botulunumtoxin A (1)
- Bouldern (1)
- Bovine Nebennierenrinden Primärkultur (1)
- Bovis (1)
- Bowel (1)
- Bowen’s disease, periungual (1)
- Braak (1)
- Brachmann-de-Lange-Syndrom (1)
- Brachmann-de-Lange-syndrome (1)
- Brachytherapie (1)
- Bracketsystem (1)
- Bradykininantagonist (1)
- Bradyrhizobium (1)
- Brain Computer Interface (1)
- Brain Electrical Activity Mapping (1)
- Brain Tumor (1)
- Brain atrophy (1)
- Brain cancer (1)
- Brain diseases (1)
- Brain doping (1)
- Brain edema (1)
- Brain endothelial cells (1)
- Brain ischemia (1)
- Brain natriuretic Peptide (1)
- Brain stem (1)
- Brain trauma (1)
- Brain μ-opioid receptors (1)
- Brainstem encephalitis (1)
- Brandes (1)
- Braune Fettzelle (1)
- BrdU replication banding pattern (1)
- BrdU/dT replication banding (1)
- Breast cancer cells (1)
- Breast-cancer (1)
- Breast-tumors (1)
- Breath tests (1)
- Breathing (1)
- Breischluckuntersuchung (1)
- Breiter Rückenmuskel (1)
- Brief (1)
- Brillantgrün (1)
- Bromdesoxyuridin <5-Brom-2-desoxyuridin> (1)
- Bromodeoxyuridine labeling (1)
- Bronchial-Carcinom (1)
- Bronchialasthma (1)
- Bronchialkarzinom (1)
- Bronchialschleimhaut (1)
- Bronchopulmonale Dysplasie (1)
- Bronchopulmonary dysplasia (1)
- Brownian ratchet (1)
- Brugia Malayi (1)
- Bruschitbeschichtung (1)
- Brushite (1)
- Brustaorta (1)
- Brustbein (1)
- Brustimplantat (1)
- Brustimplantate (1)
- Brustkompression (1)
- Brustkrebspatientinnen (1)
- Brustselbstuntersuchung (1)
- Brustwirbelsäule (1)
- Bruton Tyrosine Kinase (1)
- Bruton's tyrosine kinase inhibitor CC-292 (1)
- Brücke (1)
- Brüder Grimm (1)
- Bub1b (1)
- Buck-Gramcko-Schema (1)
- Buck-Gramcko-score (1)
- Budding (1)
- Bulimie (1)
- Bullous (1)
- Bullous pemphigoid (1)
- Bullöse Autoimmundermatosen (1)
- Bullöses Pemphigoid (1)
- Bundeswehr (1)
- Burkina Faso (1)
- Burkitt (1)
- Burkitt Lymphom (1)
- Burkitt Lymphoma (1)
- Burkitt lymphoma (1)
- Burkitt lymphoma (BL) (1)
- Business Process Models (1)
- Butyrate <Buttersäuresalze> (1)
- Bypassverschluss (1)
- Bystander (1)
- Bänder (1)
- Bürstenbiopsie (1)
- B‐cell lymphoma (1)
- C(-1019)G polymorphism (1)
- C-11-methionine pet (1)
- C-6-H (1)
- C-C Chemokinrezeptor 7 (1)
- C-Faktor <Bodenkunde> (1)
- C-Faser (1)
- C-IAP1 (1)
- C-MAC (1)
- C-MYC (1)
- C-MYC PUMA (1)
- C-Myc (1)
- C-Peptid (1)
- C-Terminus (1)
- C-raktives Protein (1)
- C-tactile fibers (1)
- C-terminal domain (1)
- C-type natriuretic peptide (1)
- C. albicans (1)
- C. dubliniensis (1)
- C. elegans (1)
- C.376A>G (p.S126G) (1)
- C.albicans (1)
- C.dubliniensis (1)
- C/EBP-Beta (1)
- C1-INH (1)
- C1-Inhibitor (1)
- C1-Inhibitor Berinert (1)
- C1q/TNF related protein (CTRP) (1)
- C282Y (1)
- C3a (1)
- C3aR (1)
- C4bp (1)
- C57/Bl6 (1)
- C57BL/6 mice (1)
- C57BL/KALWRIJ mouse (1)
- C5aR1-Antagonist (1)
- C5aR2 (1)
- C6 (1)
- C6 cells (1)
- C6-Zellen (1)
- C9orf72 (1)
- CA 19-9 (1)
- CA-Repeat Polymorphismen (1)
- CA19-9 (1)
- CA2+ channels (1)
- CA3 (1)
- CA3 pyrimidal cells (1)
- CA4 (1)
- CABG-operation (1)
- CACO-2 (1)
- CAD (1)
- CAD-CAM (1)
- CAD-Software (1)
- CAD/CAM restoration material (1)
- CADIAX (1)
- CAGSSS (1)
- CAM (1)
- CAPA (1)
- CAPS (1)
- CAR T (1)
- CAR T Zellen (1)
- CAR T-cell (1)
- CAR T-cells (1)
- CAR-T cells (1)
- CAR-T-cell (1)
- CARAT (1)
- CARE (1)
- CAS (1)
- CASP (1)
- CASPAR (1)
- CASPASE-3 (1)
- CB Receptor (1)
- CB Rezeptor (1)
- CB1 Rezeptor (1)
- CB1 receptor (1)
- CB1 receptor antagonists (1)
- CB1-Receptor (1)
- CB1-Rezeptor (1)
- CBP (1)
- CCAP (1)
- CCG (1)
- CCITT noise (1)
- CCITT-Störgeräusch (1)
- CCL3 (1)
- CCL5 (1)
- CCN Protein Familie (1)
- CCN protein familiy (1)
- CCN- Proteine (1)
- CCN2 (1)
- CCR4 (1)
- CCR6 (1)
- CCR6+ T-cells (1)
- CCS (1)
- CD 10 (1)
- CD 27 (1)
- CD 4+ T-Lymphozyten (1)
- CD 40 (1)
- CD 5 (1)
- CD 8 (1)
- CD coreceptors (1)
- CD-Marker (1)
- CD/metabolism (1)
- CD10 (1)
- CD105 (1)
- CD105 antigen (1)
- CD117 (1)
- CD11b+ myeloid cells (1)
- CD133 (1)
- CD137-Antigen (1)
- CD147 (1)
- CD150 (1)
- CD16 (1)
- CD19 (1)
- CD1c⁺ mDC (1)
- CD24 (1)
- CD27 (1)
- CD28 Superagonist (1)
- CD28 Superagonisten (1)
- CD28 costimulation (1)
- CD28 superagonist (1)
- CD28-SA (1)
- CD2AP (1)
- CD3/19 depletion (1)
- CD30-Rezeptor (1)
- CD319 (1)
- CD32 (1)
- CD34 (1)
- CD34 antigen (1)
- CD34 selection (1)
- CD4 Zellen (1)
- CD4 cells (1)
- CD4 positiv T cells (1)
- CD4+ (1)
- CD4+ T cell activation (1)
- CD4+ T-Lymphozyten (1)
- CD4+ T-cells (1)
- CD40 agonist (1)
- CD40 ligand (1)
- CD40-Ligand (1)
- CD40-spezifische Antikörperfusionsproteine (1)
- CD44 (1)
- CD45RC (1)
- CD4\(^{+}\) T helper cells (1)
- CD5-positive B-Lymphozyten (1)
- CD52 (1)
- CD56 (1)
- CD57 (1)
- CD62L (1)
- CD74 (1)
- CD8 T-Zelle (1)
- CD8 T-Zellen (1)
- CD8(+) (1)
- CD8+ T cell differentiation (1)
- CD8+ T cells (1)
- CD8-Lymphoyzten (1)
- CD8\(^+\) T cells (1)
- CD9 (1)
- CD96 (1)
- CDC14A (1)
- CDC42 (1)
- CDH (1)
- CDH13 Expression (1)
- CDH13 mRNA (1)
- CDI (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CDR3 sequences (1)
- CEACAM3 (1)
- CERK1 (1)
- CFDASE (1)
- CFR-1 (1)
- CFU (1)
- CGRP (1)
- CHAC1 (1)
- CHAQ (1)
- CHO-Zellen (1)
- CHO-cells (1)
- CHRODIS (1)
- CI-1040 (1)
- CIAP1 (1)
- CIB1 (1)
- CIDI (1)
- CIED malfunction; pacemaker (PM) (1)
- CIITA (1)
- CIN (1)
- CINE (1)
- CIS+ (1)
- CK-20 (1)
- CK-knockout Maus (1)
- CK5 (1)
- CLAD (1)
- CLEC16A (1)
- CLN3 (1)
- CLP-Verfahren (1)
- CLP-procedure (1)
- CLRN2 (1)
- CMD (1)
- CMF-Therapie (1)
- CMV T-Zellen (1)
- CMV reactivation (1)
- CMV-Reaktivierung (1)
- CMV-specific cellular immunity (1)
- CNBP (1)
- CNP (1)
- CNS Myelination (1)
- CNS cancer (1)
- CNS disease (1)
- CNS diseases (1)
- CNS imaging (1)
- CNS infection (1)
- CNS injury (1)
- CNS integrity (1)
- CNS-Infection (1)
- CNTF Sehnerv Retina Degeneration (1)
- CNTF optic nerve retina degeneration (1)
- CNVs (1)
- CO2 (1)
- CO2-response curves (1)
- COGITAT-Box (1)
- COH29 (1)
- COMPLEX 1 (1)
- COMT Val 158Met Polymorphism (1)
- COMT polymorphism (1)
- COMT-Polymorphismus (1)
- COMT-Val158Met (1)
- COOP Wonca (1)
- COPD diagnosis (1)
- COU254 (1)
- COVID 19 (1)
- COVID-19 testing (1)
- COVID-19-ARDS (1)
- COVID-19-Pademie (1)
- COVID‐19 vaccination (1)
- COX-2 (1)
- COX2 expression (1)
- CO\(_{2}\) exposure (1)
- CP-690,550 (1)
- CPAP (1)
- CPET (1)
- CPFE (1)
- CPITN-Index (1)
- CPP-ACP (1)
- CPR-Prothese (1)
- CPR-prothesis (1)
- CRAC (1)
- CRE (1)
- CREB (1)
- CRH stimulation test (1)
- CRH1 (1)
- CRHR (1)
- CRISPR (1)
- CRISPR Cas9 (1)
- CRISPR-Cas (1)
- CRISPR-Cas Systems (1)
- CRISPR-Cas9 (1)
- CRISPRs (1)
- CRKL (1)
- CRM (1)
- CRMO (1)
- CRP/crp (1)
- CRT (1)
- CRc (1)
- CS1 (1)
- CSF-1 (1)
- CSF-1 Rezeptor (1)
- CSF-1 Rezeptor Inhibitor (1)
- CSF-1 receptor (1)
- CSF-1 receptor inhibitor (1)
- CSF-1-Rezeptor-Inhibitor (1)
- CSM (1)
- CT perfusion (1)
- CT, circadian time (1)
- CT-angiography (1)
- CT-gesteuerte Punktion (1)
- CT-scan (1)
- CTCAE (1)
- CTED (1)
- CTGF (1)
- CTLA-4 Antigen (1)
- CTNNB1 (1)
- CTSE (1)
- CVM-Methode (1)
- CX-5461 (1)
- CX3CL1 (1)
- CX5461 (1)
- CXCL12-abundant reticular (CAR)-cells (1)
- CXCL4 (1)
- CXCL5 (1)
- CXCL7 (1)
- CXCL8 (1)
- CXCR$ (1)
- CXCR1 (1)
- CXCR4-targeting (1)
- CXCR4/SDF-1 (1)
- CXL (1)
- CYP induction (1)
- CYP inhibition (1)
- CYP11A1 (1)
- CYP11B enzymes (1)
- CYP11B1 (1)
- CYP17A1 (1)
- CYP1B1 (1)
- CYP24 (1)
- CYP24A1 (1)
- CYP2B6 (1)
- CYP2C9 (1)
- CYP3A4 (1)
- Ca cycling (1)
- Ca-antagonisten (1)
- Ca2+ (1)
- Ca2+ homeostasis (1)
- Ca2+ ion analysis (1)
- Ca2+ leak (1)
- Ca2+ oscillation (1)
- Ca2+ release activated Ca2+ channel (1)
- Ca2+i handling (1)
- CaCo-2 (1)
- CaCo-II-Zellen (1)
- CaM-Kinase II (1)
- CaMKII (1)
- Ca\(^{2+}\) channels (1)
- Ca\(^{2+}\) signalling (1)
- Ca\(^{2+}\)-Imaging (1)
- Ca\(_{v}\)2.2 (1)
- Cabin surfaces contaminated with MRSA (1)
- Caco2 cells (1)
- Cadherin (CDH13) (1)
- Cadherin-13 (1)
- Cadherin-13 (CDH13) (1)
- Calcineurin-NFATsignaling (1)
- Calcinose (1)
- Calcitriol (1)
- Calcium Citrate (1)
- Calcium Imaging (1)
- Calcium Phosphate (1)
- Calcium phosphate (1)
- Calcium-Aufnahme (1)
- Calcium-Magnesium-Phosphat (1)
- Calcium-Magnesium-Phosphat-Zemente (1)
- Calcium-Magnesium-Phosphates-Cements (1)
- Calcium-Phosphat-Zement (1)
- Calcium-bindende Proteine (1)
- Calciumkanal (1)
- Calciumkanäle (1)
- Calciummagnesiumphosphat (1)
- Calciummagnesiumphosphat-Keramik (1)
- Calciumoscillations (1)
- Calciumoszillationen (1)
- Calciumphosphat Knochenzement (1)
- Calciumphosphate cement (1)
- Calciumtransport (1)
- Caldas da Rainha (1)
- Caldas da Rainha / Hospital Termal das Caldas da Rainha (1)
- Calibration (1)
- Callyspongia siphonella (1)
- Calpain (1)
- Calu-3 (1)
- Calziumphosphatzemente (1)
- Cambodia (1)
- Camptothecin (1)
- Canaloplasty (1)
- Cancellous bone (1)
- Cancer Cell (1)
- Cancer immunotherapy (1)
- Cancer models (1)
- Cancer prevention (1)
- Cancer risk factors (1)
- Cancer therapeutic resistance (1)
- Cancer/Testis Antigene (1)
- Cancer/Testis antigen (1)
- Candida lusitaniae (1)
- Candida sp. (1)
- Candidiasis (1)
- Canines (1)
- Cannabinoid (1)
- Cannabionoid-1-Rezeptorantagonist (1)
- Capillaries (1)
- Capillarization (1)
- Capillary leak (1)
- Capsaicin receptor (1)
- Capsidgen (1)
- Carbamazepin (1)
- Carboanhydrase (1)
- Carbon-11 (1)
- Carcinogen risk Individual susceptibili (1)
- Carcinogenese (1)
- Carcinogenic potency (1)
- Carcinogenität (1)
- Carcinoma (1)
- Carcinoma cells (1)
- Carcinoma of oral cavity (1)
- Cardiac Antigens (1)
- Cardiac Efficiency (1)
- Cardiac Output (1)
- Cardiac dysfunction| Brain natriuretic peptide (1)
- Cardiac magnetic resonance imaging (1)
- Cardiac myocyte ; Beta-Receptor ; Muscarinic receptor ; cAMP ; G-protein ; Serum (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy defibrillator (1)
- Cardiac surgery (1)
- Cardiac ventricles (1)
- CardioMEMS™ HF system (1)
- CardioMEMS™ HF-System (1)
- Cardioid (1)
- Cardiolipin (1)
- Cardiology (1)
- Cardiomyocyte (1)
- Cardiomyocytes (1)
- Cardioperfusion (1)
- Cardiopulmonary exercise testing (1)
- Cardiovascular (1)
- Cardiovascular Riskfactors (1)
- Cardiovascular disease (1)
- Cardiovascular hospitalizations (1)
- Cardiovascular magnetic-resonance (1)
- Cardiovascular risk prediction (1)
- Cardiovascular system (1)
- Care-2-Hybridisierung (1)
- Care-Arbeit (1)
- Career choice (1)
- Carfilzomib (1)
- Carl Gustav Himly (1)
- Caroticoclinoid-Foramen (1)
- Carotid intima-media thickness (CIMT) (1)
- Carotid segment (1)
- Carotid ultrasound (1)
- Carotis (1)
- Carotischirurgie (1)
- Carotisdoppler (1)
- Carrier-Proteine (1)
- Cartiage Integration (1)
- Cartilage (1)
- Cartilage Regeneration (1)
- Cartilage Tissue Engineering (1)
- Cartilage defect (1)
- Carving (1)
- Carving-Ski (1)
- Carving-Verletzung (1)
- Carving-injuries (1)
- Casanova (1)
- Case report (1)
- Case-Control Studies (1)
- CaseTrain (1)
- Caseinkinase 2 (1)
- Casetrain (1)
- Caspase 3/7 activity (1)
- Caspase-8 activation (1)
- Caspr-1 (1)
- Caspr1 (1)
- Caspr2 (1)
- Cataract (1)
- Cataract Classification (1)
- Catechine (1)
- Catechol-0-Methyltransferase (1)
- Catechol-O-Methyltransferase (1)
- Catechol-O-methyltransferasis (1)
- Catecholmethyltransferase (1)
- Catenine (1)
- Catgut (1)
- CathI (1)
- Cathelicidin (1)
- Cathelicidine (1)
- Catheter Lock Solution (1)
- Catheter-related Bloodstream Infections (CRBSI) (1)
- Caudate nucleus (1)
- Cav2.2 (1)
- Caveolae (1)
- Cavity quantum electrodynamics (1)
- CdPHR (1)
- Cdc42 (1)
- Celecoxib (1)
- Cell Index (1)
- Cell binding (1)
- Cell cycle control (1)
- Cell cycle regulation (1)
- Cell death and comet assay (1)
- Cell lung canger (1)
- Cell migration (1)
- Cell permeability (1)
- Cell replacement therapy (1)
- Cell reprogramming (1)
- Cell signalling (1)
- Cell transformation (1)
- Cell viability, (1)
- Cell-Assisted Lipotransfer (1)
- Cell-based assays (1)
- Cell-line (1)
- Cellcycle (1)
- Cellcycle blockage (1)
- Cellular invasion (1)
- Cellular prion protein (1)
- Cement Paste (1)
- Central Nervous System (1)
- Central hyperactivity (1)
- Central nervous system infection (1)
- Central venous access (1)
- Central venous-pressure (1)
- Centrolenidae (1)
- Cephalosporine (1)
- Ceramide (1)
- Cerclage (1)
- Cerebellar nuclei (1)
- Cerebellitis (1)
- Cerebral Ischemia (1)
- Cerebral blood flow (1)
- Cerebral edema (1)
- Cerebral small vessel disease (1)
- Cerebral vasospasm (1)
- Cerebral-ischemia (1)
- Cerebrolysin (1)
- Cerivastatin (1)
- Cervical Carcinoma (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- Cestoden (1)
- Cetuximab (1)
- Cgrin (1)
- Ch'i-kung (1)
- ChAT (1)
- ChIP-seq (1)
- ChIP-sequencing (1)
- ChT1 (1)
- Chagas diagnosis (1)
- Chagas monitoring (1)
- Chagas real time PCR (1)
- Chains (1)
- Chancen (1)
- Charcot-Marie-Tooth Neuropathie (1)
- Charcot-Marie-Tooth Neuropathy (1)
- Charcot-Marie-Tooth-Hoffmann-Syndrom (1)
- Charcot–Marie–Tooth disease type 1A (1)
- Charmi-Index (1)
- Chemerin (1)
- Chemerin processing (1)
- Chemical carcinogenesis (1)
- Chemicals (1)
- Chemische Synapsen (1)
- Chemokin (1)
- Chemokin CXCL12 (1)
- Chemokine Receptor (1)
- Chemokinreceptor (1)
- Chemokinrezeptors (1)
- Chemosensititvität (1)
- Chemotactic receptors (1)
- Chemotaxis (1)
- Chemotherapeutikum (1)
- Chernobyl (1)
- Chiari Malformation (1)
- Chiari-Malformation Typ II (1)
- Child (1)
- Child Maltreatment (1)
- Child welfare (1)
- Childhood (1)
- Children`s shoe (1)
- Childrens-cancer (1)
- Chimeric Antigen Receptor T cells (1)
- Chimeric antigen receptor (1)
- Chimäre DNS (1)
- Chimären (1)
- Chimärische Rezeptoren (1)
- Chimärismusdiagnostik (1)
- Chirodiagnostik (1)
- Chirurgiegeschichte (1)
- Chirurgisch unterstützte Gaumennahterweiterung - transpalatinaler Distraktor - Hyrax Appartur - dreidimensional - Zahnkippung (1)
- Chirurgische Ausbildung (1)
- Chlorocresol (1)
- Chloroquin (1)
- Chlorpromazin (1)
- Cholesteatom (1)
- Cholesterin-Umtake (1)
- Cholesterinstoffwechsel (1)
- Cholesterol (1)
- Cholesterol metabolism (1)
- Cholezystektomie (1)
- Choline deficiency (1)
- CholinomiRs (1)
- Chondrogene Differenzierung (1)
- Chondrogenese (1)
- Chondrogenesis (1)
- Chondron (1)
- Chondrosarcoma (1)
- Chondrozyten (1)
- Chondrozyten-Subpopulationen (1)
- Chordontonal organ (1)
- Choroidea (1)
- Christian Heinrich Pander (1)
- Christianity (1)
- Chromosom 22q11 (1)
- Chromosom 9 (1)
- Chromosomal instability (1)
- Chromosome 18 (1)
- Chromosome aberration (1)
- Chromosome distribution (1)
- Chromosomenaberrationen (1)
- Chromosomenaberrationstest (1)
- Chromosomenbruchanalyse (1)
- Chromosomenbruchsyndrome (1)
- Chromosomeninstabilitätssyndrome (1)
- Chronic Constriction Injury (1)
- Chronic Coronary Ligation (1)
- Chronic Heart Failure (1)
- Chronic Kidney-disease (1)
- Chronic allograft nephropathy (1)
- Chronic disease (1)
- Chronic heart-failure (1)
- Chronic hepatitis c (1)
- Chronic kidney-disease (1)
- Chronic lung disease of infancy (1)
- Chronic lymphoblastic leukemia (1)
- Chronic myeloid leukaemia (1)
- Chronic myeloid leukemia (1)
- Chronic neuropathic pain (1)
- Chronic obstrusive pulmonary disease (1)
- Chronic rejection (1)
- Chronic respiratory diseases (1)
- Chronic rhino‑sinusitis (1)
- Chronic stress (1)
- Chronic wound (1)
- Chronical renal failure (1)
- Chronische Abstoßung (1)
- Chronische Depression (1)
- Chronische HBV-Infektion (1)
- Chronische Hepatitis C (1)
- Chronische Schizophrenie (1)
- Chronische Schmerzen (1)
- Chronische Wunde (1)
- Chronische Wunden (1)
- Cigarette smoking (1)
- Cilengitide (1)
- Ciliary beat frequency (1)
- Cine (1)
- Circa instans (1)
- Circadian (1)
- Circadianer Rhythmus (1)
- Circinella (1)
- Cisterna magna (1)
- Citalopram (1)
- Citrus (1)
- Class II (1)
- Class II antigen blockade (1)
- Clathrat (1)
- Claudicatio intermittens (1)
- Claudin (1)
- Claudin-12 (1)
- Claudin-5 (1)
- Claudin2 (1)
- Claudine (1)
- Claussen (1)
- Claustrum (1)
- Clavicula (1)
- Clawtoe (1)
- Clear-cornea (1)
- ClearSight\(^®\) (1)
- Clec16a (1)
- Cleft Lip and Palate (CLP) (1)
- Clefts (1)
- Cleidocranial dysplasia (1)
- Clindamycin (1)
- Clinical Genetics (1)
- Clinical capillaroscopy (1)
- Clinical decision support system (1)
- Clinical practice guidelines (1)
- Clinical prediction rule (1)
- Clinical proteomics (1)
- Clinical psychiatry (1)
- Clinical remission (1)
- Clinical trials (1)
- Clinical-trials (1)
- Clinically silent stroke (1)
- Clobetasolpropionat (1)
- Clobetasolpropionate (1)
- Clodronat (1)
- Clodronate (1)
- Clodronsäure (1)
- Clonality (1)
- Clone 8 (1)
- Clostridium perfringens (1)
- Clostridium-botulinum (1)
- Clubfoot (1)
- Cluster C personality disorder (1)
- Cluster C personality disorders (1)
- Cluster-RCT (1)
- Clusterkopfschmerz (1)
- Co-Analgetika (1)
- Co-Kultur (1)
- Co-culture system (1)
- CoCr (1)
- Coagulation factor IX (1)
- Cocamidopropylbetain (1)
- Cochlea Implant (1)
- Cochlea Implantaten (1)
- Cochlea Implantation (1)
- Cochleaimplantat (1)
- Cochlear Nucleus (1)
- Cochlear duct length (1)
- Cochlear nerve (1)
- Cochlear planning software (1)
- Cochrane Review (1)
- Cocktail (1)
- Cocktailparty-Effekt (1)
- Coffin–Lowry syndrome (1)
- Cofilin (1)
- Cognitional Therapy (1)
- Cognitive (1)
- Cognitive Enhancement (1)
- Cognitive Remediation (1)
- Cognitive Therapy (1)
- Cognitive behavior (1)
- Cognitive control (1)
- Cognitive decline (1)
- Cognitive impairment (1)
- Cohort study (1)
- Cold (1)
- Cold pressure test (1)
- Collaboration (1)
- Collagen Hydrogel (1)
- Collagen VII (1)
- Collagen gels (1)
- Collagen membrane (1)
- Collagenase (1)
- Collective effects in quantum optics (1)
- Colliculus inferior (1)
- Colloids (1)
- Collumfraktur (1)
- Colon cancer (1)
- Colonization (1)
- Colorectal Cancer (1)
- Colorectal Carcinoma (1)
- Colorectal cancer (1)
- Colorectal carcinoma (1)
- Colorectal liver metastases (1)
- Colorimetrie (1)
- Combination (1)
- Comet assay (1)
- Common variable immunodeficiency (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- Comparison of Analgesia (1)
- Competitive Growth (1)
- Complement (1)
- Complement system (1)
- Complex (1)
- Complex Regional Pain Syndrome (1)
- Complex regional pain syndrome (1)
- Compliance (1)
- Composit (1)
- Compressed Sensing (1)
- Compression Injury (1)
- Compression injury (1)
- Compressive Properties (1)
- Computational Fluid Dynamics (1)
- Computed axial tomography (1)
- Computer-aided diagnosis (1)
- Computer-aided therapy (1)
- Computerarbeit (1)
- Computergestützte Medizin (1)
- Computersimulation (1)
- Computertomograph (1)
- Computertomographie Angiographie (1)
- Computertomography Angiography (1)
- Computerunterstütztes Lernen (1)
- Computerunterstütztes Verfahren (1)
- Conditioning regimen (1)
- Conduct disorder (1)
- Conductance Katheter (1)
- Conductivity (1)
- Condylar fracture (1)
- Cone Beam CT (1)
- Cone-beam CT (1)
- Cone-beam computed tomography (1)
- Conflict Monitoring Theorie (1)
- Congenital abdominal wall defects (1)
- Congo (1)
- Conjugate arc therapy (1)
- Conjugation (1)
- Connective tissue (1)
- Connexin-26-Mutation (1)
- Connexin32 deficient mice (1)
- Connexin32-defiziente Maus (1)
- Constantinus, Africanus (1)
- Contact dermatitis (1)
- Contact-to-balloon (1)
- Contactin 1 (1)
- Contactin-1 (1)
- Contactin-assoziiertes Protein 2 (1)
- Containment <Gentechnologie> (1)
- Contemplative Meditation and Breathing Techniques (CMBT) (1)
- Content-analytical study (1)
- Continous performance test (1)
- Continous-Performance-Test (1)
- Contrast Agent Bolus Based Perfusion Magnetic Resonance Imaging (1)
- Contrast agent (1)
- Contrast-enhanced CT (1)
- Control centrality (1)
- Controlled cortical impact (1)
- Conversion (1)
- Convolutional Neural Network (1)
- Cooperation (1)
- Copaxone® (1)
- Copeland (1)
- Copy number changes (1)
- Copy number variation (1)
- Cord blood-derived hematopoietic stem and progenitor cells (1)
- Core-Oligosaccharid (1)
- Cornea (1)
- Corneal confocal microscopy (1)
- Cornelia-de-Lange-Syndrom (1)
- Cornelia-de-Lange-syndrome (1)
- Corona virus (1)
- Coronary artery bypass graft (1)
- Coronary artery disease (1)
- Coronavirus Disease 2019 (1)
- Correlates (1)
- Corrosion (1)
- Cortex (1)
- Corti-Organ (1)
- Cortical plasticity (1)
- Corticobasal syndrome (1)
- Corticosteroids (1)
- Corticotropin-Releasing-Factor (1)
- Cortisol (1)
- Corynebacterium urealyticum (1)
- Cotransporter 2 inhibition (1)
- Couch tracking (1)
- Coumarin (1)
- Covalent DNA binding (1)
- Covalent binding (1)
- Covalent binding index (1)
- Covalent binding index - Diethylstilbestrol (1)
- Coverage (1)
- CpG island hypermethylation (1)
- CpG-ODN (1)
- CrP (1)
- Cranial window (1)
- Cranio-Maxillo-Facial-Reconstructive (1)
- Cranio-corpo-graphy (1)
- Craniofacial (1)
- Craving (1)
- CreERT2 (1)
- Creatin Kinase (1)
- Creatine Kinase (1)
- Creatinkinase (1)
- Cremaster (1)
- Crespi effect (1)
- Critical Care (1)
- Critically-ill patients (1)
- Crohn (1)
- Crohn disease (1)
- Crohns-disease (1)
- Crohn’s Disease (1)
- CrossQuery (1)
- Crosslinking (1)
- Crosstalk (1)
- Cruzi (1)
- Cry (1)
- Cryolesion (1)
- Cryopreservation (1)
- Cryptococcus neoformans (1)
- Cryptorchidism (1)
- Crystal-structure (1)
- Crystalloids (1)
- CsrA (1)
- Cues (1)
- Cumulative incidence function (1)
- Current noise-analysis (1)
- Cushing syndrome (1)
- Cushing's (1)
- Cushing's disease (1)
- Cushings syndrome (1)
- Cutaneous hyperemia (1)
- Cutaneous leishmaniasis (1)
- Cutaneous lymphoma (1)
- Cutaneous metastatic Crohn’s disease (1)
- Cx3cr1 (1)
- Cx43 (1)
- CyaA (1)
- Cyclic AMP (1)
- Cyclic GMP (1)
- Cyclic nucleotides (1)
- Cyclic peptides (1)
- Cyclisches Nucleotid Phosphodiesterase <3,5-> (1)
- Cyclo-GMP-Derivate (1)
- Cyclodextrine (1)
- Cycloheximide (1)
- Cyclooxygenase-2 (1)
- Cyclophilin A (1)
- Cyclophosphamide (1)
- Cyclosporin (1)
- Cyrillic 2.13 (1)
- CysLTR1 (1)
- Cystatin C (1)
- Cystein (1)
- Cystein-rich-protein 61 (CYR61) (1)
- Cysteine‐Rich Domain (CRD) (1)
- Cystic Fibrosos (1)
- Cystic fibrosis (1)
- Cystic fibrosis liver disease (CFLD) (1)
- Cystic-fibriosis (1)
- Cystische Fibrose (1)
- Cytochalasin-B micronucleus assay (1)
- Cytochrom C (1)
- Cytochrome C (1)
- Cytochrome P 450 pathway (1)
- Cytochrome b5 (1)
- Cytogenetik (1)
- Cytokeratin (1)
- Cytokeratine (1)
- Cytokine GM-CSF (1)
- Cytokine receptors (1)
- Cytology (1)
- Cytomatrix der aktiven Zone (1)
- Cytomegalovirus (1)
- Cytoplasmatische Therapie (1)
- Cytostatikum (1)
- Cytotoxic T lymphocytes (1)
- D insufficiency (1)
- D serum-levels (1)
- D-Aminosäure-Oxidase (1)
- D-amino acid oxidase activator (1)
- D-amino-acid-oxidase (1)
- D2 receptors (1)
- D2 test (1)
- D2-Test (1)
- D2S123 (1)
- D5 (DRD4, DRD5) (1)
- D5S346 (1)
- DAA (1)
- DAOA (1)
- DARPA (1)
- DAS28 (1)
- DASH (1)
- DASH-Fragebogen (1)
- DASH-score (1)
- DBS biomarkers (1)
- DBS programming (1)
- DBT (1)
- DC vaccination (1)
- DC/T-Zell-Konjugate (1)
- DCAF17 (1)
- DCGAN (1)
- DCM genetic background (1)
- DCR1 (1)
- DD, constant darkness (1)
- DDS (1)
- DDS-Test (1)
- DEA/NO (1)
- DEL(5Q) (1)
- DES (1)
- DETC (1)
- DExD/H-Box RNA helicase (1)
- DF-Testung (1)
- DFNB32 (1)
- DFNB68 (1)
- DFT (1)
- DHAP (1)
- DHCR7 (1)
- DHEA-Sulfotransferase (1)
- DIA-MS (1)
- DIPG (1)
- DIPP2a (1)
- DIPP2a-Protein (1)
- DLBCL multilobated (1)
- DLBCL multilobuliert (1)
- DLBL (1)
- DLP-SLA (1)
- DLPFC (1)
- DLX5/6 (1)
- DM (1)
- DM1 (1)
- DMARD (1)
- DMF-T-Index (1)
- DMPS (1)
- DNA Breaks (1)
- DNA Damage (1)
- DNA Doppelstrangbrüche (1)
- DNA Methylation (1)
- DNA Schaden (1)
- DNA adduct . Repair endonuclease (1)
- DNA barcoding (1)
- DNA binching (1)
- DNA damage response (1)
- DNA fragments (1)
- DNA glycosation (1)
- DNA helicase (1)
- DNA hypermethylation (1)
- DNA methylation dynamics (1)
- DNA methyltransferase gene (1)
- DNA methyltransferases (1)
- DNA microarrays (1)
- DNA origami (1)
- DNA purification (1)
- DNA repair defect (1)
- DNA repair gene (1)
- DNA repair genes (1)
- DNA repair protraction (1)
- DNA repeat expansion (1)
- DNA replication (1)
- DNA sequence (1)
- DNA transfection (1)
- DNA traps (1)
- DNA vaccination (1)
- DNA-Damage (1)
- DNA-Methylation (1)
- DNA-Methylierung (1)
- DNA-Microarrays (1)
- DNA-Repair (1)
- DNA-Schäden (1)
- DNA-binding vesicles (1)
- DNA-repair (1)
- DNA-repair genes (1)
- DNA-typing . STR (1)
- DNAM-1 (1)
- DNMT3A (1)
- DNMT3B (1)
- DNS-Bindung (1)
- DNS-Strangbruch (1)
- DOACs (1)
- DOPA-responsive-dystonia (1)
- DOTA-EB-TATE (1)
- DP (1)
- DPF3a (1)
- DRAF1 (1)
- DRD1 (1)
- DRD2-Rezeptor-Gen (1)
- DRD4 (1)
- DRE (1)
- DRG-System (1)
- DRU (1)
- DS 22q11.2 (1)
- DSA (1)
- DSB damage (1)
- DSB focus substructure (1)
- DSC2 (1)
- DSIF (1)
- DSM-IV (1)
- DSM-IV Subtyp (1)
- DSM-IV Subtype (1)
- DSM-IV-TR (1)
- DSMMI-Studie (1)
- DT40 cells (1)
- DTI (1)
- DUB Mutante (1)
- DUB inhibitor (1)
- DXA (1)
- DYNC1I1 (1)
- DYNLL1 (1)
- DYT-TOR1A (1)
- Damage control surgery (1)
- Danio-rerio (1)
- Danish hernia database (1)
- Dapson (1)
- Dapsone (1)
- Dara-KDT-P(A)CE (1)
- Darmanastomose (1)
- Darmbarriere (1)
- Darmchirurgie (1)
- Darmdekontamination (1)
- Darmepithel (1)
- Darmflora (1)
- Darminfektion (1)
- Darminkontinenz (1)
- Darmkrebs (1)
- Darmmotilität (1)
- Darmsonographie (1)
- Darmvorbereitung (1)
- Darmwandnervensystem (1)
- Data Warehouse (1)
- Data acquisition (1)
- Database searching (1)
- Dauer (1)
- Dauerschwingfestigkeit (1)
- Davis gun (1)
- Daytime Sleepiness (1)
- De-novo (1)
- Death Receptor (1)
- Deceased Donor Score (1)
- Decorine (1)
- Deep Brain Stimulation (1)
- Deep-sequencing (1)
- DeepSqueak (1)
- Deeskalation (1)
- Deeskalationstherapie (1)
- Defekt (1)
- Defektdeckung (1)
- Defektspektroskopie (1)
- Defibrillator (1)
- Deficit/hyperactivity disorder (1)
- Defined burkitts lymphoma (1)
- Deformational plagiocephaly (1)
- Deformity (1)
- Defäkographie (1)
- Degeneration (1)
- Dehiszenz (1)
- Deiodase (1)
- Deiodase Typ I (1)
- Deiodasen (1)
- Dekompressionskraniektomie (1)
- Dekompressionsoperation (1)
- Dekubitalulkus (1)
- Delaire (1)
- Delay Aversion (1)
- Delay Discounting (1)
- Delayed Enhancement (1)
- Delayed cerebral infarction (1)
- Delayed ischemic neurological deficit (1)
- Deletion analysis (1)
- Deletionssyndrom (1)
- Delir (1)
- Delirium (1)
- Delphi procedure (1)
- Delta Repertoire (1)
- Deltopectoral (1)
- Dementia (1)
- Demenz vom Alzheimer Typ (1)
- Demyelination (1)
- Denaturing high-performance liquid chromatography (1)
- Dendritic Cells (1)
- Dendritic cell tumor (1)
- Denervierung (1)
- Dengue (1)
- Denoising (1)
- Dens axis (1)
- Dental Practice (1)
- Dental casting technique (1)
- Dentale Aufwachstechnik (1)
- Dentale Erosionen (1)
- Dentalimplantat (1)
- Dentalphobie (1)
- Dentate granule cells (1)
- Dentin sealing (1)
- Dentinadhäsiv (1)
- Dentinadhäsive (1)
- Dentinadhäsivsystem (1)
- Dentine Bonding Agent (1)
- Dentinhaftung (1)
- Dentinversiegelung (1)
- Dentistry (1)
- Dentoalveolär (1)
- Department of Medicine (1)
- Dephasing (1)
- Depolarisation (1)
- Depotsystem (1)
- Depression treatment (1)
- Depressive symptomatology (1)
- Depressives Syndrom (1)
- Depth of Cure (1)
- Der p 1 (1)
- Der p 23 (1)
- Dermato (1)
- Dermoid (1)
- Dermoidzysten (1)
- Descensus (1)
- Descensus uteri (1)
- Descensus vaginalis (1)
- Descensuschirurgie (1)
- Design (1)
- Desipramin (1)
- Desmoplakin (1)
- Desmoplastic fibroma (1)
- Desmoplastisches Trichoepitheliom (1)
- Detergentien (1)
- Determinanten (1)
- Deutsche Film AG (1)
- Deutsche Gesellschaft für Rheumatologie (1)
- Deutsche Rheuma-Liga (1)
- Deutsche Sprachentwicklungsstudie (1)
- Deutsche Stiftung für Internationale Entwicklung (1)
- Deutsche Teilung <Motiv> (1)
- Deutscher Schmerzfragebogen (1)
- Deutsches Zentrum für Herzinsuffizienz Würzburg (1)
- Deutschland / Bundeswehr (1)
- Deutschland / Stammzellgesetz (1)
- Deutschland <DDR, Motiv> (1)
- Development of dental medical institute Halle (1)
- Developmental biology (1)
- Devic Maus (1)
- Devic mice (1)
- Devic syndrome (1)
- Devic’s syndrome (1)
- Dextran sulphate (1)
- Dezentral (1)
- Dezentralisierung (1)
- Diabetes Mellitus Typ 2 (1)
- Diabetes history (1)
- Diabetes mellitus Extracellular matrix Polyelectrolytes (1)
- Diabetes mellitus Typ 1 (1)
- Diabetes mellitusTyp 1 (1)
- Diabetes melltius (1)
- Diabetestyp (1)
- Diabetic foot (1)
- Diabetic nephropathies (1)
- Diabetic painful neuropathy (1)
- Diabetic polyneuropathy (1)
- Diabetic-nephropathy (1)
- Diabetische Nephropathie (1)
- Diabetische Neuropathie (1)
- Diabetisches Fußsyndrom (1)
- Diagnose Algorithmus (1)
- Diagnosesicherheit (1)
- Diagnosis prediction (1)
- Diagnosis-related-groups-Konzept (1)
- Diagnostic (1)
- Diagnostic Imaging Exams (1)
- Diagnostic accuracy (1)
- Diagnostic approach (1)
- Diagnostic radiopharmaceuticals (1)
- Diagnostic validity (1)
- Diagnostik / Bildgebendes Verfahren (1)
- Diagnostische Genauigkeit (1)
- Dialogue Board (1)
- Dialysatorleistung (1)
- Dialysefilter (1)
- Dialysemembran (1)
- Diamant (1)
- Diapedese (1)
- Diaphragmatic breathing (1)
- Diarrhea (1)
- Diastocic Dysfunction (1)
- Diastolic Dysfunction (1)
- Diastolische Dysfunktion (1)
- Dicalciumphosphatanhydrid (1)
- Dichlorvinylcystein (1)
- Dichtegradient (1)
- Dichtegradientenzentrifugation (1)
- Dichtheit (1)
- Dickkopf proteins (1)
- Dictyostelium discoideum (1)
- Dieldrin (1)
- Dietary process-related contaminants (1)
- Differential RNA-sequencing (1)
- Differentialdiagnose Kindemisshandlung (1)
- Differentiation (1)
- Differenzierungspotential (1)
- Differenzierungszustand (1)
- Diffuse großzellige B-Zell Lymphome (1)
- Diffusion (1)
- Diffusion tensor imaging (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Digitale Computertomographie (1)
- Digitale Radiologie (1)
- Digitale Subtraktionsangiographie (1)
- Digitale Volumentomographie (1)
- Digitalisierung (1)
- Dignität (1)
- Dihydroethidium (1)
- Dihydrolipoamid-Dehydrogenase (1)
- Dihydroorotat-Dehydrogenase (1)
- Diisononyl phthalate (1)
- Dilatative Kardiomyopathie (1)
- Dilated Cardiomyopathy (1)
- Dilated Cardiomyopathy with Ataxia (1)
- Dimensionsstabilität (1)
- Dimerisierung (1)
- Dimethylarginin <N (1)
- Dimethylsulfoxid (1)
- Dinitrochlorbenzene (1)
- Dinitrochlorbenzol (1)
- Dinitrophenol (1)
- Dioscorea (1)
- Dioscorides, Pedanius : De materia medica (1)
- Dioskurides (1)
- Dioxygenasen (1)
- Dipeptidyl-peptidase IV inhibitors (1)
- Diphenylcyclopropenon (1)
- Diphosphonate (1)
- Diphtherie-Schutzimpfung (1)
- Diplopia Internuclear ophthalmoplegia (INO) (1)
- Direct Drive Simulation (1)
- Direct care workers (1)
- Directional Preponderance (1)
- Directional hearing (1)
- Disaster response (1)
- Discovery (1)
- Discrimination (1)
- Disease gene prioritization (1)
- Disease genetics (1)
- Disease network (1)
- Disease prevalence (1)
- Disease severity (1)
- Diskriminanzanalyse (1)
- Diskrimination (1)
- Diskriminationsverhalten (1)
- Disorders (1)
- Displaced Person (1)
- Dissertation (1)
- Dissertation for dentists (1)
- Dissociation (1)
- Dissoziation (1)
- Distal biceps tendon repair (1)
- Distal outflow trac (1)
- Distale Radiusfrakturen (1)
- Distraction (1)
- Distraktion (1)
- Disulfidbrücken (1)
- Diurese (1)
- Diuresis (1)
- Diuretikum (1)
- Diversity (1)
- Divertikulitis (1)
- Division (1)
- Dixon (1)
- Diät (1)
- Dobutamin- Stressechokardiographie (1)
- Dobutamin-Stress-Echokardiographie (1)
- Doctor (1)
- Doctor-Patient Relationship (1)
- Dokumentarischer Spielfilm (1)
- Dokumentationsqualität (1)
- Dolutegravir (1)
- Domain-specific approach (1)
- Domestic violence (1)
- Dominant intraprostatic lesion (1)
- Dominante intraprostatische Läsion (1)
- Donor lymphocytes (1)
- Donor-Score (1)
- Dopamin Agonist (1)
- Dopamin Metabolism (1)
- Dopamin-beta-Hydroxylase (1)
- Dopamin-beta-Hydroxylase Promotor (1)
- Dopamine (1)
- Dopamine Transporter (1)
- Dopamine melanin (1)
- Dopaminergic PAM cluster neurons (1)
- Dopaminmetabolismus (1)
- Dopaminrezeptor (1)
- Dopaminstoffwechsel (1)
- Doppel-Ganzkörper-CT-Schockraum (1)
- Doppelkontrastpharyngographie (1)
- Doppellumentubus (1)
- Doppler-Sonographie (1)
- Dopplersonographie (1)
- Dorsale Plikationsnaht (1)
- Dorsalextension (1)
- Dorsolateral prefrontal cortex (1)
- Dose reduction (1)
- Dosierungen von Herzinsuffizienzmedikamenten (1)
- Dosis-Wirkungs-Beziehung (1)
- Dosisanalyse (1)
- Double Negative B cells (1)
- Double crown (1)
- Double crowns (1)
- Double hemorrhage model (1)
- Double sensitization (1)
- Double-blind (1)
- Down Syndrom (1)
- Down-Syndrom (1)
- Down-regulation (1)
- Down´s Syndrome (1)
- Doxycyclin (1)
- Doxycycline (1)
- Doxyzyklin (1)
- Dr. med. Sommer II (1970) (1)
- Drainage (1)
- Draisine <Zweirad> (1)
- Dranginkontinenz (1)
- Drehmoment (1)
- Drei-Medien-Abrasion (1)
- Dreidimensional (1)
- Dreidimensionales Modell (1)
- Drosophilia (1)
- Drotrecogin alpha (1)
- Druckbarkeit (1)
- Druckbelastung (1)
- Druckfestigkeit (1)
- Druckschädigung (1)
- Druckverband (1)
- Druckverbände (1)
- Druckverteilung (1)
- Druckwerte (1)
- Drug Monitoring (1)
- Drug Targeting (1)
- Drug Therapy, Combination (1)
- Drug allergy (1)
- Drug development (1)
- Drug metabolism (1)
- Drug reaction (1)
- Drug releasing graft (1)
- Drug resistance (1)
- Drug-eluting Stent (1)
- Drug-free remission (1)
- Dsg3-Depletion (1)
- Dsg3-depletion (1)
- Dual 3'seq (1)
- Dual RNA-seq data analysis (1)
- Dual-Curing (1)
- Dual-Microphone-Technology (AudioZoom ®) (1)
- Dual-Source Computertomography (1)
- Dual-setting (1)
- Dualhärtung (1)
- Duchennesche Muskeldystrophie (1)
- Duloxetin (1)
- Dumping Syndrom (1)
- Dumping-Syndrome (1)
- Duodenal Jejunal Bypass (1)
- Duodenalatresie (1)
- Duodenopankreatektomie (1)
- Duplexsonographie (1)
- Durchblutungsmessung (1)
- Durchhärtungstiefe (1)
- Durchimpfungsrate (1)
- Durchstoßversuch (1)
- Dynamic Causal Modeling (1)
- Dynamics (1)
- Dynamics of ribosome assembly (1)
- Dysbindin (1)
- Dysfunktionsindex (1)
- Dysgnathy (1)
- Dyskinesie (1)
- Dyslexia (1)
- Dysphagie (1)
- Dysplasia cleidocranialis (1)
- Dystrophin Gene (1)
- Dystrophin-Gen (1)
- Dämpfungsmechanismen (1)
- Dünndarm-Transplantation . Mikrochirurgie (1)
- Dünndarmfunktion (1)
- Dünndarmmotilität (1)
- E-Learning (1)
- E-Modul (1)
- E-Selectin (1)
- E-Test (1)
- E-Zigaretten (1)
- E. coli Nissle 1917 (1)
- E. multilocularis (1)
- E.coli (1)
- E/T ratio (1)
- E/e’ (1)
- E06 mAb (1)
- E1 (1)
- E193 (1)
- E2 conjugating enzyme (1)
- E2F2 (1)
- E2F3 (1)
- E3 14.7-kilodalton protein (1)
- E3 ligating enzyme (1)
- EAAC1 (1)
- EAAT (1)
- EAAT2 (1)
- EAD (1)
- EAHP/SH bone marrow workshop (1)
- EANM (1)
- EANM dosage card (1)
- EATCL (1)
- EBA (1)
- EBER in situ hybridization (1)
- EBF1 (1)
- EBM (1)
- EBRA-FCA (1)
- EBRT (1)
- ECAP (1)
- ECG-gated (1)
- ECG-gated PET (1)
- ECG-recording (1)
- ECGI (1)
- ECLA (1)
- ECM coating (1)
- ECM remodeling (1)
- ECMO indication (1)
- ECMO therapy (1)
- ECORN-CF Projekt (1)
- ECV304 (1)
- ECoG (1)
- ED2 (1)
- EEG data (1)
- EEG frequency band analysis (1)
- EEG preprocessing (1)
- EEG processing (1)
- EEOS (1)
- EFV (1)
- EGFP (1)
- EGR1 (1)
- EHS classification (1)
- EHT1864 (1)
- EIA (1)
- EIP on AHA (1)
- ELBW (1)
- EMMPRIN (1)
- EMSA (1)
- ENT (1)
- EO data (1)
- EOPA-JIA (1)
- EORTC (1)
- EP Procedures (1)
- EPMS (1)
- EPN (1)
- EQUAL-Pilotstudie (1)
- ER Ca2+ imaging (1)
- ER Ca2+ store (1)
- ER dynamics in axon terminals (1)
- ER signaling (1)
- ER stress (1)
- ER-Alpha Expression (1)
- ER-Stress (1)
- ERAS (1)
- ERBB receptors (1)
- ERCC1 (1)
- ERCC1 Chemotherapie Nebennierenrindenkarzinom (1)
- ERCC1-XPF (1)
- ERCC4 (1)
- ERG Gene (1)
- ERI (1)
- ERK Dimerisierungsdefizienz (1)
- ERK map kinease (1)
- ERK signaling (1)
- ERK-Monomer (1)
- ERK1/2-Autophosphorylierung (1)
- ERK2d4 (1)
- ERM (1)
- ERM proteins (1)
- ERM- Faktor (1)
- ERM- factor (1)
- ERN/Ne (1)
- ERT (1)
- ESAT‐6‐like secretion system (1)
- ESBL (1)
- ESC (1)
- ESC Score (1)
- ESCAlife (1)
- ESDR (1)
- ESPED (1)
- ESS (1)
- ESWT (1)
- ET-15-Meningokokken (1)
- ET-15-meningococci (1)
- ET-37 Komplex (1)
- ET-37 complex (1)
- ETB-Rezeptor (1)
- ETB-receptor (1)
- ETL (1)
- ETiCS (1)
- EU (1)
- EU-RHAB registry (1)
- EULAR guidelines (1)
- EVAR (1)
- EVER1 (1)
- EVER2 (1)
- EVT (1)
- EWAS (1)
- EZH1 (1)
- EZH2 differentiation trichostatin (1)
- Eap (1)
- Earle-Kriterien (1)
- Earle-Kriterion (1)
- Early Modern (1)
- Early Onset Schulterarthrose (1)
- Early Posterior Negativity (1)
- Early infant catatonia (1)
- Early prevention (1)
- Early prevention program (1)
- Early-Life Stress (1)
- Early-onset (1)
- Earth Observation (1)
- East Germany (1)
- East New Britain (1)
- Eating Disorders (1)
- Eating disorder (1)
- Eberhard Karls Universität Tübingen <Motiv> (1)
- Ecdyson (1)
- Echinococcosis (1)
- Echo-Screen TDA (1)
- Echocardiography (1)
- Echogenität (1)
- Echoplanare Bildgebung (1)
- Echosignalverstärker (1)
- Echtes WRF (1)
- Eckzähne (1)
- Ecological Momentary Assessments (1)
- Ecological momentary assessment (1)
- Ectopic bone formation (1)
- Edelstahl (1)
- Edema (1)
- Edema factor (1)
- Edibatidine (1)
- Effective dose (1)
- Effekt-Modifizierung (1)
- Effektivität (1)
- Effektstärken (1)
- Efficiency (1)
- Effizienz (1)
- Effizienzsteigerung (1)
- Efflux transport (1)
- Ego-Shooter (1)
- Egressive Phonation (1)
- Ehescheidung (1)
- Ehrensteinfigur (1)
- Ehrensteintäuschung (1)
- Ehrlichiose (1)
- Ehrlichiosis (1)
- Eierstocktumor (1)
- Eigeninjektion / self injection (1)
- Eigenvectors (1)
- Einfluss auf die Bisskraft (1)
- Einführung (1)
- Eingangsuntersuchung (1)
- Einnähung (1)
- Einstellung zum Tod (1)
- Einstifttechnik (1)
- Einzelzellgelelektrophorese (1)
- Eisen (1)
- Eisen-III-Chlorid (1)
- Eisenhomöostase (1)
- Eisenmangel (1)
- Eisenoxid-Nanopartikel (1)
- Eisenoxidpartikel (1)
- Eklampsie (1)
- Ektomie (1)
- El Escorial (1)
- Elastizität (1)
- Elastographie (1)
- Elastomere Schmerzpumpe (1)
- Elbow (1)
- Elbow joint (1)
- Elderly patients (1)
- Elective cesarean-section (1)
- Electric Field (1)
- Electric auditory brainstem response (1)
- Electric stimulation therapy (1)
- Electrical (1)
- Electrical Storm (1)
- Electrical breakdown (1)
- Electrical impedance tomography (1)
- Electrochemical Impedance Spectroscopy (1)
- Electrocochleographic (1)
- Electrode (1)
- Electroforming (1)
- Electrophiles (1)
- Elektrisches Feld (1)
- Elektrisches Potenzial (1)
- Elektroakupunktur (1)
- Elektrochemische Abscheidung (1)
- Elektrode (1)
- Elektrodenanordnung (1)
- Elektroenzephalogramm (1)
- Elektrokardiologie (1)
- Elektronenmikroskop (1)
- Elektronische Nase (1)
- Elektrophysiologische Untersuchung (1)
- Elektroretinogramm (1)
- Elektrostimualtionstherapie (1)
- Eleonora Maria Rosalia (1)
- Elevated Plus Maze (1)
- Elispot (1)
- Elite Controller (1)
- Ellbogenhöcker (1)
- Eltern (1)
- Eltern ADHS (1)
- Embolie (1)
- Embolisation (1)
- Embryologie (1)
- Embryology (1)
- Embryonalen Stammzellen (1)
- Embryonenqualität (1)
- Embryonic stem cell (1)
- Emergence (1)
- Emergency case (1)
- Emodin (1)
- Emotion regulation (1)
- Emotional behavior (1)
- Emotional labor (1)
- Emotional state (1)
- Emotionales Befinden (1)
- Emotionen (1)
- Emotionserkennung (1)
- Emotionsregulierung (1)
- Emotionsverarbeitung (1)
- Empathie (1)
- Empfehlungen (1)
- Empfindlichkeit (1)
- Empfänger (1)
- Enamel microabrasion (1)
- Encephalitis (1)
- Encephalopathia hepatica (1)
- End- of- Life- Care (1)
- End-of-Life Decision (1)
- End-of-life-care (1)
- End-zu-End-Anastomose (1)
- Endarteriektomie (1)
- Enddiastolisches Volumen (1)
- Endocrinology (1)
- Endocytose (1)
- Endocytosis (1)
- Endodontics (1)
- Endogene Hypoxiemarker (1)
- Endogenes Ekzem (1)
- Endogenes Erythropoietin und Mortalität (1)
- Endogenous Glucocorticoids (1)
- Endogenous erythropoietin and all-cause mortality (1)
- Endogenous genotoxicity (1)
- Endogenous opioids (1)
- Endokarderkennung (1)
- Endokrine Onkologie (1)
- Endokrine Orbitopathie (1)
- Endolymphdrainage (1)
- Endolymphe (1)
- Endometriose (1)
- Endometriumkarzinom (1)
- Endometriumvolumen (1)
- Endomyokardbiopsie (1)
- Endophenotype (1)
- Endophänotyp (1)
- Endoplasmatisches Retikulum (1)
- Endoplasmic-Reticulum Stress (1)
- Endorectal Ultrasound (1)
- Endorphin (1)
- Endosymbiont (1)
- Endothelaktivierung (1)
- Endotheldysfunction (1)
- Endothelfunktion (1)
- Endothelial barrier functions (1)
- Endothelial cell (1)
- Endothelial growth-factor (1)
- Endothelin B-Receptor (1)
- EndothelinB-Rezeptor (1)
- EndothelinB-knockout mice (1)
- EndothelinB-knockout-Mäuse (1)
- Endothelpermeabilität (1)
- Endotoxin (1)
- Endotoxinämie (1)
- Endotracheale Intubation (1)
- Endurant® (1)
- Energetik (1)
- Energieumsatz <Medizin> (1)
- Energiezufuhr (1)
- Energy depletion (1)
- Energy expenditure (1)
- English version (1)
- Enhancement (1)
- Enrichment analysis (1)
- Entamoeba histolytica (1)
- Enteral nutrition (1)
- Enterale Ernährung (1)
- Enteric nervous system (1)
- Enteric neuropathies (1)
- Enterica serovar typhimurium (1)
- Enterisches Nervensystem (1)
- Enteritis (1)
- Enterococcus faecalis (1)
- Enterococcus faecium (1)
- Enteropathie-Typ (1)
- Enterovirus (1)
- Entfernung (1)
- Entgiftung (1)
- Enthemmungsrichtungsüberwiegen (1)
- Enthemmungsüberwiegen (1)
- Entlassung (1)
- Entlassungsmanagement (1)
- Entmarkung (1)
- Entnahmedefekt (1)
- Entnahmestelle (1)
- Entscheidungsprozess (1)
- Entwicklung Zahnmedizinisches Institut Halle (1)
- Entwicklung chimärer Antigenrezeptor T-Zellen (1)
- Entwicklung im 2. und 3. Lebensjahr (1)
- Entwicklung im 2. und 3. Lebensjahr, Entwicklungsdokumentation, Pikler, Pikler-Konzept, Beobachtungsbogen (1)
- Entwicklungsbiologie (1)
- Entwicklungsdokumentation (1)
- Entwicklungsdokumentationsbogen (1)
- Entwicklungsoptimierung (1)
- Entzug (1)
- Entzündungsfördernde Mediatoren (1)
- Entzündungsmodell (1)
- Entzündungsparametern (1)
- Entzündungsreaktion (1)
- Entzündungsschmerz (1)
- Entzündungszellen (1)
- Environment (1)
- Environmental Tobacco Smoke (ETS) (1)
- Environmental enrichment (1)
- Enzalutamid (1)
- Enzym-Ersatz-Therapie (1)
- Enzymatische Oxidation (1)
- Enzyme (1)
- Enzyme Regulation (1)
- Enzyme immunoassay (1)
- Enzyme‐Linked Immunosorbent Assay (1)
- Enzyminhibitor (1)
- Enzyminhibitoren (1)
- Ep45 (1)
- EpCAM (1)
- Epac (1)
- EphA4 (1)
- Epiaortaler Scan (1)
- Epibatidin (1)
- Epidemiological analysis (1)
- Epidemiological study (1)
- Epidermismodell (1)
- Epidural Analgesia (1)
- Epigenesis (1)
- Epigenetic regulation (1)
- Epigenetics (1)
- Epignathus (1)
- Episkin (1)
- Epistaxis (1)
- Epitaxy (1)
- Epithelgewebe (1)
- Epitheliom (1)
- Epitheliopathie (1)
- Epithelkörperchen (1)
- Epithelzellen (1)
- Epithese <Medizin> (1)
- Epitop (1)
- Epitope (1)
- Eplerenon (1)
- Epoetin beta (1)
- Epoxide hydrolase (1)
- Epsilon-Toxin (1)
- Epstein-Ba (1)
- Epstein-Barr virus (1)
- Epstein-Barr virus-induced gene 2 (1)
- Epworth Schläfrigkeits Skala (1)
- Epworth Sleepiness Scale (1)
- Erbgrind (1)
- Erbium (1)
- Erbkrankheiten (1)
- Erbliche Neuropathien (1)
- Erblichkeit (1)
- Erbse (1)
- Ereigniskorrelierte Potentiale EKP (1)
- Ereigniskorreliertes Potential (1)
- Erfolg (1)
- Erfolg und Misserfolg (1)
- Erfolgsrate (1)
- Ergebnis (1)
- Ergebnisreproduzierbarkeit (1)
- Ergobiography (1)
- Ergosterolsyntheseweg (1)
- Erhaltungstherapie (1)
- Eriksen Flanker Task (1)
- Eriksen flanker task (1)
- Eriksen-Flanker-Test (1)
- Erk (1)
- Erkenntnistherapie (1)
- Erkrankungen der Atemwege (1)
- Erkrankungswahrscheinlcihkeit (1)
- Ernährungs- und Bewegungstherapie (1)
- Ernährungsstatus (1)
- Ernährungstherapie (1)
- Erosio (1)
- Erreger (1)
- Erregerspektrum (1)
- Ersatzstoff (1)
- Ertrinkungsunfälle (1)
- Erwachsenenbehandlung (1)
- Erwartungshaltung (1)
- Erwinia amylovora (1)
- Erworbene und natürliche Resistenzen (1)
- Erythema chronicum migrans (1)
- Erythrocyte deformability in Healthy Women (1)
- Erythrozyten Verformbarkeit bei gesunden Frauen (1)
- Erythrozytenkonzentrat (1)
- EsaA (1)
- Escalation therapy (1)
- Escherichia Coli (1)
- Escherichia coli AlkA (1)
- Escherichia coli infections (1)
- Escherichia coli strains (1)
- Escherichia coli-Hfq (1)
- Escherichia coli-Stämme (1)
- Escherichia coli-derived recombinant human bone morphogenetic protein-2 (1)
- Escherichia-coli (1)
- Escherichia-coli K-12 (1)
Institute
- Medizinische Klinik und Poliklinik I (547)
- Medizinische Klinik und Poliklinik II (473)
- Neurologische Klinik und Poliklinik (438)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (412)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (378)
- Theodor-Boveri-Institut für Biowissenschaften (315)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (304)
- Graduate School of Life Sciences (299)
- Institut für Pharmakologie und Toxikologie (293)
- Institut für Virologie und Immunbiologie (292)
Schriftenreihe
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (18)
- IZKF Nachwuchsgruppe Geweberegeneration für muskuloskelettale Erkrankungen (7)
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (5)
- Johns Hopkins University School of Medicine (5)
- Bernhard-Heine-Centrum für Bewegungsforschung (4)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (4)
- Klinikum Fulda (3)
- Zentraleinheit Klinische Massenspektrometrie (3)
- CHC Würzburg (Comprehensive Hearing Center) (2)
- Center for Interdisciplinary Clinical Research, Würzburg University, Würzburg, Germany (2)
ResearcherID
- D-1221-2009 (1)
EU-Project number / Contract (GA) number
- 701983 (39)
- 602805 (22)
- 728018 (14)
- 309962 (7)
- 602133 (7)
- 101007642 (5)
- 259867 (5)
- 643051 (5)
- 241778 (4)
- 607051 (4)
- 617989 (4)
- 678119 (4)
- 766118 (4)
- 813871 (4)
- 825575 (4)
- 848261 (4)
- 01EW1902 (3)
- 223153 (3)
- 261357 (3)
- 602300 (3)
- 721016 (3)
- 733297 (3)
- 223138 (2)
- 224631 (2)
- 262055 (2)
- 277775 (2)
- 281338 (2)
- 288566 (2)
- 311932 (2)
- 312325 (2)
- 335568 (2)
- 503474 (2)
- 633983 (2)
- 667302 (2)
- 680966 (2)
- 722046 (2)
- 754658 (2)
- 758985 (2)
- 759139 (2)
- 761307 (2)
- 764860 (2)
- 847507 (2)
- 953327 (2)
- 956414 (2)
- 018696 (1)
- 026155 (1)
- 037220 (1)
- 037602 (1)
- 0800978 (1)
- 101003595 (1)
- 10100764 (1)
- 101015930 (1)
- 101016923 (1)
- 101034412 (1)
- 101041177 (1)
- 101045956 (1)
- 115525 (1)
- 18741 (1)
- 19-COP-0031 (1)
- 20100407 (1)
- 201099 (1)
- 2016 FGR 0053 (1)
- 202088 (1)
- 203291 (1)
- 211078 (1)
- 222719 (1)
- 222943 (1)
- 223044 (1)
- 224635 (1)
- 229289 (1)
- 229294 (1)
- 229571 (1)
- 232944 (1)
- 241447 (1)
- 241592 (1)
- 242175-VascuBone (1)
- 242175‐VascuBone (1)
- 242257 (1)
- 245009 (1)
- 249177 (1)
- 249929 (1)
- 250320 (1)
- 259753 (1)
- 260338 (1)
- 260464 (1)
- 261492 (1)
- 266777 (1)
- 278514 (1)
- 278864 (1)
- 278864-2 (1)
- 287320 (1)
- 289600 (1)
- 291840 (1)
- 296679 (1)
- 304961 (1)
- 305421 (1)
- 305653 (1)
- 307701 (1)
- 312147 (1)
- 318987 (1)
- 322865 (1)
- 336045 (1)
- 602102 (1)
- 602531 (1)
- 610307 (1)
- 613931 (1)
- 617198 (1)
- 641458 (1)
- 641833 (1)
- 647426 (1)
- 658195 (1)
- 667421 (1)
- 667787 (1)
- 668036 (1)
- 668353 (1)
- 677020 (1)
- 677302 (1)
- 677673 (1)
- 677819 (1)
- 681103 (1)
- 692185 (1)
- 694913 (1)
- 696802 (1)
- 715466 (1)
- 716344 (1)
- 720270 (1)
- 722064 (1)
- 723770 (1)
- 739593 (1)
- 759206 (1)
- 772376 (1)
- 777215 (1)
- 810850 (1)
- 818846 (1)
- 819800 (1)
- 836421 (1)
- 848002 (1)
- 853988 (1)
- 874758 (1)
- 874827 (1)
- 955910 (1)
- 955974 (1)
- 965286 (1)
- BWF/H/52228/2012/13.10.10-1/3.4,6 (1)
- CP22/00082 (1)
- CoG 721016–HERPES (1)
- ERC-2016-CoG 721016-HERPES (1)
- ERC335568 (1)
- EU-1650-0006 (1)
- FKZ01EW1902 (1)
- FOOD‑CT‑2004‑506378 (1)
- FP7-ICT MINIMAL (1)
- FP7/2007-2013 (1)
- HEALTHF2- 2008-201099 (1)
- PI21/00314 (1)
- PTQ2020-011372 (1)
- QLK1-2001-01614 (1)
- RTI2018-093747-B-10 (1)
- ZAM 5-85018031 (1)
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE-syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%-subcutaneous; 29%-intravenous; 1%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
Heterozygous mutations in the glucocerebrosidase gene (GBA1) represent the most common genetic risk factor for Parkinson's disease (PD) and are histopathologically associated with a widespread load of alpha-synuclein in the brain. Therefore, PD patients with GBA1 mutations are a cohort of high interest for clinical trials on disease-modifying therapies targeting alpha-synuclein. There is evidence that detection of phospho-alpha-synuclein (p-syn) in dermal nerve fibers might be a biomarker for the histopathological identification of PD patients even at premotor or very early stages of disease. It is so far unknown whether dermal p-syn deposition can also be found in PD patients with GBA1 mutations and may serve as a biomarker for PD in these patients. Skin biopsies of 10 PD patients with different GBA1 mutations (six N3705, three E326K, one L444P) were analyzed by double-immunofluorescence labeling with anti-p-syn and anti-protein gene product 9.5 (PGP9.5, axonal marker) to detect intraaxonal p-syn deposition. Four biopsy sites (distal, proximal leg, paravertebral Th10, and C7) per patient were studied. P-syn was found in six patients (three N370S, three E326K). P-syn deposition was mainly detected in autonomic nerve fibers, but also in somatosensory fibers and was not restricted to a certain GBA1 mutation. In summary, dermal p-syn in PD patients with GBA1 mutations seems to offer a similar distribution and frequency as observed in patients without a known mutation. Skin biopsy may be suitable to study p-syn deposition in these patients or even to identify premotor patients with GBA1 mutations.
In young (n = 36, mean +/- SD: 24.8 +/- 4.5 years) and older (n = 34, mean +/- SD: 65.1 +/- 6.5 years) healthy participants, we employed a modified version of the Serial Reaction Time task to measure procedural learning (PL) and consolidation while providing monetary and social reward. Using voxel-based morphometry (VBM), we additionally determined the structural correlates of reward-related motor performance (RMP) and PL. Monetary reward had a beneficial effect on PL in the older subjects only. In contrast, social reward significantly enhanced PL in the older and consolidation in the young participants. VBM analyses revealed that motor performance related to monetary reward was associated with larger grey matter volume (GMV) of the left striatum in the young, and motor performance related to social reward with larger GMV of the medial orbitofrontal cortex in the older group. The differential effects of social reward in young (improved consolidation) and both social and monetary rewards in older (enhanced PL) healthy subjects point to the potential of rewards for interventions targeting aging-associated motor decline or stroke-induced motor deficits.
In the recent two decades, LIM and SH3 protein 1 (LASP1) has been developed from a simple actin-binding structural protein to a tumor biomarker and subsequently to a complex, nuclear transcriptional regulator. Starting with a brief historical perspective, this review will mainly compare and contrast LASP1 and LASP2 from the angle of the newest data and importantly, examine their role in transcriptional regulation. We will summarize the current knowledge through pictorial models and tables including the roles of different microRNAs in the differential regulation of LASP1 levels and patient outcome rather than specify in detail all tumor entities. Finally, the novel functional roles of LASP1 in secretion of vesicles, expression of matrix metalloproteinases and transcriptional regulation as well as the activation of survival and proliferation pathways in different cancer types are described.
Bone represents a common site of metastases for several solid tumors. However, the ability of neuroendocrine neoplasms (NENs) to localize to bone has always been considered a rare and late event. Thanks to the improvement of therapeutic options, which results in longer survival, and of imaging techniques, particularly after the introduction of positron emission tomography (PET) with gallium peptides, the diagnosis of bone metastases (BMs) in NENs is increasing. The onset of BMs can be associated with severe skeletal complications that impair the patient's quality of life. Moreover, BMs negatively affect the prognosis of NEN patients, bringing out the lack of curative treatment options for advanced NENs. The current knowledge on BMs in gastro-entero-pancreatic (GEP) and bronchopulmonary (BP) NENs is still scant and is derived from a few retrospective studies and case reports. This review aims to perform a critical analysis of the evidence regarding the role of BMs in GEP- and BP-NENs, focusing on the molecular mechanisms underlining the development of BMs, as well as clinical presentation, diagnosis, and treatment of BMs, in an attempt to provide suggestions that can be used in clinical practice.
The probiotic escherichia coli strain Nissle 1917 combats lambdoid bacteriophages stx and lambda
(2018)
Shiga toxin (Stx) producing E. coli (STEC) such as Enterohemorrhagic E. coli (EHEC) are the major cause of foodborne illness in humans. In vitro studies showed the probiotic Escherichia coil strain Nissle 1917 (EcN) to efficiently inhibit the production of Stx. Life threatening EHEC strains as for example the serotype 0104:H4, responsible for the great outbreak in 2011 in Germany, evolutionary developed from certain E. coll strains which got infected by stx2-encoding lambdoid phages turning the E. coil into lysogenic and subsequently Stx producing strains. Since antibiotics induce stx genes and Stx production, EHEC infected persons are not recommended to be treated with antibiotics. Therefore, EcN might be an alternative medication. However, because even commensal E. coli strains might be converted into Stx-producers after becoming host to a stx encoding prophage, we tested EcN for stx-phage genome integration. Our experiments revealed the resistance of EcN toward not only stx-phages but also against lambda-phages. This resistance was not based on the lack of or by mutated phage receptors. Rather it involved the expression of a phage repressor (pr) gene of a defective prophage in EcN which was able to partially protect E. coli K-12 strain MG1655 against stx and lambda phage infection. Furthermore, we observed EcN to inactivate phages and thereby to protect E. coli K-12 strains against infection by stx- as well as lambda-phages. Inactivation of lambda-phages was due to binding of lambda-phages to LamB of EcN whereas inactivation of stx-phages was caused by a thermostable protein of EcN. These properties together with its ability to inhibit Stx production make EcN a good candidate for the prevention of illness caused by EHEC and probably for the treatment of already infected people.
Glycine receptors (GlyRs) are important mediators of fast inhibitory neurotransmission in the mammalian central nervous system. Their function is controlled by multiple cellular mechanisms, including intracellular regulatory processes. Modulation of GlyR function by protein kinases has been reported for many cell types, involving different techniques, and often yielding contradictory results. Here, we studied the effects of protein kinase C (PKC) and cAMP-dependent protein kinase A (PKA) on glycine induced currents in HEK293 cells expressing human homomeric \(\alpha\)1 and heteromeric \(\alpha\)1-\(\beta\) GlyRs using whole-cell patch clamp techniques as well as internalization assays. In whole-cell patch-clamp measurements, modulators were applied in the intracellular buffer at concentrations between 0.1 \(\mu\)M and 0.5 \(\mu\)M. EC50 of glycine increased upon application of the protein kinase activators Forskolin and phorbol-12-myristate-13-acetate (PMA) but decreased in the presence of the PKC inhibitor Staurosporine aglycon and the PKA inhibitor H-89. Desensitization of recombinant \(\alpha\)1 receptors was significantly increased in the presence of Forskolin. Staurosporine aglycon, on the other hand decreased desensitization of heteromeric \(\alpha\)1-\(\beta\) GlyRs. The time course of receptor activation was determined for homomeric \(\alpha\)1 receptors and revealed two simultaneous effects: cells showed a decrease of EC50 after 3-6 min of establishing whole-cell configuration. This effect was independent of protein kinase modulators. All modulators of PKA and PKC, however, produced an additional shift of EC50, which overlay and eventually exceeded the cells intrinsic variation of EC50. The effect of kinase activators was abolished if the corresponding inhibitors were co-applied, consistent with PKA and PKC directly mediating the modulation of GlyR function. Direct effects of PKA-and PKC-modulators on receptor expression on transfected HEK cells were monitored within 15 min of drug application, showing a significant increase of receptor internalization with PKA and PKC activators, while the corresponding inhibitors had no significant effect on receptor surface expression or internalization. Our results confirm the observation that phosphorylation via PKA and PKC has a direct effect on the GlyR ion channel complex and plays an important role in the fine-tuning of glycinergic signaling.
Voluntary movements induce postural perturbations which are counteracted by anticipatory postural adjustments (APAs). These actions are known to build up long fixation chains toward available support points (inter-limb APAs), so as to grant whole body equilibrium. Moreover, recent studies highlighted that APAs also build-up short fixation chains, within the same limb where a distal segment is moved (intra-limb APAs), aimed at stabilizing the proximal segments. The neural structures generating intra-limb APAs still need investigations; the present study aims to compare focal movement kinematics and intra-limb APA latencies and pattern between healthy subjects and parkinsonian patients, assuming the latter as a model of basal ganglia dysfunction. Intra-limb APAs that stabilize the arm when the index-finger is briskly flexed were recorded in 13 parkinsonian patients and in 10 age-matched healthy subjects. Index-finger movement was smaller in parkinsonian patients vs. healthy subjects (p = 0.01) and more delayed with respect to the onset of the prime mover flexor digitorum superficialis (FDS, p < 0.0001). In agreement with the literature, in all healthy subjects the FDS activation was preceded by an inhibitory intra-limb APA in biceps brachii (BB) and anterior deltoid (AD), and almost simultaneous to an excitatory intra-limb APA in triceps brachii (TB). In parkinsonian patients, no significant differences were found for TB and AD intra-limb APA timings, however only four patients showed an inhibitory intra-limb APA in BB, while other four did not show any BB intra-limb APAs and five actually developed a BB excitation. The frequency of occurrence of normal sign, lacking, and inverted BB APAs was different in healthy vs. parkinsonian participants (p = 0.0016). The observed alterations in index-finger kinematics and intra-limb APA pattern in parkinsonian patients suggest that basal ganglia, in addition to shaping the focal movement, may also contribute to intra-limb APA control.
Introduction: Acute stroke care delivered by interdisciplinary teams is time-sensitive. Simulation-based team training is a promising tool to improve team performance in medical operations. It has the potential to improve process times, team communication, patient safety, and staff satisfaction. We aim to assess whether a multi-level approach consisting of a stringent workflow revision based on peer-to-peer review and 2–3 one-day in situ simulation trainings can improve acute stroke care processing times in high volume neurocenters within a 6 months period.
Methods and Analysis: The trial is being carried out in a pre-test-post-test design at 7 tertiary care university hospital neurocenters in Germany. The intervention is directed at the interdisciplinary multiprofessional stroke teams. Before and after the intervention, process times of all direct-to-center stroke patients receiving IV thrombolysis (IVT) and/or endovascular therapy (EVT) will be recorded. The primary outcome measure will be the “door-to-needle” time of all consecutive stroke patients directly admitted to the neurocenters who receive IVT. Secondary outcome measures will be intervention-related process times of the fraction of patients undergoing EVT and effects on team communication, perceived patient safety, and staff satisfaction via a staff questionnaire.
Interventions: We are applying a multi-level intervention in cooperation with three “STREAM multipliers” from each center. First step is a central meeting of the multipliers at the sponsor's institution with the purposes of algorithm review in a peer-to-peer process that is recorded in a protocol and an introduction to the principles of simulation training and debriefing as well as crew resource management and team communication. Thereafter, the multipliers cooperate with the stroke team trainers from the sponsor's institution to plan and execute 2–3 one-day simulation courses in situ in the emergency department and CT room of the trial centers whereupon they receive teaching materials to perpetuate the trainings.
Clinical Trial Registration: STREAM is a registered trial at https://clinicaltrials.gov/ct2/show/NCT03228251.
Staphylococcus epidermidis, the common inhabitant of human skin and mucosal surfaces has emerged as an important pathogen in patients carrying surgical implants and medical devices. Entering the body via surgical sites and colonizing the medical devices through formation of multi-layered biofilms leads to refractory and persistent device-related infections (DRIs). Staphylococci organized in biofilms are more tolerant to antibiotics and immune responses, and thus are difficult-to-treat. The consequent morbidity and mortality, and economic losses in health care systems has strongly necessitated the need for development of new anti-bacterial and anti-biofilm-based therapeutics. In this study, we describe the biological activity of a marine sponge-derived Streptomyces sp. SBT348 extract in restraining staphylococcal growth and biofilm formation on polystyrene, glass, medically relevant titan metal, and silicone surfaces. A bioassay-guided fractionation was performed to isolate the active compound (SKC3) from the crude SBT348 extract. Our results demonstrated that SKC3 effectively inhibits the growth (MIC: 31.25 \(\mu\)g/ml) and biofilm formation (sub-MIC range: 1.95-<31.25 \(\mu\)g/ml) of S. epidermidis RP62A in vitro. Chemical characterization of SKC3 by heat and enzyme treatments, and mass spectrometry (HRMS) revealed its heat-stable and non-proteinaceous nature, and high molecular weight (1258.3 Da). Cytotoxicity profiling of SKC3 in vitro on mouse fibroblast (NIH/3T3) and macrophage (J774.1) cell lines, and in vivo on the greater wax moth larvae Galleria mellonella revealed its non-toxic nature at the effective dose. Transcriptome analysis of SKC3 treated S. epidermidis RP62A has further unmasked its negative effect on central metabolism such as carbon flux as well as, amino acid, lipid, and energy metabolism. Taken together, these findings suggest a potential of SKC3 as a putative drug to prevent staphylococcal DRIs.
In most organisms, ribosomal RNA (rRNA) contributes to >85% of total RNA. Thus, to obtain useful information from RNA-sequencing (RNA-seq) analyses at reasonable sequencing depth, typically, mature polyadenylated transcripts are enriched or rRNA molecules are depleted. Targeted depletion of rRNA is particularly useful when studying transcripts lacking a poly(A) tail, such as some non-coding RNAs (ncRNAs), most bacterial RNAs and partially degraded or immature transcripts. While several commercially available kits allow effective rRNA depletion, their efficiency relies on a high degree of sequence homology between oligonucleotide probes and the target RNA. This restricts the use of such kits to a limited number of organisms with conserved rRNA sequences. In this study we describe the use of biotinylated oligos and streptavidin-coated paramagnetic beads for the efficient and specific depletion of trypanosomal rRNA. Our approach reduces the levels of the most abundant rRNA transcripts to less than 5% with minimal off-target effects. By adjusting the sequence of the oligonucleotide probes, our approach can be used to deplete rRNAs or other abundant transcripts independent of species. Thus, our protocol provides a useful alternative for rRNA removal where enrichment of polyadenylated transcripts is not an option and commercial kits for rRNA are not available.
Fused silica glass is the preferred material for applications which require long-term chemical and mechanical stability as well as excellent optical properties. The manufacturing of complex hollow microstructures within transparent fused silica glass is of particular interest for, among others, the miniaturization of chemical synthesis towards more versatile, configurable and environmentally friendly flow-through chemistry as well as high-quality optical waveguides or capillaries. However, microstructuring of such complex three-dimensional structures in glass has proven evasive due to its high thermal and chemical stability as well as mechanical hardness. Here we present an approach for the generation of hollow microstructures in fused silica glass with high precision and freedom of three-dimensional designs. The process combines the concept of sacrificial template replication with a room-temperature molding process for fused silica glass. The fabricated glass chips are versatile tools for, among other, the advance of miniaturization in chemical synthesis on chip.
The pediatric immune deficiency X-linked proliferative disease-2 (XLP-2) is a unique disease, with patients presenting with either hemophagocytic lymphohistiocytosis (HLH) or intestinal bowel disease (IBD). Interestingly, XLP-2 patients display high levels of IL-18 in the serum even while in stable condition, presumably through spontaneous inflammasome activation. Recent data suggests that LPS stimulation can trigger inflammasome activation through a TNFR2/TNF/TNFR1 mediated loop in xiap−/− macrophages. Yet, the direct role TNFR2-specific activation plays in the absence of XIAP is unknown. We found TNFR2-specific activation leads to cell death in xiap−/− myeloid cells, particularly in the absence of the RING domain. RIPK1 kinase activity downstream of TNFR2 resulted in a TNF/TNFR1 cell death, independent of necroptosis. TNFR2-specific activation leads to a similar inflammatory NF-kB driven transcriptional profile as TNFR1 activation with the exception of upregulation of NLRP3 and caspase-11. Activation and upregulation of the canonical inflammasome upon loss of XIAP was mediated by RIPK1 kinase activity and ROS production. While both the inhibition of RIPK1 kinase activity and ROS production reduced cell death, as well as release of IL-1β, the release of IL-18 was not reduced to basal levels. This study supports targeting TNFR2 specifically to reduce IL-18 release in XLP-2 patients and to reduce priming of the inflammasome components.
Background
Peritoneal carcinomatosis (PC) represents an unfavourable prognostic factor for patients with gastric cancer (GC). Intraperitoneal treatment with the bispecific and trifunctional antibody catumaxomab (EpCAM, CD3), in addition to systemic chemotherapy, could improve elimination of PC.
Methods
This prospective, randomised, phase II study investigated the efficacy of catumaxomab followed by chemotherapy (arm A, 5-fluorouracil, leucovorin, oxaliplatin, docetaxel, FLOT) or FLOT alone (arm B) in patients with GC and PC. Primary endpoint was the rate of macroscopic complete remission (mCR) of PC at the time of second diagnostic laparoscopy/laparotomy prior to optional surgery.
Results
Median follow-up was 52 months. Out of 35 patients screened, 15 were allocated to arm A and 16 to arm B. mCR rate was 27% in arm A and 19% in arm B (p = 0.69). Severe side effects associated with catumaxomab were nausea, infection, abdominal pain, and elevated liver enzymes. Median progression-free (6.7 vs. 5.4 months, p = 0.71) and overall survival (13.2 vs. 13.0 months, p = 0.97) were not significantly different in both treatment arms.
Conclusions
Addition of catumaxomab to systemic chemotherapy was feasible and tolerable in advanced GC. Although the primary endpoint could not be demonstrated, results are promising for future investigations integrating intraperitoneal immunotherapy into a multimodal treatment strategy.
Tumor treating fields (TTFields) are approved for glioblastoma (GBM) therapy. TTFields disrupt cell division by inhibiting spindle fiber formation. Spindle assembly checkpoint (SAC) inhibition combined with antimitotic drugs synergistically decreases glioma cell growth in cell culture and mice. We hypothesized that SAC inhibition will increase TTFields efficacy. Human GBM cells (U-87 MG, GaMG) were treated with TTFields (200 kHz, 1.7 V/cm) and/or the SAC inhibitor MPS1-IN-3 (IN-3, 4 µM). Cells were counted after 24, 48, and 72 h of treatment and at 24 and 72 h after end of treatment (EOT). Flow cytometry, immunofluorescence microscopy, Annexin-V staining and TUNEL assay were used to detect alterations in cell cycle and apoptosis after 72 h of treatment. The TTFields/IN-3 combination decreased cell proliferation after 72 h compared to either treatment alone (−78.6% vs. TTFields, P = 0.0337; −52.6% vs. IN-3, P = 0.0205), and reduced the number of viable cells (62% less than seeded). There was a significant cell cycle shift from G1 to G2/M phase (P < 0.0001). The apoptotic rate increased to 44% (TTFields 14%, P = 0.0002; IN-3 4%, P < 0.0001). Cell growth recovered 24 h after EOT with TTFields and IN-3 alone, but the combination led to further decrease by 92% at 72 h EOT if IN-3 treatment was continued (P = 0.0288). The combination of TTFields and SAC inhibition led to earlier and prolonged effects that significantly augmented the efficacy of TTFields and highlights a potential new targeted multimodal treatment for GBM.
The neurotransmitter serotonin plays a key role in the control of aggressive behaviour. While so far most studies have investigated variation in serotonin levels, a recently created tryptophan hydroxylase 2 (Tph2) knockout mouse model allows studying effects of complete brain serotonin deficiency. First studies revealed increased aggressiveness in homozygous Tph2 knockout mice in the context of a resident-intruder paradigm. Focussing on females, this study aimed to elucidate effects of serotonin deficiency on aggressive and non-aggressive social behaviours not in a test situation but a natural setting. For this purpose, female Tph2 wildtype (n = 40) and homozygous knockout mice (n = 40) were housed with a same-sex conspecific of either the same or the other genotype in large terraria. The main findings were: knockout females displayed untypically high levels of aggressive behaviour even after several days of co-housing. Notably, in response to aggressive knockout partners, they showed increased levels of defensive behaviours. While most studies on aggression in rodents have focussed on males, this study suggests a significant involvement of serotonin also in the control of female aggression. Future research will show, whether the observed behavioural effects are directly caused by the lack of serotonin or by potential compensatory mechanisms.
Histone H3 serine 28 (H3S28) phosphorylation and de-repression of polycomb repressive complex (PRC)-mediated gene regulation is linked to stress conditions in mitotic and post-mitotic cells. To better understand the role of H3S28 phosphorylation in vivo, we studied a Drosophila strain with ectopic expression of constitutively-activated H3S28A, which prevents PRC2 binding at H3S28, thus mimicking H3S28 phosphorylation. H3S28A mutants showed prolonged life span and improved resistance against starvation and paraquat-induced oxidative stress. Morphological and functional analysis of heart tubes revealed smaller luminal areas and thicker walls accompanied by moderately improved cardiac function after acute stress induction. Whole-exome deep gene-sequencing from isolated heart tubes revealed phenotype-corresponding changes in longevity-promoting and myotropic genes. We also found changes in genes controlling mitochondrial biogenesis and respiration. Analysis of mitochondrial respiration from whole flies revealed improved efficacy of ATP production with reduced electron transport-chain activity. Finally, we analyzed posttranslational modification of H3S28 in an experimental heart failure model and observed increased H3S28 phosphorylation levels in HF hearts. Our data establish a critical role of H3S28 phosphorylation in vivo for life span, stress resistance, cardiac and mitochondrial function in Drosophila. These findings may pave the way for H3S28 phosphorylation as a putative target to treat stress-related disorders such as heart failure.
Increased sympathetic noradrenergic signaling is crucially involved in fear and anxiety as defensive states. MicroRNAs regulate dynamic gene expression during synaptic plasticity and genetic variation of microRNAs modulating noradrenaline transporter gene (SLC6A2) expression may thus lead to altered central and peripheral processing of fear and anxiety. In silico prediction of microRNA regulation of SLC6A2 was confirmed by luciferase reporter assays and identified hsa-miR-579-3p as a regulating microRNA. The minor (T)-allele of rs2910931 (MAFcases = 0.431, MAFcontrols = 0.368) upstream of MIR579 was associated with panic disorder in patients (pallelic = 0.004, ncases = 506, ncontrols = 506) and with higher trait anxiety in healthy individuals (pASI = 0.029, pACQ = 0.047, n = 3112). Compared to the major (A)-allele, increased promoter activity was observed in luciferase reporter assays in vitro suggesting more effective MIR579 expression and SLC6A2 repression in vivo (p = 0.041). Healthy individuals carrying at least one (T)-allele showed a brain activation pattern suggesting increased defensive responding and sympathetic noradrenergic activation in midbrain and limbic areas during the extinction of conditioned fear. Panic disorder patients carrying two (T)-alleles showed elevated heart rates in an anxiety-provoking behavioral avoidance test (F(2, 270) = 5.47, p = 0.005). Fine-tuning of noradrenaline homeostasis by a MIR579 genetic variation modulated central and peripheral sympathetic noradrenergic activation during fear processing and anxiety. This study opens new perspectives on the role of microRNAs in the etiopathogenesis of anxiety disorders, particularly their cardiovascular symptoms and comorbidities.
BRCA1 is a tumor suppressor that regulates DNA repair by homologous recombination. Germline mutations in BRCA1 are associated with increased risk of breast and ovarian cancer and BRCA1 deficient tumors are exquisitely sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors. Therefore, uncovering additional components of this DNA repair pathway is of extreme importance for further understanding cancer development and therapeutic vulnerabilities. Here, we identify EDC4, a known component of processing-bodies and regulator of mRNA decapping, as a member of the BRCA1-BRIP1-TOPBP1 complex. EDC4 plays a key role in homologous recombination by stimulating end resection at double-strand breaks. EDC4 deficiency leads to genome instability and hypersensitivity to DNA interstrand cross-linking drugs and PARP inhibitors. Lack-of-function mutations in EDC4 were detected in BRCA1/2-mutation-negative breast cancer cases, suggesting a role in breast cancer susceptibility. Collectively, this study recognizes EDC4 with a dual role in decapping and DNA repair whose inactivation phenocopies BRCA1 deficiency.
Background:
Concomitant radiation with BRAF inhibitor (BRAFi) therapy may increase radiation-induced side effects but also potentially improve tumour control in melanoma patients.
Methods:
A total of 155 patients with BRAF-mutated melanoma from 17 European skin cancer centres were retrospectively analysed. Out of these, 87 patients received concomitant radiotherapy and BRAFi (59 vemurafenib, 28 dabrafenib), while in 68 patients BRAFi therapy was interrupted during radiation (51 vemurafenib, 17 dabrafenib). Overall survival was calculated from the first radiation (OSRT) and from start of BRAFi therapy (OSBRAFi).
Results:
The median duration of BRAFi treatment interruption prior to radiotherapy was 4 days and lasted for 17 days. Median OSRT and OSBRAFi in the entire cohort were 9.8 and 12.6 months in the interrupted group and 7.3 and 11.5 months in the concomitant group (P=0.075/P=0.217), respectively. Interrupted vemurafenib treatment with a median OSRT and OSBRAFi of 10.1 and 13.1 months, respectively, was superior to concomitant vemurafenib treatment with a median OSRT and OSBRAFi of 6.6 and 10.9 months (P=0.004/P=0.067). Interrupted dabrafenib treatment with a median OSRT and OSBRAFi of 7.7 and 9.8 months, respectively, did not differ from concomitant dabrafenib treatment with a median OSRT and OSBRAFi of 9.9 and 11.6 months (P=0.132/P=0.404). Median local control of the irradiated area did not differ in the interrupted and concomitant BRAFi treatment groups (P=0.619). Skin toxicity of grade ≥2 (CTCAE) was significantly increased in patients with concomitant vemurafenib compared to the group with treatment interruption (P=0.002).
Conclusions:
Interruption of vemurafenib treatment during radiation was associated with better survival and less toxicity compared to concomitant treatment. Due to lower number of patients, the relevance of treatment interruption in dabrafenib treated patients should be further investigated. The results of this analysis indicate that treatment with the BRAFi vemurafenib should be interrupted during radiotherapy. Prospective studies are desperately needed.
In der vorliegenden Dissertationsarbeit wurden Sphäroide aus mesenchymalen Stammzellen aus dem Fettgewebe oder dem Knochenmark mittels der Micromold-Methode hergestellt. Den Sphäroiden wurden entweder Calciumphosphat- oder Calcium-Magnesium-Phosphat-Partikel hinzugefügt. Zum einen sollte überprüft werden, ob die Zugabe von Partikeln die osteogene Differenzierung der Sphäroide fördert und somit zur weiteren Entwicklung von körpereigenem Knochenersatzmaterial in der regenerativen Medizin beiträgt. Zum anderen sollte festgestellt werden, ob eine der beiden Biokeramiken hinsichtlich der osteogenen Differenzierung überlegen ist.
The relation between LV function and cardiac MRI tissue characteristics in separate myocardial segments and their change over time has yet to be explored in myocarditis. Thus, our research aimed to investigate possible associations between global and regional myocardial T1 and T2 times and peak strain in patients with suspected myocarditis.
From 2012 to 2015, 129 patients with clinically suspected myocarditis of the prospective, observational MyoRacer-Trial underwent systematic biventricular EMB at baseline and cardiac MRI at baseline and after three months as a follow-up. We divided the LV myocardium into 17 segments and estimated the segmental myocardial strain using FT. We registered T1 and T2 maps to the cine sequences and transferred the segmentations used for FT to ensure conformity of the myocardial segments. Multi-level multivariable linear mixed effects regression was applied to investigate the relation of segmental myocardial strain to relaxation times and their respective change from baseline to follow-up.
We found a significant improvement in myocardial peak strain from baseline to follow-up (p < 0.001; all p-values given for likelihood ratio tests) and significant associations between higher T1 and T2 times and lower segmental myocardial peak strain (p ranging from < 0.001 to 0.049). E.g., regression coefficient (Reg. coef.) for segmental radial peak strain in short axis view (SRPS_SAX) and T1 time: -1.9, 95% CI (-2.6;-1.2) %/100 ms, p < 0.001. A decrease in T1 and T2 times from baseline to follow-up was also significantly related to a recovery of segmental peak strains (p ranging from < 0.001 to 0.050). E.g., Reg. coef. for SRPS_SAX per ΔT1: -1.8, 95% CI (-2.5;-1.0) %/100 ms, p < 0.001. Moreover, the higher the baseline T1 time, the more substantial the functional recovery from baseline to follow-up (p ranging from 0.004 to 0.042, e.g., for SRPS_SAX: Reg. coef. 1.3, 95% CI (0.4;2.1) %/100 ms, p 0.004). We did not find an effect modification by the presence of myocarditis in the EMB (p > 0.1).
Our cross-sectional and longitudinal analyses provide evidence of dose-dependent correlations between T1 and T2 relaxation times and myocardial peak strain in patients with clinical presentation of myocarditis, regardless of the EMB result. Thus, assessing strain values and mapping relaxation times helps estimate the functional prognosis in patients with clinically suspected myocarditis.
Colorectal cancer (CRC) is the second most common tumour disease in Germany, with the sequential accumulation of certain mutations playing a decisive role in the transition from adenoma to carcinoma. In particular, deregulation of the Wnt signalling pathway and the associated deregulated expression of the MYC oncoprotein play a crucial role. Targeting MYC thus represents an important therapeutic approach in the treatment of tumours. Since direct inhibition of MYC is challenging, various approaches have been pursued to date to target MYC indirectly. The MYC 5' UTR contains an internal ribosomal entry site (IRES), which has a particular role in the initiation of MYC translation, especially in multiple myeloma. As basis for this work, it was hypothesised on the basis of previous data that translation of MYC potentially occurs via its IRES in CRC as well. Based on this, two IRES inhibitors were tested for their potential to regulate MYC expression in CRC cells. In addition, alternative, 5’ UTR-dependent translation of MYC and interacting factors were investigated. EIF3D was identified as a MYC 5' UTR binding protein which has the potential to regulate MYC expression in CRC. The results of this work suggest that there is a link between eIF3D and MYC expression/translation, rendering eIF3D a potential therapeutic target for MYC-driven CRCs.
Life-threatening systemic infections often occur due to the translocation of pathogens across the gut barrier and into the bloodstream. While the microbial and host mechanisms permitting bacterial gut translocation are well characterized, these mechanisms are still unclear for fungal pathogens such as Candida albicans, a leading cause of nosocomial fungal bloodstream infections. In this study, we dissected the cellular mechanisms of translocation of C. albicans across intestinal epithelia in vitro and identified fungal genes associated with this process. We show that fungal translocation is a dynamic process initiated by invasion and followed by cellular damage and loss of epithelial integrity. A screen of >2,000 C. albicans deletion mutants identified genes required for cellular damage of and translocation across enterocytes. Correlation analysis suggests that hypha formation, barrier damage above a minimum threshold level, and a decreased epithelial integrity are required for efficient fungal translocation. Translocation occurs predominantly via a transcellular route, which is associated with fungus-induced necrotic epithelial damage, but not apoptotic cell death. The cytolytic peptide toxin of C. albicans, candidalysin, was found to be essential for damage of enterocytes and was a key factor in subsequent fungal translocation, suggesting that transcellular translocation of C. albicans through intestinal layers is mediated by candidalysin. However, fungal invasion and low-level translocation can also occur via non-transcellular routes in a candidalysin-independent manner. This is the first study showing translocation of a human-pathogenic fungus across the intestinal barrier being mediated by a peptide toxin. IMPORTANCE Candida albicans, usually a harmless fungus colonizing human mucosae, can cause lethal bloodstream infections when it manages to translocate across the intestinal epithelium. This can result from antibiotic treatment, immune dysfunction, or intestinal damage (e.g., during surgery). However, fungal processes may also contribute. In this study, we investigated the translocation process of C. albicans using in vitro cell culture models. Translocation occurs as a stepwise process starting with invasion, followed by epithelial damage and loss of epithelial integrity. The ability to secrete candidalysin, a peptide toxin deriving from the hyphal protein Ece1, is key: C. albicans hyphae, secreting candidalysin, take advantage of a necrotic weakened epithelium to translocate through the intestinal layer.
Evolutionary conserved networks of human height identify multiple Mendelian causes of short stature
(2019)
Height is a heritable and highly heterogeneous trait. Short stature affects 3% of the population and in most cases is genetic in origin. After excluding known causes, 67% of affected individuals remain without diagnosis. To identify novel candidate genes for short stature, we performed exome sequencing in 254 unrelated families with short stature of unknown cause and identified variants in 63 candidate genes in 92 (36%) independent families. Based on systematic characterization of variants and functional analysis including expression in chondrocytes, we classified 13 genes as strong candidates. Whereas variants in at least two families were detected for all 13 candidates, two genes had variants in 6 (UBR4) and 8 (LAMA5) families, respectively. To facilitate their characterization, we established a clustered network of 1025 known growth and short stature genes, which yielded 29 significantly enriched clusters, including skeletal system development, appendage development, metabolic processes, and ciliopathy. Eleven of the candidate genes mapped to 21 of these clusters, including CPZ, EDEM3, FBRS, IFT81, KCND1, PLXNA3, RASA3, SLC7A8, UBR4, USP45, and ZFHX3. Fifty additional growth-related candidates we identified await confirmation in other affected families. Our study identifies Mendelian forms of growth retardation as an important component of idiopathic short stature.
Dishevelled (DVL) is the key component of the Wnt signaling pathway. Currently, DVL conformational dynamics under native conditions is unknown. To overcome this limitation, we develop the Fluorescein Arsenical Hairpin Binder- (FlAsH-) based FRET in vivo approach to study DVL conformation in living cells. Using this single-cell FRET approach, we demonstrate that (i) Wnt ligands induce open DVL conformation, (ii) DVL variants that are predominantly open, show more even subcellular localization and more efficient membrane recruitment by Frizzled (FZD) and (iii) Casein kinase 1 ɛ (CK1ɛ) has a key regulatory function in DVL conformational dynamics. In silico modeling and in vitro biophysical methods explain how CK1ɛ-specific phosphorylation events control DVL conformations via modulation of the PDZ domain and its interaction with DVL C-terminus. In summary, our study describes an experimental tool for DVL conformational sampling in living cells and elucidates the essential regulatory role of CK1ɛ in DVL conformational dynamics.
Pan-cancer analyses that examine commonalities and differences among various cancer types have emerged as a powerful way to obtain novel insights into cancer biology. Here we present a comprehensive analysis of genetic alterations in a pan-cancer cohort including 961 tumours from children, adolescents, and young adults, comprising 24 distinct molecular types of cancer. Using a standardized workflow, we identified marked differences in terms of mutation frequency and significantly mutated genes in comparison to previously analysed adult cancers. Genetic alterations in 149 putative cancer driver genes separate the tumours into two classes: small mutation and structural/copy-number variant (correlating with germline variants). Structural variants, hyperdiploidy, and chromothripsis are linked to TP53 mutation status and mutational signatures. Our data suggest that 7–8% of the children in this cohort carry an unambiguous predisposing germline variant and that nearly 50% of paediatric neoplasms harbour a potentially druggable event, which is highly relevant for the design of future clinical trials.
Preclinical studies point to a pivotal role of the orexin 1 (OX1) receptor in arousal and fear learning and therefore suggest the HCRTR1 gene as a prime candidate in panic disorder (PD) with/without agoraphobia (AG), PD/AG treatment response, and PD/AG-related intermediate phenotypes. Here, a multilevel approach was applied to test the non-synonymous HCRTR1 C/T Ile408Val gene variant (rs2271933) for association with PD/AG in two independent case-control samples (total n = 613 cases, 1839 healthy subjects), as an outcome predictor of a six-weeks exposure-based cognitive behavioral therapy (CBT) in PD/AG patients (n = 189), as well as with respect to agoraphobic cognitions (ACQ) (n = 483 patients, n = 2382 healthy subjects), fMRI alerting network activation in healthy subjects (n = 94), and a behavioral avoidance task in PD/AG pre- and post-CBT (n = 271). The HCRTR1 rs2271933 T allele was associated with PD/AG in both samples independently, and in their meta-analysis (p = 4.2 × 10−7), particularly in the female subsample (p = 9.8 × 10−9). T allele carriers displayed a significantly poorer CBT outcome (e.g., Hamilton anxiety rating scale: p = 7.5 × 10−4). The T allele count was linked to higher ACQ sores in PD/AG and healthy subjects, decreased inferior frontal gyrus and increased locus coeruleus activation in the alerting network. Finally, the T allele count was associated with increased pre-CBT exposure avoidance and autonomic arousal as well as decreased post-CBT improvement. In sum, the present results provide converging evidence for an involvement of HCRTR1 gene variation in the etiology of PD/AG and PD/AG-related traits as well as treatment response to CBT, supporting future therapeutic approaches targeting the orexin-related arousal system.
Zinc (Zn2+) can modulate platelet and coagulation activation pathways, including fibrin formation. Here, we studied the (patho)physiological consequences of abnormal platelet Zn2+ storage and release. To visualize Zn2+ storage in human and mouse platelets, the Zn2+ specific fluorescent dye FluoZin3 was used. In resting platelets, the dye transiently accumulated into distinct cytosolic puncta, which were lost upon platelet activation. Platelets isolated from Unc13d−/− mice, characterized by combined defects of α/δ granular release, showed a markedly impaired Zn2+ release upon activation. Platelets from Nbeal2−/− mice mimicking Gray platelet syndrome (GPS), characterized by primarily loss of the α-granule content, had strongly reduced Zn2+ levels, which was also confirmed in primary megakaryocytes. In human platelets isolated from patients with GPS, Hermansky-Pudlak Syndrome (HPS) and Storage Pool Disease (SPD) altered Zn2+ homeostasis was detected. In turbidity and flow based assays, platelet-dependent fibrin formation was impaired in both Nbeal2−/− and Unc13d−/− mice, and the impairment could be partially restored by extracellular Zn2+. Altogether, we conclude that the release of ionic Zn2+ store from secretory granules upon platelet activation contributes to the procoagulant role of Zn2+ in platelet-dependent fibrin formation.
That the human brain contains magnetite is well established; however, its spatial distribution in the brain has remained unknown. We present room temperature, remanent magnetization measurements on 822 specimens from seven dissected whole human brains in order to systematically map concentrations of magnetic remanence carriers. Median saturation remanent magnetizations from the cerebellum were approximately twice as high as those from the cerebral cortex in all seven cases (statistically significantly distinct, p = 0.016). Brain stems were over two times higher in magnetization on average than the cerebral cortex. The ventral (lowermost) horizontal layer of the cerebral cortex was consistently more magnetic than the average cerebral cortex in each of the seven studied cases. Although exceptions existed, the reproducible magnetization patterns lead us to conclude that magnetite is preferentially partitioned in the human brain, specifically in the cerebellum and brain stem.
B cell development in bone marrow is a precisely regulated complex process. Through successive stages of differentiation, which are regulated by a multitude of signaling pathways and an array of lineage-specific transcription factors, the common lymphoid progenitors ultimately give rise to mature B cells. Similar to early thymocyte development in the thymus, early B cell development in bone marrow is critically dependent on IL-7 signaling. During this IL-7-dependent stage of differentiation, several transcription factors, such as E2A, EBF1, and Pax5, among others, play indispensable roles in B lineage specification and maintenance. Although recent studies have implicated several other transcription factors in B cell development, the role of NFATc1 in early B cell developmental stages is not known. Here, using multiple gene-manipulated mouse models and applying various experimental methods, we show that NFATc1 activity is vital for early B cell differentiation. Lack of NFATc1 activity in pro-B cells suppresses EBF1 expression, impairs immunoglobulin gene rearrangement, and thereby preBCR formation, resulting in defective B cell development. Overall, deficiency in NFATc1 activity arrested the pro-B cell transition to the pre-B cell stage, leading to severe B cell lymphopenia. Our findings suggest that, along with other transcription factors, NFATc1 is a critical component of the signaling mechanism that facilitates early B cell differentiation.
The remarkable diversity of sex determination mechanisms known in fish may be fuelled by exceptionally high rates of sex chromosome turnovers or transitions. However, the evolutionary causes and genomic mechanisms underlying this variation and instability are yet to be understood. Here we report on an over 30-year evolutionary experiment in which we tested the genomic consequences of hybridisation and selection between two Xiphophorus fish species with different sex chromosome systems. We find that introgression and imposing selection for pigmentation phenotypes results in the retention of an unexpectedly large maternally derived genomic region. During the hybridisation process, the sex-determining region of the X chromosome from one parental species was translocated to an autosome in the hybrids leading to the evolution of a new sex chromosome. Our results highlight the complexity of factors contributing to patterns observed in hybrid genomes, and we experimentally demonstrate that hybridisation can catalyze rapid evolution of a new sex chromosome.
Die Arbeit befasst sich mit der Akademisierung und Professionalisierung der Zahnheilkunde, insbesondere der Zahnchirurgie, in Würzburg und Unterfranken im 19. Jahrhundert. Dies wurde insbesondere anhand des zahnchirurgischen Teils der Lehrchirurgischen Instrumentensammlung der Universität Würzburg bzw. des Juliusspitals erforscht. Der zahnchirurgische Teil der Instrumentensammlung war bisher noch nicht erforscht worden und besteht aktuell aus 34+1 Instrumenten, die für diese Arbeit komplett katalogisiert wurden. Für die Entwicklung der Instrumente im Verlauf des 19. Jahrhunderts wurde die Provenienz der Teilsammlung ergründet und diese in den Kontext der Akademisierungsbewegung des 19. Jahrhunderts eingeordnet.
Die Forschung wurde anhand der tatsächlich in der Praxis tätigen und nach und nach akademisch ausgebildeten Personen nachvollzogen. Hierzu wurden neben den Instrumenten als Quelle die Adressbücher der Stadt Würzburg und die Matrikel-, Personal- und Vorlesungsverzeichnisse der Universität Würzburg des gesamten 19. Jahrhunderts systematisch durchgearbeitet. Außerdem wurden Lehrbücher aus dem nichtakademischen zahnchirurigischen Bereich (Bader) mit denen aus dem sich beginnenden akademischen Bereich analysiert. Anhand dieser Forschungsarbeit konnte dargelegt werden, dass die Zahnchirurgie sich analog zur Chiurgie aus dem handwerklichen Bereich abgekoppelt und nach und nach auf verschiedenen Stufen akademisiert hat. Die Zahnchirurgie hat sich "von unten nach oben" durch das Bestreben nichtakademisch ausgebildeter Menschen akademisiert.
Die distale Radiusfraktur gehört zu den häufigsten Frakturen in Deutschland mit einem Inzidenzanstieg im Alter unter Betonung des weiblichen Geschlechts. Dabei zeigt sich ein zunehmender Trend in Richtung operative Versorgung, allen voran die Versorgung mittels winkelstabiler Plattensysteme. Instabile, distale Radiusfrakturen werden dabei vor geplanter operativer Versorgung im Rahmen der Initialbehandlung üblicherweise geschlossen reponiert und im Gipsverband retiniert. Ziel der vorliegenden monozentrischen, prospektiv randomisierten Studie mit zwei Studiengruppen war es herauszufinden, ob sich das Unterlassen der Reposition vor geplanter Operation nachteilig auf das Schmerzniveau in der präoperativen Phase auswirkt und ob sich durch die Dislokation Nachteile in Bezug auf den Nervus medianus im Sinne eines Traktionsschadens sowie bezüglich des klinisch-radiologischen Ausheilungsergebnisses zeigen.
Die Studie zeigte, dass das Schmerzempfinden während der präoperativen Gipsbehandlung unabhängig von einer vorherigen Reposition war. Für den primären Endpunkt an Tag 1 nach der Akutbehandlung konnte statistisch signifikante Nichtunterlegenheit der Gruppe ohne Reposition gegenüber der Gruppe mit Reposition nachgewiesen werden. Gleiches galt für Tag 2, sowohl für die absoluten Schmerzniveaus als auch für die Schmerzlinderung.
Das Unterlassen der Reposition hatte zudem keine nachteiligen Effekte auf den Nervus medianus.
Gleiches zeigte sich für das klinische und radiologische Ausheilungsergebnis. Für die funktionellen DASH- und Krimmer-Scores konnte ein Jahr postoperativ ebenfalls statistisch signifikante Nichtunterlegenheit der Gruppe ohne Reposition nachgewiesen werden.
Diese Erkenntnisse bestätigen die in der Literatur vorhandenen Ergebnisse verschiedener Studien dahingehend, dass das Unterlassen der Reposition keine nachteiligen Effekte auf das postoperative Outcome hat. Einige Studien verdeutlichen zudem, dass es nach Reposition, insbesondere bei Vorliegen gewisser Risiko- und Instabilitätsfaktoren, ohnehin zur sekundären Dislokation kommt, sodass die generelle Notwendigkeit der Reposition vor Gipsanlage sowohl vor einer operativen als auch vor einer konservativen Weiterbehandlung angezweifelt werden
muss.
Among the defense strategies developed in microbes over millions of years, the innate adaptive CRISPR-Cas immune systems have spread across most of bacteria and archaea. The flexibility, simplicity, and specificity of CRISPR-Cas systems have laid the foundation for CRISPR-based genetic tools. Yet, the efficient administration of CRISPR-based tools demands rational designs to maximize the on-target efficiency and off-target specificity. Specifically, the selection of guide RNAs (gRNAs), which play a crucial role in the target recognition of CRISPR-Cas systems, is non-trivial. Despite the fact that the emerging machine learning techniques provide a solution to aid in gRNA design with prediction algorithms, design rules for many CRISPR-Cas systems are ill-defined, hindering their broader applications.
CRISPR interference (CRISPRi), an alternative gene silencing technique using a catalytically dead Cas protein to interfere with transcription, is a leading technique in bacteria for functional interrogation, pathway manipulation, and genome-wide screens. Although the application is promising, it also is hindered by under-investigated design rules. Therefore, in this work, I develop a state-of-art predictive machine learning model for guide silencing efficiency in bacteria leveraging the advantages of feature engineering, data integration, interpretable AI, and automated machine learning. I first systematically investigate the influential factors that attribute to the extent of depletion in multiple CRISPRi genome-wide essentiality screens in Escherichia coli and demonstrate the surprising dominant contribution of gene-specific effects, such as gene expression level. These observations allowed me to segregate the confounding gene-specific effects using a mixed-effect random forest (MERF) model to provide a better estimate of guide efficiency, together with the improvement led by integrating multiple screens. The MERF model outperformed existing tools in an independent high-throughput saturating screen. I next interpret the predictive model to extract the design rules for robust gene silencing, such as the preference for cytosine and disfavoring for guanine and thymine within and around the protospacer adjacent motif (PAM) sequence. I further incorporated the MERF model in a web-based tool that is freely accessible at www.ciao.helmholtz-hiri.de.
When comparing the MERF model with existing tools, the performance of the alternative gRNA design tool optimized for CRISPRi in eukaryotes when applied to bacteria was far from satisfying, questioning the robustness of prediction algorithms across organisms. In addition, the CRISPR-Cas systems exhibit diverse mechanisms albeit with some similarities. The captured predictive patterns from one dataset thereby are at risk of poor generalization when applied across organisms and CRISPR-Cas techniques. To fill the gap, the machine learning approach I present here for CRISPRi could serve as a blueprint for the effective development of prediction algorithms for specific organisms or CRISPR-Cas systems of interest. The explicit workflow includes three principle steps: 1) accommodating the feature set for the CRISPR-Cas system or technique; 2) optimizing a machine learning model using automated machine learning; 3) explaining the model using interpretable AI. To illustrate the applicability of the workflow and diversity of results when applied across different bacteria and CRISPR-Cas systems, I have applied this workflow to analyze three distinct CRISPR-Cas genome-wide screens. From the CRISPR base editor essentiality screen in E. coli, I have determined the PAM preference and sequence context in the editing window for efficient editing, such as A at the 2nd position of PAM, A/TT/TG downstream of PAM, and TC at the 4th to 5th position of gRNAs. From the CRISPR-Cas13a screen in E. coli, in addition to the strong correlation with the guide depletion, the target expression level is the strongest predictor in the model, supporting it as a main determinant of the activation of Cas13-induced immunity and better characterizing the CRISPR-Cas13 system. From the CRISPR-Cas12a screen in Klebsiella pneumoniae, I have extracted the design rules for robust antimicrobial activity across K. pneumoniae strains and provided a predictive algorithm for gRNA design, facilitating CRISPR-Cas12a as an alternative technique to tackle antibiotic resistance.
Overall, this thesis presents an accurate prediction algorithm for CRISPRi guide efficiency in bacteria, providing insights into the determinants of efficient silencing and guide designs. The systematic exploration has led to a robust machine learning approach for effective model development in other bacteria and CRISPR-Cas systems. Applying the approach in the analysis of independent CRISPR-Cas screens not only sheds light on the design rules but also the mechanisms of the CRISPR-Cas systems. Together, I demonstrate that applied machine learning paves the way to a deeper understanding and a broader application of CRISPR-Cas systems.
Evaluierung prognostischer und prädiktiver Biomarker beim neoadjuvant vorbehandelten Rektumkarzinom
(2024)
Fragestellung. Osteopontin (OPN) kann im Blut nachgewiesen werden und wird bei vielen Tumorentitäten exprimiert, wie auch der Tyrosinkinaserezeptor c-Met und sein Ligand, das Zytokin Hepatocyte Growth Factor (HGF). In der vorliegenden Arbeit untersuchten wir die prognostische und prädiktive Wertigkeit der Plasmakonzentrationen von OPN, c-Met und HGF bei Patienten mit lokal fortgeschrittenem Rektumkarzinom (LARC).
Methodik. Das Plasma von 63 Patienten mit LARC wurde untersucht. Die Blutentnahmen (EDTA-Plasma) erfolgten vor Therapiebeginn sowie im Verlauf. Die Plasmaspiegel von OPN, c-Met und HGF wurden mittels Enzyme-Linked Immunosorbent Assay analysiert. Die Konzentrationen wurden auf eine Korrelation mit den klinischen Parametern untersucht.
Ergebnisse. 68 Patienten wurden neoadjuvant mit einer Radiochemotherapie behandelt, 63 Blutproben wurden untersucht. Initial befanden sich nach UICC 14 Patienten in Stadium II, 47 in Stadium III und 7 in Stadium IV. Das mediane Follow-Up betrug 29,87 Monate. 20 der 68 Patienten (29,4 %) verstarben, 19 entwickelten Fernmetastasen. OPN korrelierte signifikant mit dem Überleben (p=0,001). OPN-Werte korrelierten mit dem pT-Stadium (R:0,445 p=0,018) und dem pUICC-Stadium (R:0,412 p=0,018), sowie mit dem Auftreten von Fernmetastasen (R:0,271 p=0,031). Eine Korrelation zwischen OPN und dem Therapieansprechen konnte gezeigt werden: pathologisch komplette Remission (pCR) (R:0,379 p=0,001), NAR-Score (R:0,373 p=0,015), TRG (R:0,380 p=0,020). Die logistische Regressionsanalyse ergab eine Prädiktivität OPNs für pCR (OR:0,990 p=0,009), NAR-Score (OR:1,008 p=0,007), TRG (OR:0,459 p=0,008). C-Met und HGF korrelierten nicht mit dem Überleben. Für c-Met und HGF ergab sich keine Korrelation zu initialen klinischen Daten und Therapieansprechen. Die logistische Regression ergab keinen prädiktiven Wert.
Schlussfolgerung. Die Plasmakonzentration von OPN besitzt prognostische und prädiktive Wertigkeit beim LARC. Die Konzentrationen von c-Met und HGF sind nicht prognostisch für das Überleben oder prädiktiv für das Therapieansprechen.
There is a great need for valuable ex vivo models that allow for assessment of cartilage repair strategies to reduce the high number of animal experiments. In this paper we present three studies with our novel ex vivo osteochondral culture platform. It consists of two separated media compartments for cartilage and bone, which better represents the in vivo situation and enables supply of factors pecific to the different needs of bone and cartilage. We investigated whether separation of the cartilage and bone compartments and/or culture media results in the maintenance of viability, structural and functional properties of cartilage tissue. Next, we valuated for how long we can preserve cartilage matrix stability of osteochondral explants during long-term culture over 84 days. Finally, we determined the optimal defect size that does not show spontaneous self-healing in this culture system. It was demonstrated that separated compartments for cartilage and bone in combination with tissue-specific medium allow for long-term culture of osteochondral explants while maintaining cartilage viability, atrix tissue content, structure and mechanical properties for at least 56 days. Furthermore, we could create critical size cartilage defects of different sizes in the model. The osteochondral model represents a valuable preclinical ex vivo tool for studying clinically relevant cartilage therapies, such as cartilage biomaterials, for their regenerative potential, for evaluation of drug and cell therapies, or to study mechanisms of cartilage regeneration. It will undoubtedly reduce the number of animals needed for in vivotesting.
Hintergrund
Ein neues Rahmenkonzept hat die flexible Ableitung und Nutzung von rheumatologischen Schulungsprogrammen für unterschiedliche Versorgungsbereiche ermöglicht. Auf dieser Grundlage wurde eine 5‑stündige Basisschulung für Patienten mit rheumatoider Arthritis (RA) entwickelt, es wurden rheumatologische Fachärzte und Psychologen trainiert, und dann wurde die Wirksamkeit nach dem Wirkmodell der Patientenschulung evaluiert.
Methoden
Mit dem Studiendesign einer extern randomisierten Wartekontrollgruppenstudie mit 3 Messzeitpunkten wurde geprüft, wie sich die 5‑stündige Basisschulung auf das Erkrankungs- und Behandlungswissen sowie auf die Gesundheitskompetenz von RA-Patienten (n = 249) auswirkt. Weitere Fragen betrafen Einstellungsparameter, Kommunikationskompetenz, Erkrankungsauswirkungen und die Zufriedenheit mit der Schulung. Die Auswertungen erfolgten auf Intention-to-treat-Basis mit Kovarianzanalysen für die Hauptzielgrößen unter Berücksichtigung des Ausgangswertes.
Ergebnisse
Die Analysen zeigen, dass die Basisschulung RA wirksam ist. Noch 3 Monate nach der Schulung verfügten die Schulungsteilnehmer über mehr Wissen und Gesundheitskompetenz als die Wartekontrollgruppe mit kleinem bis mittelgroßem Effekt (d = 0,37 bzw. 0,38). In den Nebenzielgrößen zeigten sich mit Ausnahme der Krankheitskommunikation keine weiteren Schulungseffekte.
Diskussion
Die Basisschulung bietet eine gute Grundlage, auf der weitere Interventionen zur Verbesserung von Einstellungs- und Erkrankungsparametern aufbauen können. Sie eignet sich damit als zentraler Baustein für die rheumatologische Versorgung auf verschiedenen Ebenen.
Background
Deregulated expression of MYC is a driver of colorectal carcinogenesis, suggesting that decreasing MYC expression may have significant therapeutic value. CIP2A is an oncogenic factor that regulates MYC expression. CIP2A is overexpressed in colorectal cancer (CRC), and its expression levels are an independent marker for long-term outcome of CRC. Previous studies suggested that CIP2A controls MYC protein expression on a post-transcriptional level.
Methods
To determine the mechanism by which CIP2A regulates MYC in CRC, we dissected MYC translation and stability dependent on CIP2A in CRC cell lines.
Results
Knockdown of CIP2A reduced MYC protein levels without influencing MYC stability in CRC cell lines. Interfering with proteasomal degradation of MYC by usage of FBXW7-deficient cells or treatment with the proteasome inhibitor MG132 did not rescue the effect of CIP2A depletion on MYC protein levels. Whereas CIP2A knockdown had marginal influence on global protein synthesis, we could demonstrate that, by using different reporter constructs and cells expressing MYC mRNA with or without flanking UTR, CIP2A regulates MYC translation. This interaction is mainly conducted by the MYC 5′UTR.
Conclusions
Thus, instead of targeting MYC protein stability as reported for other tissue types before, CIP2A specifically regulates MYC mRNA translation in CRC but has only slight effects on global mRNA translation. In conclusion, we propose as novel mechanism that CIP2A regulates MYC on a translational level rather than affecting MYC protein stability in CRC.
Formation and treatment of biofilms present a great challenge for health care and industry. About 80% of human infections are associated with biofilms including biomaterial centered infections, like infections of prosthetic heart valves, central venous catheters, or urinary catheters. Additionally, biofilms can cause food and drinking water contamination. Biofilm research focusses on application of experimental biofilm models to study initial adherence processes, to optimize physico-chemical properties of medical materials for reducing interactions between materials and bacteria, and to investigate biofilm treatment under controlled conditions. Exploring new antimicrobial strategies plays a key role in a variety of scientific disciplines, like medical material research, anti-infectious research, plant engineering, or wastewater treatment. Although a variety of biofilm models exist, there is a lack of standardization for experimental protocols, and designing experimental setups remains a challenge. In this study, a number of experimental parameters critical for material research have been tested that influence formation and stability of an experimental biofilm using the non-pathogenic model strain of Pseudomonas fluorescens. These parameters include experimental time frame, nutrient supply, inoculum concentration, static and dynamic cultivation conditions, material properties, and sample treatment during staining for visualization of the biofilm. It was shown, that all tested parameters critically influence the experimental biofilm formation process. The results obtained in this study shall support material researchers in designing experimental biofilm setups.
Abstract
To compare intravenous contrast material (CM) injection protocols for dual-energy CT pulmonary angiography (CTPA) in patients with suspected acute pulmonary embolism with regard to image quality and pulmonary perfused blood volume (PBV) values. A total of 198 studies performed with four CM injection protocols varying in CM volume and iodine delivery rates (IDR) were retrospectively included: (A) 60 ml at 5 ml/s (IDR = 1.75gI/s), (B) 50 ml at 5 ml/s (IDR = 1.75gI/s), (C) 50 ml at 4 ml/s (IDR = 1.40gI/s), (D) 40 ml at 3 ml/s (IDR = 1.05gI/s). Image quality and PBV values at different resolution settings were compared. Pulmonary arterial tract attenuation was highest for protocol A (397 ± 110 HU; p vs. B = 0.13; vs. C = 0.02; vs. D < 0.001). CTPA image quality of protocol A was rated superior compared to protocols B and D by reader 1 (p = 0.01; < 0.001), and superior to protocols B, C and D by reader 2 (p < 0.001; 0.02; < 0.001). Otherwise, there were no significant differences in CTPA quality ratings. Subjective iodine map ratings did not vary significantly between protocols A, B, and C. Both readers rated protocol D inferior to all other protocols (p < 0.05). PBV values did not vary significantly between protocols A and B at resolution settings of 1, 4 and 10 (p = 0.10; 0.10; 0.09), while otherwise PBV values displayed a decreasing trend from protocol A to D (p < 0.05). Higher CM volume and IDR are associated with superior CTPA and iodine map quality and higher absolute PBV values.
Purpose
Radiotherapy (RT) was identified as a risk factor for long-term cardiac effects in breast cancer patients treated until the 1990s. However, modern techniques reduce radiation exposure of the heart, but some exposure remains unavoidable. In a retrospective cohort study, we investigated cardiac mortality and morbidity of breast cancer survivors treated with recent RT in Germany.
Methods
A total of 11,982 breast cancer patients treated between 1998 and 2008 were included. A mortality follow-up was conducted until 06/2018. In order to assess cardiac morbidity occurring after breast cancer treatment, a questionnaire was sent out in 2014 and 2019. The effect of breast cancer laterality on cardiac mortality and morbidity was investigated as a proxy for radiation exposure. We used Cox Proportional Hazards regression analysis, taking potential confounders into account.
Results
After a median follow-up time of 11.1 years, there was no significant association of tumor laterality with cardiac mortality in irradiated patients (hazard ratio (HR) for left-sided versus right-sided tumor 1.09; 95% confidence interval (CI) 0.85–1.41). Furthermore, tumor laterality was not identified as a significant risk factor for cardiac morbidity (HR = 1.05; 95%CI 0.88–1.25).
Conclusions
Even though RT for left-sided breast cancer on average incurs higher radiation dose to the heart than RT for right-sided tumors, we found no evidence that laterality is a strong risk factor for cardiac disease after contemporary RT. However, larger sample sizes, longer follow-up, detailed information on individual risk factors and heart dose are needed to assess clinically manifest late effects of current cancer therapy.
Ende des 19. Jahrhunderts standen sich in Deutschland zwei verschiedene Arten psychiatrischer Institutionen gegenüber, die Anstaltspsychiatrien auf der einen, die universitären psychiatrischen Kliniken auf der anderen Seite. Die psychiatriehistorische Forschung widmete sich überwiegend psychiatrischen Anstalten während Kliniken hier unterrepräsentiert sind. Die vorliegende Arbeit möchte zur historischen Kenntnis universitärer psychiatrischer Einrichtungen beitragen. Hierzu werden die Charakteristika einer psychiatrischen Klinik um 1900 anhand des Beispiels der psychiatrischen Klinik der Universität Würzburg betrachtet. Der Fokus liegt hierbei neben Lage und Aufbau der Klinik sowie deren Personal auf den drei Bereichen Patient*innen, Forschung und Lehre.
Objectives
To determine sleep bruxism (SB) behavior during five consecutive nights and to identify correlations between SB episodes per hour (SB index) and sleep-time masseter-muscle activity (sMMA).
Material and methods
Thirty-one participants were included in the study. Of these, 10 were classified as sleep bruxers (group SB-1) and nine as non-sleep bruxers (group non-SB). The bruxism status of these 19 patients was identified by means of questionnaires, an assessment of clinical symptoms, and electromyographic/electrocardiographic data (Bruxoff® device). The remaining 12 participants were also identified as bruxers, but based exclusively on data from the Bruxoff device (group SB-2). Data analysis included descriptive statistics and Spearman’s correlation to assess the relationship between the SB index and sMMA.
Results
Participants in group SB-1 showed an overall mean SB index of 3.1 ± 1.6 and a mean total sMMA per night of 62.9 ± 38.3. Participants in group SB-2 had an overall mean SB index of 2.7 ± 1.5 and a mean total sMMA of 56.0 ± 29.3. In the non-SB group, participants showed an overall mean SB index of 0.8 ± 0.5 and a mean total sMMA of 56.8 ± 30.3. Spearman’s correlation yielded values of − 0.27 to 0.71 for the correlation between sMMA and SB index.
Conclusions
The data revealed variable SB activity and the absence of a reliable correlation between sMMA and the SB index.
Clinical relevance
The high variation in SB activity and lack of correlation between sMMA and the SB index should be considered when diagnosing SB.
Trial registration
Clinical Trials [NIH], clinical trial no. NCT03039985.
Objectives
Micro-computed tomography (μ-CT) and histology, the current gold standard methods for assessing the formation of new bone and blood vessels, are invasive and/or destructive. With that in mind, a more conservative tool, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), was tested for its accuracy and reproducibility in monitoring neovascularization during bone regeneration. Additionally, the suitability of blood perfusion as a surrogate of the efficacy of osteoplastic materials was evaluated.
Materials and methods
Sixteen rabbits were used and equally divided into four groups, according to the time of euthanasia (2, 3, 4, and 6 weeks after surgery). The animals were submitted to two 8-mm craniotomies that were filled with blood or autogenous bone. Neovascularization was assessed in vivo through DCE-MRI, and bone regeneration, ex vivo, through μ-CT and histology.
Results
The defects could be consistently identified, and their blood perfusion measured through DCE-MRI, there being statistically significant differences within the blood clot group between 3 and 6 weeks (p = 0.029), and between the former and autogenous bone at six weeks (p = 0.017). Nonetheless, no significant correlations between DCE-MRI findings on neovascularization and μ-CT (r =−0.101, 95% CI [−0.445; 0.268]) or histology (r = 0.305, 95% CI [−0.133; 0.644]) findings on bone regeneration were observed.
Conclusions
These results support the hypothesis that DCE-MRI can be used to monitor neovascularization but contradict the premise that it could predict bone regeneration as well.
Objectives
To investigate plaque inhibition of 0.1% octenidine mouthwash (OCT) vs. placebo over 5 days in the absence of mechanical plaque control.
Materials and methods
For this randomized, placebo-controlled, double-blind, parallel group, multi-center phase 3 study, 201 healthy adults were recruited. After baseline recording of plaque index (PI) and gingival index (GI), collection of salivary samples, and dental prophylaxis, subjects were randomly assigned to OCT or placebo mouthwash in a 3:1 ratio. Rinsing was performed twice daily for 30 s. Colony forming units in saliva were determined before and after the first rinse. At day 5, PI, GI, and tooth discoloration index (DI) were assessed. Non-parametric van Elteren tests were applied with a significance level of p < 0.05.
Results
Treatment with OCT inhibited plaque formation more than treatment with placebo (PI: 0.36 vs. 1.29; p < 0.0001). OCT reduced GI (0.04 vs. placebo 0.00; p = 0.003) and salivary bacterial counts (2.73 vs. placebo 0.24 lgCFU/ml; p < 0.0001). Tooth discoloration was slightly higher under OCT (DI: 0.25 vs. placebo 0.00; p = 0.0011). Mild tongue staining and dysgeusia occurred.
Conclusions
OCT 0.1% mouthwash inhibits plaque formation over 5 days. It therefore can be recommended when regular oral hygiene is temporarily compromised.
Clinical relevance
When individual plaque control is compromised, rinsing with octenidine mouthwash is recommended to maintain healthy oral conditions while side effects are limited.
Vorliegende Untersuchung am Universitätsklinikum Würzburg sowie die Befragung von Anästhesisten/Anästhesistinnen im Raum der 3 DACH-Länder zeigen, dass bildgebende Verfahren bei Säuglingen mit einer niedrigen Rate an Komplikationen, zumeist in medikamentöser Sedierung mit Propofol, durchgeführt werden. Wie international üblich ist im Säuglingsalter die Magnetresonanztomographie das bildgebende Verfahren der Wahl und wird, mit überzeugender Häufigkeit, erfolgreich durchgeführt.
Die Untersuchung am Universitätsklinikum Würzburg legt nahe, dass männliche Säuglinge häufiger eine Bildgebung benötigen und häufiger höheren ASA-Kategorie zugeschrieben werden. Dabei scheinen sie auch häufiger Komplikationen zu erleben und bedürfen daher besonderer Aufmerksamkeit. Eine eventuelle Alternative zur Sedierung kann dabei die „feed-and-sleep“ Methode darstellen. In unserer Umfrage konnten wir erheben, dass diese Methode bisher wenig verbreitet ist, obwohl in diesem Zusammenhang eventuell Abläufe und Prozesszeiten strukturiert und optimiert werden können, da beispielsweise die Nachüberwachung entfällt. Vorstellbar wäre beispielsweise, mehrere Säuglinge zum gleichen Zeitpunkt ins MRT zu bestellen, um gegebenenfalls den am frühesten eingeschlafenen Säugling vorzuziehen. Diese Methode sollte zukünftig Einzug in die wissenschaftliche Untersuchung von bildgebenden Verfahren bei Säuglingen finden.
Die Umfrage im deutschsprachigen Raum zeigt eine Leitlinien-gerechte Betreuung von Säuglingen für bildgebende Verfahren, die mit einer hohen Qualität, und zumeist erfolgreich von erfahrenen Anästhesisten/Anästhesistinnen durchgeführt wird. Eventuelle Verbesserungen können im Bereich der Ausbildung nachfolgender Ärztinnen/Ärzte und in der häufigeren Verwendung der „feed-and-sleep“ Methode liegen, die vielen Kollegen/Kolleginnen bekannt ist, aber nur selten durchgeführt wird.
Ziel ist eine qualitativ hochwertige, schnellstmöglich durchgeführte Bildgebung, die ohne oder mit der niedrigst möglichen Dosierung eines sedierenden Medikamentes zu erreichen ist.
Rag1\(^{−/−}\) mice, lacking functional B and T cells, have been extensively used as an adoptive transfer model to evaluate neuroinflammation in stroke research. However, it remains unknown whether natural killer (NK) cell development and functions are altered in Rag1\(^{−/−}\) mice as well. This connection has been rarely discussed in previous studies but might have important implications for data interpretation. In contrast, the NOD-Rag1\(^{null}\)IL2rg\(^{null}\) (NRG) mouse model is devoid of NK cells and might therefore eliminate this potential shortcoming. Here, we compare immune-cell frequencies as well as phenotype and effector functions of NK cells in Rag1\(^{−/−}\) and wildtype (WT) mice using flow cytometry and functional in vitro assays. Further, we investigate the effect of Rag1\(^{−/−}\) NK cells in the transient middle cerebral artery occlusion (tMCAO) model using antibody-mediated depletion of NK cells and adoptive transfer to NRG mice in vivo. NK cells in Rag1\(^{−/−}\) were comparable in number and function to those in WT mice. Rag1\(^{−/−}\) mice treated with an anti-NK1.1 antibody developed significantly smaller infarctions and improved behavioral scores. Correspondingly, NRG mice supplemented with NK cells were more susceptible to tMCAO, developing infarctions and neurological deficits similar to Rag1−/− controls. Our results indicate that NK cells from Rag1−/− mice are fully functional and should therefore be considered in the interpretation of immune-cell transfer models in experimental stroke. Fortunately, we identified the NRG mice, as a potentially better-suited transfer model to characterize individual cell subset-mediated neuroinflammation in stroke.
Despite successful recanalization of large-vessel occlusions in acute ischemic stroke, individual patients profit to a varying degree. Dynamic susceptibility-weighted perfusion and dynamic T1-weighted contrast-enhanced blood-brain barrier permeability imaging may help to determine secondary stroke injury and predict clinical outcome. We prospectively performed perfusion and permeability imaging in 38 patients within 24 h after successful mechanical thrombectomy of an occlusion of the middle cerebral artery M1 segment. Perfusion alterations were evaluated on cerebral blood flow maps, blood-brain barrier disruption (BBBD) visually and quantitatively on ktrans maps and hemorrhagic transformation on susceptibility-weighted images. Visual BBBD within the DWI lesion corresponded to a median ktrans elevation (IQR) of 0.77 (0.41–1.4) min−1 and was found in all 7 cases of hypoperfusion (100%), in 10 of 16 cases of hyperperfusion (63%), and in only three of 13 cases with unaffected perfusion (23%). BBBD was significantly associated with hemorrhagic transformation (p < 0.001). While BBBD alone was not a predictor of clinical outcome at 3 months (positive predictive value (PPV) = 0.8 [0.56–0.94]), hypoperfusion occurred more often in patients with unfavorable clinical outcome (PPV = 0.43 [0.10–0.82]) compared to hyperperfusion (PPV = 0.93 [0.68–1.0]) or unaffected perfusion (PPV = 1.0 [0.75–1.0]). We show that combined perfusion and permeability imaging reveals distinct infarct signatures after recanalization, indicating the severity of prior ischemic damage. It assists in predicting clinical outcome and may identify patients at risk of stroke progression.
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion
(2021)
Background
The presence or future development of metastatic pheochromocytomas or paragangliomas (mPPGLs) can be difficult to diagnose or predict at initial presentation. Since production of catecholamines from mPPGLs is different from non-metastatic tumors (non-mPPGLs), this study aimed to clarify whether presenting catecholamine-related signs and symptoms (cSS) might also differ.
Methods
The study included 249 patients, 43 with mPPGL and 206 with non-mPPGL. Clinical data at the time of biochemical diagnosis (i.e. at entry into the study) were used to generate a cumulative score of cSS for each patient.
Results
Patients with mPPGL were significantly younger (43.3 ± 14 vs. 48.9 ± 16.1 years) and included a lower proportion of females (39.5% vs. 60.7%) than patients with non-mPPGLs. Frequencies of signs and symptoms did not differ between the two groups. Patients with mPPGLs had lower (P < 0.001) urinary excretion of epinephrine (3.5 (IQR, 1.9—6.5) µg/day) than those with non-mPPGLs (19.1 (IQR, 4.3—70.2) µg/day). There was no difference in urinary excretion of norepinephrine. In patients with mPPGLs a high cSS score was associated with high urinary excretion of norepinephrine and normetanephrine. In contrast, in patients with non-mPPGLs, a high cSS was associated with high urinary excretion of epinephrine and metanephrine.
Conclusion
Although presenting signs and symptoms were associated with production of norepinephrine in patients with mPPGLs and of epinephrine in patients with non-mPPGLs, there were no differences in signs and symptoms between the two groups. Therefore, consideration of signs and symptoms does not appear helpful for distinguishing patients with and without mPPGLs.
In this study, we examined the conditional indirect and direct relations of pain-related cognitions to depression. Subjective helplessness was included as presumably mediating the relations of catastrophizing and thought suppression to depression due to motivational deficits. In addition, moderating effects of dispositional action versus state orientation were analyzed, whereby state orientation indicates volitional deficits in coping with distress. The study was based on self-report data from 536 patients with chronic non-specific low back pain at the beginning of inpatient rehabilitation. Moderated mediation analyses were performed. The indirect catastrophizing- and thought suppression-depression relations were (partially) mediated by subjective helplessness; and moderated by failure-related action versus state orientation. Moreover, action versus state orientation moderated the direct relation of thought suppression to depression. Results suggest that catastrophizing, thought suppression, and subjective helplessness do not lead to depression unless associated with self-regulatory inability (i.e., state orientation). In contrast, action-oriented patients more effectively self-regulate pain-related emotions, disengage from rumination, and distract from pain and thus better avoid the debilitating effects of negative pain-related cognitions on depression. Future research and treatment may more strongly focus on the role of motivational and volitional deficits underlying learned helplessness and depression in chronic pain.
Purpose
The subclassification of adrenal cancers according to the WHO classification in ordinary, myxoid, oncocytic, and sarcomatoid as well as pediatric types is well established, but the criteria for each subtype are not sufficiently determined and the relative frequency of the different types of adrenal cancers has not been studied in large cohorts. Therefore, our large collection of surgically removed adrenal cancers should be reviewed o establish the criteria for the subtypes and to find out the frequency of the various types.
Methods
In our series of 521 adrenal cancers the scoring systems of Weiss et al., Hough et al., van Slooten et al. and the new Helsinki score system were used for the ordinary type of cancer (97% of our series) and the myxoid type (0.8%). For oncocytic carcinomas (2%), the scoring system of Bisceglia et al. was applied.
Results
Discrepancies between benign and malignant diagnoses from the first thee classical scoring systems are not rare (22% in our series) and could be resolved by the Helsinki score especially by Ki-67 index (more than 8% unequivocally malignant). Since all our cancer cases are positive in the Helsinki score, this system can replace the three elder systems. For identification of sarcomatoid cancer as rarest type in our series (0.2%), the scoring systems are not practical but additional immunostainings used for soft tissue tumors and in special cases molecular pathology are necessary to differentiate these cancers from adrenal sarcomas. According to the relative frequencies of the different subtypes of adrenal cancers the main type is the far most frequent (97%) followed by the oncocytic type (2%), the myxoid type (0.8%) and the very rare sarcomatoid type (0.2%).
Conclusions
The Helsinki score is the best for differentiating adrenal carcinomas of the main, the oncocytic, and the myxoid type in routine work. Additional scoring systems for these carcinomas are generally not any longer necessary. Signs of proliferation (mitoses and Ki-67 index) and necroses are the most important criteria for diagnosis of malignancy.
Context
Primary aldosteronism (PA) is the most frequent form of endocrine hypertension. Besides its deleterious impact on cardiovascular target organ damage, PA is considered to cause osteoporosis.
Patients and methods
We assessed bone turnover in a subset of 36 postmenopausal women with PA. 18 patients had unilateral PA and were treated by adrenalectomy, whereas 18 patients had bilateral PA and received mineralocorticoid receptor antagonist (MRA) therapy respectively. 18 age- and BMI-matched females served as controls. To estimate bone remodeling, we measured the bone turnover markers intact procollagen 1 N-terminal propeptide, bone alkaline phosphatase, osteocalcin and tartrate resistant acid phosphatase 5b in plasma by chemiluminescent immunoassays at time of diagnosis and one year after initiation of treatment.
Study design
Observational longitudinal cohort study.
Setting
Tertiary care hospital.
Results
Compared with controls, patients with PA had mildly elevated osteocalcin at baseline (p = 0.013), while the other bone markers were comparable between both groups. There were no differences between the unilateral and the bilateral PA subgroup. One year after initiation of MRA treatment with spironolactone bone resorption and bone formation markers had significantly decreased in patients with bilateral PA. In contrast, patients adrenalectomized because of unilateral PA showed no significant change of bone turnover markers.
Conclusion
This study shows that aldosterone excess in postmenopausal women with PA is not associated with a relevant increase of bone turnover markers at baseline. However, we observed a significant decrease of bone markers in patients treated with spironolactone, but not in patients treated by adrenalectomy.
Purpose
Pheochromocytomas and Paragangliomas (PPGL) result in chronic catecholamine excess and serious health complications. A recent study obtained a metabolic signature in plasma from PPGL patients; however, its targeted nature may have generated an incomplete picture and a broader approach could provide additional insights. We aimed to characterize the plasma metabolome of PPGL patients before and after surgery, using an untargeted approach, and to broaden the scope of the investigated metabolic impact of these tumors.
Design
A cohort of 36 PPGL patients was investigated. Blood plasma samples were collected before and after surgical tumor removal, in association with clinical and tumor characteristics.
Methods
Plasma samples were analyzed using untargeted nuclear magnetic resonance (NMR) spectroscopy metabolomics. The data were evaluated using a combination of uni- and multi-variate statistical methods.
Results
Before surgery, patients with a nonadrenergic tumor could be distinguished from those with an adrenergic tumor based on their metabolic profiles. Tyrosine levels were significantly higher in patients with high compared to those with low BMI. Comparing subgroups of pre-operative samples with their post-operative counterparts, we found a metabolic signature that included ketone bodies, glucose, organic acids, methanol, dimethyl sulfone and amino acids. Three signals with unclear identities were found to be affected.
Conclusions
Our study suggests that the pathways of glucose and ketone body homeostasis are affected in PPGL patients. BMI-related metabolite levels were also found to be altered, potentially linking muscle atrophy to PPGL. At baseline, patient metabolomes could be discriminated based on their catecholamine phenotype.
Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
(2021)
Adrenal insufficiency (AI) is a life-threatening condition requiring life-long glucocorticoid (GC) substitution therapy, as well as stress adaptation to prevent adrenal crises. The number of individuals with primary and secondary adrenal insufficiency in Europe is estimated to be 20–50/100.000. A growing number of AI cases are due to side effects of GC treatment used in different treatment strategies for cancer and to immunotherapy in cancer treatment. The benefit of hormone replacement therapy is evident but long-term adverse effects may arise due to the non-physiological GC doses and treatment regimens used. Given multiple GC replacement formulations available comprising short-acting, intermediate, long-acting and novel modified-release hydrocortisone as well as subcutaneous formulations, this review offers a concise summary on the latest therapeutic improvements for treatment of AI and prevention of adrenal crises. As availability of various glucocorticoid formulations and access to expert centers across Europe varies widely, European Reference Networks on rare endocrine conditions aim at harmonizing treatment and ensure access to specialized patient care for individual case-by-case treatment decisions. To improve the availability across Europe to cost effective oral and parenteral formulations of hydrocortisone will save lives.
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study
(2022)
Objective
Immune checkpoint inhibitors can cause various immune-related adverse events including secondary hypophysitis. We compared clinical characteristics of immunotherapy-induced hypophysitis (IIH) and primary hypophysitis (PH)
Design
Retrospective multicenter cohort study including 56 patients with IIH and 60 patients with PH.
Methods
All patients underwent extensive endocrine testing. Data on age, gender, symptoms, endocrine dysfunction, MRI, immunotherapeutic agents and autoimmune diseases were collected.
Results
Median time of follow-up was 18 months in IIH and 69 months in PH. The median time from initiation of immunotherapy to IIH diagnosis was 3 months. IIH affected males more frequently than PH (p < 0.001) and led to more impaired pituitary axes in males (p < 0.001). The distribution of deficient adenohypophysial axes was comparable between both entities, however, central hypocortisolism was more frequent (p < 0.001) and diabetes insipidus considerably less frequent in IIH (p < 0.001). Symptoms were similar except that visual impairment occurred more rarely in IIH (p < 0.001). 20 % of IIH patients reported no symptoms at all. Regarding MRI, pituitary stalk thickening was less frequent in IIH (p = 0.009). Concomitant autoimmune diseases were more prevalent in PH patients before the diagnosis of hypophysitis (p = 0.003) and more frequent in IIH during follow-up (p = 0.002).
Conclusions
Clinically, IIH and PH present with similar symptoms. Diabetes insipidus very rarely occurs in IIH. Central hypocortisolism, in contrast, is a typical feature of IIH. Preexisting autoimmunity seems not to be indicative of developing IIH.
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
(2021)
Purpose
Survival in recurrent ependymoma (EPN) depends mainly on the extent of resection achieved. When complete resection is not feasible, chemotherapy is often used to extend progression-free and overall survival. However, no consistent effect of chemotherapy on survival has been found in patients with recurrent EPN.
Methods
Systemic chemotherapeutic treatment of 138 patients enrolled in the German HIT-REZ-studies was analyzed. Survival depending on the use of chemotherapy, disease-stabilization rates (RR), duration of response (DOR) and time to progression (TTP) were estimated.
Results
Median age at first recurrence was 7.6 years (IQR: 4.0–13.6). At first recurrence, median PFS and OS were 15.3 (CI 13.3–20.0) and 36.9 months (CI 29.7–53.4), respectively. The Hazard Ratio for the use of chemotherapy in local recurrences in a time-dependent Cox-regression analysis was 0.99 (CI 0.74–1.33). Evaluable responses for 140 applied chemotherapies were analyzed, of which sirolimus showed the best RR (50%) and longest median TTP [11.51 (CI 3.98; 14.0) months] in nine patients, with the strongest impact found when sirolimus was used as a monotherapy. Seven patients with progression-free survival > 12 months after subtotal/no-resection facilitated by chemotherapy were found. No definitive survival advantage for any drug in a specific molecularly defined EPN type was found.
Conclusion
No survival advantage for the general use of chemotherapy in recurrent EPN was found. In cases with incomplete resection, chemotherapy was able to extend survival in individual cases. Sirolimus showed the best RR, DOR and TTP out of all drugs analyzed and may warrant further investigation.
Strategies to Enhance Retention in a Cohort Study Among Adults of Turkish Descent Living in Berlin
(2022)
Retention is important for statistical power and external validity in long-term cohort studies. The aims of our study were to evaluate different retention strategies within a cohort study of adults of Turkish descent in Berlin, Germany, and to compare participants and non-participants. In 2011–2012, a population-based study was conducted among adults of Turkish descent to primarily examine recruitment strategies. 6 years later, the participants were re-contacted and invited to complete a self-report questionnaire regarding their health status, health care utilization, and satisfaction with medical services. The retention strategy comprised letters in both German and Turkish, phone calls, and home visits (by bilingual staff). We calculated the response rate and retention rate, using definitions of the American Association for Public Opinion Research, as well as the relative retention rate for each level of contact. Associations of baseline recruitment strategy, sociodemographic, migration-related and health-related factors with retention were investigated by logistic regression analysis. Of 557 persons contacted, 249 (44.7%) completed the questionnaire. This was 50.1% of those whose contact information was available. The relative retention rate was lowest for phone calls (8.9%) and highest for home visits (18.4%). Participants were more often non-smokers and German citizens than non-participants. For all remaining factors, no association with retention was found. In this study, among adults of Turkish descent, the retention rate increased considerably with every additional level of contact. Implementation of comprehensive retention strategies provided by culturally matched study personnel may lead to higher validity and statistical power in studies on migrant health issues.
Purpose
Biallelic pathogenic NBAS variants manifest as a multisystem disorder with heterogeneous clinical phenotypes such as recurrent acute liver failure, growth retardation, and susceptibility to infections. This study explores how NBAS-associated disease affects cells of the innate and adaptive immune system.
Methods
Clinical and laboratory parameters were combined with functional multi-parametric immunophenotyping methods in fifteen NBAS-deficient patients to discover possible alterations in their immune system.
Results
Our study revealed reduced absolute numbers of mature CD56dim natural killer (NK) cells. Notably, the residual NK cell population in NBAS-deficient patients exerted a lower potential for activation and degranulation in response to K562 target cells, suggesting an NK cell–intrinsic role for NBAS in the release of cytotoxic granules. NBAS-deficient NK cell activation and degranulation was normalized upon pre-activation by IL-2 in vitro, suggesting that functional impairment was reversible. In addition, we observed a reduced number of naïve B cells in the peripheral blood associated with hypogammaglobulinemia.
Conclusion
In summary, we demonstrate that pathogenic biallelic variants in NBAS are associated with dysfunctional NK cells as well as impaired adaptive humoral immunity.
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
(2021)
The aim of the current review was to provide a new, in-depth insight into possible pharmacological targets of amantadine to pave the way to extending its therapeutic use to further indications beyond Parkinson’s disease symptoms and viral infections. Considering amantadine’s affinities in vitro and the expected concentration at targets at therapeutic doses in humans, the following primary targets seem to be most plausible: aromatic amino acids decarboxylase, glial-cell derived neurotrophic factor, sigma-1 receptors, phosphodiesterases, and nicotinic receptors. Further three targets could play a role to a lesser extent: NMDA receptors, 5-HT3 receptors, and potassium channels. Based on published clinical studies, traumatic brain injury, fatigue [e.g., in multiple sclerosis (MS)], and chorea in Huntington’s disease should be regarded potential, encouraging indications. Preclinical investigations suggest amantadine’s therapeutic potential in several further indications such as: depression, recovery after spinal cord injury, neuroprotection in MS, and cutaneous pain. Query in the database http://www.clinicaltrials.gov reveals research interest in several further indications: cancer, autism, cocaine abuse, MS, diabetes, attention deficit-hyperactivity disorder, obesity, and schizophrenia.
Mit der Entdeckung altersabhängiger epigenetischer Veränderungen, der DNA-Methylierung (DNAm), hat sich eine neue Möglichkeit aufgezeigt, das Alter eines Individuums zu schätzen. Die Methode wurde intensiv erforscht und ihre Anwendung in der forensischen Fallarbeit durch die Aktualisierung des § 81e der Strafprozessordnung (StPO) in Deutschland reguliert. Zur Untersuchung des DNAm-Grades müssen neue Techniken etabliert und validiert werden. Dies macht die Prüfung der Vergleichbarkeit von Messergebnissen aus verschiedenen forensischen Laboren erforderlich.
Hierzu führte die Arbeitsgruppe „Molekulare Altersschätzung“ der Deutschen Gesellschaft für Rechtsmedizin (DGRM) im Winter 2019/2020 den 2. Ringversuch (RV) zur quantitativen DNAm-Analyse mithilfe der Mini- und der Pyrosequenzierung durch. Dieser basierte auf den Erfahrungen des 1. RV 2018/2019, dessen Ergebnisse in dieser Ausgabe ebenfalls vorgestellt werden. Die aktuelle Studie umfasst Analyseergebnisse aus 12 Laboren (ingesamt 14 teilnehmende Labore), von denen einige beide Methoden angewandt haben. Zusätzlich führten 4 Labore eine Altersschätzung an den RV-Proben mit eigenen Markerkombinationen und Modellen durch. Da diese auf unterschiedlichen Referenzdaten und Markerkombinationen beruhen, erfolgte kein qualitativer Vergleich der Modelle, sondern das grundsätzliche Potenzial der Methodik wurde verdeutlicht. Ziele des RV waren die Evaluierung der Vergleichbarkeit der DNAm-Messungen und die Bewertung möglicher Einflussfaktoren, wie Extraktionsmethode und verwendetes Gerät.
Die Ergebnisse zeigen, dass sich die gemessenen DNAm-Werte der untersuchten Marker sowohl zwischen Mini- und Pyrosequenzierung als auch innerhalb der jeweiligen Methode zwischen den Laboren unterscheiden können, sodass mit Schwankungen gerechnet werden muss.
Die quantitative Analyse der relativen DNA-Methylierung gilt als eine der vielversprechendsten Methoden der molekularen Altersschätzung. Viele Studien der letzten Jahre identifizierten geeignete Positionen im Genom, deren DNA-Methylierung sich altersabhängig verändert. Für den Einsatz dieser Methode in der Routine- bzw. Fallarbeit ist es von großer Bedeutung, angewandte Analysetechniken zu validieren. Als ein Teilaspekt dieser Validierung sollte die Vergleichbarkeit der Analyseergebnisse zur DNA-Methylierung mithilfe der Mini- und Pyrosequenzierung zwischen verschiedenen Laboren evaluiert werden. Die Arbeitsgruppe „Molekulare Altersschätzung“ der Deutschen Gesellschaft für Rechtsmedizin (DGRM) führte hierzu den ersten, technischen Ringversuch durch, der 4 Positionen in den Genen PDE4C, EDARADD, SST und KLF14 umfasste. Diese Marker waren in vorangegangenen Studien als altersabhängige Biomarker charakterisiert worden. Am Ringversuch nahmen 12 Labore teil, wobei jedes die Wahl zwischen der Minisequenzierung und/oder der Pyrosequenzierung für die quantitative Methylierungsanalyse hatte. Jedem teilnehmenden Labor wurden Blut- und Speichelproben von 3 Personen unterschiedlichen Alters übersandt. Die Wahl der Reagenzien für die Probenbearbeitung wurde den Teilnehmern freigestellt.
Die Ergebnisse der Minisequenzierung zeigten systematische Abweichungen zwischen den Laboren, die am ehesten auf die Verwendung unterschiedlicher Reagenzien und Analyseplattformen zurückzuführen sein können. Die Resultate der Pyrosequenzierung hingegen wiesen nicht auf systematische Abweichungen zwischen den Laboren hin, hier zeigte sich jedoch die Tendenz einer markerabhängigen Abweichung. Darüber hinaus konnten Unterschiede hinsichtlich technischer Probleme zwischen Laboren mit mehr Erfahrung in der jeweiligen Sequenzierungsmethode und Laboren mit weniger Erfahrung festgestellt werden. Sowohl die Beobachtung von systematischen als auch die von markerabhängigen Abweichungen lässt den Schluss zu, dass eine Übertragung von Analysemethoden zwischen Laboren grundsätzlich möglich ist, eine Anpassung des jeweiligen Modells zur Altersschätzung jedoch notwendig sein kann.
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
The mechanisms behind carbon dioxide (CO2) dependency in non-autotrophic bacterial isolates are unclear. Here we show that the Staphylococcus aureus mpsAB operon, known to play a role in membrane potential generation, is crucial for growth at atmospheric CO2 levels. The genes mpsAB can complement an Escherichia coli carbonic anhydrase (CA) mutant, and CA from E. coli can complement the S. aureus delta-mpsABC mutant. In comparison with the wild type, S. aureus mps mutants produce less hemolytic toxin and are less virulent in animal models of infection. Homologs of mpsA and mpsB are widespread among bacteria and are often found adjacent to each other on the genome. We propose that MpsAB represents a dissolved inorganic carbon transporter, or bicarbonate concentrating system, possibly acting as a sodium bicarbonate cotransporter.
Traumatic spinal cord injuries result in impairment or even complete loss of motor, sensory and autonomic functions. Recovery after complete spinal cord injury is very limited even in animal models receiving elaborate combinatorial treatments. Recently, we described an implantable microsystem (microconnector) for low-pressure re-adaption of severed spinal stumps in rat. Here we investigate the long-term structural and functional outcome following microconnector implantation after complete spinal cord transection. Re-adaptation of spinal stumps supports formation of a tissue bridge, glial and vascular cell invasion, motor axon regeneration and myelination, resulting in partial recovery of motor-evoked potentials and a thus far unmet improvement of locomotor behaviour. The recovery lasts for at least 5 months. Despite a late partial decline, motor recovery remains significantly superior to controls. Our findings demonstrate that microsystem technology can foster long-lasting functional improvement after complete spinal injury, providing a new and effective tool for combinatorial therapies.
The NEDD8-activating enzyme (NAE) inhibitor MLN4924 inhibits cullin-RING ubiquitin ligase complexes including the SKP1-cullin-F-box E3 ligase βTrCP. MLN4924 therefore inhibits also the βTrCP-dependent activation of the classical and the alternative NFĸB pathway. In this work, we found that a subgroup of multiple myeloma cell lines (e.g., RPMI-8226, MM.1S, KMS-12BM) and about half of the primary myeloma samples tested are sensitized to TNF-induced cell death by MLN4924. This correlated with MLN4924-mediated inhibition of TNF-induced activation of the classical NFκB pathway and reduced the efficacy of TNF-induced TNFR1 signaling complex formation. Interestingly, binding studies revealed a straightforward correlation between cell surface TNFR1 expression in multiple myeloma cell lines and their sensitivity for MLN4924/TNF-induced cell death. The cell surface expression levels of TNFR1 in the investigated MM cell lines largely correlated with TNFR1 mRNA expression. This suggests that the variable levels of cell surface expression of TNFR1 in myeloma cell lines are decisive for TNF/MLN4924 sensitivity. Indeed, introduction of TNFR1 into TNFR1-negative TNF/MLN4924-resistant KMS-11BM cells, was sufficient to sensitize this cell line for TNF/MLN4924-induced cell death. Thus, MLN4924 might be especially effective in myeloma patients with TNFR1+ myeloma cells and a TNFhigh tumor microenvironment.
Skeletal dysplasia with multiple dislocations are severe disorders characterized by dislocations of large joints and short stature. The majority of them have been linked to pathogenic variants in genes encoding glycosyltransferases, sulfotransferases or epimerases required for glycosaminoglycan synthesis. Using exome sequencing, we identify homozygous mutations in SLC10A7 in six individuals with skeletal dysplasia with multiple dislocations and amelogenesis imperfecta. SLC10A7 encodes a 10-transmembrane-domain transporter located at the plasma membrane. Functional studies in vitro demonstrate that SLC10A7 mutations reduce SLC10A7 protein expression. We generate a Slc10a7−/− mouse model, which displays shortened long bones, growth plate disorganization and tooth enamel anomalies, recapitulating the human phenotype. Furthermore, we identify decreased heparan sulfate levels in Slc10a7−/− mouse cartilage and patient fibroblasts. Finally, we find an abnormal N-glycoprotein electrophoretic profile in patient blood samples. Together, our findings support the involvement of SLC10A7 in glycosaminoglycan synthesis and specifically in skeletal development.
Surgical extrusion is a recognised treatment option for teeth that have insufficient coronal tooth structure remaining due to deep caries, resorption or traumatic injury. However, the technique has not been widely adopted, arguably because extraction of a severely compromised tooth may be difficult to achieve in a gentle and predictable way. In this paper, we present our novel approach to surgical extrusion and subsequent management of teeth using a vertical extraction system (Benex), which has become the method of choice in the authors' practice for many teeth that would otherwise be deemed unrestorable. We describe the clinical procedure in detail and discuss the advantages and disadvantages compared to alternative approaches, including surgical crown lengthening and orthodontic extrusion.
C9ORF72 mutations are the most common cause of familial frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). MRI studies have investigated structural changes in C9ORF72-associated FTLD (C9FTLD) and provided first insights about a prominent involvement of the thalamus and the cerebellum. Our multicenter, 18F-fluorodeoxyglucose positron-emission tomography study of 22 mutation carriers with FTLD, 22 matched non-carriers with FTLD, and 23 cognitively healthy controls provided valuable insights into functional changes in C9FTLD: compared to non-carriers, mutation carriers showed a significant reduction of glucose metabolism in both thalami, underscoring the key role of the thalamus in C9FTLD. Thalamic metabolism did not correlate with disease severity, duration of disease, or the presence of psychotic symptoms. Against our expectations we could not demonstrate a cerebellar hypometabolism in carriers or non-carriers. Future imaging and neuropathological studies in large patient cohorts are required to further elucidate the central role of the thalamus in C9FTLD.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects 1 in ~350 individuals. Genetic association studies have established ALS as a multifactorial disease with heritability estimated at ~61%, and recent studies show a prominent role for rare variation in its genetic architecture. To identify rare variants associated with disease onset we performed exome array genotyping in 4,244 cases and 3,106 controls from European cohorts. In this largest exome-wide study of rare variants in ALS to date, we performed single-variant association testing, gene-based burden, and exome-wide individual set-unique burden (ISUB) testing to identify single or aggregated rare variation that modifies disease risk. In single-variant testing no variants reached exome-wide significance, likely due to limited statistical power. Gene-based burden testing of rare non-synonymous and loss-of-function variants showed NEK1 as the top associated gene. ISUB analysis did not show an increased exome-wide burden of deleterious variants in patients, possibly suggesting a more region-specific role for rare variation. Complete summary statistics are released publicly. This study did not implicate new risk loci, emphasizing the immediate need for future large-scale collaborations in ALS that will expand available sample sizes, increase genome coverage, and improve our ability to detect rare variants associated to ALS.
Psychiatric disorders are thought to have a complex genetic pathology consisting of interplay of common and rare variation. Traditionally, pedigrees are used to shed light on the latter only, while here we discuss the application of polygenic risk scores to also highlight patterns of common genetic risk. We analyze polygenic risk scores for psychiatric disorders in a large pedigree (n ~ 260) in which 30% of family members suffer from major depressive disorder or bipolar disorder. Studying patterns of assortative mating and anticipation, it appears increased polygenic risk is contributed by affected individuals who married into the family, resulting in an increasing genetic risk over generations. This may explain the observation of anticipation in mood disorders, whereby onset is earlier and the severity increases over the generations of a family. Joint analyses of rare and common variation may be a powerful way to understand the familial genetics of psychiatric disorders.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) imposes a significant burden on Westernized regions. The Western diet, high in salt intake, significantly contributes to disease development. However, there are a lack of data on salt literacy and salt intake among MASLD patients in Germany. Our study aims to analyze daily salt intake and salt-intake-related behavior in MASLD patients. Methods: 234 MASLD patients were prospectively included. Daily salt intake and salt-intake-related behavior were assessed via a food frequency questionnaire (FFQ—DEGS) and a salt questionnaire (SINU). Statistical analyses were performed using SPSS. Results: Mean daily salt intake was higher in men than in women (7.3 ± 5 g/d vs. 5.3 ± 4 g/d; p < 0.001). There was significant agreement between increased daily salt intake (6 g/d) and the behavioral salt index (SI) (p < 0.001). Men exhibited higher SI scores compared to women, indicating lower awareness of salt in everyday life. Multivariate analysis identified specific salt-intake-related behaviors impacting daily salt consumption. Conclusions: Our study reveals a strong link between daily salt intake and salt-intake-related behavior, highlighting sex-specific differences in an MASLD cohort. To enhance patient care in high-cardiovascular-risk populations, specific behavioral approaches may be considered, including salt awareness, to improve adherence to lifestyle changes, particularly in male patients.
To define frailty in older cancer patients, the aim of this study was to assess the geriatric status and quality of life (QoL) aspects in patients suffering from recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC) under palliative treatment. A comprehensive geriatric assessment (CGA) was performed on 21 r/m HNSCC patients at two defined assessments, and the QoL aspects and the impact of descriptive data were evaluated. The Kolmogorov–Smirnov test, Spearman’s rho correlation, and two-way mixed ANOVA were used for statistical analysis. All patients were found to be “frail”. Pain, fatigue, and the burden of illness were the highest-rated symptoms. Oral function and orofacial appearance were highly impaired. A significant impact of descriptive data on the CGA and QoL results was found (all p ≤ 0.05). Thus, the CGA results revealed high frailty, severe comorbidities, and high impairments in QoL aspects. The CGA and QoL results were negatively affected by the primary HNSCC treatment approach, the need for prosthetic treatment, and worse oral functional capacity. Therefore, frailty in r/m HNSCC patients seems to be multidimensional. The evaluation of the CGA and QoL aspects in r/m HNSCC patients can be recommended to detect special needs, organize aftercare, and improve the support for frail and vulnerable cancer patients to create a multidisciplinary treatment approach.
Herpesviruses have mastered host cell modulation and immune evasion to augment productive infection, life-long latency and reactivation thereof 1,2. A long appreciated, yet elusively defined relationship exists between the lytic-latent switch and viral non-coding RNAs 3,4. Here, we identify miRNA-mediated inhibition of miRNA processing as a thus far unknown cellular mechanism that human herpesvirus 6A (HHV-6A) exploits to disrupt mitochondrial architecture, evade intrinsic host defense and drive the lytic-latent switch. We demonstrate that virus-encoded miR-aU14 selectively inhibits the processing of multiple miR-30 family members by direct interaction with the respective pri-miRNA hairpin loops. Subsequent loss of miR-30 and activation of the miR-30/p53/Drp1 axis triggers a profound disruption of mitochondrial architecture. This impairs induction of type I interferons and is necessary for both productive infection and virus reactivation. Ectopic expression of miR-aU14 triggered virus reactivation from latency, identifying viral miR-aU14 as a readily drugable master regulator of the herpesvirus lytic-latent switch. Our results show that miRNA-mediated inhibition of miRNA processing represents a generalized cellular mechanism that can be exploited to selectively target individual members of miRNA families. We anticipate that targeting miR-aU14 provides exciting therapeutic options for preventing herpesvirus reactivations in HHV-6-associated disorders.
The N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium A belongs to a novel class of natural products with potent antiprotozoal activity. Its effects on tumor cells, however, have not yet been explored. We demonstrate the antitumor activity of ancistrocladinium A in multiple myeloma (MM), a yet incurable blood cancer that represents a model disease for adaptation to proteotoxic stress. Viability assays showed a potent apoptosis-inducing effect of ancistrocladinium A in MM cell lines, including those with proteasome inhibitor (PI) resistance, and in primary MM cells, but not in non-malignant blood cells. Concomitant treatment with the PI carfilzomib or the histone deacetylase inhibitor panobinostat strongly enhanced the ancistrocladinium A-induced apoptosis. Mass spectrometry with biotinylated ancistrocladinium A revealed significant enrichment of RNA-splicing-associated proteins. Affected RNA-splicing-associated pathways included genes involved in proteotoxic stress response, such as PSMB5-associated genes and the heat shock proteins HSP90 and HSP70. Furthermore, we found strong induction of ATF4 and the ATM/H2AX pathway, both of which are critically involved in the integrated cellular response following proteotoxic and oxidative stress. Taken together, our data indicate that ancistrocladinium A targets cellular stress regulation in MM and improves the therapeutic response to PIs or overcomes PI resistance, and thus may represent a promising potential therapeutic agent.
Background and objectives: Cartilage surgery constitutes a standard intervention in foot and ankle procedures. Currently, there is a lack of epidemiological data on its frequency, age distribution, and surgical options for cartilage surgery. This study aimed to investigate the current landscape of cartilage surgery in Germany and identify the most common procedures from an epidemiological standpoint. Materials and methods: Medical billing and reporting data from the Federal Statistical Office of Germany, encompassing the period 2006–2020, was examined, including all foot and ankle cartilage surgical procedures (summarized under OPS codes 5-812 and 5-801). The dataset incorporated information on the affected joint, patient age and sex, and surgery type. Each surgical procedure was categorized as “debridement”, “regeneration” or “refixation”. Linear and nonlinear regression analyses were employed, with a statistical significance threshold of 0.05. Results: From the total of 136,501 procedures conducted during the study period, the most frequently performed interventions were microfracture (58,252) and chondroplasty (56,135), and thus, debridement procedures were in the leading position. The use of acellular membranes was the most used regenerative technique (n = 11,414). At the ankle joint, interventions were mostly arthroscopic and in men, while foot cartilage surgeries were preferably performed via open surgery and mostly in women. Age distribution analysis revealed two primary peaks: the first in the 20–25-year-old group (ankle and foot) and the second in the 45–50-year-old group (ankle) and 55–60-year-old group (foot). Refixation and regenerative procedures were more frequent among younger individuals, while debriding procedures were more frequent among older individuals. Regenerative procedures, particularly in the ankle, significantly increased over time. Conclusions: Cartilage surgery of the foot and ankle was common, with two primary age groups predominantly affected. Notably, recent years have witnessed a considerable rise in cartilage regenerative procedures.
The use of bone-cement-enforced osteosynthesis is a growing topic in trauma surgery. In this context, drillability is a desirable feature for cements that can improve fracture stability, which most of the available cement systems lack. Therefore, in this study, we evaluated a resorbable and drillable magnesium-phosphate (MgP)-based cement paste considering degradation behavior and biocompatibility in vivo. Two different magnesium-phosphate-based cement (MPC) pastes with different amounts of phytic acid (IP 6) as setting retarder (MPC 22.5 and MPC 25) were implanted in an orthotopic defect model of the lateral femoral condyle of New Zealand white rabbits for 6 weeks. After explantation, their resorption behavior and material characteristics were evaluated by means of X-ray diffraction (XRD), porosimetry measurement, histological staining, peripheral quantitative computed tomography (pQCT), cone-beam computed tomography (CBCT) and biomechanical load-to-failure tests. Both cement pastes displayed comparable results in mechanical strength and resorption kinetics. Bone-contact biocompatibility was excellent without any signs of inflammation. Initial resorption and bone remodeling could be observed. MPC pastes with IP 6 as setting retardant have the potential to be a valuable alternative in distinct fracture patterns. Drillability, promising resorption potential and high mechanical strength confirm their suitability for use in clinical routine.
In heart failure and atrial fibrillation, a persistent Na\(^+\) current (I\(_{NaL}\)) exerts detrimental effects on cellular electrophysiology and can induce arrhythmias. We have recently shown that Na\(_V\)1.8 contributes to arrhythmogenesis by inducing a I\(_{NaL}\). Genome-wide association studies indicate that mutations in the SCN10A gene (Na\(_V\)1.8) are associated with increased risk for arrhythmias, Brugada syndrome, and sudden cardiac death. However, the mediation of these Na\(_V\)1.8-related effects, whether through cardiac ganglia or cardiomyocytes, is still a subject of controversial discussion. We used CRISPR/Cas9 technology to generate homozygous atrial SCN10A-KO-iPSC-CMs. Ruptured-patch whole-cell patch-clamp was used to measure the I\(_{NaL}\) and action potential duration. Ca\(^{2+}\) measurements (Fluo 4-AM) were performed to analyze proarrhythmogenic diastolic SR Ca\(^{2+}\) leak. The I\(_{NaL}\) was significantly reduced in atrial SCN10A KO CMs as well as after specific pharmacological inhibition of Na\(_V\)1.8. No effects on atrial APD\(_{90}\) were detected in any groups. Both SCN10A KO and specific blockers of Na\(_V\)1.8 led to decreased Ca\(^{2+}\) spark frequency and a significant reduction of arrhythmogenic Ca\(^{2+}\) waves. Our experiments demonstrate that Na\(_V\)1.8 contributes to I\(_{NaL}\) formation in human atrial CMs and that Na\(_V\)1.8 inhibition modulates proarrhythmogenic triggers in human atrial CMs and therefore Na\(_V\)1.8 could be a new target for antiarrhythmic strategies.
Colorectal Cancer (CRC) is the third most common cancer in the US. The majority of CRC cases are due to deregulated WNT-signalling pathway. These alterations are mainly caused by mutations in the tumour suppressor gene APC or in CTNNB1, encoding the key effector protein of this pathway, β-Catenin. In canonical WNT-signalling, β-Catenin activates the transcription of several target genes, encoding for proteins involved in proliferation, such as MYC, JUN and NOTCH. Being such a critical regulator of these proto-oncogenes, the stability of β-Catenin is tightly regulated by the Ubiquitin-Proteasome System. Several E3 ligases that ubiquitylate and degrade β-Catenin have been described in the past, but the antagonists, the deubiquitylases, are still unknown. By performing an unbiased siRNA screen, the deubiquitylase USP10 was identified as a de novo positive regulator of β-Catenin stability in CRC derived cells. USP10 has previously been shown in the literature to regulate both mutant and wild type TP53 stability, to deubiquitylate NOTCH1 in endothelial cells and to be involved in the regulation of AMPKα signalling. Overall, however, its role in colorectal tumorigenesis remains controversial. By analysing publicly available protein and gene expression data from colorectal cancer patients, we have shown that USP10 is strongly upregulated or amplified upon transformation and that its expression correlates positively with CTNNB1 expression. In contrast, basal USP10 levels were found in non-transformed tissues, but surprisingly USP10 is upregulated in intestinal stem cells. Endogenous interaction studies in CRC-derived cell lines, with different extend of APCtruncation, revealed an APC-dependent mode of action for both proteins. Furthermore, by utilising CRISPR/Cas9, shRNA-mediated knock-down and overexpression of USP10, we could demonstrate a regulation of β-Catenin stability by USP10 in CRC cell lines. It is widely excepted that 2D cell culture systems do not reflect complexity, architecture and heterogeneity and are therefore not suitable to answer complex biological questions. To overcome this, we established the isolation, cultivation and genetically modification of murine intestinal organoids and utilised this system to study Usp10s role ex vivo. By performing RNA sequencing, dependent on different Usp10 levels, we were able to recapitulate the previous findings and demonstrated Usp10 as important regulator of β-dependent regulation of stem cell homeostasis. Since genetic depletion of USP10 resulted in down-regulation of β-Catenin-dependent transcription, therapeutic intervention of USP10 in colorectal cancer was also investigated. Commercial and newly developed inhibitors were tested for their efficacy against USP10, but failed to significantly inhibit USP10 activity in colorectal cancer cells. To validate the findings from this work also in vivo, development of a novel mouse model for colorectal cancer has begun. By combining CRISPR/Cas9 and classical genetic engineering with viral injection strategies, WT and genetically modified mice could be transformed and, at least in some animals, intestinal lesions were detectable at the microscopic level. The inhibition of USP10, which we could describe as a de novo tumour-specific regulator of β-Catenin, could become a new therapeutic strategy for colorectal cancer patients.
In March 2020, Germany imposed a nationwide lockdown to curb the spread of COVID-19, prompting questions about the impact on the incidence of common fractures. This study examined 15 fracture types in pre-outbreak (2010–2019) and post-outbreak (2020–2021) periods, using data categorized by age (18–64 years, 65 years) and sex (male, female). Linear regression assessed annual growth rates, and mean fracture numbers were compared across periods for significant differences. Results indicated a positive correlation between fracture incidence rates and time for various types, such as cervical, thoracic, lumbar, and pelvic spine fractures, rib fractures, femoral neck, pertrochanteric femur, femoral shaft, and ankle fractures. Frequencies of proximal humerus, distal radius, femoral neck, pertrochanteric femur, femoral shaft, and ankle fractures in 2020 and 2021 were within predicted ranges from previous years. However, rib fractures and spinal fractures (cervical, thoracic, lumbar, and pelvic spine) occurred less frequently during this time. Notably, this study found a consistent decline in most fracture types for individuals aged 18–64 after the pandemic’s onset, while the fracture incidence of hip fractures, often referred to as fragility fractures, for those over 65 remained unchanged. Fibula fractures showed the most considerable decrease in both age groups. In conclusion, the COVID-19 pandemic substantially impacted fracture incidence, with lower rates among individuals under 65 and unchanged fragility fractures in the elderly population.
Recent dissection studies resulted in the introduction of the term “chiasma antebrachii”, which represents an intersection of the flexor digitorum superficialis (FDS) tendons for digits 2 and 3 in the distal third of the forearm. This retrospective investigation aimed to provide an MRI-based morphologic analysis of the chiasma antebrachii. In 89 patients (41 women, 39.3 ± 21.3 years), MRI examinations of the forearm (2010–2021) were reviewed by two radiologists, who evaluated all studies for the presence and length of the chiasma as well as its distance from the distal radioulnar and elbow joint. The chiasma antebrachii was identified in the distal third of the forearm in 88 patients (98.9%), while one intersection was located more proximally in the middle part. The chiasma had a median length of 28 mm (interquartile range: 24–35 mm). Its distances to the distal radioulnar and elbow joint were 16 mm (8–25 mm) and 215 mm (187–227 mm), respectively. T1-weighted post-contrast sequences were found to be superior to T2- or proton-density-weighted sequences in 71 cases (79.8%). To conclude, the chiasma antebrachii is part of the standard FDS anatomy. Knowledge of its morphology is important, e.g., in targeted injections of therapeutics or reconstructive surgery.
Ultra-high-resolution photon-counting detector CT arthrography of the ankle: a feasibility study
(2023)
This study was designed to investigate the image quality of ultra-high-resolution ankle arthrography employing a photon-counting detector CT. Bilateral arthrograms were acquired in four cadaveric specimens with full-dose (10 mGy) and low-dose (3 mGy) scan protocols. Three convolution kernels with different spatial frequencies were utilized for image reconstruction (ρ\(_{50}\); Br98: 39.0, Br84: 22.6, Br76: 16.5 lp/cm). Seven radiologists subjectively assessed the image quality regarding the depiction of bone, hyaline cartilage, and ligaments. An additional quantitative assessment comprised the measurement of noise and the computation of contrast-to-noise ratios (CNR). While an optimal depiction of bone tissue was achieved with the ultra-sharp Br98 kernel (S ≤ 0.043), the visualization of cartilage improved with lower modulation transfer functions at each dose level (p ≤ 0.014). The interrater reliability ranged from good to excellent for all assessed tissues (intraclass correlation coefficient ≥ 0.805). The noise levels in subcutaneous fat decreased with reduced spatial frequency (p < 0.001). Notably, the low-dose Br76 matched the CNR of the full-dose Br84 (p 0.999) and superseded Br98 (p < 0.001) in all tissues. Based on the reported results, a photon-counting detector CT arthrography of the ankle with an ultra-high-resolution collimation offers stellar image quality and tissue assessability, improving the evaluation of miniscule anatomical structures. While bone depiction was superior in combination with an ultra-sharp convolution kernel, soft tissue evaluation benefited from employing a lower spatial frequency.
Vestibular schwannoma (VS) are benign cranial nerve sheath tumors of the vestibulocochlear nerve. Their incidence is mostly sporadic, but they can also be associated with NF2-related schwannomatosis (NF2), a hereditary tumor syndrome. Metastasis associated in colon cancer 1 (MACC1) is known to contribute to angiogenesis, cell growth, invasiveness, cell motility and metastasis of solid malignant cancers. In addition, MACC1 may be associated with nonsyndromic hearing impairment. Therefore, we evaluated whether MACC1 may be involved in the pathogenesis of VS. Sporadic VS, recurrent sporadic VS, NF2-associated VS, recurrent NF2-associated VS and healthy vestibular nerves were analyzed for MACC1 mRNA and protein expression by quantitative polymerase chain reaction and immunohistochemistry. MACC1 expression levels were correlated with the patients’ clinical course and symptoms. MACC1 mRNA expression was significantly higher in sporadic VS compared to NF2-associated VS (p < 0.001). The latter expressed similar MACC1 concentrations as healthy vestibular nerves. Recurrent tumors resembled the MACC1 expression of the primary tumors. MACC1 mRNA expression was significantly correlated with deafness in sporadic VS patients (p = 0.034). Therefore, MACC1 might be a new molecular marker involved in VS pathogenesis.
Das maligne Melanom, eine der seltensten, aber gleichzeitig auch die tödlichste dermatologische Malignität, gekennzeichnet durch die Neigung zu einer frühen Metastasierung sowie die rasche Entwicklung von Therapieresistenzen, zählt zu den Tumorentitäten mit dem höchsten Anstieg der Inzidenz weltweit. Mausmodelle werden häufig verwendet, um die Melanomagenese zu erforschen und neue effektive therapeutische Strategien zu entwickeln, spiegeln die menschliche Physiologie allerdings nur unzureichend wider. In zweidimensionalen (2D) Zellkulturen mangelt es dagegen an wichtigen Komponenten der Mikroumgebung des Tumors und dem dreidimensionalen Gewebekontext. Um dieses Manko zu beheben und die Entwicklung von auf den Menschen übertragbaren Tumormodellen in der onkologischen Forschung voranzutreiben, wurde als Alternative zu Zellkulturen und Tierversuchen humane organotypische dreidimensionale (3D) Melanom-Modelle als in vitro Testsystem für die Bewertung der Wirksamkeit von anti-Tumor Therapeutika entwickelt.
Im Zuge dieser Arbeit konnte das in vitro Melanom-Modell entscheidend weiterentwickelt werden. So konnten Modelle unterschiedlichster Komplexität etabliert werden, wobei abhängig von der Fragestellung einfachere epidermale bis hin zu unterschiedlich komplexen Vollhautmodellen Anwendung finden. Durch Simulation der Tumor-Mikroumgebung eignen sich diese zur präklinischen Validierung neuer Tumor-Therapeutika, sowie der Erforschung pathologischer Vorgänge, von der Tumor-Formierung bis zur Metastasierung. Zudem konnten erfolgreich unterschiedlichste humane Melanomzelllinien ins Modell integriert werden; dadurch, dass sich diese durch ihre Treibermutationen, die zur Krankheitsentstehung beitragen, unterscheiden, stellen sie unterschiedliche Ansprüche an potentielle therapeutische Angriffspunkte und ermöglichen das Widerspiegeln vieler Melanom-Subtypen im Modell. Ferner ist es möglich, verschiedene Stadien der Tumor-Entwicklung über die Zugabe von Melanomzellen in Einzelsuspension bzw. von Melanom-Sphäroiden widerzuspiegeln. Es konnte für bestimmte Therapie-Ansätze, wie zielgerichtete Therapien, z.B. die Gabe von sich in der Klinik im Einsatz befindlicher BRAF-/MEK-Inhibitoren, gezeigt werden, dass sich die etablierten Modelle hervorragend als präklinische Testsysteme zur Wirksamkeitsbewertung eignen. Zudem bieten sich einzigartige Möglichkeiten, um die Interaktion humaner Tumorzellen und gesunder Zellen in einem Gewebeverband zu untersuchen. Ferner konnten drei neue technische Analyse-Verfahren zur nicht-invasiven Detektion der Tumor- Pro- und Regression, Beurteilung der Wirksamkeit von potenziellen Anti-Tumor-Therapien sowie der Evaluierung des Tumor-Metabolismusses implementiert werden. Perspektivisch ermöglichen immun-kompetente Melanom-Modelle die Austestung neuer Immun- und Zelltherapien in einem voll humanen System; gleichzeitig leisten die etablierten Modelle einen signifikanten Beitrag zur Reduktion von Tierexperimenten.
Multiple myeloma (MM) frequently induces persisting osteolytic manifestations despite hematologic treatment response. This study aimed to establish a biometrically valid study endpoint for bone remineralization through quantitative and qualitative analyses in sequential CT scans. Twenty patients (seven women, 58 ± 8 years) with newly diagnosed MM received standardized induction therapy comprising the anti-SLAMF7 antibody elotuzumab, carfilzomib, lenalidomide, and dexamethasone (E-KRd). All patients underwent whole-body low-dose CT scans before and after six cycles of E-KRd. Two radiologists independently recorded osteolytic lesion sizes, as well as the presence of cortical destruction, pathologic fractures, rim and trabecular sclerosis. Bland–Altman analyses and Krippendorff’s α were employed to assess inter-reader reliability, which was high for lesion size measurement (standard error 1.2 mm) and all qualitative criteria assessed (α ≥ 0.74). After six cycles of E-KRd induction, osteolytic lesion size decreased by 22% (p < 0.001). While lesion size response did not correlate with the initial lesion size at baseline imaging (Pearson’s r = 0.144), logistic regression analysis revealed that the majority of responding osteolyses exhibited trabecular sclerosis (p < 0.001). The sum of osteolytic lesion sizes on sequential CT scans defines a reliable study endpoint to characterize bone remineralization. Patient level response is strongly associated with the presence of trabecular sclerosis.
The tumor microenvironment (TME) in breast cancer is determined by the complex crosstalk of cancer cells with adipose tissue-inherent cells such as adipose-derived stromal cells (ASCs) and adipocytes resulting from the local invasion of tumor cells in the mammary fat pad. This leads to heterotypic cellular contacts between these cell types. To adequately mimic the specific cell-to-cell interaction in an in vivo-like 3D environment, we developed a direct co-culture spheroid model using ASCs or differentiated adipocytes in combination with MDA-MB-231 or MCF-7 breast carcinoma cells. Co-spheroids were generated in a well-defined and reproducible manner in a high-throughput process. We compared the expression of the tumor-promoting chemokine CCL5 and its cognate receptors in these co-spheroids to indirect and direct standard 2D co-cultures. A marked up-regulation of CCL5 and in particular the receptor CCR1 with strict dependence on cell–cell contacts and culture dimensionality was evident. Furthermore, the impact of direct contacts between ASCs and tumor cells and the involvement of CCR1 in promoting tumor cell migration were demonstrated. Overall, these results show the importance of direct 3D co-culture models to better represent the complex tumor–stroma interaction in a tissue-like context. The unveiling of tumor-specific markers that are up-regulated upon direct cell–cell contact with neighboring stromal cells, as demonstrated in the 3D co-culture spheroids, may represent a promising strategy to find new targets for the diagnosis and treatment of invasive breast cancer.
Background: Aging increases individual susceptibility to falls and injuries, suggesting poorer adaptation of balance responses to perturbation during locomotion, which can be measured with the locomotor adaptation task (LAT). However, it is unclear how aging and lifestyle factors affect these responses during walking. Hence, the present study investigates the relationship between balance and lifestyle factors during the LAT in healthy individuals across the adult lifespan using a correlational design. Methods: Thirty participants aged 20–78 years performed an LAT on a split-belt treadmill (SBT). We evaluated the magnitude and rate of adaptation and deadaptation during the LAT. Participants reported their lifelong physical and cognitive activity. Results: Age positively correlated with gait-line length asymmetry at the late post-adaptation phase (p = 0.007). These age-related effects were mediated by recent physical activity levels (p = 0.040). Conclusion: Our results confirm that locomotor adaptive responses are preserved in aging, but the ability to deadapt newly learnt balance responses is compromised with age. Physical activity mediates these age-related effects. Therefore, gait symmetry post-adaptation could effectively measure the risk of falling, and maintaining physical activity could protect against declines in balance.
Background: Monitoring the vital signs of delirious patients in an intensive care unit (ICU) is challenging, as they might (un-)intentionally remove devices attached to their bodies. In mock-up scenarios, we systematically assessed whether a motion detector (MD) attached to the bed may help in identifying emergencies. Methods: We recruited 15 employees of the ICU and equipped an ICU bed with an MD (IRON Software GmbH, Grünwald, Germany). Participants were asked to replay 22 mock-up scenes of one-minute duration each: 12 scenes with movements and 10 without movements, of which 5 were emergency scenes (“lying dead-still, with no or very shallow breathing”). Blinded recordings were presented to an evaluation panel consisting of an experienced ICU nurse and a physician, who was asked to assess and rate the presence of motions. Results: Fifteen participants (nine women; 173 ± 7.0 cm; 78 ± 19 kg) joined the study. In total, 286 out of 330 scenes (86.7%) were rated correctly. Ratings were false negative (FN: “no movements detected, but recorded”) in 7 out of 180 motion scenes (3.9%). Ratings were false positive (FP: “movements detected, but not recorded”) in 37 out of 150 scenes (24.7%), more often in men than women (26 out of 60 vs. 11 out of 90, respectively; p < 0.001). Of note, in 16 of these 37 FP-rated scenes, a vibrating mobile phone was identified as a potential confounder. The emergency scenes were correctly rated in 64 of the 75 runs (85.3%); 10 of the 11 FP-rated scenes occurred in male subjects. Conclusions: The MD allowed for identifying motions of test subjects with high sensitivity (96%) and acceptable specificity (75%). Accuracy might increase further if activities are recorded continuously under real-world conditions.
The expression of the MYC proto-oncogene is elevated in a large proportion of patients with pancreatic ductal adenocarcinoma (PDAC). Previous findings in PDAC have shown that this increased MYC expression mediates immune evasion and promotes S-phase progression. How these functions are mediated and whether a downstream factor of MYC mediates these functions has remained elusive. Recent studies identifying the MYC interactome revealed a complex network of interaction partners, highlighting the need to identify the oncogenic pathway of MYC in an unbiased manner.
In this work, we have shown that MYC ensures genomic stability during S-phase and prevents transcription-replication conflicts. Depletion of MYC and inhibition of ATR kinase showed a synergistic effect to induce DNA damage. A targeted siRNA screen targeting downstream factors of MYC revealed that PAF1c is required for DNA repair and S-phase progression. Recruitment of PAF1c to RNAPII was shown to be MYC dependent. PAF1c was shown to be largely dispensable for cell proliferation and regulation of MYC target genes.
Depletion of CTR9, a subunit of PAF1c, caused strong tumor regression in a pancreatic ductal adenocarcinoma model, with long-term survival in a subset of mice. This effect was not due to induction of DNA damage, but to restoration of tumor immune surveillance.
Depletion of PAF1c resulted in the release of RNAPII with transcription elongation factors, including SPT6, from the bodies of long genes, promoting full-length transcription of short genes. This resulted in the downregulation of long DNA repair genes and the concomitant upregulation of short genes, including MHC class I genes. These data demonstrate that a balance between long and short gene transcription is essential for tumor progression and that interference with PAF1c levels shifts this balance toward a tumor-suppressive transcriptional program. It also directly links MYC-mediated S-phase progression to immune evasion. Unlike MYC, PAF1c has a stable, known folded structure; therefore, the development of a small molecule targeting PAF1c may disrupt the immune evasive function of MYC while sparing its physiological functions in cellular growth.
(1) Background: The first-line treatment for patients with focal or segmental dystonia with a craniocervical distribution is still the intramuscular injection of botulinum neurotoxin (BoNT). However, some patients experience primary or secondary treatment failure from this potential immunogenic therapy. Deep brain stimulation (DBS) may then be used as a backup strategy in this situation. (2) Methods: Here, we reviewed the current study literature to answer a specific question regarding the efficacy and safety of the use of DBS, particularly for cervical dystonia (CD) and Meige syndrome (MS) in patients with documented treatment failure under BoNT. (3) Results: There are only two studies with the highest level of evidence in this area. Despite this clear limitation, in the context of the narrowly defined research question of this paper, it is possible to report 161 patients with CD or MS who were included in studies that were able to show a statistically significant reduction in dystonic symptoms using DBS. Safety and tolerability data appeared adequate. However, much of the information is based on retrospective observations. (4) Conclusions: The evidence base in this area is in need of further scientific investigation. Most importantly, more randomized, controlled and double-blind trials are needed, possibly including a head-to-head comparison of DBS and BoNT.
Ag- but not ZnO-nanoparticles disturb the airway epithelial barrier at subtoxic concentrations
(2023)
Inhalation is considered to be the most relevant source of human exposure to nanoparticles (NPs); however, only a few investigations have addressed the influence of exposing the respiratory mucosal barrier to subcytotoxic doses. In the nasal respiratory epithelium, cells of the mucosa represent one of the first contact points of the human organism with airborne NPs. Disruption of the epithelial barrier by harmful materials can lead to inflammation in addition to potential intrinsic toxicity of the particles. The aim of this study was to investigate whether subtoxic concentrations of zinc oxide (ZnO)- and silver (Ag)-NPs have an influence on upper airway barrier integrity. Nasal epithelial cells from 17 donors were cultured at the air–liquid interface and exposed to ZnO- and Ag-NPs. Barrier function, quantified by transepithelial electrical resistance (TEER), decreased after treatment with 10 µg/mL Ag-NPs, but FITC-dextran permeability remained stable and no change in mRNA levels of tight junction proteins and E-cadherin was detected by real-time quantitative PCR (RT-qPCR). The results indicate that subtoxic concentrations of Ag-NPs may already induce damage of the upper airway epithelial barrier in vitro. The lack of similar disruption by ZnO-NPs of similar size suggests a specific effect by Ag-NPs.
Kisspeptins (KPs, KISS1) and their receptor (KISS1R) play a pivotal role as metastasis suppressor for many cancers. Low or lost KP expression is associated with higher tumor grade, increased metastatic potential, and poor prognosis. Therefore, KP expression has prognostic relevance and correlates with invasiveness in cancers. Furthermore, KISS1R represents a very promising target for molecular imaging and therapy for KISS1R-expressing tumors. The goal of this study was to evaluate the developed KISS1-54 derivative, [\(^{68}\)Ga]KISS1-54, as a PET-imaging probe for KISS1R-expressing tumors. The NODAGA-KISS1-54 peptide was labeled by Gallium-68, and the stability of the resulting [\(^{68}\)Ga]KISS1-54 evaluated in injection solution and human serum, followed by an examination in different KISS1R-expressing tumor cell lines, including HepG2, HeLa, MDA-MB-231, MCF7, LNCap, SK-BR-3, and HCT116. Finally, [\(^{68}\)Ga]KISS1-54 was tested in LNCap- and MDA-MB-231-bearing mice, using µ-PET, assessing its potential as an imaging probe for PET. [\(^{68}\)Ga]KISS1-54 was obtained in a 77 ± 7% radiochemical yield and at a >99% purity. The [\(^{68}\)Ga]KISS1-54 cell uptake amounted to 0.6–4.4% per 100,000 cells. Moreover, the accumulation of [\(^{68}\)Ga]KISS1-54 was effectively inhibited by nonradioactive KISS1-54. In [\(^{68}\)Ga]KISS1-54-PET, KISS1R-positive LNCap-tumors were clearly visualized as compared to MDA-MB-231-tumor implant with predominantly intracellular KISS1R expression. Our first results suggest that [\(^{68}\)Ga]KISS1-54 is a promising candidate for a radiotracer for targeting KISS1R-expressing tumors via PET.
Ziel der vorliegenden Studie war es zu untersuchen, ob anhand geometrischer Merkmale der HWK im Kindesalter eine sichere individuelle Vorhersage der Morphologie der HWK zum Ende der Entwicklung möglich ist. Hierdurch könnte eine Individualisierung der CVM-Methode und somit eine Einschätzung des bereits verstrichenen Wachstums erfolgen.
Zu diesem Zweck wurden insgesamt 1377 FRS-Aufnahmen von 267 Patienten – 110 weibliche und 157 männliche – aus dem Archiv der Poliklinik für Kieferorthopädie des Universitätsklinikums Würzburg digitalisiert und untersucht. Die HWK wurden im Programm OnyxCeph (Herst.: Image Instruments GmbH) quantifiziert und die berechneten Werte mit der Software SPSS statistisch ausgewertet. Mittels linearer Regressionen wurde versucht, anhand der Morphologie der Wirbelkörper vor dem puberalen Wachstumsschub auf die Geometrie der HWK im Erwachsenenalter zu schließen. Zur Illustrierung wurden Streudiagramm und die dazugehörigen Abfolgen von Röntgenbildern dargestellt.
Eine Schätzung der Geometrie der HWK im Erwachsenenalter würde bei den separat betrachteten Parametern und bei einer gemeinsamen Betrachtung der Parameter kaum zu korrekten Einschätzungen führen.
Die Streudiagramme mit den Bilderabfolgen stützen diese These ebenfalls und illustrieren die mögliche Fehleinschätzung der Geometrie.
Die Ergebnisse der Studie zeigen erneut, dass die Geometrie der HWK im Erwachsenenalter sehr variabel ist, wie komplex die Entwicklung der HWK ist und dass anhand ihrer Geometrie im Kindesalter keine sichere Einschätzung der skelettalen Reife möglich ist.
Eine Individualisierung der CVM-Methode ist anhand der in dieser Studie untersuchten Parameter nicht möglich. Somit lässt sich schlussfolgern, dass die CVM-Methode nicht als alleinige Methode zur präzisen skelettalen Alterseinschätzung verlässlich genutzt werden kann, sondern für eine sichere Beurteilung weitere Reifeindikatoren hinzugezogen werden sollten. Allerdings sollten hierzu zusätzliche radiologische Untersuchungen, wie beispielsweise die Handröntgenaufnahme, nur dann durchgeführt werden, wenn diese dem ALARA-Prinzip entsprechen.
Adrenocortical carcinoma (ACC) represents a rare tumor entity with limited treatment options and usually rapid tumor progression in case of metastatic disease. As further treatment options are needed and ACC metastases are sensitive to external beam radiation, novel theranostic approaches could complement established therapeutic concepts. Recent developments focus on targeting adrenal cortex-specific enzymes like the theranostic twin [\(^{123/131}\)I]IMAZA that shows a good image quality and a promising therapeutic effect in selected patients. But other established molecular targets in nuclear medicine such as the C-X-C motif chemokine receptor 4 (CXCR4) could possibly enhance the therapeutic regimen as well in a subgroup of patients. The aims of this review are to give an overview of innovative radiopharmaceuticals for the treatment of ACC and to present the different molecular targets, as well as to show future perspectives for further developments since a radiopharmaceutical with a broad application range is still warranted.
Die vorliegende Studie untersuchte den Effekt von Levosimendan auf die mitochondriale Funktionen im Herzmuskel, insbesondere im Zusammenhang mit dem Ischämie/Reperfusions-Schaden. Methoden: In der Studie wurde ein retrogrades Langendorff-Modell verwendet, um die Auswirkungen von Levosimendan, dem Ischämie/Reperfusions-Schaden sowie deren Kombination auf die mitochondrialen Funktionen im Herzmuskel zu untersuchen. Dazu wurden vier verschiedene Gruppen von Rattenherzen entsprechend den experimentellen Bedingungen perfundiert, und ihre Funktionen wurden analysiert. Ergebnisse: Der Ischämie/Reperfusions-Schaden beeinträchtigte die myokardiale Ventrikelfunktion. Zusätzlich wurde eine Hypopolarisation des mithochondrialen Membranpotentials in den mit Levosimendan oder Ischämie behandelten Gruppen festgestellt. Die ATP-Synthese in den Gruppen mit Levosimendan und Ischämie war reduziert. Schlussfolgerung: Levosimendan zeigt signifikante Einflüsse auf die Atmungsfunktion der mitochondrialen Komplexe IV und V sowie auf das Membranpotential. Diese Phänomene könnten einem mito-K+ ATP-abhängigen Mechanismus zugrunde liegen. Obwohl Levosimendan während des Ischämie/Reperfusionsschadens eine protektive Wirkung hinsichtlich einer Ca2+- Überlastung aufweist, bleibt der kumulative Einfluss der beeinträchtigten ATP-Generierung auf die gesamte Myokardfunktion zu klären.
Serum liquid chromatography–tandem mass spectrometry (LC–MS/MS) steroid profiling is used for the diagnosis of adrenocortical carcinoma (ACC). Guidelines recommend endocrine work-up in addition to radiological imaging for follow-up in ACC, but data on this topic are scarce. Patients were included in this retrospective study if pre-therapeutic hormone values, regular tumour evaluation by imaging, steroid measurements by LC–MS/MS, and details on therapies were available. The utility of steroid profiles in detecting recurrence or disease progression was assessed, whereby “endocrine progress” was defined by an elevation of at least 3 of 13 analysed hormones. Cohort A included 47 patients after R0 resection, of whom 15 experienced recurrence and 32 did not. In cohort B, 52 patients with advanced disease (including 7 patients of cohort A with recurrence) could be evaluated on 74 visits when progressive disease was documented. In 20 of 89 cases with documented disease progression, “endocrine progress” was detectable prior to radiological progress. In these cases, recurrence/progression was detected at a median of 32 days earlier by steroid measurement than by imaging, with 11-deoxycortisol and testosterone being the most sensitive markers. Notably, these patients had significantly larger tumour burden. In conclusion, steroid profiling by LC–MS/MS is of value in detecting recurrent/progressive disease in ACC.